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Environmentally-Benign Imidazolium-Based Ionic Liquids:  
Synthesis, Characterisation and Applications in Hydrogenation Reactions 
Saibh Morrissey 
 
A library of novel achiral imidazolium ionic liquids (ILs) comprising an ester 
functionality were synthesised and characterised. From the library, the synthesis and 
characterisation of 94 novel compounds are covered in this thesis. In order to compare 
the affect of the ester functionality on the biodegradation of the ILs, amide derivatives 
were prepared. The toxicity of the ILs was investigated (*), with most ILs being non-
toxic to bacteria. The biodegradability of the [OctOSO3] ILs was measured (**). 
Biodegradability of 55 – 66 % was obtained for the ester containing [OctOSO3] ILs, 
while biodegradabilities ranging from 29-36 % was obtained with the amide derivatives.  
Chirality was introduced to the novel ILs with the incorporation of mandelate and 
lactate moieties in the cations of the ILs. The preparation of 40 mandelate-based ILs and 
21 lactate-based derivatives is covered herein. Most [OctOSO3] ILs are shown to be 
‘readily biodegradable’, the mandelate-based [OctOSO3] salts displaying higher 
biodegradability (65-82 %) than the lactate counterparts (55-74 %).  
Heterogeneous hydrogenation reactions were carried out in a selection of the novel 
achiral ILs. The ILs were shown to be robust to these reactions conditions, with no 
degradation of the novel reaction media being evident following numerous recycling 
procedures. Superior results in terms of selectivity were obtained using the novel ILs in 
comparison to commercially available ILs and common organic solvents. 
Heterogeneous and homogeneous hydrogenation of prochiral substrates were carried out 
in a selection of novel chiral ILs (CIL). Although no enantiomeric excess was seen to be 
induced from the use of the CILs, their use as robust reaction solvents was 
demonstrated. These solvents were also shown to have potential as recyclable media. 
Their potential as chiral additives was also shown, with increased percentage conversion 
being evident with the addition of small quantities of CIL to an achiral IL as reaction 
solvent. 
 
* Toxicity studies were carried out by Dr. Bríd Quilties group in DCU 
** Biodegradability studies were carried out at the ‘Department of Surfactant 
Technology, IIQAB-CSIC, Jordi Girona 18-26, 08034, Spain’ by M. Teresa Garcia 
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Project Aims 
 
• To synthesise and characterise a library of novel non-toxic, biodegradable achiral 
ionic liquids (ILs) containing the ester functionality in the side-chain of the cation 
moiety 
• To investigate the toxicity and biodegradation properties of the achiral IL library 
• To establish the effects of the ester moiety, oxygen-containing side-chain and anion 
on the toxicity and biodegradability 
• To synthesise and characterise a library of novel mandelate and lactate based chiral 
ILs (CILs) containing the ester functionality 
• To investigate the biodegradation properties of the CIL library 
• To establish the effects of the ester moiety, side-chain and stereochemistry on the 
biodegradability of these novel compounds 
• To evaluate the differences in both properties and biodegradability between the 
mandelate and lactate CILs 
• To screen the novel achiral ILs as suitable reaction solvents for hydrogenation 
reactions for a wide variety of substrates 
• To enhance the ‘green’ nature of the ILs by recycling the systems used in the 
hydrogenation reactions 
• To investigate the chemoselectivity of the reactions using the achiral ILs 
• To investigate the potential differences in reactions due to the type of achiral IL 
used as solvent 
• To employ the CILs as reaction solvents in the hydrogenation of prochiral 
substrates 
• To test the suitability of the chiral ILs as suitable reaction media for these 
hydrogenation reactions 
• To investigate the potential of the novel chiral solvents as potential asymmetric 
induction media 
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1 Literature Review 
1.1 General Introduction 
Flourishing research in the field of organic chemistry has been one of the factors to lead 
to the development of multinational pharmaceutical companies. As the demand for 
drugs has been increasing, so has the scale of manufacturing. Large scale synthesis of 
innumerable drugs is now widespread. The concern for the welfare of our planet has 
never been so much to the forefront of everyone’s minds as now. The overall ignorance 
towards issues such as global warming is diminishing. The concept of ‘Green 
Chemistry’, to reduce or eliminate the use of hazardous chemicals and the production of 
perilous chemical waste by designing ‘environmentally friendly’ substitutes, is therefore 
a key issue in a contribution to ensuring the existence of our planet for proceeding 
generations. Large scale synthesis of drugs can lead to the production of mass amounts 
of harmful waste. The concept of ‘Green Chemistry’ comprises the attempts to develop 
new cleaner technologies and methodologies that are less harmful to the environment.  
Volatile organic compounds (VOC), due to their high vapour pressure, contribute to the 
destruction of our atmosphere. Their widespread use in the synthesis of compounds 
leads to the search for less harmful alternatives. In recent years, Ionic Liquids (ILs) have 
been considered and successfully utilised as alternatives to these VOCs in fields as 
diverse as analytical separations1, 2 and transition metal catalysis.3 In order to decrease 
or eliminate the use of harmful VOCs used in organic synthesis, chemists are trying to 
find suitable alternatives, such as solventless conditions.4, 5 ILs offer another option in 
place of the use of these destructive solvents. On account of their negligible vapour 
pressure, ILs pose less of a threat to the atmosphere than VOCs as this low volatility 
eliminates a pathway for release into the environment.  
The first recorded observation of an IL occurred in the mid 19th century when a separate 
‘red oil’ phase formed during Friedel-Crafts reactions.6 This red oil was only however 
deemed to be a salt when the use of NMR spectroscopy became widespread, identifying 
the salt to be a stable intermediate complex formed during Friedel-Crafts reactions.7 
Synthesis of the first IL transpired shortly after, at the beginning of the 20th century. 
Ethylammonium nitrate [EtNH3][NO3] (1) was found to have a melting point of only 12 
ºC.8 Although widespread interest was slow to take off, in recent years the number of 
papers published on ILs has been steadily accelerating.9, 10 The remarkably interesting 
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properties of ILs stem naturally from the fact that these salts are liquids at or close to 
RT (room temperature). Most ILs are composed of a large bulky unsymmetrical cation, 
and a smaller evenly shaped anion (Figure 1.1). 
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Figure 1.1 Cation and anion examples used frequently in ILs 
Considering the composition of ILs, they are not able to pack as well as common salts 
such as sodium chloride. This inability to form efficient ion-ion packing reduces 
electrostatic interactions and renders ILs with reduced lattice energies. The diffuse 
charge found in the unsymmetrical cation coupled with the weakly coordinating anion 
reduces coulombic interactions. These two factors, namely weak electrostatic forces and 
delocalised diffuse charge in the anion, lead to ILs with low melting points. It is due to 
this desirable property that interest in ILs is growing. The solubility of ILs in various 
solvents can be regulated by choosing a specific anion or cation, the commonly used 
[PF6] ILs being hydrophobic, with the [BF4] salts being hydrophilic. The ability to tune 
the IL for a particular use, together with their negligible vapour pressures, low melting 
points, and the fact that they can be reused, are some of the reasons why ILs have this 
alluring nature. Many ILs synthesised to date have been based on the imidazolium 
moiety as cation, with weakly coordinating species, such as [BF4] and [PF6], dominating 
the choice of anion. The discovery that the aforementioned ILs can liberate the highly 
corrosive acid hydrofluoric acid (HF), has however, recently been becoming a deterrent 
in choosing these inorganic perfluorinated anions. Synthesis of ILs is often quite 
straightforward, generally the first step being the formation of the cation, which is then 
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followed by an anion exchange. Cation formation can be performed by protonation of a 
suitable basic starting material with an acid, or, quaternization of an amine or related 
starting material, for example a phosphine. Anion metathesis proceeds, in most cases, 
by the reaction of the halide salt, the precursor to the desired IL, with an inorganic salt 
consisting of the desired anion. Mostly, the unwanted inorganic salts from these 
reactions are insoluble in the reaction solvent and thus simple filtration allows the 
desired IL to be obtained. 
Due to the vast possible combinations of cations and anions, the challenge surrounding 
IL formation is not only the design and synthesis of a safer, more environmentally 
friendly substance. The IL should merit its replacement for a more harmful alternative 
(e.g. VOC) in a process by enhancing the procedure by means of, for example, 
increased yield/separation, decreased formation of side products or higher 
enantioselectivity.  
Most researchers working in the field of ‘Green Chemistry’ will be familiar with the 12 
basic principles devised by Clark and Macquarrie in 2002.11 The work presented herein 
can be related to many of the principles.  
 
Principle 3. Less hazardous chemical use. Synthetic methods should be designed to use 
and generate substances that possess little or no toxicity to the environment and public 
at large. Many of the novel ILs presented in this thesis are non-toxic to bacteria. 
 
Principle 4. Design for safer chemicals. Chemical products should be designed so that 
they not only perform their designed function but are also less toxic in the short and 
long terms. The ester functionality present in these ILs increases the biodegradability, 
and in many cases does not increase the melting point, thus the ILs can be utilised as 
reaction solvents at close to ambient temperature.  
 
Principle 5. Safer solvents and auxiliaries. The use of auxiliary substances such as 
solvent or separation agents should not be used whenever possible. If their use cannot 
be avoided, they should be used as mildly or innocuously as possible. Again, the ILs 
designed herein are non-toxic, thus could be considered as a ‘mild’ alternative to a 
harmful VOC. 
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Principle 9. Catalysis. Catalytic reagents are superior to stoichiometric reagents. The 
use of heterogeneous catalysts has several advantages over the use of homogeneous or 
liquid catalysts. Use of oxidation catalyst and air is better than using stoichiometric 
quantities of oxidising agents. For use in the hydrogenation of achiral substrates, a 
palladium heterogeneous catalyst was used. It was also immobilised in the IL thus 
facilitating the recycling of experiments, an inherently ‘green’ process. 
 
Principle 10. Design for degradation. Chemical products should be designed so that at 
the end of their function they break down into innocuous degradation products and do 
not persist in the environment. A life-cycle analysis (beginning to end) will help in 
understanding its persistence in nature. Many of the ILs comprising the ester 
functionality and the [OctOSO3] anion are shown to surpass the 60 % pass rate for 
biodegradability required for the OECD 301B test. 
 
Principle 12. Inherently safer chemistry for accident prevention. Substances and the 
form of a substance used in a chemical process should be chosen to minimize the 
potential for chemical accident, including releases, storage of toxic chemicals, 
explosions, and fires. Due to their negligible vapour pressure, ILs in general are non-
flammable, therefore limiting them as a source of ignition of fires and explosions. 
1.2 Toxicity and Biodegradability of ILs 
1.2.1 Introduction 
Though ILs are classed as ‘green solvents’ mainly due to their negligible vapour 
pressure, consideration for their end of life factors should be of equivalent importance in 
this classification. To satisfy the requirements of being ‘green solvents’, it is desirable 
for ILs not to persist in the environment and should be non-toxic or of limited toxicity 
to the environment and life within. If ILs are to be used in industry for large scale 
synthesis, their disposal could be detrimental to the environment if their toxicity and 
biodegradability in the environment are not studied beforehand. Even though ILs may 
be benign to the atmosphere compared to toxic VOC fumes, their effect on aquatic and 
terrestrial life is still of key importance and a detailed study is paramount.  
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1.2.2 History of Toxicity of ILs 
A brief history of ILs was documented by Zhao et al. in their review12 and an overview 
of toxicological data of ILs was published by Ranke et al..13 Laboratory tests have been 
used by various groups, each focusing on key parts of a system. Toxicological and 
ecotoxicological data has been gathered by using test systems based on different 
biological complexity levels. Toxicity and antimicrobial studies have been performed 
on a range of bacteria and fungi, acute toxicity studies have been carried out on fish, 
growth inhibition studies have been carried out on algae, terrestrial plants have been 
tested for growth and these will be presented in the following sections.  
The organisms studied range from bacteria and fungi, to higher organisms such as the 
soil nematode and the freshwater snail to terrestrial plants. The ILs studied are mainly 
of imidazolium and pyridinium classes, with alkyl or alkoxy side chains, containing 
[Br], [Cl], [PF6] or [BF4] anions. Preliminary studies on the effects of ILs on 
mammalian cell lines have also been conducted, as well as enzymatic studies.  
Collected results show the toxicity of ILs increase with increasing alkyl chain length. 
The similarity of ILs to cationic surfactants entails that the toxicity of ILs may be due to 
the increasing membrane permeability. Increasing chain length could thus lead polar 
narcosis. 14, 15, 16 
1.2.2.1 Toxicity testing using bacterial species 
The antimicrobial activities of a range of methylimidazolium ILs containing an 
alkoxymethyl side chain (Figure 1.2) ranging from C3 – C16 2 - 15 with anions [Cl] a, 
[BF4] b and [PF6] c were measured by Pernak et al..17 Cocci (Micrococcus luteus, 
Staphylococcus epidermidis, Staphylococcus aureus, Staphylococcus aureus MRSA, 
Enterococcus hirae), rods (Escherichia coli, Proteus vulgaris, Klebsiella pneumoniae, 
Pseudomonas aeruginosa) and fungi (Candida albicans, Rhodotorula rubra) were 
tested. The minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) values were noted and compared to the commercially available 
benzalkonium chloride (BAC) 16. The authors showed all ILs with a side chain greater 
than C6 to be active against all organisms, and the activity to be dependent on side chain 
length and not the anion. The most active ILs against rods and cocci were those with the 
side-chain of C10 9, C11 10, C12 11 and C14 13; C12 11 being the most active of these. All 
three salts containing C12 in the alkoxy side chain approached the activity of BAC.  
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RCl
BAC: benzalkonium chloride3-alkoxymethyl-1-methylimidazolium salt
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Figure 1.2 Imidazolium ILs containing alkoxy side-chain 
Results obtained from two cocci strains and three strains of rods can be seen in Table 
1.1 and Table 1.2. The MIC values obtained for BAC ranged from as low as 7 - 11 µM 
against strains S. aureus, E. hirae, E. coli and K. pneumoniae to 54 µM against P. 
aeruginosa. 
N
N OR
 
 Staphylococcus aureus MIC (µM) E. hirae MIC (µM) 
R [Cl] (a) [BF4] (b) [PF6] (c) [Cl] (a) [BF4] (b) [PF6] (c) 
C3H7 2 > 8600 > 7000 > 5850 >  8600 > 7000 > 5850 
C4H9 3 > 8600 > 7000 > 5850 > 8600 > 7000 > 5850 
C5H11 4 > 8600 > 7000 > 5850 > 8600 > 7000 > 5850 
C6H13 5 4300 7000 2900 8600 3500 2900 
C7H15 6 500 840 2800 8100 3360 2800 
C8H17 7 480 800 1350 1900 1600 2700 
C9H19 8 228 384 650 228 384 330 
C10H21 9 54 92 160 108 92 630 
C11H23 10 52 22 19 103 88 152 
C12H25 11 25 21 18 99 95 37 
Table 1.1 MIC values obtained against cocci strains 
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N
N OR
 
 E. coli MIC (µM) K. pneumoniae MIC 
(µM) 
P. aeruginosa MIC (µM) 
R [Cl] 
(a) 
[BF4] 
(b) 
[PF6] 
(c) 
[Cl] 
(a) 
[BF4] 
(b) 
[PF6] 
(c) 
[Cl]  
(a) 
[BF4] 
(b) 
[PF6] 
 
(c) 
C3H7 2 > 8600 > 7000 > 5850 > 8600 > 7000 > 5850 > 8600 > 7000 > 5850 
C4H9 3 > 8600 > 7000 > 5850 > 8600 > 7000 > 5850 > 8600 > 7000 > 5850 
C5H11 4 > 8600 > 7000 > 5850 > 8600 > 7000 > 5850 > 8600 > 7000 > 5850 
C6H13 5 8600 7000 5850 8600 7000 5850 8600 7000 5850 
C7H15 6 8100 6700 5600 8100 6700 5600 4060 6700 5600 
C8H17 7 3800 3200 2700 3800 1600 2700 3800 3200 2700 
C9H19 8 1820 1540 1300 1820 3070 2600 1820 1540 2600 
C10H21 9 433 368 1250 433 368 630 867 1471 1250 
C11H23 10 413 177 607 207 177 152 826 707 1214 
C12H25 11 99 170 73 197 170 147 395 340 587 
C14H29 12 181 316 138 181 158 138 726 632 1100 
C16H33 13 671 - - 168 - - 2680 - - 
Table 1.2 MIC values obtained against three strains of rods 
Pernak et al. synthesized and investigated physical properties and biological activities 
of a series of DL- and L- alkyl (17/18) and alkoxy (19/20) imidazolium lactate ILs18 
(Figure 1.3). The side chain lengths investigated ranged from C1 to C12. 5 strains of rods 
(Escherichia coli, Proteus vulgaris, Klebsiella pneumoniae, Pseudomonas aeruginosa, 
Serratia marcescens), 5 strains of cocci (Micrococcus luteus, Staphylococcus epidermis, 
Staphylococcus aureus, Staphylococcus aureus MRSA, Enterococcus hirae) and 2 
strains of fungi (Candida albicans, Rhodotorula rubra) were subjected to a selection of 
the lactate ILs. In general, the L-lactates (18 and 20) showed lower MIC values than the 
DL- lactates (17 and 19), with the lowest values seen for L - lactates with 11 or 12 
carbons in the side chain, the most inhibitory being the C11 alkoxy L-lactate IL (20h). 
The lowest MBC values for cocci was noted for DL- lactates containing 12 carbons and 
L-lactates containing 11 carbons. Compared to the MIC and MBC values of BAC, it 
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was shown that the L-lactates with the longest chains exhibited similar activity. Lactates 
C1 - C5 generally proved to be inactive.  
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Figure 1.3 Lactate ILs 
Results obtained from two strains of cocci and three strains or rods can be viewed in 
Table 1.3 and Table 1.4 for the alkylimidazolium ILs (17/18) and Table 1.5 and Table 
1.6 for the alkoxy derivatives (19/20). MIC values obtained for BAC ranged from 2.8 – 
11 µM for S. aureus, E. hirae, E. coli and K. pneumoniae and was 175 µM for P. 
aeruginosa. 
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O
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H
H3C
,
N
N
R
 
 DL (17) L (18) 
R S. aureus MIC 
(µM) 
E. hirae MIC 
(µM) 
S. aureus MIC 
(µM) 
E. hirae MIC 
(µM) 
CH3 a > 5814 > 5814 > 5814 > 5814 
C2H5 b > 5814 > 5814 > 5814 > 5814 
C3H7 c > 5814 > 5814 > 5814 > 5814 
C4H9 d > 5814 > 5814 > 5814 > 5814 
C5H11 e > 5814 > 5814 > 5814 > 5814 
C6H13 f > 4132 > 4132 4132 > 4132 
C7H15 g > 3906 > 3906 1953 3906 
C8H17 h 926 1852 926 1852 
C9H19 i 110 440 110 220 
C10H21 j 105 209 52 105 
C11H23 k 75 100 25 50 
C12H25 l 144 96 24 48 
Table 1.3 MIC values obtained using alkylimidazolium ILs against cocci 
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 DL (17) L (18) 
R E. coli 
MIC 
(µM) 
K. 
pneumoniae 
MIC (µM) 
P. 
aeruginosa 
MIC (µM) 
E. coli 
MIC 
(µM) 
K. 
pneumoniae 
MIC (µM) 
P. 
aeruginosa 
MIC (µM) 
CH3 a > 5814 > 5814 > 5814 > 5814 > 5814 > 5814 
C2H5 b > 5814 > 5814 > 5814 > 5814 > 5814 > 5814 
C3H7 c > 5814 > 5814 > 5814 > 5814 > 5814 > 5814 
C4H9 d > 5814 > 5814 > 5814 > 5814 > 5814 > 5814 
C5H11 e > 5814 > 5814 > 5814 > 5814 > 5814 > 5814 
C6H13 f 2066 2066 4132 2066 2066 4132 
C7H15 g 1953 1953 > 3906 977 1953 3906 
C8H17 h 463 463 1852 463 463 3704 
C9H19 i 220 220 1761 220 220 880 
C10H21 j 209 209 1678 105 209 839 
C11H23 k 200 200 3205 50 100 802 
C12H25 l 192 192 3067 48 96 1534 
Table 1.4 MIC values obtained using alkylimidazolium ILs against rods 
 11 
 
HO
O
O
CH3
H
HO
O
O
H
H3C
HO
O
O
H
H3C
,
N
N
R
 
 DL (19) L (20) 
R S. aureus MIC 
(µM) 
E. hirae MIC 
(µM) 
S. aureus MIC 
(µM) 
E. hirae MIC 
(µM) 
C4H9 a > 4098 > 4098 4098 > 4098 
C5H11 b 3876 > 3876 > 3876 > 3876 
C6H13 c 3676 > 3676 3676 3676 
C7H15 d 1748 > 3497 874 1748 
C8H17 e 417 1667 417 1667 
C9H19 f 498 1592 199 398 
C10H21 g 380 1524 47.6 95 
C11H23 h 183 183 11.4 45.6 
C12H25 i 88 176 10.9 44 
Table 1.5 MIC values obtained using alkoxyimidazolium ILs against cocci 
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 DL (19) L (20) 
R E. coli 
MIC 
(µM) 
K. 
pneumoniae 
MIC (µM) 
P. 
aeruginosa 
MIC (µM) 
E. coli 
MIC 
(µM) 
K. 
pneumoniae 
MIC (µM) 
P. 
aeruginosa 
MIC (µM) 
C4H9 a 2049 > 4098 > 4098 4098 2049 > 4098 
C5H11 b 969 1938 > 3876 1938 1938 > 3876 
C6H13 c 459 229 3676 919 459 > 3676 
C7H15 d 219 219 3497 437 219 3497 
C8H17 e 104 208 3333 208 208 1667 
C9H19 f 49 199 3185 199 199 1592 
C10H21 g 95 190 3049 95 190 3049 
C11H23 h 92 183 2924 183 92 > 2924 
C12H25 i 350 176 2809 88 88 > 2809 
Table 1.6 MIC values obtained using alkoxyimidazolium ILs against rods 
Toxicity of imidazolium and pyridinium ILs with varying side-chain length was 
measured in the bioluminescent marine bacteria, Vibrio fischeri, a decrease in light 
output signifying an increase in toxicity.19 The antimicrobial effect of these ILs was also 
determined using five different microorganisms from a variety of physiological and 
respiratory capabilities (Escherichia coli, Staphylococcus aureus, Bacillus subtilis, 
Pseudomonas fluorescens and Saccharomyces cerevisiae). Toxicity results showed an 
increasing toxicity with an increase in the alkyl chain length. The hexyl and octyl side 
chains were shown to be more toxic than commonly used organic solvents, with the 
butyl side chain being the same as some of the less toxic solvents. For the pyridinium 
IL, toxicity increased with an increase in the number of substituents on the ring of the 
cationic species. Pyridinium ILs could not be deemed as more or less toxic than their 
imidazolium counterparts as can be seen from the fact that [bmim][Br] (21) is less toxic 
than [bmpyr][Br] (22), [hmim][Br] (23) is more toxic than [hmpyr][Br] (24) and 
[omim][Br] (25) is of approximately equal toxicity as [ompyr][Br] (26). The 
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antimicrobial activity for all organisms was shown to increase with increasing alkyl 
chain length. The octyl containing side chain was shown to be the most effective at 
inhibiting colony formation, followed by hexyl, with butyl not showing much difference 
to the buffer. [Omim][Br] (25) and [ompyr][Br] (26) were shown to be the most 
effective antimicrobial ILs tested in the study. All ILs were shown to be most inhibitory 
to Bacillus subtilis. Escherichia coli and Pseudomonas fluorescens were significantly 
affected by all ILs and Staphylococcus aureus and Saccharomyces cerevisiae were the 
least affected. Since the same trend of increasing toxicity with increasing alkyl chain 
length can be seen for all organisms, the authors suggest that the toxicity may be related 
to a cellular structure or process that is common in all the organisms studied. 
Vibrio fischeri is a commonly used organism to measure toxicity as the acute 
bioluminescence inhibition assay (DIN EN ISO 11348) is widely used in Europe and 
therefore a variety of EC values are available for comparison. Using these organisms, 
increasing alkyl chain length of ILs was found to increase toxicity.15, 16, 20 Another 
luminescent bacteria, Photobacterium phosphoreum (Figure 1.4), was used by 
Gathergood et al.21 which again displayed the same trend.  
 
Figure 1.4 Culture showing Photobacterium phosphoreum 22 
While studying a range of aquatic organisms including Vibrio fischeri, Stolte et al.23 
investigated the effects of IL head groups, functionalised side chains and anions of ILs 
on toxicity. They found the halide anions (chloride and bromide) did not exhibit an 
intrinsic effect on toxicity, however the [NTf2] anion was found to display toxicity. 
Together with demonstrating the increasing toxicity with increasing side-chain length 
effect, they found the introduction of polar groups to the side chain of the IL to decrease 
toxicity.  
While investigating the possibility of using imidazolium based ILs for the extractive 
fermentation of lactate, Matsumoto et al. investigated the toxicity of these ILs on the 
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lactic acid producing bacterium Lactobacillus rhamnosus NBRC 3863.24 The ILs tested 
were [bmim] (27), [hmim] (28) and [omim][PF6] (29) and batch test culture experiments 
were performed to investigate the toxicity. The results of these experiments were based 
on the activity of the bacterium. The amount of glucose consumed was measured, along 
with the colony forming unit (CFU) values. CFU values measured the survival rate of 
Lactobacillus rhamnosus and these corresponded to the glucose consumption, thus 
indicating that the viable cells produced lactate. The overall results showed that this 
bacterium survived in all ILs measured, but demonstrated a low activity. These results 
were compared with toluene, for which almost no survival of the bacteria could be 
noted. There was little difference exhibited in results shown for the three varying side 
chain lengths, with butyl and hexyl being approximately equal and showing slightly 
more activity than octyl. To examine the suitability of ILs as a replacement for organic 
solvents in in situ extractive fermentation of lactic acid, Matsumoto et al. investigated 
the toxicity of the same imidazolium ILs used in their previous test on a series of nine 
bacteria (Lactobacillus Rhamnosus, Lactobacillus Homohiochi (NRIC 0119 and 1815), 
Lactobacillus Fructivorans (NRIC 0224 and 1814), Lactobacillus Delbruekii, 
Lactobacillus Pentosaceus, Leuconostoc Fallax, Bacillus coagulans).25 The ability of 
the bacteria to produce lactic acid was a measure of the toxicity. The results showed all 
bacteria produce lactic acid in the presence of the ILs, with Lactobacillus delbruekii 
showing the highest concentrations produced. The ability to produce the acid was seen 
to decrease upon increasing alkyl chain length.  
Docherty et al.26 performed the first Ames test on ILs. The Ames test is a method of 
elucidating the mutagenicity of a compound. 10 bromide salts were tested based on the 
popular imidazolium, pyridinium and quaternary ammonium cations. The strains of 
Salmonella typhimurium bacteria used were the histidine-requiring TA98 and TA100. 
The ability of the IL to cause mutation in these bacteria was measured. After interaction 
with mutagens, these strains of bacteria revert to histidine independent strains. This rate 
of reversion is used as a measure of the mutagenicity of the tested compound. The ILs 
were tested over a broad concentration range (0.01 – 20 mg per plate) however none of 
the ILs met the United States Environmental Protection Agency (US EPA) criteria for 
mutagenicity. Some ILs did nevertheless show potential to be mutagenic at high doses. 
The imidazolium based ILs were the culprits of this mutagenic effect however the 
authors advise further work to be carried out for these results to be conclusive.  
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1.2.2.2 Toxicity testing using aquatic eukaryotes (Daphnia magna) 
The aquatic eukaryotes, Daphnia Magna (Figure 1.5) are popular for the investigation 
of IL toxicity. 
 
Figure 1.5 Daphnia Magna12 
Increasing alkyl chain length was again found to increase toxicity in imidazolium ILs.21, 
27
 The acute and chronic toxicity of imidazolium based ILs was measured against these 
organisms.28 The ILs used were [bmim][Br] (21), [Cl] (30), [PF6] (29) and [BF4] (31). 
These ILs were compared to the corresponding sodium salts containing the same anion. 
It was concluded that the cationic species of the IL affected toxicity. LC50 values were 
an order of magnitude lower for all ILs containing the imidazolium moiety compared to 
their sodium analogues. Concerning the acute toxicity study, the most toxic species was 
found to be [bmim][Br] (21) (LC50: 8.03 mg L-1), with NaPF6 being the least toxic 
(LC50: 9344.81 mg L-1). The reproductive output of Daphnia magna was negatively 
affected regarding all the imidazolium ILs. In order to judge the relative toxicity of 
these ILs, the authors compared their LC50 values to those of commonly used organic 
solvents. It was shown that the ILs demonstrated LC50 approximately equal to those of 
phenol (LC50: 10-17 mg L-1), tetrachloromethane (LC50: 35 mg L-1) and trichlormethane 
(LC50: 29 mg L-1), however the values of the ILs were lower than benzene (LC50: 356-
620 mg L-1), methanol (LC50: 3289 mg L-1) and acetonitrile (LC50: 3600 mg L-1). The 
authors also note these particular ILs to be less toxic than chlorine (LC50: 0.12-0.15 mg 
L-1) and ammonia (LC50: 2.90-6.93 mg L-1). It is stated that the mechanism of toxicity to 
Daphnia magna is unknown, but based on previous studies29-31 they propose enzyme 
inhibition, disruption of membrane permeability or structural DNA damage as possible 
modes of action. 
A range of ILs containing imidazolium, pyridinium and ammonium cations were tested 
for toxicity against two aquatic organisms (Vibrio fischeri and Daphnia magna) in order 
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to create quantitative structure property relationship models, to be thus used to predict 
toxicity.15 Neonates of Daphnia magna less than 24 hours old were used in a 48 hour 
acute toxicity bioassay to measure the toxicity of the ILs on this organism. The authors 
used the results obtained to build a predictive toxicity model based upon QSPR 
modelling in order to be able to design ILs with limited toxicity. This QSPR modelling 
is based on the idea that for a given compound, chemical structure determines physical 
properties. The experimental results show that the toxicity increases with alkyl chain 
length of the cation, and that the corresponding salts used to synthesise the IL, i.e. 
NaBr, are less toxic than the ILs. This indicates the negligible effect of the anionic 
species on toxicity. The results also show that ILs containing the imidazolium and 
pyridinium cations are more toxic than those containing the quaternary ammonium 
species. The predictive results based on these experimental results indicated again 
increasing alkyl chain length to increase toxicity. Also predicted was the fact that the 
toxicity would increase with an increase in the number of nitrogen atoms on the cationic 
species. The addition of methyl groups to the aromatic ring of the cation is predicted to 
decrease toxicity and monoatomic anions, i.e. Br, should be less toxic than anions 
containing regions of positive charge, i.e. [NTf2]. The imidazolium cation was predicted 
to be more toxic than the pyridinium, which in turn was predicted to be more toxic than 
the ammonium (cation toxicity: imidazolium > pyridinium > ammonium).  
Nockemann et al.32 investigated the ecotoxicity of their choline saccharinate (32) and 
acesulfamate (33) ILs (Figure 1.6).  
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Figure 1.6 Choline saccarinate and choline acesulfamate ILs 
Choline chloride is used as an additive in chicken feed, and saccharinate and 
acesulfamate are salts of artificial sweeteners. The authors suggest these ILs to be of 
‘food grade’ thus should display limited toxicity. Indeed these two ILs displayed 
toxicity to Daphnia magna two orders of magnitude less than common imidazolium and 
pyridinium ILs.  
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1.2.2.3 Toxicity testing using algal species 
The toxicity of imidazolium ILs was investigated on two taxonomically different algal 
species, Oocystis submarina and Cyclotella meneghiniana.33 The growth inhibition of 
these species was measured in relation to [emim] (34), [bmim] (32), [hmim] (35) and 
[benzylmim][BF4] (36). As was demonstrated here, diatoms (Cyclotella meneghiniana) 
are normally used when investigating marine alga, as they are the most sensitive to 
organic compounds. Growth inhibition was measured over 3 concentration values of 
each IL. For Oocystis submarina, the results show the same pattern of cell growth 
inhibition for all the ILs tested. The two lowest concentrations showed cell growth to be 
inhibited initially and then resume within the time frame of the experiment, showing the 
alga to acclimatize to the conditions of the IL. The highest concentration however 
showed the growth to be inhibited completely for the duration of the experiment. In the 
case of Oocystis submarina, growth inhibition was at its greatest for the shortest alkyl 
chain length, [emim][BF4] (34). For Cyclotella meneghiniana, growth inhibition was 
observed for all concentrations of IL throughout the experiment.  
The unicellular freshwater alga, Pseudokirchneriella subcapitata (formerly known as 
Selenastrum capricornutum), was used as test organism for measuring the toxicity of 
ILs.27, 34 Cho et al.34 examined the anion effect of imidazolium ILs on the toxicity. Their 
results showed the [SbF6] anion to be most toxic, with the other anions tested 
decreasing in toxicity in the order [PF6] > [BF4] > [CF3SO3] > [C8H18OSO3] > [Br] ≈ 
[Cl]. Cho et al.35 also investigated the side-chain effect on the toxicity using the same 
organism. Imidazolium bromide salts with side chain lengths, [omim], [hmim], [bmim], 
[pmim], were found to display decreasing toxicity with decreasing chain length. Using 
the same alga as an indicator for toxicity, Pham et al.36 found the same trend of 
decreasing toxicity with decreasing alkyl chain length. They also found the pyridinium 
ILs tested to be more toxic than their imidazolium counterparts. In comparison with 
organic solvents, most of the ILs they tested were more toxic than methanol, DMF and 
2-propanol. The same trend of decreasing toxicity with decreasing alkyl chain length 
was found by Kulacki and Lamberti37 using [bmim] (21), [hmim] (23) and [omim] 
bromide (25) ILs. They examined the non-motile Scenedesmus quadricauda and the 
mobile Chlamydomonas reinhardtii freshwater algae in nutrient-rich media and low-
nutrient groundwater to uncover if these parameters altered toxicity. The same trend 
was however observed with both algae in both media tested. Scenedesmus vacuolatus 
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was used as a test organism for IL toxicity by Stolte et al.38 and Matzke et al..39 The 
side-chain effect was presented in both studies. 
1.2.2.4 Toxicity studies using plants 
Jastorff et al. studied the ecotoxicity and the genotoxicity of [BF4] ILs.40 Together with 
their studies using higher plants, they also used the WST cell viability assays to 
determine the effects that the anion and headgroup have on toxicity. Two higher plants 
(Figure 1.7), namely the floating aquatic organism lesser duckweed (Lemna minor) and 
the fast growing terrestrial plant, garden cress (Lepidium sativum), were used to study 
the toxicity of the ILs [bmim] (31) and [omim][BF4] (37). 
  
Figure 1.7 Lesser duckweed41 and garden cress42 
Both tests showed [omim][BF4] (37) to be more toxic than [bmim][BF4] (31). In the 
case of L. minor, the number of foliaceous fronds produced in comparison to a control 
plant indicated the toxicity level. [Omim][BF4] (37) showed an 87 % reduction in 
growth at a concentration of 10 mgkg-1, while the [bmim] IL showed no reduction even 
at an IL concentration of 100 mgkg-1. The effect of the ILs on Lepidium sativum was 
monitored by the number of seedlings produced by the plant. At a concentration of 100 
mgkg-1, [omim][BF4] (37) significantly reduced the number of seedlings produced, 
while a significant effect was only noted for [bmim] at a concentration of 1000 mgkg-1. 
Stolte et al.38 and Matzke et al.39 studied the toxic effects of ILs on Lemna minor, wheat 
(Triticum aestivum) and Lepidium sativum.The side-chain length effect was observed in 
both cases.  
Balczewski et al.43 synthesised novel CILs and tested them for toxicity using the 
superior plants, Spring Barley (Hordeum vulgare) and Common Radish (Raphanus 
Sativus). A selection of their ILs was toxic and toxicity was found to be concentration-
dependent.  
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1.2.2.5 Toxicity testing using mammalian cell lines 
The toxicity of imidazolium based ILs was tested on the luminescent bacteria, Vibrio 
fischeri and rat cell lines C6 (glioma cells) and IPC 81 (leukaemia cells).16 These cell 
lines were chosen to obtain information about the effect of the ILs on two 
physiologically different areas, namely the haematopoietic system and the central 
nervous system. The effects of increasing chain length of the R1 (methyl and ethyl) and 
R2 (C3 – C6) position on the imidazolium moiety was investigated, together with the 
effect of the anionic species on the cell viability assays. 
NN
R1 R2
 
Figure 1.8 R1 and R2 positions on imidazolium cation 
The anions chosen were the popular [PF6] and [BF4], which were then compared to 
[Br], [Cl] and [pTS] anions. It was shown that toxicity increased with increasing alkyl 
chain length, both for the R1 and R2 positions, for each system tested. The authors 
propose this effect to be due to the increased lipophilicity and therefore increased ease 
of permeability. Their results showed an increase in toxicity when the length of the R1 
side chain was increased in comparison with increasing length of the R2 side chain. 
Overall no effect of the different anion on the test systems could be noted therefore 
rendering the cationic species the determining factor for toxicity. A comparison with the 
widely used organic solvents, methanol, acetone, acetonitrile and MTBE, showed the 
ILs to be more toxic than all the organic solvents except for the case of MTBE, which 
showed similar toxicity to the ILs studied in the Vibrio fischeri assay.  
Mammalian blood cells were used to test the genotoxicity of two ILs, [bmim] (31) and 
[dmim][BF4] (38), using the SCE (sister chromatid exchange) assay.40 [Bmim][BF4] 
(31) was shown to have no genotoxic effects within the given concentration range, 
while [dmim][BF4] (38) showed a dose dependent trend within half of this 
concentration range. The group also mention their preliminary finding on the anion 
effects of ILs on toxicity. A significant difference in toxicity between the [BF4] and 
[NTf2] anion was shown. Also, significant differences in toxicity between various 
headgroups of the ILs, namely between [bmpyr] and [bmim], and [bmpy] and [bmim] 
were evident. Finally, this group theoretically formulated the possible metabolites of the 
[bmim] and [omim] cations (Figure 1.9 and Figure 1.10). The most probable metabolites 
were synthesised and their toxicity was measured, using the WST cell viability assay, to 
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compare their toxicity to the parent IL. As can be seen from Figure 1.9 and Figure 1.10, 
all metabolites were shown to be less toxic than the parent IL, with the introduction of 
polar groups to the side chain further reducing their toxic effect.  
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Figure 1.9 Cytotoxicity of [bmim] cation in comparison to some of its hypothetical 
metabolites 
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Figure 1.10 Cytotoxicity of [omim] cation in comparison to some of its hypothetical 
metabolites 
Progressing from this work, Stolte et al.44 embarked on a study investigating the anion 
effects of ILs on cytotoxicity using the WST-1 cell viability assay, this time however 
using the IPC-81 rat leukaemia cell line. Out of 27 commercially available anions 
tested, only 10 displayed cytotoxicity (Figure 1.11).  
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Figure 1.11 Anions that tested positive for cytotocicity 
They tested a concentration range of 1µM – 1mM, and if no effect was evident, the 
upper range was extended to 20 mM. EC50 values were used as a measure of the 
cytotoxicity. As sodium or lithium chloride showed no cytotoxic effects within this 
range, the cations of these salts were used for the cytotoxicity study of the intrinsic 
effects of the anionic moiety of the IL. In order to ascertain an effect of the anion 
combined with typical IL cations, the anions were combined with the widely used 
[mim] cation with side chain lengths ranging from C2 to C6. The tests revealed that the 
combination of the anions with these cationic headgroups did indeed increase the 
toxicitiy results obtained.  
Stolte et al.38 again used the rat cell line IPC-81 to assess the cytotoxicity of a range of 
ILs. They screened 100 ILs, varying the headgroup, side-chain and anion of the ILs in 
order to observe the effect of each respective moiety on toxicity. Using the previously 
derived correlation between lipophilicity of the IL side-chain and cyctotoxicity using 
HPLC,45 it was established that the side-chain was the most influential factor in 
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comparison with headgroup and anion in terms of toxicity. This supports the hypothesis 
about ILs and toxicity, that toxic effects are a direct result of lipophilic interactions with 
the cell membrane. Also observed was that the [NTf2] anion had an intrinsic cytotoxic 
effect. However, when this anion was combined with a polar cationic moiety, the 
cytotoxitiy was not as severe. A significant result obtained from this study showed the 
presence of functional groups (ether, hydroxyl and nitrile) in the side chain of the ILs to 
lower cytotoxicity.  
Epithelial cells are the sites for the first point of contact in an organism with toxic 
compounds. Three types of human epithelial cells have been examined in terms of 
cytotoxicity of ILs, namely, the breast cancer cell line MCF7, the carcinoma cell line 
HeLa and the Caco-2 cell line. Suggesting alternatives to imidazolium and pyridinium 
ILs, Salminen et al.46 studied the toxicities of a range of hydrophobic pyrrolidinium and 
piperidinium ILs using the MCF7 cell line. The same increasing toxicity trend with 
increasing alkyl chain length was observed and the cytotoxicity of these compounds fell 
in the same range as imidazolium ILs. With few exceptions, the [NTf2] anion was found 
to increase cytotoxicity in comparison with the bromide salt.  
The cytotoxicity of ILs towards the HeLa cell line was investigated by Wang et al.47 
with imidazolium, pyridinium, triethylammonium and choline IL derivatives. Increasing 
toxicity with increasing side chain length was observed, and it was shown that changing 
the anion displayed a less significant effect than changing the side-chain length.  
The cytotoxicity of imidazolium ILs towards the Caco-2 cell line was investigated by 
Garcia et al..48 Increasing alkyl chain length increasing the toxicity was observed and 
the ILs tested were shown to be more toxic than acetone, methanol, acetic acid and 
benzene.  
1.2.2.6 Enzyme inhibition toxicity testing 
The purified enzyme, acetylcholinesterase, from the electric eel (Electrophorus 
electricus) was used to test the affect of ILs on the inhibition of this enzyme.49 The 
authors tested pyridinium, imidazolium and phosphonium ILs, with varying side-chain 
lengths, and also varying anions. Also investigated were the effects of inserting an 
aromatic substituent into the side chain. Regarding the cationic species of the ILs, 
results show pyridinium to have the highest inhibitory value, followed by imidazolium 
and finally phosphonium. The inhibitory effect of the ILs to increase with increasing 
alkyl chain length on the R2 position of the cation was shown. Regarding aromatic 
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substituents in the side chain, they conclude that the slight increase in inhibition of the 
enzyme by the aromatic containing side chain ILs is due to the increased lipophilic 
nature in comparison with the straight chain moieties tested. The effect of lengthening 
the side chain at the R1 position of the cation was investigated. No measurable 
difference in inhibitory values was observed, suggesting that the steric position of the 
lipophilic side chain also influences toxicity. The EC50 values for imidazolium and 
pyridinium ILs regarding the effect of the anion showed conflicting results. For 
imidazolium, [Br] and [Cl] showed the highest inhibitory effect, followed by [BF4] and 
then [PF6]. However, pyridinium showed the IL containing [PF6] to be more inhibitory 
than that containing [BF4].  
Skladanowski et al.50 used AMP deaminase isolated from rat skeletal muscle to 
investigate the toxicity of imidazolium based ILs. Together with the ILs tested were 
known pollutant musks, such as musk xylene (39) and galaxolide (40) (Figure 1.12). 
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Figure 1.12 Synthetic musks 
IC50 values were used as a measure of toxicity of these compounds. Four [bmim] ILs 
were tested, each holding a different anion, namely, [BF4] (31), [PF6] (27), [Cl] (30) and 
[pTs] (41). Unsurprisingly, all the tested ILs displayed IC50 values higher than those of 
the synthetic musks, thus indicating lower toxicity. The ILs were however indeed found 
to be toxic. The fluorine containing species of ILs [bmim][BF4] (31) and [bmim][PF6] 
(27) were found to be the most toxic (IC50=5 µM), compared to the other two ILs tested 
(IC50=10 µM). 
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1.2.2.7 Toxicity studies using higher organisms 
The anatomically transparent free living soil roundworm, Caenorhabditis elegans 
(Figure 1.13) was studied regarding the toxic effects of imidazolium chloride ILs with 
chain lengths of C4, C8 and C14.51 
 
Figure 1.13 Caenorhabditis elegans12 
It was found that the IL containing the longest alkyl chain was the most toxic, with 
toxicity decreasing thus from C8 to C4.  The C4 IL caused no adverse effects to the 
worms, while the C14 IL was lethal to them at all three concentrations of IL.  
J. Randall et al. studied the effects of ILs containing imidazolium and pyridinium 
cations with varying chain length with anions [Br] and [PF6], on the freshwater 
pulmonate snail, Physa acuta.52 The acute toxicity, as well as the behavioural 
(locomotor and feeding) effects of the ILs on the snail were investigated. Results for the 
acute toxicity study show [ompyr][Br] (26) to be the most toxic IL investigated, with 
[TBA][Br] (42) being the least toxic. LC50 values in general then decreased with 
increasing alkyl chain length. The range of LC50 values obtained for the ILs studied are 
shown to be in the same range as values for organic solvents such as ammonia and 
phenol.  The imidazolium and pyridinium containing cations could not be distinguished 
according to toxicity level, as [hmim][Br] (23) was shown to be more toxic than 
[hmpyr][Br] (24), while [omim][Br] (25) was less toxic than [ompyr][Br] (26). The 
grazing rate of the snails decreased with increasing concentration of IL and also upon 
increasing chain length. The results for the movement study showed the movement of 
the snails to decrease initially with low concentrations of ILs, but then increase above a 
certain threshold where IL concentration increased. The combination of the results for 
locomotor and feeding behaviour shows an escape response, implying that the 
organisms search for refuge from the IL when a certain concentration threshold is 
reached.  
The toxicity of ILs to zebrafish (Danio rerio) (Figure 1.14) was investigated.53 
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Figure 1.14 Zebrafish (Danio rerio) 12 
Ammonium, imidazolium, pyridinium and pyrrolidinium based ILs were used. The 
ammonium based ILs were shown to be by far the most toxic, with LC50 values lower 
than those of commonly used organic solvents, i.e. MeOH, DCM, ACN and TEA. The 
fish exposed to these ILs showed erratic behaviour compared to the control fish, and 
also upon histopathological inspection, numerous abnormalities were noted in the fish. 
All other ILs exhibited LC50 values greater than 100 mg/L, therefore were not 
investigated further, and deemed by the authors to be ‘non-highly lethal towards zebra 
fish’.  
Although these tests give some indication of the relationship between structure and 
toxicity, more in-depth studies are needed to confirm this preliminary data. Relating to 
structure, similar trends occur in various test systems, therefore this aids the 
advancement of future SAR studies.  
Some ILs studied have been clearly shown to be toxic, although their risk to the 
environment may not be as severe if they do not persist in the environment and are 
readily degraded.  
1.2.3 History of Biodegradability of ILs 
ILs adding to anthropogenic waste is a factor hindering their valid classification as 
‘green solvents’. The fate of organic chemicals in the environment is dependent on the 
action of living organisms to breakdown the compound into its natural components, 
returning it to the cycle of life. Degradation can be carried out by higher organisms, by 
utilising a family of isozymes called cytochrome P450. Cytochrome P450 are the key 
enzymes in the MFO (mixed function oxidase) system. This detoxification system is 
probably the most important element of phase I metabolism.54 The enzymes facilitate 
the oxidation of aliphatic groups in the compounds to be degraded. Microbial 
transformation is however the most important process that can decompose an organic 
xenobiotic chemical in the environment.54 The main biodegradation pathways include 
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hydrolysis and oxidation. Hydrolysable functionalities, such as esters, amides and 
urethanes, increase biodegradation potential. Flexibility of the main alkyl chain of a 
compound also aids biodegradation as it facilitates the binding of the molecule to the 
active sites of the enzymes.   
Biodegradation testing is carried out to determine the fate of chemicals in the natural 
environment. Due to the great variety of biodegradation mechanisms in the natural 
environment, many methods are used to test biodegradation of substances. The methods 
that have been thus far used to test the biodegradation of ILs are the Sturm and the 
Closed bottle test, approved by The Organisation for Economic Cooperation and 
Development (OECD 301B and D respectively), and also the BOD5 test.  
Due to the similarity between ammonium and imidazolium based surfactants and some 
common ILs, Gathergood et al. studied the factors applied to surfactants to improve 
their biodegradation.55 They found that reduced branching in LASs (linear alkyl 
sulfonates)56 and the presence of a possible site for enzymatic hydrolysis in QACs 
(quaternary ammonium compounds)57-60 led to improved biodegradation. Using this 
knowledge together with following Boethlings rationale of identifying three factors that 
are important in the design of biodegradable compounds,59 Gathergood et al. 
synthesized imidazolium based ILs with ester and amide functionalities in the side 
chain. These functionalities were chosen above alcohol or carboxylic acid 
functionalities due to their reduced reactivity in comparison, while still incorporating 
possible sites of enzymatic hydrolysis into the side chain. Together with investigating 
their biodegradability using a modified Sturm test (OECD 301B) and closed Bottle Test 
(OECD 301D), and comparison to the popular [bmim] series, they investigated the 
melting point of the prepared compounds, in an effort to design biodegradable ILs 
without compromising the depressed melting points that make these solvents so 
attractive. All ILs prepared had a melting point below 100 ºC, with almost all ILs 
containing the ester functionalities being liquids at RT, however ILs containing the 
amide functionality were more likely to be solids. Preliminary studies on 
biodegradability involved testing the amount of CO2 evolved from wastewater micro 
organisms in an aerobic aqueous medium containing the compound to be tested, using 
the Sturm test. A CO2 evolution level of above 60 % was considered to pass this test. 
Bromide (43a) and [BF4] (43b) ILs (Figure 1.15) and [bmim][PF6] all showed values of 
CO2 evolution close to or equal to 60 %.  
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Figure 1.15 Bromide and [BF4] imidazolium IL (43a and b) containing ester 
functionality 
Using OECD 301D, to an aerobic aqueous medium inoculated with wastewater micro 
organisms, IL is added, and the depletion of dissolved molecular oxygen is measured. 
60 % is again the pass rate for this test, with compounds obtaining above this value 
being deemed readily biodegradable. The results obtained using both these tests 
differed. Although the ILs with the ester functionality increased biodegradation 
compared to [bmim][BF4] (31) and [bmim][PF6] (27), bromide salt esters with alkyl 
chain length ≥ 4 being the most biodegradable, the biodegradability level obtained was 
significantly lower than that obtained using the Strum test.  
The lag phase period of the organisms’ life cycle is reduced using a denser inoculum of 
organisms, therefore the amount of compound degraded in a certain time frame 
increases. The authors suggest that the difference in results obtained may be attributed 
to the fact that the inoculum density using the closed bottle test is lower than that used 
in the Sturm test.  
Advancing from their preliminary biodegradability studies, this group began 
investigating ILs containing an ester group in the side chain with regard to the effect the 
anion had on biodegradation.21 Biodegradation was again tested using the closed bottle 
test (OECD 301D). They tested the [bmim] and [3-methyl-1-(propoxycarbonylmethyl) 
imidazole] (44) ILs with different counterions, [Br], [BF4], [PF6], [NTf2], [N(CN)2], and 
[OctOSO3] (Figure 1.16). 
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Figure 1.16 [3-methyl-1-(propoxycarbonylmethyl) imidazole] cation with differing 
anions 
The ILs containing the ester functionality showed the highest biodegradation in 
comparison with the [bmim] ILs, with the ester linkage containing IL and the 
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[OctOSO3] anion (44f) being the most biodegradable. No significant change however 
was noted between the varying anions.  
BOD5 measurements were carried out by Wells and Coombe27 on imidazolium, 
pyridinium, phosphonium and ammonium ILs (27, 30 and 45, 46 and 48) to establish 
their biodegradation (Figure 1.17). They also examined anion effects by measuring the 
biodegradation of simple compounds of the appropriate anion, for example 47. Three 
concentrations were tested. The percentage uptake of oxygen after 28 days, and the 
complete organic carbon removal from the system were investigated. Most of the ILs 
studied, due to their high toxicity were resistant to biodegradation. 6 ILs were inhibitory 
at the test concentration.  
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Figure 1.17 Biodegradation of selected ILs 
Romero et al.20  found a range of imidazolium ILs not to be biodegradable by 
measuring BOD5 of aqueous samples of the ILs. 
Docherty et al.61 used an OECD DOC (dissolved organic carbon) Die-Away test to 
examine the biodegradability of imidazolium and pyridinium ILs by an activated sludge 
microbial community. While none of the imidazolium ILs could be classed as 
biodegradable, because after 28 days only partial mineralization was observed, the 
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pyridinium ILs of hexyl and octyl side chains were fully mineralized. Neither of the 
butyl side chain ILs for the imidazolium and pyridinium derivatives were 
biodegradable. 
Stolte et al.23 also used an activated sludge microbial community to investigate the 
biodegradation of imidazolium and pyridinium ILs. The long alkyl length side chain 
was found to be more readily degraded than the shorter side chains. Considering the 
shorter side chains, no improvement was observed even with the introduction of 
functional groups such as ether or nitrile. Harjani et al.62 use the CO2 Headspace test 
(ISO 14593) to evaluate the biodegradability of a range of pyridinium ILs (49 - 51) 
(Figure 1.18). 
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Figure 1.18 Pyridinium ILs 
It was found that these ILs constituting the pyridinium cation were indeed 
biodegradable. Interestingly, the use of the [OctOSO3] anion as opposed to the bromide 
anion did not significantly increase the biodegradation, an increase in only 2 % being 
observed from 49a to 49b (87 to 89 % respectively). An increase in alkyl chain length 
of the side chain was observed to increase biodegradation; 50b displayed a 
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biodegradation value of 75 %, while the butyl derivative of this compound showed an 
increased value of 82 %. The introduction of an amide functionality for the case of the 
nicotinamide IL (51) drastically decreased the biodegradation to 30 %.  
1.3 Synthesis of CILs based on the lactate or mandelate moiety 
1.3.1  Introduction 
Although the first evidence of chiral solvents used in asymmetric synthesis dates back 
to 1975, when Seebach and Oei63 used a chiral aminoether as a solvent for the 
electrochemical reduction of ketones, little has been seen since due to the difficult 
synthesis of chiral solvents and their high cost. In the past few years however, it is 
evident that the field of chiral ILs (CIL) has been steadily coming into effect.64-68 It can 
be noted that preliminary work in this field concentrated on the preparation of the CILs, 
with later work progressing to the application of these prepared CILs.  
According to a search done using SciFi Scholar and the term ‘chiral ILs’, results show 
that since the initial tentative introduction to CILs in the early years of the 21st century, 
the amount of work published in the last three years is steadily increasing (Figure 4). 
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Figure 1.19 SciFi Scholar search results with term ‘chiral ILs’ 
For the full potential of ILs to be reached they should be widely used on an industrial 
basis as alternatives to VOC’s. One of the principal reasons hindering their manufacture 
and use on a large scale is the high cost of starting materials. Lactic acid (52a/b/c) and 
mandelic acid (53a/b/c) serve as useful and cost-effective compounds for chirality 
introduction to the IL. 
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1.3.2 Lactate-based CILs 
1.3.2.1 Lactate moiety in CIL anion 
Along with achiral ILs, in 1998, Seddon et al.69 used 1-butyl-3-methylimidazolium 
lactate (54) as an alternative to lithium perchlorate-diethylether mixtures in Diels-Alder 
reactions. The synthesis of the chiral lactate IL was performed by reaction of sodium 
(S)-2-hydroxypropionate (55) and [bmim][Cl] (30) in acetone (Figure 1.20). It was 
found that although the lactate IL showed to be as effective as the other ILs used for the 
reaction of cyclopentadiene and 3 different dienophiles (in this case, ethylacrylate and 
cyclopentadiene), no enantioselectivity was observed. 
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Figure 1.20 Synthesis of chiral lactate IL 
To date, this is one of the few examples where the chirality of the IL resides in the 
anion.  
Xin et al.70 used their cyclic guanidinium lactate IL (56) as a solvent and the catalyst for 
a Knoevenagel condensation of aromatic aldehydes with active methylene compounds 
(Figure 1.22). The synthesis of the IL proceeded by neutralisation of the guanidinium 
moiety (57) with lactic acid (52) in 90 % yield in one step (Figure 1.21). 
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Figure 1.21 Synthesis of guanidinium lactate IL 
With few exceptions, good yields were obtained with a range of substrates (58/59) (> 92 
%) in short time periods (< 7 minutes). 
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Figure 1.22 Knoevenagel condensation 
Recylcing of this IL proved efficient; after 6 runs the percentage yield of a model 
reaction had only decreased by 0.4 % (from 96.8 to 96.4 %). 
Neutralization of a guanidinium moiety with lactic acid (52) was again performed by 
Zhu et al.71 to furnish 1,1,3,3-tetramethylguanidine lactate IL (62) (Figure 1.23). 
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Figure 1.23 Synthesis of 1,1,3,3-tetramethylguanidine lactate (62) 
This IL (62) was successfully used as a recyclable catalyst and solvent medium for 
direct aldol reactions. Respectable yields and diastereoselectivities were obtained using 
a range of aldehydes and ketones. A model reaction of 4-nitroaldehyde with 
cyclopentanone was recycled 3 times, with little decrease in percentage yield, and 
relatively small change in diastereoselectivity (Figure 1.24). 
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Figure 1.24 Aldol reaction 
The same tetramethylguanidinium lactate IL (62) was used by Liang et al.72 for efficient 
Michael addition reactions. As previously described the IL acted as dual catalyst and 
solvent for the reactions of chalcones, nitromethanes and active methylene compounds. 
The reaction between diethyl malonate and chalcone was recycled 5 times with the 
percentage yield decreasing only 1 % by the final run (from 99 % to 98 %).  
1.3.2.2 Lactate moiety in CIL cation 
In 2004, Jodry et al.73 prepared imidazolium CILs (Figure 1.25, CILs 66a – e) from (S)-
ethyl lactate (52b) (Figure 1.25). This is the only example of a lactate IL with the lactate 
moiety residing in the cation of the IL. All salts were shown to be liquids at RT, with 
the exception of the triflate anion containing CIL, however, racemization of the chiral 
salts was shown to easily occur in a basic environment.  
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Figure 1.25 Synthesis of chiral imidazolium ILs 
The enantiomeric purity of the CILs was investigated by 1H NMR studies. The racemic 
triflate salt was first measured by using Lacour’s TRISPHAT anion as NMR chiral shift 
reagent. When this salt was added to the racemic CIL a separation of signals of 2 
enantiomers could be seen on the 1H NMR spectrum. However, when the (S) 
enantiomers of the triflate salt is used, only one set of signals could be observed, thus 
confirming enantiomeric purity of the product.  
1.3.2.3 Lactate moiety used in synthesis of CIL 
Wang et al.74 synthesised imidazolium CILs derived from the chiral pool, and also 
investigated their usefulness as chiral induction solvents. The enantioselective Michael 
addition of diethyl malonate (67) to 1, 3-diphenyl-prop-2-en-1-one (68) (Figure 1.26) 
was investigated.  
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Figure 1.26 Enantioselective addition of diethyl malonate to 1,3-diphenyl-prop-2-en-1-
one 
The tartrate derived CIL (69) was synthesised in 5 steps (Figure 1.27) in 51 % overall 
yield, however the melting point of the resulting bromide salt was high (182 – 183 °C).  
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Figure 1.27 Synthesis of CIL derived from tartrate 
In an effort to reduce the melting point, unsymmetrical L-(–) ethyl lactate (73) was used 
as starting material for the  5 step synthesis of the corresponding salt 74 (Figure 1.28) in 
60 % overall yield, thus reducing the melting point to 57 – 58 °C.  
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Figure 1.28 Synthesis of CIL from L-(-)ethyl lactate 
Anion exchange reactions with [BF4] and [PF6] salts (Figure 1.29) resulted in various 
CILs (75-78) in good yields (87 – 92 %), the lactate-based [BF4] salt (75) giving the 
lowest melting point salt (41 – 42 °C).  
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Figure 1.29 Anion exchange reactions 
As the melting points of the CILs were relatively high, a co-solvent was used in 
addition with CIL 78 for the Michael addition reactions, the best result being obtained 
with toluene as co-solvent (96 % yield, 25 % ee).  
In order to investigate the use of CILs in the ATRP of acrylates, Biedron et al.75 
synthesised an imidazolium CIL (79) in good yield (71 %) in 2 steps followed by anion 
exchange (Figure 1.30). 
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Figure 1.30 Synthesis of imidazolium CILs from chiral alcohol 
The investigation showed the CIL to have a negligible effect on polymer tacticity. Their 
investigation was however limited by the expensive starting material used to synthesise 
their CIL. In a bid to overcome this problem, they synthesised 2 CILs (81a and b) from 
the more cost efficient lactic acid (Figure 1.31). 
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Figure 1.31 Synthesis of imidazolium based CILs from lactic acid 
Their continuing investigation with their newest CILs showed again that the CIL did 
have an effect on polymer tacticity.  
1.3.3 Mandelate-based CILs 
The chiral mandelate moiety is only presented so far in the anion of the CIL. Together 
with synthesising a lactate derivative, Branco et al.76 synthesised a mandelate 
guanidinium CIL (83a). Their guanidinium ILs were obtained by simple anion 
exchange of the chloride salt with the readily available chiral anion in DCM at RT 
(Figure 1.32). 
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Figure 1.32 Guanidinium ILs 
They synthesised their novel CILs using readily available anions as the chiral source. 
They subsequently used these CILs as media for two procedures, namely a Rh(II) 
carbenoid asymmetric C-H insertion and a Sharpless asymmetric dihydroxylation, as the 
source of chiral induction. The lactate CIL displayed the lowest viscosity for the range 
of their ILs. The Tg values for the mandelate and lactate guanidinium ILs were -56.9 
and 72.9 °C respectively. Using the mandelate derivative (83a) as reaction solvent and 
chiral induction source, they obtained enantioselectivity of 27 % for the asymmetric C-
H insertion (Figure 1.33). 
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Figure 1.33 Asymmetric C-H insertion 
However, a more impressive enantioselectivity was obtained, up to 85 % ee, using their 
quinic guanidinium CIL for Sharpless asymmetric dihydroxylation.  
By reaction of tetrabutylammonium hydroxide (86) with a range of amino acids and 
other organic acids including mandelic acid, Allen et al.77 prepared a range of CILs (87) 
(Figure 1.34). The novel CILs were synthesised by reaction of the chiral acid with 
tetrabutylammonium hydroxide. 
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Figure 1.34 CILs prepared from [TBA][OH] 
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Both L and D mandelate derivatives of the CILs were colourless liquids at RT and no 
decomposition was observed when heated at 110 °C for 24 h.  
 
1.4 Hydrogenation in ILs 
1.4.1 Introduction 
One of the principal present-day dilemmas facing the field of transition metal catalysis 
is the inefficient recycling and reuse of costly catalysts and ligands. The use of ILs is 
rapidly advancing in this discipline. Due to their physico-chemical properties, compared 
with those of organic and aqueous media, ILs provide a means of catalyst 
immobilization. The non-nucleophilic nature bestows an inert reaction medium that can 
provide an extension of the catalyst lifetime. Recyclability of the catalyst system is a 
key attribute of IL media and it is this extension of catalyst performance that is a main 
factor attracting research in this field. Low-polarity compounds, for example diethyl 
ether and n-hexane, are commonly insoluble in ILs. This varying solubility of the 
aforementioned organic solvents in ILs provides a suitable environment for biphasic 
catalysis. The positive aspects of homogeneous and heterogeneous catalysis are 
combined using a biphasic system. In this phase system, the catalyst resides in the IL 
and the substrates/products reside in the alternate phase. This system can implement a 
cost-effective way to successfully separate the desired product by simple decantation, 
leaving the catalyst immobilised in the IL, equipped for reuse. In the case of monophase 
catalysis in ILs, where the substrates are soluble in the IL medium, simple extraction or 
indeed facile distillation, due to the low vapour pressure of the IL, can be utilised as an 
alternative method for separating products from the IL/catalyst system. The reduced 
polarity of the hydrogenated products in comparison with the substrates can also be 
exploited for separation from the IL/catalyst phase. The increasing difference in polarity 
between the IL and hydrogenated product can render the product insoluble in the IL thus 
allowing for mere decantation of the product from the IL leaving the IL/catalyst phase 
intact. 
Catalytic hydrogenations in ILs began in 1995 with the almost simultaneous work of 
Chauvin78 and Dupont.79  
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1.4.2 Achiral transition metal hydrogenation in ILs 
Commonly used heterogeneous catalysts such as palladium or platinum on solid 
supports are among the catalysts employed for the hydrogenation of achiral substrates in 
ILs. Although increased temperature and pressure may be a necessity using the IL, 
classic palladium and platinum catalysts have been shown to give superior results when 
used in an IL as opposed to a common organic solvent. 
Xu et al.80 used a range of imidazolium ILs containing [BF4] and [PF6] anions for the 
catalytic heterogeneous hydrogenation of halonitrobenzenes (88) to the corresponding 
haloanilines (89) (Figure 1.35).  
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Figure 1.35 Hydrogenation of halonitrobenzenes to haloanilines 
Raney nickel (90), platinum on carbon (91) and palladium on carbon (92) were 
employed as metal catalysts, and methanol was used as a reference organic solvent as it 
has similar polarity to [bmim][BF4] (31) and is the most widely used in heterogeneous 
catalysis hydrogenations. Although increased temperatures and pressures were required 
for the IL systems, they performed better as reaction solvents for these reactions, the 
dehalogenation being greatest for all substrates tested in methanol over ILs. Taking for 
example ortho, meta and para chloronitrobenzene, and 5% Palladium on Carbon (92), 
for which the greatest differences in results between IL and organic solvent were 
evident. Using [bmim][BF4] (31), dehalogenation ranged from as low as 0 % with o-
chlronitrobenzene to 0.8 % with the meta derivative and 2.5 % with the para substituted 
derivative. However when methanol was used as solvent, dehalogenation ranges from 
22.7 % and 29.0 % (ortho and meta chloronitrobenzene respectively) to as high as 44.2 
% for para-chloronitrobenzene. The same trend was evident using catalysts 5% 90 and 
91, however albeit to a lesser extent. 
Anderson et al.81 chose the α,β-unsaturated aldehydes, citral (93) and cinnamaldehyde 
(94) (Figure 1.36 and Figure 1.37), to demonstrate the superior selectivity obtained 
using pyridinium, imidazolium and ammonium ILs for hydrogenation reactions over 
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common organic solvents. A classic palladium supported on carbon catalyst (92) was 
used for the reactions. 
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Figure 1.36 Reaction pathway of cinnamaldehyde hydrogenation 
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Figure 1.37 Reaction pathway of citral hydrogenation 
In the case of cinnamaldehyde (94), although the temperature was increased for the 
reaction carried out in the IL (60 ºC), the selectivity to hydrocinnamaldehyde (95) 
obtained using the IL (78-100 %) was far superior to that obtained using the selected 
organic solvents, which did not surpass 89 % (78-89 %). Worth noting for these 
hydrogenations is the varying of selectivities across a series of [bmim] ILs. 
[Bmim][PF6] (27) showed selectivities of 100 %, [bmim][OTf] (105) 91 %, and 78 % 
for [bmim][OAc] (105). Recycling of the [bmim][BF4] system showed catalyst activity 
to decrease by 50 % upon the first recycle but remained constant for five successive 
reactions. The selectivity however remained almost constant for all recycles carried out. 
The authors do note that if the IL system is treated for one hour prior to reaction 
commencement with hydrogen gas, in the absence of substrate, the recycling ability of 
the system can be improved. In the case of citral hydrogenation, similar trends were 
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observed. The selectivity towards citronellal (100) obtained using various IL ranged 
from 81-100 %, with the organic solvents displaying only 62-77 % selectivity. 
Geldbach et al.82 attemped to generate catalysts from metal chlorides in the Lewis acidic 
IL, [N-Octyl-3-picolinium]Cl-AlCl3 (106) (Figure 1.38), by dissolving a series of metal 
chlorides in the IL and adding the substrate benzene.  
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Figure 1.38 [N-Octyl-3-picolinium]Cl-AlCl3 (106) 
Hydrogen was then added to the biphasic mixture and the percentage conversions to 
cyclohexane recorded. Of all the metal chlorides used, only the palladium (PdCl2) and 
platinum (K2PtCl4) examples showed any significant activity, with 57 and 99 % 
conversion respectively. The platinum containing metal chloride was investigated 
further in relation to catalyst concentration and temperature as it showed the most 
promising result. Generally, higher catalyst loadings gave increased conversion, and 
raising the temperature also led to an increase in conversion. This groups research also 
extends to the examination of a ruthenium cluster catalyst in [bmim][BF4] (31) for the 
same hydrogenation reactions however no activity was observed using the IL. 
Although ILs have many ‘green’ attributes when it comes to their use in hydrogenation 
reactions, in some cases, the common organic solvent prevails. Using the bimetallic 
catalyst system, Ag-In/SiO2 for the hydrogenation of the α,β-unsaturated aldehyde citral 
(93) to selectively form acyclic/allylic terpene alcohols geraniol (98a) and nerol (98b), 
Steffan et al.83 showed the non-polar solvent hexane to be superior to the polar 
[bmim][NTf2] (107) IL. The chemoselective hydrogenation of citral (93) to geraniol 
(98a) and nerol (98b) was lower in the IL compared to the organic solvent. Their results 
depict lower conversion of citral in ILs compared to hexane and suggest the lower 
solubility of hydrogen in the IL to be the limiting factor. 
While investigating the mass transfer effects in the hydrogenation of phenyl acetylene 
(108) to styrene (109) and ethyl benzene (110) (Figure 1.39), using their rotating disc 
reactor, Hardacre et al.84 found an IL to give lower reaction rates than a molecular 
solvent.  
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Figure 1.39 Hydrogenation of phenyl acetylene 
Using palladium on calcium carbonate as catalyst, they investigated varying properties 
between [bmim][NTf2] (107) and heptane, for example the effect of phenyl acetylene 
concentration in the solvent and the rotation speed. The rate of reaction was reduced in 
the IL compared to the organic solvent, postulated by the group to be due to the varying 
rate of diffusion of gaseous hydrogen through the liquid medium to reach the catalyst 
surface.  
Recently Khodadadi-Moghaddam et al.85 investigated the kinetic parameters of the 
hydrogenation of a non-polar substrate, cyclohexene (111), in mixtures of the IL 2-
hydroxyethylammonium formate (112) and various alcohols (methanol, ethanol and 
propan-2-ol). Using a platinum on aluminium oxide catalyst, the rate constant for the 
reaction carried out in the IL/propan-2-ol mixture was twenty eight times higher than 
when carried out in the alcohol as sole reaction medium. From studying the solvent 
effects on the reaction, the authors explain this result to be due to the varying polarities 
of solvent and substrate: they suggest that due to the polar nature of the IL, the non-
polar cyclohexene (111) is more abundant on the catalyst surface, therefore promoting 
the reaction.  
Biphasic reaction conditions are one important method for hydrogenations using 
homogeneous catalysts when efficient recycling of catalyst is of importance. 
Hydrogenation reactions have been carried out using rhodium and ruthenium catalysts 
in biphasic systems using imidazolium and ammonium-based ILs. With the use of a 
rhodium catalyst ([Rh(η4-C7H8)(PPh3)][BF4]) (113), Dyson et al.86 demonstrated a 
biphasic hydrogenation of an alkyne (114) using IL and water phases. Their system 
consisted of [omim][BF4] (37) containing the catalyst and an aqueous phase containing 
the substrate, 2-butyne-1,4-diol (114) (Figure 1.40). 
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Figure 1.40 Hydrogenation of butyne-1,4-diol 
At room temperature, the phases were immiscible; however the reaction was carried out 
at 80 ºC thus allowing the reaction to be homogeneous. Facile separation of the reduced 
products from the catalyst/IL phase was obtained by cooling the reaction. The products 
dissolved in the aqueous phase were isolated and reuse of the IL/catalyst system 
demonstrated. The limitations of this system were shown with maleic acid, where the 
reduced product, succinic acid, was soluble in both the IL and aqueous phase. 
Wolfson et al.87 used [bmim][PF6] (27) as reaction medium in the hydrogenation of 2-
cyclohexen-1-one (118) with Wilkinson’s catalyst (119) (Figure 1.41).  
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Figure 1.41 Hydrogenation of 2-cyclohexen-1-one 
As water was shown to enhance the activity of Wilkinson’s catalyst (119), it was used 
in the biphasic hydrogenation of the substrate (118). Diethyl ether and hexane were 
screened but demonstrated low hydrogenation activity. The conversion to 
cyclohexanone (120) increased from 4 % in diethyl ether and 7 % in hexane to 26 % in 
water. 
Scurto et al.88 used biphasic hydrogenation conditions with scCO2 and a rhodium 
catalyst (121) for the hydrogenation of 2-vinyl-naphthalene (122) (Figure 1.42). 
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Figure 1.42 Hydrogenation of 2-vinyl-naphthalene 
[TBA][BF4] (124) was pressurised with CO2 to give a high melting point depression of 
the salt for subsequent use as a reaction solvent in the liquid phase. Conversions for the 
first three runs using the IL were high (> 93 %). The authors explained that the drop in 
conversion to 62 % by the fifth run may have been due to accidental oxygen 
introduction or loss of catalyst during the recycling procedure.  
Suarez et al.89 used a ruthenium catalyst (RuCl2(TPPMS)3(DMSO); TPPMS: 
triphenylphosphine monoosulfonate 125) immobilised in [bmim][PF6] (27) for the 
biphasic hydrogenation of 1-hexene (126). They investigated the effect of different 
parameters on the hydrogenation rate and conversion. It was observed that up to a 
certain temperature, the viscosity of the IL decreased therefore the conversion rate 
increased, however above 120 ºC, decomposition of the catalyst was observed. 
Increasing the pressure also increased the percentage of conversion, until it levelled off 
at a pressure of higher than 500 psi. Overall, greater than 99 % conversion was observed 
for the hydrogenation of 1-hexene in the IL, however upon recycling, the total 
conversion level decreased (70 % after six reuses). Two other substrates were also 
investigated (cyclohexene (127) and crotonaldehyde (128)). 34 % conversion was 
achieved with cyclohexene (127), while only 25 % was achieved using crotonaldehyde 
(128), with 1-butanol formed as the only product.  
The tailoring of ILs to carry out a specific role together with acting as reaction medium 
is emerging as an efficient way to limit the number of reagents required in a chemical 
reaction. The synthesis of a task-specific imidazolium IL (1-(N,N-dimethylaminoethyl)-
2,3-dimethylimidazolium trifluoromethanesulfonate) (129) was carried out in three 
steps to yield a basic IL for the hydrogenation of carbon dioxide (130) to form formic 
acid (131) (Figure 1.43).90  
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Figure 1.43 Hydrogenation of carbon dioxide 
The IL acts as a base for the promotion of the hydrogenation reaction. A ruthenium 
catalyst immobilised on silica (132) was used as heterogeneous catalyst phase dispersed 
in a solution of aqueous IL. It was shown that water was necessary for the success of the 
reaction, the reason being presumed to be to lower the viscosity of the IL. The task-
specific basic IL (129) favoured the formation of the product, the formation of a salt 
with the latter driving the reaction. TOFs as high as 103 h-1 were reached. An increase 
in H2 and CO2 pressure together with increasing the amount of IL used was found to 
favour higher TOFs. The process was shown to be suitable for recycling procedures, 
with no significant reduction in TOF being observed after four recycles. 
Bouquillon et al.18 used novel ILs, including a readily biodegradable IL for the 
hydrogenation of phenoxyocta-2,7-diene (133).91 Impressive conversions were obtained 
for the hydrogenation of the diene substrate using a palladium catalyst (134) (Figure 
1.44). The biodegradable [OctOSO3] imidazolium IL (135f) displayed superior 
conversion (85 %) to the [NTf2] derivative (135d) (75 %). The potential for reuse of the 
IL/catalyst system was portrayed by the recycling of the [OctOSO3] system albeit with a 
significant decrease in conversion to 55 % observed.  
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Figure 1.44 Hydrogenation of phenoxyocta-2,7-diene 
1.4.3 Asymmetric Hydrogenation in ILs 
Asymmetric hydrogenation is one of the main pathways for the synthesis of 
enantiomerically pure products.92 For the greater part, the source of chiral induction 
originates from chiral ligands coordinated to a metal catalyst. 93It has been demonstrated 
that tertiary phosphine stabilised-rhodium, ruthenium and iridium catalysts are the most 
likely to induce substantial enantiomeric excess in the formation of the chiral product.94-
96
 Extensive research into the hydrogenation of prochiral substrates in ILs has been 
carried out over the past few years. The majority of this work has employed ruthenium 
or rhodium based catalysts. Ruthenium and rhodium catalysts, DiPFc-Rh (138), 
EtDuPHOS-Rh (139) and BINAP-Ru (140), were compared by Boyle et al.97 The 
hydrogenation of α-benzamido cinnamate (141) (Figure 1.45) in ILs, [bmim][BF4] (31) 
and [emim][OTf] (142), without the use of a co-solvent was carried out. As the 
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conversion was negligible using the IL [bmim][BF4] (31) (0 - < 2 %), the second IL was 
the focus of the following reactions, eventually giving a conversion of 95 % and 89 % 
ee using Ru-140 as catalyst.  
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Figure 1.45 Hydrogenation of α-benzamido cinnamate 
1.4.3.1 Hydrogenation using rhodium catalysts 
Schmitkamp et al.98 investigated the hydrogenation of dimethyl itaconate (144) and 
methyl 2-acetamidoacrylate (145) (Figure 1.46) using [NTf2] CILs derived from L-
proline (146) and L-valine (147) and a rhodium catalyst with tropoisomeric ligands (148 
and 149).  
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Figure 1.46 Hydrogenation of prochiral substrates using CILs and a rhodium catalyst 
They investigated the effects of using different CILs (146 and 147) and the effect of 
sulfonated ligands on the conversion and enantioselectivity of the reactions. For the 
hydrogenation of methyl 2-acetamidoacrylate (145), using the sulfonated ligand (148), 
49 (S) % ee was obtained using 146, where a racemic mixture was obtained under the 
same conditions using 147. This group thus used 146 for all subsequent hydrogenations. 
Concerning the acrylate substrate, considerable enantiomeric excess was obtained for 
the (S) enantiomer when triethylamine was used as an additive in the reaction (69 %). 
Using dimethyl itaconate as the substrate, the amine additive was again found to 
increase the enantioselectivity (from 20 (R) % ee without additive to 29 (R) % ee with 
additive). The sulfonate groups present in the tropos ligand (138) were shown to be 
essential for increased enantioselectivity for both substrates. Enantioselectivity 
decreased dramatically when the unsulfonated ligand (149) was employed. Converting 
from 148 to 149, a drop in enantioselectivity was observed for methyl 2-
acetamidoacrylate (145), from 49 (S) to 28 (S) % ee, and using triethylamine as 
additive, from 69 (S) to 52 (S) % ee. Recycling of the system was proven possible by 
product extraction using scCO2. The recycling procedure showed a compromise in 
conversion from > 99 % for the first run to 57 % upon run three. Enantioselectivity was 
also moderately compromised during the recycling procedure, decreasing from 69 % ee 
upon run one to 52 % ee over three cycles.  
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Sulfonated ligands were also investigated by She et al.99 for investigation into the 
hydrogenation of dimethyl itaconate (144). A chiral rhodium complex containing water 
soluble BINAPS ligands (150) (Figure 1.47) was used for the reaction in ILs 
[bmim][BF4] (31) and [PF6] (27).  
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Figure 1.47 Chiral rhodium complex 
An IL/IPA biphasic system was used and conversions up to 100 % were obtained, with 
moderate enantioselectivities (49 - 70 %). Catalytic activity began decreasing however 
after four runs of recycling the system, but the authors found that the addition of fresh 
ligand to the catalyst re-established its performance.  
[Bmim][PF6] (27) was used as reaction medium in the asymmetric hydrogenation of 
methyl 2-acetamidoacrylate (145) with a rhodium catalyst (Rh-EtDuPHOS) (151) 
(Figure 1.48).87 
H2
H
H
COOMe
NHCOMe
Rh-EtDuPHOS
COOMe
NHCOMeH3C
H
145
151
152
 
Figure 1.48 Hydrogenation of 2-acetamidoacrylate 
The reaction did not proceed when performed in the IL alone. To enable the recycling of 
the catalyst immobilised in the IL, solvents immiscible in the IL were screened. Water 
gave the highest conversion (68 %) compared to hexane (0 %), diethyl ether (12 %) and 
IPA (31 %).  However the enantioselectivity remained the same (95 -96 % ee) for the 
three solvents that gave conversion. The authors postulate water is the superior solvent 
due to greater mixing with the IL phase, with the water droplets dispersed more 
effectively in the IL medium than the organic solvents. 
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The hydrogenation of (Z)-α-acetamidocinnamic acid (153) and methyl-(Z)-α-
acetamidocinnamate (154), was carried out in the ILs, [bmim][BF4] (31), [bmim][PF6] 
(27) and [mbpy][BF4] (155) using a rhodium catalyst ([Rh(COD)(DIPAMP)][BF4])  
(156) (Figure 1.49).100  
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Figure 1.49 Hydrogenation of (Z)-α-acetamidocinnamic acid and methyl-(Z)-α-
acetamidocinnamate 
In this case, IPA was used as a co-solvent in a biphasic system to facilitate recycling of 
the catalyst phase. A study of the temperature on the enantioselectivity showed this 
value to peak at 55 °C. At 5 bar H2 pressure, conversion percentage was above 97 % for 
the both substrates in [bmim][BF4] (31) and [bmim][PF6] (27). Enantioselectivity was 
also good, with enantioselectivities between 71-92 % being obtained. Frater et al.100 
showed the catalyst system to retain activity up to the fourth recycle, after which the 
conversion decreased slightly, with enantioselectivity remaining constant for each 
subsequent recycle. 
1.4.3.2 Hydrogenation using ruthenium catalysts 
Using methanol as co-solvent, ILs were tested for the hydrogenation of dimethyl 
itaconate (144) to dimethyl methylsuccinate (157) (Figure 1.50), using the catalyst (R)-
Ru-BINAP ((R)-Ru-140), at near ambient temperature (35°C), and 20 bar H2.101  
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Figure 1.50 Hydrogenation of dimethyl itaconate 
In order to recycle the system, organic solvent nanofiltration (OSN) was used to 
separate the catalyst and IL from the product. Recycling of their methanol/CyPhos101 
(158) system was achieved eight times with no loss in enantioselectivity or catalyst 
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activity. Compared to using pure methanol as solvent, the methanol/CyPhos101 (158a) 
and methanol/[TBA][Cl] (159) systems showed increased enantioselectivities, ranging 
from 75 % in pure methanol, to 95 % in the co-solvent system. The authors showed the 
dependence of catalytic activity on the anion of the IL. Using CyPhos101 (158a), good 
enantioselectivities and process yields were obtained, however when the anion was 
changed, in the case of CyPhos103 (158b), 110 (158c) and 111 (158d) (Figure 1.51), no 
improvement in ee or process yield was observed. 
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Figure 1.51 CyPhos ILs 
The hydrogenation of ethyl 4-chloro-3-oxobutyrate (160) to give ethyl 4-chloro-3-
hydroxy butyrate (161) (Figure 1.52) was investigated by Starodubtseva et al.102 using a 
Ru-BINAP (Ru-140) catalyst in various IL systems.  
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Figure 1.52 Hydrogenation of 4-chloro-3-oxobutyrate 
Hydrogenation results were poor using the ILs neat or in combination with an aprotic 
co-solvent. Starodubtseva then examined the use [bmim][PF6] (27), [bmim][NTf2] (107) 
and [TEA][Br] (162) with protic solvents, in particular ethanol. It was found that water 
content was also important with superior results obtained for wet ethanol compared to 
anhydrous ethanol. The anhydrous ethanol formed a biphasic system with the IL and 
catalyst. When wet ethanol was used a homogeneous mixture with the IL/catalyst 
system formed. Good conversion, selectivity and enantioselectivity were observed in 
the case of the [bmim][NTf2] (107)/hydrous ethanol/DCM system (100, 100, and 92 % 
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respectively). The conversion however decreased by more than half its original value (to 
46 %) upon the third run. Selectivity remained excellent (100 %) for all three runs, and 
the enantioselectivity only slightly decreased (85 % for run three). Using the [TEA][Br] 
(162) IL as an example, the authors showed increasing temperature to be important for 
enhanced catalyst activity. By increasing the temperature from 30 °C (conversion = 42 
%, selectivity = 93 %, ee = 85 %), to 70 °C (conversion = 100 %, selectivity = 100 %, 
ee = 96 %) improvements in catalytic performance were evident. 
With their novel ruthenium catalyst (RuCl2(TPPTS)2]2-(1S,2S)-DPENDS-KOH; 
TPPTS: P(m-C6H4SO3Na)3 (163) and DPENDS: (1S,2S)-1,2-diphenyl-1,2-ethylene 
diamine sulfonate disodium) (164), Xiong et al.103 carried out the hydrogenation of 
various aromatic ketones using a selection of ILs ([emim] (165), [bmim] (166), [omim] 
(167) and [dodecylmim] (168) [p-CH3C6H4SO3] and [bmim][BF4] (31) and [PF6] (27)) 
(Figure 1.53).  
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Figure 1.53 Para-sulfonate imidazolium ILs and DPENDS 
The best results were obtained using the aromatic anionic ILs with a dramatic decrease 
in conversion and enantioselectivity being obtained with the [bmim][PF6] (27) IL. The 
authors attributed this fact to be due to hydrophobicity of the IL hindering the activity of 
the hydrophilic catalyst. A decrease in enantioselectivities was observed with an 
increase in alkyl chain length of the cation of the IL. Various parameters were 
investigated as a function of catalyst activity in the IL that showed the most promising 
results, namely [bmim][p-CH3C6H4SO3] (166). It was seen that increasing temperature 
brought about a decrease in enantioselectivity. An increase in the amount of base added 
(KOH) significantly increased the conversion and the enantioselectivity, as did the 
addition of (1S, 2S)-DPENDS. The best catalyst precursor was shown to be 
[RuCl2(TPPTs)2]2 with a conversion of 100 % and enantioselectivity of 79.2 % 
obtained. In total, nine aromatic ketones were tested, giving good conversions (68.0 - 
100 %) and moderate enantioselectivities (40.0 – 80.6 %). Recycling of the IL/catalyst 
system over nine runs showed conversions ranging between 100 % and 68.7 %, where 
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even the lowest value of 68.7 % was redeemed by the addition of more KOH. The same 
group104 used their novel catalyst for the hydrogenation of α, β-unsaturated ketones 
using ILs. Using benzalacetone (169) as a reference substrate (Figure 1.54), they found 
that the lipophilic chains on the cations of the ILs influenced the enantioselectivity.  
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Figure 1.54 Selective hydrogenation of benzalacetone 
Although selectivity was always high towards the unsaturated alcohol (170) with all ILs 
tested, enantioselectivity can be seen to decrease as alkyl chain length is increased (from 
71.8 % ee for [emim] to 59.9 % for the [dodecyl] chain).  
This group also investigated the effect of base and water content on the reaction. 100 % 
conversion was reached using strong bases such as NaOH and KOH, while only 4.6 % 
conversion was obtained in the presence of K2CO3. Higher enantioselectivies were also 
observed with the stronger hydroxide bases (ca. 70%) compared to 58.7% ee for K2CO3. 
Water was found to be a valuable co-solvent, and optimised conditions led to 100 % 
conversion, 100 % chemoselectivity and 75.9 % enantioselectivity.  When other α, β-
unsaturated ketones were investigated, promising results were also obtained. 
Hydrogenation of 2-cyclohexen-1-one (118) gave good conversion (100 %) and 
chemoselectivity (94.1 % for the unsaturated alcohol), however with a moderate ee 
value (48.1 %). On the other hand, 4-methyl-3-penten-2-one (171) showed good 
enantioselectivity (84.7 %) and chemoselectivity (84.9 %), however with only poor 
conversion (29.1 %). The IL/catalyst system was efficiently recycled eight times with 
conversion always above 87.9 % from an initial 100 % for the first run. A slight 
reduction was observed for the chemoselectivity (from 100 % to 99.1 %) and the 
enantioselectivity remained almost constant for each successive recycle. 
Lam et al.105 used a ruthenium catalyst with a dipyridylphosphine ligand (P-Phos) (172) 
for the asymmetric hydrogenation of α- and β-keto esters (Figure 1.55).  
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Figure 1.55 Asymmetric hydrogenation of α- and β-keto esters 
Methyl pyruvate (173) was taken as an example from the α-keto esters and the 
hydrogenation was carried out with 172 and a standard ruthenium BINAP catalyst. It 
was found that a co-solvent was a necessity for these hydrogenations, as using the IL on 
its own as reaction solvent gave negligible conversions. Methanol was used in equal 
volumes as co-solvent and using 172 tethered to the ruthenium catalyst, good 
conversions were obtained (73 and 95 % conversion for [bmim][PF6] (27) and 
[bmim][BF4] (31) respectively) with good enantioselectivity (86 and 83 % ee). 
Enantioselectivies decreased when moving to the BINAP ligand, however conversions 
achieved were higher. A range of α-keto esters were tested, conversions ranging from 
18 % in [bmim][BF4] (31), however to 65 % for the same substrate using the 
[bmim][PF6] (27) IL. The best results in terms of conversion (65 %) and 
enantioselectivity (93 %) were obtained with the substrate methyl 2-oxo-2-
phenylacetate (174) in the [bmim][PF6] (27) IL. Methyl acetoacetate (175) was used as 
a reference substrate for the hydrogenation of the β-keto esters, giving conversions and 
enantioselectivity values greater than 98 % for 172 as well as the BINAP ligand. In 
general, the range of β-keto esters subjected to hydrogenation with the ruthenium P-
Phos catalyst displayed improved results, with most conversions reaching at least 70 %, 
enantioselectivity values also being as high as greater than 99 %. The hydrogenation of 
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methyl acetoacetate (175) was investigated in the two ILs for recycling ability. Both IL 
systems were recycled nine times with similar results although the conversion had 
dramatically decreased by run nine for both ILs (39 % for [BF4] and 49 % for [PF6]), 
enantioselectivities did not fall below 94 % for both ILs over the nine runs. 
1.5 General conclusion 
With increased environmental awareness throughout the chemical industry, the use of 
hydrogen gas for hydrogenation reactions is especially popular as it is a clean reducing 
agent. Coupled with the use of ILs as safer alternatives to VOCs as reaction solvents, 
hydrogenation reactions can be very attractive as clean, ‘green’ synthetic methods. The 
solubility of gaseous H2 has been shown to be lower in ionic liquids than in common 
organic solvents, however mass transfer effects of the gas in the IL are high enough in 
some cases to overcome this limitation. The availability of the hydrogen at the catalyst 
site may be replenished due to the relative ease of mass transfer of the gas in the 
solvent, leading to high conversions. Recyclability of the catalyst system is a major 
factor in the potential use of the IL. ILs provide a stabilising media for catalysts and 
facilitate their immobilisation therefore rendering possible recycling procedures. 
IL/catalyst systems have been shown to be easily recycled in numerous cases while 
retaining their activity. Biphasic hydrogenations have also demonstrated recyclability, 
the substrates and products residing in a separate phase to the IL and catalyst. A 
particularly efficient method that has been outlined is where the substrate is dissolved in 
the IL phase, and the reduction products form a second phase, thus facilitating clean, 
simple decantation of the desired product from the IL phase. However if the products 
are also soluble in the IL phase and a second organic solvent is needed for extraction 
from the mixture, the requirement for the harmful VOC solvent detracts from the benefit 
of using the IL unless the recycling ability of the IL is considerable. Although ILs are 
duly attracting a staggering magnitude of attention, their benefits must be balanced with 
their limitations, and these elements investigated if the solvents are to replace volatile 
organic solvents on an industrial scale. Although the principal ILs studied for 
hydrogenation reactions have been the popular [bmim][BF4] (31) and [bmim][PF6] (27), 
novel ILs have been synthesised and studied as reaction media for these reactions. The 
cost of synthesis of these novel ILs should be at the forefront of our minds if these 
solvents are to be used on a large scale. A predominant factor contributing to cost 
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reduction, and also a possible way forward, may be the use of the supported systems, 
thus requiring a smaller quantity of the IL.  
Recycling of the IL is also important. An IL which can only maintain its required 
performance for 2-5 cycles has limited use. A significantly higher number of effective 
recycles is one of the major goals for this research area.  
The ‘greenness’ of ILs has been disputed due to their possible persistence and toxicity 
in the environment. It is not only the cost and performance that should be a component 
in designing ILs for use in hydrogenation technologies, but toxicity, bioaccumulation 
and biodegradability should be given equal merit to the process selection before the IL 
development and use in large scale chemical synthesis. 
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2 Synthesis, characterization and biological testing of a 
library of novel achiral imidazolium ILs 
2.1 Introduction 
An important factor in the design of biodegradable compounds is the presence of 
potential sites of enzymatic hydrolysis.1-3 Due to their potential to be hydrolyzed, ester 
and ether/polyether side chains are incorporated into the achiral ILs in order to facilitate 
their breakdown in the environment. Lipophilic side chains present in previously 
synthesised ILs have been shown to be toxic. The presence of the ether oxygen atoms in 
the side chains of the novel ILs prepared are shown to reduce toxicity of the ILs. The 
bromide salts formed are converted to ILs of varying anions in order to modulate the 
properties of the novel ILs.  
2.2 Synthesis of novel achiral ILs 
The synthesis of these achiral ILs was carried out in two steps followed by anion 
exchange reactions (Figure 2.1).  
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Figure 2.1 Three step synthesis of achiral ILs 
2.2.1 Step 1: Esterification - Synthesis of α-bromoesters 
The first step of the three-step synthesis of the achiral ILs involved the synthesis of the 
bromoesters, by the reaction of bromoacetyl bromide with alcohols of various side chain 
lengths and with differing numbers of oxygen atoms in their side chain (Table 2.1).  
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Table 2.1 α-bromoesters 
The reaction yielded crude products which, although very darkly coloured, had high 
purity (> 97 %) by 1H NMR analysis. As can be seen from a comparison of the 
spectrum of the pure and crude product respectively (Figure 2.2), little difference is 
evident between the two. 
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Figure 2.2 1H NMR of crude and pure bromoester (176j) 
Following purification of the crude esters by vacuum distillation, pure products were 
obtained in good yields (58 – 83 %). The crude product (darkly coloured) was distilled 
to yield colourless to pale yellow pure products. This reaction was performed on a wide 
scale range, from 10 – 500 mmol, with no compromise in yield or purity. The reaction 
on the larger scales did however require increased reaction times, and the amount of 
bromoacetyl bromide used was increased to ensure reaction completion. Distillations of 
the crude products proved increasingly difficult as the side chain and the number of 
coordinating atoms in the side chain extended. This was presumably due to the 
increased molecular weight of the compound to be distilled, therefore possessing an 
increased boiling point. It is also evident from the lowest yield (58 %) being obtained 
for pure product for the bromoester with the longest chain and bearing oxygen atoms in 
this chain (176k).  
2.2.2 Step 2: Alkylation - Synthesis of imidazolium bromide salts 
The alkylation of 1-methyl- and 1,2-dimethyl- imidazole with the esters and ethers of 
bromoacetyl bromide resulted in formation of the bromide salts (Table 2.2).  
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Table 2.2 Bromide salts 
Excellent yields were obtained for this step of the reaction (82 – 98 %), apart from the 
synthesis of the longest chain bromide salt containing 3 ethereal oxygen atoms 187a (55 
%) and the C10 lipophilic chain bromide salt (51 %). Although most of the bromide salts 
obtained were solids at RT (179-188 and 191), their melting points were close to RT 
(Table 2.5). The initial duration of the reaction was 1 hour at – 15 ºC then warmed to 
RT for 3 hours. This time increased as the reactions were performed on larger scales. 
Diethyl ether was the solvent of choice for the reaction, with the desired imidazolium 
bromide salt precipitating out of solution. The number of washings of the product and 
the quantity of solvent used to wash them depended mostly on the viscosity of the IL. 
ILs which were solid at RT were usually clean after 3 - 4 washes for approximately 1 
hour of stirring. On occasion, it took 2 days with continuous stirring to wash the viscous 
ILs in order to yield the bromide salts free from starting material contaminants. Time 
required for washing of the desired salts also took longer for the bromide salts based on 
the dimethyl imidazolium cation (Table 3). This was, in effect, due to the reduced 
solubility of the starting material, namely 1,2-dimethylimidazole, in the diethyl ether. 
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Due to this time taken and extensive washing required to obtain the pure bromide salt, 
THF was used in certain cases as washing solvent. The imidazole starting material, 
which was the main impurity, was more soluble in THF than diethyl ether, therefore 
facilitating more facile removal of this starting material from the bromide salt. In some 
cases, the IL was dissolved in DCM and washed with diethyl ether, thus the viscosity no 
longer posed the same problem. This method however did not appear to be efficient, 
and it was found that more starting material was removed if the IL was washed neat.  
Three bromoesters of varying side chain lengths (176b, 176f and 176g) were used to 
synthesise the dimethylimidazolium bromide salts (Figure 2.3). 
N N
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O Br
N N
O
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N N
O
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O
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Figure 2.3 1,2-Dimethylimidazolium bromide salts 
Significant differences in the 1H NMR spectra between the methyl imidazolium and 
dimethylimidazolium derivatives were that the aromatic imidazolium peaks were split 
into a doublet in the case of the dimethylimidazolium derivatives, and triplets for the 
methylimidazolium derivatives (Figure 2.4).  
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Figure 2.4 1H NMR triplet and doublet signals from imidazolium ILs 
The splitting of the 1-methylimidazolium proton peaks into triplet signals is due to the 
mutual coupling of the three aromatic protons as can be seen from the COSY NMR 
spectrum (Figure 2.5). 
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Figure 2.5 COSY 1H-1H NMR spectrum 
Another difference between the 1-methyl and the 1,2-dimethyl derivatives of the 
imidazolium ILs is that an increase in melting point was observed for the dimethyl 
derivatives (Table 2.3). 
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Table 2.3 Melting point differences between 1-methylimidazolium and 1,2-
dimethylimidazolium ILs 
As can be seen from the differences in melting points between the different imidazolium 
derivatives (Table 2.3), the addition of a methyl group to the C2 position leads to an 
increase in melting point of the IL. This is contrary to what would be expected as the 
removal and subsequent substitution of the C2 acidic hydrogen should decrease the 
possibility of hydrogen bonding which, in theory, should hence decrease the melting 
point. This effect has been noted before and it seems that other interactions between the 
methyl group and the rest of the IL are more significant and thus increase the melting 
point.4 
An interesting trend in melting point of bromide ILs is evident as the length of the side-
chain and number of ethereal oxygens increases (Figure 2.6). 
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Figure 2.6 Bromide salt melting points (RT is taken to be 25 °C) 
The highest melting points (peaks 179a, 183a and 187a) are observed for the ILs 
terminating in a methyl group bonded directly to an ethereal oxygen atom. The reason 
for the elevated melting points is postulated to be due to the easier ability of the less 
flexible methyl terminus to fit into a crystal lattice in comparison with the increased 
flexibility of the ethyl/propyl/butyl termini.  
The colours of the bromide salts varied from white and pale yellow to dark brown. In 
order to decolourise a selection of the bromide salts, activated charcoal was used. A 
method for purification of ILs was extracted and optimised for these novel ILs from 
Burrell et al..5 2,3-Dimethyl-1-(pentoxycarbonylmethyl)imidazolium bromide (189a) 
was dissolved in distilled water containing charcoal and heated at 65 °C for 24 h. 
Following filtering of the solution from the charcoal and evaporation of the solvent, the 
initial bromide salt had changed colour from yellow to colourless (Figure 2.7). 
 
Figure 2.7 189a Before and after purification 
The same effect was also observed for 178a, which was a similar colour to 189a. 180a 
was subjected to the same procedure in an attempt to remove the darker brown colour 
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from the IL. After undergoing the same purification procedure, although a reduction in 
colour, from dark brown to yellow was observed (Figure 2.8), the colourless version of 
the IL could not be attained. Further heating for an extra 24 h resulted in degradation of 
the IL. 
 
Figure 2.8 180a Before and after purification 
Many of the bromide salts prepared were white powders. The viscous ILs can trap 
impurities more easily than the salts which precipitate as solids. The trace impurities are 
highly coloured, however, bromide salts which precipitate as white solids have high 
purity.  
2.2.3 Step 3: Anion metathesis 
Counter ion exchange reactions were carried out with sodium, postassium and lithium 
salts (potassium hexafluorophosphate, sodium tetrafluoroborate, sodium dicyanoamide, 
lithium trifluoromethanesulfonimide, sodium octyl sulfate) (Table 2.4). 
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Table 2.4 ILs with different counter ions 
Changing the counter ion of the bromide salts led to different properties observed for 
the ILs. Five different salts were used to observe this alteration in property. A general 
observation showed that changing the anion from bromide to [NTf2] depressed the 
melting point of the IL. [NTf2] and [PF6] ILs were hydrophobic, and the [OctOSO3] ILs 
were synthesised to increase biodegradability, as previously demonstrated by 
Gathergood et al.6-9 All bromide salts converted to salts of different counter ions were 
predominantly liquids. The [OctOSO3] salts were however greases at RT, with the 
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exception of two dimethylimidazolium derivatives (189f and 190f), which displayed 
elevated melting points.  
2.2.3.1 [NTf2] ILs (d) 
In order to synthesise the [NTf2] salt, the bromide IL and the lithium salt were stirred 
vigorously at RT in water for times ranging from 4 – 18 hours. During this reaction time 
the hydrophobic IL precipitated out of solution and therefore could be washed with 
water to eliminate impurities. This reaction proceeded in good yield (68 – 95 %).  
The hydrophobicity of these ILs meant that the decolourisation procedure previously 
described could not be carried out in the same manner. In an attempt to remove or 
reduce the colour of the preformed [NTf2] salts, the IL was added to acetonitrile, and 
then stirred with charcoal and water at 65 °C for 24 h. The use of only acetonitrile as 
solvent showed no decolourisation of the product. However, the addition of water with 
the charcoal gave the result of 186d changing colour from yellow/orange to practically 
colourless (Figure 2.9). 
 
Figure 2.9 186d Before and after decolourisation 
2.2.3.2 [PF6] ILs (c) 
The synthesis of the second hydrophobic IL, that of the [PF6] counter ion, was initially 
carried out under similar conditions as the [NTf2] salts; this however led to very poor 
yields. A change of solvent from water to acetone improved the yield slightly but still 
left room for improvement. Ultimately the [PF6] ILs were synthesised by refluxing the 
two salts in acetone for four days with subsequent yields of > 90 % being obtained.  
2.2.3.3 [BF4] ILs (b) 
The [BF4] ILs were synthesised in the same manner as the [PF6] ILs, for four days using 
acetone as a solvent. Excellent yields were obtained for this anion exchange reaction (> 
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92 % yield). Often however, the resulting alkali salts from the reactions were partially 
soluble in the IL, therefore making filtration challenging. If the acetone was however 
first evaporated and the product subsequently dissolved in dichloromethane, the 
unwanted salts precipitated thus facilitating their separation from the desired IL.  
2.2.3.4 [N(CN)2] ILs (e) 
The synthesis of the [N(CN)2] salts involved using acetonitrile as the solvent, but the 
reaction time of four days remained the same as the [PF6] and [BF4] ILs, again giving 
mostly good yields (51 – 99 %).  
2.2.3.5 [OctOSO3] ILs (f) 
With the [OctOSO3] ILs, the reaction conditions were changed dramatically. According 
to the literature,10 the bromide salt and NaOctOSO3 were stirred in water for 2 h at 60 
ºC. The water was then slowly removed under vacuum. The precipitate was dissolved in 
DCM and washed with a small amount of distilled water. After evaporation of the 
solvent, the product was obtained in good yield, up to 98 %. The yield could however 
decrease rapidly if extreme caution was not taken during the water washing. That could 
be explained by the fact that the [OctOSO3] IL is soluble in water and is therefore easily 
removed upon washing with water. Once again it could be noted that only two of the 
[OctOSO3] ILs (189f and 190f) are solid at room temperature but with melting points 
below 100 ºC. A major drawback of synthesising the [OctOSO3] ILs is the expense of 
the sodium salt. Due to this high cost, a method for its synthesis was extracted and 
developed from Ravi et al..11 1-Octanol was dissolved in dichloromethane, followed by 
addition of chlorosulfonic acid. Subsequent neutralization of the mixture with NaHCO3 
and filtration with methanol permitted the synthesis of sodium octyl sulfate on a 
relatively large scale (20 mmol) in excellent yields (> 98 %).  
A comparison of the yields and melting points of all novel achiral ILs can be viewed in 
Table 2.5. 
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IL cation  
% yield 
Melting point 
[Br] 
a 
 
[NTf2] 
d 
[BF4] 
b 
[PF6] 
c 
[N(CN)2] 
e 
[OctOSO3] 
f 
177 82 86 97 93 87 61 
178 97 93 95 98 98 96 
179 89  53-55 ºC 91 95 96 58 –60 ºC 80 95 
180 93 24-26 ºC 90 96 98 99 96 
181 88 25-27 ºC 68 97 97 91 85 
182 89 28- 30 ºC 84 96 95 51 93 
183 97 52- 54 ºC 91 94 91 94 82 
184 92 28-30ºC 87 96 96 99 93 
185 98 32- 34 ºC 82 93 91 85 98 
186 94 48- 50 ºC 86 92 79 98 34 – 36 ºC 92 
187 55 59 – 61 ºC 93 94 57 75 84 
188 51 49-51 ºC 95 - - - - 
189 81 95 93 97 40 -42 ºC 85 86 63- 65 ºC 
190 92 83 95 97 78 84  50-52 °C 
190 88 74-75 ºC 96 94 95 99 94 
Table 2.5 Achiral ILs (yields and melting points) 
2.2.4 Halide content of ILs 
As residual halides remaining in the IL can pose problems for the ILs used in certain 
processes,12, 13 the halide content of the ILs was investigated. The IL was dissolved in 
water/acetone and acidified with dilute nitric acid. Upon addition of silver nitrate, if a 
precipitate was observed (indicating the presence of residual halide) water washes were 
performed on the IL. Removal of excess halide from the hydrophobic ILs was therefore 
relatively straightforward. Hydrophilic ILs with [BF4] and [N(CN)2] counterions were a 
greater challenge to purify. In order to remove the residual halide, the IL in question 
was dissolved in dichloromethane and then washed with water. Numerous ( >10) water 
washes were often required to completely remove the halide, thus the yield of the IL 
was often dramatically reduced due to its solubility in both the DCM and water layers.  
 
 80 
2.2.5 NMR studies 
All of the achiral salts were characterised by 1H and 13C NMR. For a series of ILs based 
on the same cation, with varying anion, the most distinguishing feature of the spectra is 
the shift in the signal for the acidic hydrogen of the imidazolium moiety. As can be seen 
from the spectra (Table 2.6), the chemical shift varies from 8.5 ppm in the case of the 
[PF6] counterion to 10.3 in the case determining the bromide salt. This facilitates a way 
of elucidation of the structure as well as which anion is present, even though the anion 
does not contain hydrogen atoms.  
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               ppm 
(approx. measurement)10.4 10.0 9.4 8.9 8.5
[Br] [N(CN)2] [OctOSO3] [NTf2] / [BF4] [PF6]
 
N N
O
O
O
O
 
185 
10 9 8 7 6 5 4 3 2 1 ppm
 
 
[Br]  
a 
10 9 8 7 6 5 4 3 2 1 ppm
 
 
[N(CN)2] 
e 
10 9 8 7 6 5 4 3 2 1 ppm
 
 
[OctOSO3] 
f 
10 9 8 7 6 5 4 3 2 1 ppm
 
 
[NTf2] 
d 
10 9 8 7 6 5 4 3 2 1 ppm
 
 
[BF4] 
b    
10 9 8 7 6 5 4 3 2 1 ppm
 
 
[PF6] 
c 
Table 2.6 1H NMR spectra for chemical shift comparison 
 82 
This feature may also be used as a rough estimation of the varying degree of charge 
separation of the anion from the cation. The more deshielded the proton, the further 
downfield it appears, therefore indicating a more intense charge induced in the cation by 
the anion of the particular IL. From this estimation it can be seen that this pathway of 
elucidation of different anionic strengths imposed on their respective cations is 
relatively accurate. The bromide anion is seen have the greatest deshielding effect, as 
would indeed be estimated from the localised charge on this ion. As the anion becomes 
larger, and therefore the charge becomes more diffuse, the charge separation can be 
seen to decrease. The fluorinated anions in this case demonstrate the weakest 
deshielding effect on the cation. As the spectra for the same cations of the ILs of 
varying anions were similar, all ILs prepared were confirmed by mass spectrometry. 
2.2.6 Amide ILs 
The method for the preparation of the amide ILs was analogous to that for the ester 
derivatives except that the alcohol starting material was replaced by an amine (Table 
2.7). The only difference noted was a slight possible change in method for the 
purification of the alkylating agent in the case of compound 202. It was found that 
recrystallisation of the crude product from diethyl ether afforded the pure product, as an 
alternative to vacuum distillation. Excellent yields were obtained for the majority of the 
bromide and [OctOSO3] amide derivatives; however elevated melting points were 
apparent in the case of the bromide salts, with all but one amide derivative being solid at 
RT (Table 2.8).  
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Amide bromoesters 
 
Yield 
(%) 
O
N
O
O
Br
199
 
 
 
49 
 
N
Br
O
200
 
 
 
52 
 
O
N
H
O
Br
201
 
 
 
17 
 
O
N
H
Br
O
202
 
 
 
51 
 
Table 2.7 Amide bromoester synthesis 
The yield for the preparation of the amide derived alkylating agents is lower than 
obtained for the α-bromoesters. The yield ranged from 17-52 % in comparison with 68 - 
83 % for the bromoesters. The amide functionality present also increased the melting 
point of these compounds as they are all in solid form as opposed to the bromoesters 
which were for the most part in liquid form. Due to the crystallinity of these materials, 
the procedure was changed slightly for the formation of the bromide salt. The dropwise 
addition was no longer used, and the solid material was dissolved in diethyl ether and 
added slowly to a solution of the imidazolium starting material in diethyl ether. 
The yield for the synthesis of the amide derivatives of the bromide and [OctOSO3] salts 
remains high (Table 2.8). A melting point above 100 °C, beyond the range for an IL, 
was observed for the pyrrolidine derivative. Changing the counter ion to [OctOSO3], 
was shown to decrease this high melting point of a solid to a grease.  
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IL cation 
% yield 
Melting point 
[Br]  
a 
[OctOSO3] 
f 
N
N
N
O  
197 
 
56 
109-111 ºC 
 
97 
N
N
N
O  
198 
 
82 
142-144 ºC 
 
98 
N
N
O
NH
O
 
203 
 
97 
 
-- 
N
N
O
NH
O
 
204 
 
91 
75-77 ºC 
 
-- 
N
N
O
N
O
O
 
205 
 
91 
68-70 ºC 
 
92 
Table 2.8 Amide ILs (yields and melting points) 
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2.3 Toxicity and Biodegradation Studies 
2.3.1 Toxicity studies 
Toxicity studies have been performed on a wide range of the novel ILs synthesised to 
date. Seven strains of bacteria (Table 2.9) were used in the assessment of the level of 
activity against these strains on the ILs. 
Gram negative bacteria Gram positive bacteria 
Pseudomonas aeruginosa Staphylococcus aureus 
Escherichia coli Enterococcus spp. 
Klebsiella spp. Bacillus subtilis 
Salmonella spp.  
Table 2.9 Bacteria used for toxicity testing 
The minimum inhibitory concentrations were measured for those ILs which showed 
activity. A wide concentration range was tested (0 – 20000 µg/ml) to yield reliable 
results. It is evident from the resulting toxicity data that most of the novel ILs are non-
toxic to these selected strains of bacteria. 3-Methyl-1-(decoxycarbonylmethyl) 
imidazolium bromide (166l) (Figure 2.10) was submitted for testing as a reference 
compound.  
N N
O
O
Br
 
Figure 2.10 188a 
Due to its long lipophilic side chain, lacking in coordinating atoms, it was presumed to 
be toxic. MIC values obtained from screening this compound against the seven strains 
of bacteria (Table 2.10) are low (1.9 – 125 µg/ml) thus signifying a high level of 
toxicity.  
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E. coli 
Concentration 
(µg/ml) 
1000 500 250 125 62.5 31.25 15.62 7.8 3.9 1.9 Control 
Kill (%) 91 82 92 92 37 28 17 8.5 10 9 0 
Pseudomonas sp. 
Concentration 
(µg/ml) 
1000 500 250 125 62.5 31.25 15.62 7.8 3.9 1.9 Control 
Kill (%) 100 82 82 55.5 0 6 0 0 0 0 0 
Salmonella sp. 
Concentration 
(µg/ml) 
1000 500 250 125 62.5 31.25 15.62 7.8 3.9 1.9 Control 
Kill (%) 86 88 73.5 58 10 0 0 0 0 0 0 
Enterococcus sp. 
Concentration 
(µg/ml) 
1000 500 250 125 62.5 31.25 15.62 7.8 3.9 1.9 Control 
Kill (%) 96.4 84 83.4 49.5 48.7 18.7 23 6 6.5 6 0 
Klebsiella sp. 
Concentration 
(µg/ml) 
1000 500 250 125 62.5 31.25 15.62 7.8 3.9 1.9 Control 
Kill (%) 91.8 68.2 64 21 7 0 0 0 0 0 0 
S. aureus 
Concentration 
(µg/ml) 
1000 500 250 125 62.5 31.25 15.62 7.8 3.9 1.9 Control 
Kill (%) 100 96 93.8 80.7 90.3 86.4 88.2 90 66 27 0 
B. subtilis 
Concentration 
(µg/ml) 
1000 500 250 125 62.5 31.25 15.62 7.8 3.9 1.9 Control 
Kill (%) 100 83.2 81.5 80.2 0 0 0 0 0 0 0 
Table 2.10 Toxicity of 188a to bacteria strains 
The same trend is evident in all bacteria used (Figure 2.11) with the exception of S. 
aureus. Bacterial growth is inhibited up to a concentration range of approximately 62 
µg/mL. There is then a sharp increase in the percentage of bacteria killed. As can be 
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seen from the graph (Figure 2.11) after this sharp increase, the percentage of bacteria 
killed can be seen to plateau.  
 
Figure 2.11 Toxicity profile of 188a 
Although some of the ILs tested demonstrate anti-microbial activity (Table 2.11), the 
MIC concentrations are still relatively high, thus indicating a lower level of toxicity 
than the readily toxic reference bromide salt.  
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MIC values (µg/ml) IL Cation 
[Br] 
a 
[PF6] 
c 
[OctOSO3] 
f 
[NTf2] 
d 
[BF4] 
b 
[N(CN)2] 
e 
177 >20000 >20000 5000 10000 >20000 5000 
178 >20000 >20000 >20000 10000 10000 10000 
179 >20000 >20000 >20000 10000 >20000 >20000 
180 >20000 >20000 >20000 >20000 >20000 >20000 
181 >20000 >20000 >20000 10000 >20000 >20000 
182 >20000 >20000 >20000 >20000 >20000 >20000 
183 >20000 2500 >20000 10000 >20000 >20000 
184 >20000 >20000 10000 >20000 >20000 >20000 
185 >20000 >20000 >20000 >20000 >20000 >20000 
186 >20000 >20000 10000 >20000 >20000 >20000 
189 >20000 >20000 >20000 >20000 5000 >20000 
190 >20000 >20000 10000 >20000 >20000 >20000 
191 >20000 >20000 10000 >20000 >20000 >20000 
Table 2.11 Toxicity of ILs to seven bacteria strains 
The evidence obtained from this study demonstrates that the anion has a significant 
influence on toxicity. Analysis of this table of toxicity data demonstrates the bromide 
salts to be non-toxic. ILs with [OctOSO3] and [NTf2] as anion are the most toxic, 
followed by [BF4] and [N(CN)2], with [PF6] showing similar non-toxicity to the 
bromide salts; only one [PF6] IL (183c) shows toxicity.  
Also evident, is that regardless of anion influence the short butyl (177d, 177e, 177f) and 
pentyl (178b, 178d, 178e) lipophilic side chain containing ILs display toxic effects for 
three ILs, rendering them the most toxic cations tested thus far. The absence of acidic 
hydrogen on the C2 position of the imidazolium moiety is shown to alter the toxicity of 
some cations in comparison with 1-methylimidazolium derivatives. In the case of the 
pentyl derivative (178 and 189), the 1-methylimidazolium ILs are more toxic than the 
1,2-dimethylimidazolium derivatives. Although the dimethylimidazolium derivative of 
this cation is shown to be toxic in conjunction with the [BF4] salt (189b), this [BF4] salt 
(178b), as well as the [NTf2] (178d) and [N(CN)2] (178e) salts are toxic in the case of 
the 1-methylimidazolium derivative. The opposite effect can be noted for the 
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butoxyethoxy side chain derivative (cations 182 and 188). The 1-methylimidazolium 
salts are non toxic, while the [OctOSO3] salt of the dimethylimidazolium derivative 
(190f) is toxic at a concentration of 1000 µg/ml. The methoxyethoxyethoxy ILs are 
more toxic to these bacteria with the 1-methylimidazolium cation (183). At a low 
concentration of 2500 µg/ml, the [PF6] IL of this derivative (183c) is toxic, as well as 
the [NTf2] IL (183d) which is toxic at a higher concentration (10000 µg/ml). It is only 
with the [OctOSO3] salt of the dimethylimidazolium derivative of this IL that toxicity is 
observed (191f).   
2.3.2 Biodegradation studies 
To evaluate the biodegradability of the [OctOSO3] ILs, the ‘‘CO2 Headspace’’ test (ISO 
14593)14 was applied (Table 2.12). This method allows the evaluation of the ultimate 
aerobic biodegradability of an organic compound in aqueous medium at a given 
concentration of micro-organisms by analysis of inorganic carbon. The test IL, as the 
sole source of carbon and energy, was added at a concentration of 40 mg L-1 to a 
mineral salt medium. These solutions were inoculated with activated sludge collected 
from an activated sludge treatment plant, washed and aerated prior to use and incubated 
in sealed vessels with a headspace of air. Biodegradation (mineralization to carbon 
dioxide) was determined by measuring the net increase in total organic carbon (TOC) 
levels over time. 
Days Days 
IL no. 
0 7 15 21 28 
 
IL no. 
 
0 7 15 21 28 
SDS 0 81 85 90 92 184f 0 51 56 56 56 
177f 0 45 54 56 59 185f 0 42 62 63 66 
178f 0 52 59 60 64 186f 0 56 61 64 65 
179f 0 54 59 59 59 190f 0 53 54 62 65 
180f 0 54 57 59 57 191f 0 50 52 54 55 
181f 0 51 58 61 65 197f 0 27 32 36 36 
182f 0 53 59 60 61 198f 0 26 30 35 35 
183f 0 32 56 58 58 205f 0 26 30 29 29 
Table 2.12 CO2-Headspace Test Results for [OctOSO3] ILs 
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It can be seen that the ILs containing the ester linkage, regardless of side chain, display 
a similar pattern of biodegradation, all coming close to or surpassing the pass level 
within 28 days (55-66 %) (Figure 2.12). 
 
Figure 2.12 IL biodegradation results 
The importance of having an ester linkage present in the ILs is highlighted by the fact 
that when this functionality is replaced by an amide linker, the biodegradation is seen to 
decrease dramatically. After 28 days, the percentage biodegradation obtained for the 
amide [OctOSO3] ILs ranged from a mere 29 - 36%. It is also interesting to note the 
effect a single methylene group can have on the biodegradation of a compound. 
Compound 184f displayed a satisfactory biodegradation result of 56 %, while the 
incorporation of a methylene group in compound 185f raised this compound above the 
pass level (66 %). The same effect is evident again, albeit to a lesser extent with 
compounds 180f and 181f and lipophilic side chain ILs 177f and 178f. The presence of 
an extra oxygen atom in the side chain can be seen to negatively interfere with the 
biodegradation in certain cases. The only difference between compounds 190f and 191f 
is the last ethereal oxygen atom on the side chain of 191f is replaced in 190f by a 
methylene group. There is a 10 % decrease in biodegradation however with the presence 
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of this supplementary oxygen. A similar effect may be observed comparing compounds 
182f and 183f, although the difference in percentage biodegradation is less dramatic.  
2.4 Structural study of selected bromide ILs 
Although, most uses of ILs are performed while in the liquid state, valuable information 
may be gathered about local interactions in the IL from the solid state crystal structure. 
From a selection of bromide salts that were solid at RT, an attempt was made to grow 
crystals for X-ray crystallographic analysis. Many different methods and solvent 
systems were attempted for a variety of the solid salts. The two compounds that 
successfully formed crystals suitable for measurement were 186a and 191a. 186a was 
grown from a hot saturated solution of the product in an NMR tube containing 
acetonitrile. The hot saturated solution was allowed to cool and was left for several 
weeks, until the acetonitrile had evaporated, after which identifiable crystals could be 
removed from the tube. Crystals were grown from 191a using a binary solvent system 
(dichloromethane and hexane) by a vapour diffusion method. The IL was dissolved in 
dichloromethane in a small plastic vial. This vial was then placed into a bigger plastic 
vial containing hexane. The system was sealed and allowed to stand for one month 
before crystals were evident. Both crystals were colourless and some relevant 
crystallographic information on them is summarised in sections 2.4.1 and 2.4.2.  
2.4.1 191a 
191a crystallises in the monoclinic space group P21/c with one ionic pair per 
asymmetric unit (Figure 2.13).  
C3
C1 C2N1
C12
N2
C6
C5
C7 O2
O4
C4
O1
C11
O3C8
C10
C9 Br
 
Figure 2.13 191a thermal ellipsoids are drawn on the 50 % probability level 
The electrons of the planar imidazolium ring are delocalised. This is evident from the 
shortened C-N and C-C bonds comprising the aromatic ring in comparison with the C-N 
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and C-C bonds for the rest of the structure. Bond lengths for N1-C2, N2-C2, N1-C5 and 
N2-C4 are ≤ 1.380 Å. These values are less than the bond length observed for the same 
nitrogen atoms bonded to atoms adjacent to, but not directly involved in the delocalised 
bonding (C1-N1 = 1.469 Å, N2-C6 = 1.454 Å). The same phenomenon can be seen with 
the bond length value for the aromatic C4-C5 bond (1.340 Å) being less than the non-
aromatic C2-C3 bond (1.476 Å). The lengths of the bonds in the imidazolium ring are 
not evenly distributed, with the bonds directly bonded to the C2 bearing the second 
methyl group being shorter (N1-C2 = 1.334 Å and C2-N2 = 1.343 Å) than the other two 
remaining nitrogen containing aromatic bonds (N1-C5 = 1.378 Å and N2-C4 = 1.380 
Å). The ethereal side chain of the IL is not planar with the imidazolium ring, the first 
deviation occurring between C2-N2 and C6-C7 (C2-N2-C6-C7 = -86.6 °). The bond 
length for C7-O1 is shorter (1.198 Å) than that of C7-O2 (1.335 Å), resulting from the 
stronger double bond holding atoms C7 and O1 together. The evidence of partial double 
bond character can be seen from the bond length of C7-O2, which, although greater than 
that of the carbonyl group, is less than the bond lengths between carbon and ethereal 
oxygen atoms in the side chain, which range from 1.413 – 1.425 Å. The greatest C-O 
bond length is evident between O2 and C8. The mesomeric effect of the ester moiety 
resulting in less net negative charge on the O2 atom is evident, thus leading to a weaker 
bond and therefore a longer bond length in comparison to the bond lengths observed for 
the ethereal oxygens to adjacent methylene groups.  
2.4.2 186a 
186a (Figure 2.14) also crystallises in the monoclinic space group P21/c, however it has 
two structurally similar but crystallographically distinct ion pairs (A and B) per 
asymmetric unit (Figure 2.15).  
C11
C10
C13
C2
C1
O4
C5
C12
C9
C14
N1
N2 O3O2
C6
C3
C4
C8
C7
O1
Br2
 
Figure 2.14 186a thermal ellipsoids are drawn on the 50% probability level 
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Figure 2.15 Ortep representation of molecule A and molecule B 
The bond lengths for both molecule A and molecule B were approximately equal, and 
no notable differences were observed. The greatest differences noted between the two 
molecules however were the torsion angles. As there were many differences in these 
values, differences of ≥ 4 ° were noted. The torsion angle between the imidazolium 
atoms (C2 and N2) and the methylene and carbonyl carbons (C5 and C6) is more 
pronounced in molecule A (-114.1 °) than in molecule B (-110.6 °). The case is the 
same for the C4 and N2 plane where, this time molecule B displays the greatest torsion 
angle (65.7 °) as opposed to molecule A (60.4 °). By far the greatest deviation in terms 
of torsion angle may be noted around the ester moieties of both molecules. It is between 
the N2-C5 plane and the C6-O2 plane that molecules A and B can be seen to adopt 
almost equal but opposite conformations (-177.8 ° and 179.1 ° respectively). The 
carbonyl group of molecule A is more in plane (-3.0 °) with the other ester oxygen and 
following methylene group (O2-C7) than molecule B (-6.7 °). A significant difference 
can also be seen between both molecules for the C9-C10/O4-C11 planes (170.6 and 
176.0 ° for molecules A and B respectively).  
It can be seen by comparison between 186a and 191a that not many differences are 
observed between these molecules in terms of bond angles or length due to the presence 
of a methyl group at the C2 position of 191a. The same phenomenon can be seen in 
186a as was found in 191a in terms of the differing bond lengths in the imidazolium 
ring, and the nitrogens being more closely bound to the intermittent carbon atom than to 
the two carbon atoms joined by a double bond. The same expected trend in bond lengths 
between carbon atoms and ester or ethereal oxygens can also be seen for both 186a and 
191a.  
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2.5 Conclusion 
The synthesis and structural characterization of a library of novel achiral ILs has been 
carried out. 12 bromoesters were prepared. 15 bromide salts, 15 [NTf2], 14 [N(CN)2], 
14 [BF4], 14 [PF6] and 14 [OctOSO3] were successfully synthesised and characterised. 
Concerning the amide derivatives, 4 bromoesters, 5 bromide salts and 3 [OctOSO3] ILs 
were prepared. It was shown that these achiral ILs containing polyether and alkyl side 
chains of varying lengths could indeed be classified under the term ionic liquid and 
therefore be potentially used as alternatives to harmful organic solvents. It has also been 
established that altering the counter ion leads to varying properties, such as the viscosity 
or an increase or depression of melting point. The toxicity data obtained shows that the 
addition of oxygen atoms in the side chains of the ILs is shown to decrease toxicity. It is 
thought that this is due to the oxygen atoms decrease the lipophilicity of the side chain, 
thus making it more difficult to penetrate the cell membrane. The biodegradability data 
gathered confirms that the inclusion of an ester linkage in the ionic liquid assists in the 
biodegradation of the compounds. The ester and polyether functionality in these novel 
ILs show that a range of ILs can be synthesised which lie within the definition of ILs.  
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3 Synthesis, characterisation and biological testing of a 
library of novel imidazolium CILs 
3.1 Introduction 
Preparation of enantiomerically pure compounds is of utmost importance, with the 
formation of one of a pair of enantiomers being desirable. This has been demonstrated 
by the tragic effects that can be caused by the presence of the opposite enantiomer of a 
drug in an otherwise successful drug, a prominent example being that of the thalidomide 
tragedy.1 Another example, albeit of less detrimental consequences is the NSAID 
ibuprofen (206) (Figure 3.1), which is sold over the counter in many countries. 
ibuprofen
206
O
HO
 
Figure 3.1 (S) Ibuprofen (206) 
The (S) enantiomer of this 2-arylpropionic acid derivative is three times more potent 
than the (R) enantiomer, therefore the requirement for asymmetric synthesis of the 
desirable enantiomer is of importance.2 Penicillamine (207), used to treat the 
autoimmune disease, rheumatoid arthritis, is sold in the (S) form because the (R) form 
inhibits the action of pyridoxine (208) (also known as vitamin B6) and thus has led to 
severe adverse effects in patients (Figure 3.2).3 
H2N
SH
O
OH
Penicillamine
207
NHO
HO OH
pyridoxine
208
 
Figure 3.2 Penicillamine (207) and pyridoxine (208) 
The use of enantiomerically pure precursors with the desired absolute configuration 
already present derived directly from the chiral pool4 is attractive and widely used, 
however there is a limit to naturally occurring products available in this form. The use 
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of enantiomeric separation techniques, such as chiral separation by chromatography5 
can also be used to extract the desired enantiomer following a symmetric synthesis of 
the desired product. This can however prove to be costly, and of negative impact to the 
environment, with large quantities of solvent often being needed to perform these 
procedures. Traditional asymmetric synthesis provides a practical method for achieving 
enantiomeric purity. Enantioselective synthesis may be carried out using a chiral 
starting material. This however entails that at least a stoichiometric amount of the 
starting material would be essential, thus possibly rendering this method expensive. The 
use of chiral catalysts6 may overcome this problem as only a sub-stoichiometric amount 
would be required to induce chirality. One technique which is constantly evolving is 
chiral induction arising from the use of a chiral solvent.7-9  A library of novel chiral ILs 
containing an ester linkage is prepared from mandelic and lactic acid with a view to be 
used as chiral induction solvents in asymmetric synthesis.  
3.2 Synthesis of novel CILs 
Mandelic (53) and lactic acid (52) are readily commercially available in their racemic 
and enantiomerically pure forms (Figure 3.3), thus making these compounds ideal for 
the introduction of chirality into the novel ILs. Mandelic acid was chosen to integrate 
into the ILs due to its chiral centre being surrounded by the hydroxyl and phenyl group. 
This was thought to have potential for chirality induction. As the phenyl group was 
presumed to increase the melting points of the formed ILs, lactic acid was used also due 
to the absence of this group.  
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Figure 3.3 Mandelic and Lactic acid 
These chiral carboxylic acids can easily be modified by esterification, thus adding 
potential to modulate their properties. The ester linkage evident in our achiral ILs may 
be maintained by reaction of the formed esters with bromoacetyl bromide. The synthetic 
steps followed to obtain these chiral ILs are essentially the same as carried out with the 
achiral derivatives (Figure 3.4). 
Br
Br
O
+ Br
O
DCM
-78 ºC
N2
N N
O
(iii) anion exchange
diethyl ether
Br
(i)  esterification (ii) alkylation
NN
N2
N N
OY
O
OR' OR'
O
OH OH
R*OH =
*R OH
OR*
OR*OR*
 
Figure 3.4 Synthesis of chiral ILs 
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3.2.1 Esterification of mandelic and lactic acid 
An extra step was introduced at the beginning of the synthesis in order to synthesise the 
chiral ester with varying side chains (R) (Figure 3.5). This reaction, adapted from 
Moormann et al.10 is carried out under reflux conditions, using no solvent, a sub-
stoichiometric amount of thionyl chloride, and the alcohol in excess. This reaction was 
monitored by TLC, and it was found after a few trial reactions that six hours was 
sufficient time for reaction completion.  
O
OR'
OR''
O
OH
OH
O
OH
OH
O
OH
OH
R'OH
SOCl2, reflux
R''OH
SOCl2, reflux
R'OH = ethanol, butanol, pentanol, ethoxyethanol
R''OH = methanol, ethanol, propanol, butanol, pentanol, ethoxyethanol
 
Figure 3.5 Synthesis of chiral starting materials 
This reaction proceeded in excellent yields for both mandelate (209) (82 – 100 %) and 
lactate (210) (74 – 97 %) derivatives (Table 3.1). 
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Mandelate derivative 
209 
O
OR
OH
 
Lactate derivative 
210 
OR
O
OH
 
R: R S RS R: R RS 
CH3 85* m 82* n 99 o CH3 79 a 84* b 
C2H5 98 a 84 b 100 c C2H5 77* c 97 d 
 - - - C3H7 79* e 74* f 
C4H9 100 d 98 e 100 f C4H9 78* g 80* h 
C5H11 95 g 97 h 98 i C5H11 88* i 75* j 
C2H4OC2H5 84 j 85 k 99 l C2H4OC2H5 79* k 92* l 
Table 3.1 Synthesis of mandelate and lactate esters (*: synthesised by BP) 
3.2.2 Step 1: Esterification – Synthesis of α-bromoesters 
The synthesis of the alkylating agents proceeded in average to good yield, loss in yield 
being due to the purification step required (Table 3.2). 
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Mandelate derivative 
211 
O
OR
O
O
Br
 
Lactate derivative 
212 
OR
O
O
O
Br
 
R: R S RS R: R RS 
 58* m 69* n 73 o CH3 59 a 37 b 
C2H5 69 a 66 b 90 c C2H5 41* c 57 d 
 - - - C3H7 82* e 70* f 
C4H9 80 d 69 e 75 f C4H9 35* g 40 h 
C5H11 57 g 37 h 63 i C5H11 58* i 33* j 
C2H4OC2H5 76 j 65 k 65 l C2H4OC2H5 58* k 60* l 
Table 3.2 Synthesis of mandelate and lactate α-bromoesters (*: synthesised by BP) 
Purification of the crude mandelate-based bromoesters involved column 
chromatography. DCM : hexane proved to be the best mobile phase for most mandelate 
derivatives in varying proportions, ranging from 50 : 50 DCM : hexane, for ethyl 
derivatives, to 70 : 30 DCM : hexane, for pentyl and 80 : 20 DCM : hexane for 
ethoxytethyl side-chain derivatives. The pure product was the last spot to elute from the 
column, generally as a pale yellow oil. Analysis of the 1H NMR spectra of the pure 
products obtained for this step of the synthesis display interesting features. As can be 
noted in the case of both the mandelate and lactate derivatives (Table 3.3), the signal for 
the proton (integration = 1) shifts by approximately 0.8 ppm in both cases, upon 
formation of the bromoester, as the other signals remain at approximately the same 
chemical shift. This is thought to be due to the increased electronegativity of its 
environment due to the addition of the bromoester moiety.  
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Table 3.3 Chemical shift investigation of 1H NMR spectra 
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More importantly to note is the appearance of a doublet in the spectrum of the 
mandelate bromoester (Figure 3.6). These signals, due to diastereotopic protons, display 
evidence of the roofing effect. 
3.913.923.933.943.953.963.973.983.994.004.014.024.034.04 ppm 
Figure 3.6 Roofing effect 
3.2.3 Step 2: Alkylation – Synthesis of imidazolium bromide salts 
The synthesis of the bromide salts proceeded in good yields (Table 3.4). Synthesis of 
the lactate bromide derivatives yielded viscous liquids at RT. The same reaction 
conditions were used for the synthesis of these bromide salts, as were used for the 
synthesis of the achiral derivatives. 
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Mandelate derivative 
213 
N N O
O
Ph
O
OR
Br
 
Lactate derivative 
214 
N N O
O
O
OR
Br
 
R: R S RS R: R RS 
CH3 93 m 
99-101 °C 
78 n  
97-99 °C 
94 o  
140-142 °C 
CH3 66 a  
115-117 °C 
50*b  
C2H5 81 a  
130-132 °C 
82 b  
129-131 °C  
68 c  
132-134 °C  
C2H5 77 c 88 d 
 - - - C3H7 87*e 88 f 
C4H9 82 d  
88-90 °C 
64 e  
89-91 °C 
58 f  
118-120 °C 
C4H9 86 g 82 h 
C5H11 68 g  
44-45 °C 
73 h  
73-75 °C 
60 i  
127-129 °C 
C5H11 89*i 87*j 
C2H4OC2H5 71 j  
31-33 °C   
85 k 76 l  
124-126 °C 
C2H4OC2H5 84*k 95*l 
Table 3.4 Mandelate and lactate bromide salts (*: synthesised by BP) 
The coupling of diastereotopic protons in the spectrum of 214a as an example can be 
seen in Figure 3.7. H1 and H2 protons are in inequivalent environments. They are thus 
coupling with each other, to give two different sets of doublet signals. Here also is an 
example of the roofing effect, which shows us that these two protons are strongly 
coupled.  
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Figure 3.7 1H NMR of 214a 
Further evidence of the mutual coupling of these two methylene protons can be seen in 
the COSY NMR spectrum of this bromide salt 214b (Figure 3.8). 
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Figure 3.8 COSY spectrum of 214b 
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An increase in melting point was observed in the case of the mandelate bromide 
derivatives with the formation of solid powders at RT. An example of a 1H NMR 
spectrum of a typical bromide mandelate based salt, namely the butyl derivative, (213e) 
can be seen in Figure 3.9. 
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Figure 3.9 3-methyl-1-(S)-(butylmandelylcarbonylmethyl)imidazolium bromide 213e 
The same roofing effect can be seen here as was noted for the lactate derivatives at 
approximately 5.5 ppm.  
An interesting effect can be seen from examining the signals from the 1H NMR of these 
particular diastereotopic protons. As in the case of the achiral ILs, the charge separation 
between the anion and the cation may be estimated from the signals of these protons. 
Again, the deshielding effect of the anion can be viewed. The greater deshielding effect 
the anion has on the cation of the IL, the greater the distance between the two inner 
signals. The more deshielded the cation, the more influential the effect of the adjacent 
chiral centre is. The same trend of anion effect on charge separation as was 
demonstrated with the achiral ILs is now evident: ∆δ is greatest for the bromide salts, 
this value is less for the [OctOSO3] derivatives, and is the least for the [NTf2] 
derivatives. Therefore, the more deshielded the protons, the weaker their mutual 
coupling.  With the ILs of the bromide anion, ∆δ is the largest. Also, the chemical shift 
for these protons, taking as an example RS-ethyl mandelate, are the lowest downfield 
for the bromide salt (~5.6 ppm) (213a), more upfield (~5.3 ppm) for [OctOSO3] (217a) 
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and the most upfield for the [NTf2] salt (215a) (~5.0 ppm). From examining the spectra 
of 213a and 215a, it can be seen that the distance measured between the two inner 
signals for the methylene protons of the bromide salt is 0.195 ppm, whereas the 
spectrum of the [NTf2] salt shows the overlapping of these peaks to form one peak. The 
effect for the [OctOSO3] ILs can be seen when the distance between signals displaying 
the roofing effect in the spectrum of 217a are less than 0.195 but greater than 0, which 
is the case for the [NTf2] derivative of this IL.  
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Table 3.5 Comparison of chemical shift differences of diastereotopic protons 
In the case of the (S)-butyl mandelate derivative ([Br] 213e and {NTf2] 215e), the 
signals for the [NTf2] IL display the roofing effect, ∆δ being however much less in the 
case of the [NTf2] salt in comparison with the bromide derivative. 
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Table 3.6 Comparison of chemical shifts of diastereotopic protons 
With the use of this method however evolved problems concerning the formation of the 
mandelate bromide salt. Upon addition of the bromoester, to the stirred solution of 
methyl imidazole in diethyl ether, brown/black viscous material gradually appeared. An 
example spectrum of this impure material in comparison with the pure product can be 
seen in Figure 3.10.  
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Figure 3.10 1H NMR of impurity spectrum and pure product (213e) 
The main difference noted between this spectrum and the spectrum of the pure product, 
is that the impure viscous material bears the same peaks as the pure material, however 
containing extra impurity peaks. A conspicuous extra peak at 9.1 ppm could suggest 
remaining methyl imidazole in the viscous material. The broad band occurring at 3.4 
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ppm however may suggest that some moisture entered the reaction flask thus resulting 
in hydrolysis and the starting alcohol being present. This material was occasionally 
observed appearing at the start of the reaction, whilst still at – 20 ºC, but often time seen 
as the reaction mixture was warmed up to room temperature. Progression of the reaction 
showed formation of lightly coloured to white powders forming, separately to the 
impurity. Numerous attempts were made to curb the formation of this impurity. The 
reaction temperature was lowered to - 78 ºC for the dropwise addition of the bromoester 
with no change observed. Slower addition of the bromoester to the stirring solution of 1-
methylimidazole also resulted in no change observed. An alternative addition method 
was attempted; i.e. dropwise addition of 1-methylimidazole to a stirring solution of 
bromoester however no change was observed. On occasion, when the pure product was 
the first observed to be forming at the reduced temperature, the reaction was allowed to 
warm up to just below room temperature and then stopped. Although this effort led to 
the formation of only one pure product, a huge compromise in yield was observed, the 
bromide salts, although being pure, obtained in this manner being present in 
approximately 5 % yield. The reaction solvent was exchanged from diethyl ether to 
THF, however again, no change was observed. The bromoester was added dropwise at 
RT, with no change observed. 1-methylimidazole was added dropwise at RT to the 
reaction solvent containing the bromoester, but still the impurity was observed. 
As the synthesis of these bromide salts progressed, it was noticed that the impurity was 
only formed on very small scale relative to the formation of the product, and due to the 
differing natures of the two materials, could easily be separated from each other during 
the reaction work-up. It was also observed on occasion, that no impurity formed during 
reaction, and thus many bromide salts were formed in almost 100 % purity. Thus, 
efforts to optimise this method by eliminating the formation of the impure material were 
abandoned, as the pure product could be obtained in satisfactory yields.  
The one exception to this occurrence was the case of the (S) – ethoxyethyl mandelate 
bromide derivative (213k). This was formed as a viscous liquid, NMR analysis showing 
it to contain the undesired impurity (Figure 3.11).  
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Figure 3.11 1H NMR spectrum of 213k 
Although the R- (213j) and RS- (213l) versions of this salt proceeded as expected, with 
the formation of powders, the nature of the S- (213k) version rendered it impossible to 
separate from this impurity using the current purification method. 213k was however 
used for the synthesis of the [NTf2] salt (215k). It was hoped that these impurities 
would be water soluble, and indeed some impurity was eliminated with the water 
washes. A spectrum of the 215k can be seen below (Figure 3.12). Although not as pure 
as other mandelate [NTf2] salts formed, a decrease in impurity can be observed in 
comparison with the spectrum for the corresponding bromide salt (213k). 
 112 
1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5 ppm
2.
97
2.
30
2.
17
3.
12
2.
26
2.
14
0.
96
1.
12
7.
06
1.
00
 
Figure 3.12 1H NMR spectrum of 215k 
3.2.4 Step 3: Anion metathesis 
3.2.4.1 [NTf2] ILs 
Synthesis of the chiral [NTf2] salts remained unchanged from the synthesis of their 
achiral counterparts. Depressed melting points in comparison to their bromide salt 
derivatives were again observed. Reactions proceeded in good to excellent yields for 
both mandelate (79 -98 %) and lactate (57 – 92 %) derivatives (Table 3.7). 
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Mandelate derivative 
215 
N N O
O
Ph
O
OR
NTf2
 
Lactate derivative 
216 
N N O
O
O
OR
NTf2
 
R: R S RS R: R RS 
CH3 - m - n 92 o 
73-75 °C 
CH3 57 a 65 b 
C2H5 95 a  
44-46 ºC 
85 b  
44-46 ºC 
95c C2H5 72 c 63 d 
    C3H7 92 e 86 f 
C4H9 98 d 93 e 94 f C4H9 64 g 83 h 
C5H11 87 g 96 h 93 i C5H11 87 i 87 j 
C2H4OC2H5 92 j 86 k 79 l C2H4OC2H5 67 k 76 l 
Table 3.7 Mandelate and lactate derived [NTf2] ILs 
From the example spectra shown for 214a and 216a (Table 3.8), it can be seen that the 
signals due to the imidazolium moiety of the cation are shifted upfield in the case of the 
spectra for the [NTF2] salt, from 7.6 ppm to 7.4 ppm. The acidic proton signal of the 
imidazolium ring is also more downfield in the case of the bromide salt. Also shifted 
upfield in the case of [NTf2] are the signals for the inequivalent methylene protons. 
Other signals however remain at approximately the same chemical shift for each salt. 
Thus it is evident that it is only these protons that experience a greater influence from 
deshielding by the anion. 
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Table 3.8 Chemical shift comparison of ILs of different anions 
In the case of the mandelate derivatives, as can be seen for 213f and 215f, the same 
effect is evident. The signals in the aliphatic region of the spectrum remain more or less 
unchanged from the bromide to the [NTf2] salt. The signal for the aromatic protons also 
remains unchanged. The signal due to the methyl group bound to the imidazolium ring 
shows a minor downfield shift (~ 0.1 ppm) in the spectrum of the bromide salt in 
comparison to that of the [NTf2] salt.  
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Table 3.9 Comparison of chemical shift values for ILs of different anions 
The roofing effect is also much more significant in the case of the counterion exchange 
salt 215f (Figure 3.13). 
4.985.005.025.045.065.085.105.125.145.165.18 ppm
 
Figure 3.13 Roofing effect in 1H NMR spectrum of 215f 
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3.2.4.2 [OctOSO3] ILs 
The method used for the synthesis of the achiral [OctOSO3] salts was modified slightly 
for the formation of the chiral derivatives. A reaction was initially carried out under the 
same conditions as used for the achiral salts (H2O, 60 º, and 2 h). The resulting 1H NMR 
obtained from this reaction showed a hydrolysis reaction having occurred due to the 
increased temperature and presence of water in the reaction. The reaction was therefore 
carried out at RT with an extended reaction time (from 2 h to overnight) in order to 
ensure reaction completion. This indeed resulted in the formation of the pure products 
with no compromise in yield (71 – 99 %) for mandelate salts and 87 – 95 % for the 
lactate derivatives (Table 3.10). 
Mandelate derivative 
217 
Lactate derivative 
218 
N N O
O
Ph
O
OR
OctOSO3
 
N N O
O
O
OR
OctOSO3
 
R R S RS R R RS 
CH3 75* m 89* n 97 o CH3 94 a 90* b 
C2H5 95 a  
40-42 ºC 
91 b 
 38-40 ºC 
92 c C2H5 93* c 95* d 
    C3H7 90* e 89* f 
C4H9 98 d 
  
77 e  
30-32 ºC 
99 f C4H9 89* g 90 h 
C5H11  99 g 
29-31 ºC 
99 h  95 i 
30-32 ºC 
C5H11 87* i 89* j 
C2H4OC2H5 82 j 71 k 83* l C2H4OC2H5 90 k 91* l 
Table 3.10 Mandelate and lactate derived [OctOSO3] salts 
3.3 Biodegradation Studies  
Biodegradation studies were carried out on the novel [OctOSO3] CILs. (Toxicity testing 
was not performed in advance due to time constraints regarding patent filing.) In 
comparison with the achiral counterparts of the chiral ILs, the lactate derivatives 
demonstrate similar biodegradation values to the achiral ILs. The most noticeable 
difference was observed with the addition of a phenyl group to the ILs as in the case of 
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the mandelate derivatives. Higher biodegradation percentages were obtained from the 
mandelate derivatives after 28 days in comparison with the lactate derivatives. 
3.3.1 Mandelate derivatives 
All mandelate ILs were readily biodegradable. Regarding the effect of the side chain 
length on the biodegradation of the mandelate derivatives, not much difference is 
evident between the [OctOSO3] salts. The most prominent result was obtained from the 
ethyl derivative which displayed the lowest biodegradation of the mandelate derivatives. 
No significant variation was evident between the same ILs of different enantiomeric 
composition except for the ethoxyethyl derivative. The racemic form of this [OctOSO3] 
IL gave 68 % however its enantiomeric forms display significantly higher 
biodegradation after 28 days equal to or exceeding 80 %.  
Days Days 
IL no. 
0 7 15 21 28 
 
IL no. 
 
0 7 15 21 28 
SDS   0  79  85  89    89 217f* 0 66 75 83 82 
217m 0 58 66 70 77 217g 0 64 78 79 82 
217n 0 62 68 70 71 217h 0 62 72 77 79 
217o 0 58 64 69 74 217i 0 66 76 81 79 
217a 0 50 58 65 65 217j 0 51 62 68 68 
217b* 0 51 62 67 67 217k 0 63 73 78 80 
217d 0 62 71 78 78 217l 0 73 77 85 83 
Table 3.11 Biodegradation of Mandelic [OctOSO3] ILs 
* ILs 217 c and e were omitted from this study due to funding constraints 
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Figure 3.14 Biodegradation of Mandelic [OctOSO3] ILs 
3.3.2 Lactate derivatives 
Nine out of twelve lactate ILs tested were readily biodegradable. Again, as with the 
mandelate derivatives, the ethyl derivative of the lactate [OctOSO3] ILs demonstrated 
the lowest biodegradation result. The greatest difference evident between the racemic 
form and enantiomeric form of a lactate IL of the same side chain length was observed 
with the butyl derivative. A difference of 7 % was observed between the two forms of 
this [OctOSO3] IL.  
Days Days 
IL no. 
0 7 15 21 28 
 
IL no. 
 
0 7 15 21 28 
SDS 0 76 85 86 89 218g 0 52 61 58 61 
218a 0 46 57 61 64 218h 0 41 51 50 55 
218b 0 49 60 63 67 218i 0 52 65 72 72 
218c 0 44 54 52 56 218j 0 54 67 70 71 
218d 0 41 53 51 59 218k 0 55 64 69 69 
218e 0 50 63 66 67 218l 0 59 69 74 74 
218f 0 51 62 69 69       
Table 3.12 Biodegradation of Lactate [OctOSO3] ILs 
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Figure 3.15 Biodegradation of Lactate [OctOSO3] ILs 
3.4 Structural studies of enantiomers (213m and n) of ILs 
Crystals suitable for crystallographic analysis were grown from (R) and (S) 
enantiomers, 213m and 213n. 213m was grown in an NMR tube from a saturated 
solution of the product in dichloromethane to give small slightly yellow oblong-shaped 
crystals. A binary solvent system consisting of dichloromethane and hexane was used to 
grow colourless block-shaped crystals of 213n.  
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213m 213n 
N
N
O
O
O
O
Br
 
N
N
O
O
O
O
Br
 
C14 C15
C13
O1
C12
C10
C3
C11
C7
C4
O3
C6
C1
N1
C8
O2
N2
C2
C5
O4
C9
 
C14
C13
C15
C12
C10
O1
C11
C7
C3 C4
O3
C6
C8
N1
C1
O2
N2
C2
C5
O4
C9
 
Table 3.13 Crystal structures of enantiomeric forms of 213m and 213n 
Both 213m and 213n crystallise in the triclinic space group P1 and contain two ionic 
pairs per asymmetric unit. Both crystals contain a water molecule hydrogen bonded to 
the bromine atoms in the crystallographic lattice.  
213m 213n 
O10
H1O1Br2
H2O1
O3
Br1
H1O9
C9
H2O9
C28
C29
C8
O9
O4
C27
C30
C15
C7
C25
C26
C14
C10
O2
O1
O6
C22
C6
C20 C21
C13
C11
C19
C2
C1
N4
C5
O5
C12
N1
N2
C23
C18 O8
C17 O7
C3C4
N3
C24
C16
 
O10
H1O1
Br2H2O1
O3
Br1
C9
H1O9
H2O9
C28
C29
C8O9
O4
C30
C27 C15
C7
C25
C26 C14
C10
O2
O6
O1
C22
C6
C20
C21
C13
C11
C19
C2
C1
N4
O5
C5
C12
N1
N2
C23
C18
O8
C17O7
C3
C4
N3
C24
C16
 
Table 3.14 Molecules with the counter ions and the hydrogen bond linked water 
molecules 
Comparing the data collected from both crystal structures, both enantiomers are almost 
identical. Taking 213m as an example, the aromatic character of the imidazole ring can 
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be identified. The C-C bond length in the imidazole ring (C4-C5: 1.356 Å) is similar to 
the C-C bond lengths of the aromatic phenyl group which range from 1.370 to 1.397 Å. 
These aromatic bond lengths are substantially less than the C-C bond length of a non-
aromatic carbons (C7-C10: 1.514 Å).  
3.5 Conclusion 
From the library of compounds prepared, from 24 starting materials, 13 mandelate 
esters and 2 lactate esters were prepared. The remaining compounds in the library were 
prepared by BP (*). 13 mandelate and 4 lactate bromoesters were prepared out of a 
possible 24. 15 mandelate and 6 lactate bromide salts, 13 mandelate and 12 lactate 
[NTf2] ILs and 12 mandelate and 3 lactate [OctOSO3] ILs were prepared. The starting 
materials were synthesised in pure form in order to synthesise all chiral ILs for this 
library of compounds. It was found that chirality could indeed be integrated into these 
ILs by this method. The novel ILs were characterized by 1H and 13C NMR and by mass 
spectrometry. The melting points for the mandelate bromide salts however were in some 
cases above the currently defined range for ILs (> 100 °C), the changing of the counter 
ion to [NTf2] or [OctOSO3] was shown to lower the melting point to within this range. 
The biodegradability of all the chiral mandelate ILs was found to be above the pass 
level for the test, > 60 %. For nine out of twelve chiral lactate examples, they also 
passed the CO2 Headspace test. The three ILs which were not found to be readily 
biodegradable gave 55-59 %. 
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4 Application of novel achiral ILs in hydrogenation reactions 
4.1 Introduction 
With current increased environmental awareness, hydrogenation is an especially popular 
reduction reaction, as hydrogen gas is an inexpensive reagent and by far the cleanest 
reducing agent.1 Also, hydrogenation in the form of heterogeneous catalysis facilitates 
facile catalyst separation from the desired product and in some cases catalyst recycling.  
Hydrogenation is used to reduce various functional groups. This reaction is widely used 
throughout the petrochemical industry2 as well as being used extensively in the 
synthesis of products and intermediates for the pharmaceutical industry.3, 4 
Heterogeneous hydrogenation is advantageous over homogeneous hydrogenation, 
because in the liquid phase, the catalyst can be separated and regenerated and thus the 
products isolated in their pure form. Selective hydrogenation is important as often there 
are many reducible functionalities present in a compound. A prime example is the 
terpene, carvone (219) (Figure 4.1). It has three possible reduction sites, the carbonyl 
group, and both endo-cyclic and exo-cyclic olefinic groups, with products of its 
selective hydrogenation being desirable.5-8 
O
carvone
219
 
Figure 4.1 Carvone (219) 
The classic metals used for hydrogenation are noble metals, for example palladium and 
platinum, finely distributed on solid supports such as activated carbon.  
Using heterogeneous hydrogenation, a destructive form of hydrogenation can be 
achieved – hydrogenolysis. A common use of hydrogenolysis is for removal of 
protecting groups such as benzyl ethers9 or silyl ethers (TMS – trimethylsilyl or 
TBDMS – tert-butyldimethylsilyl).10 
The hydrogenation at 1 atm H2 pressure of various substrates (trans-stilbene (220), 
trans-cinnamaldehyde (94), trans-cinnamic acid (221), methyl cinnamate (222), ethyl 
trans-cinnamate (223), benzyl cinnamate (224), cinnamonitrile (225), cinnamamide 
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(226), allyl cinnamate (227), vinyl cinnamate (228)) in a range of novel achiral ILs was 
investigated (Figure 4.2).  
trans-stilbene
O
trans-cinnamaldehyde
O
HO
trans-cinnamic acid
O
O
methyl cinnamate
O
O
ethyl trans-cinnamate
O
O
benzyl cinnamate
O
H2N
cinnamamide
N
cinnamonitrile
O
O
allyl cinnamate
O
O
vinyl cinnamate
222 223
228
227
224
94
221
220
226 225
 
Figure 4.2 Investigated substrates in novel ILs 
Trans-stilbene (220) was used as a test substrate to explore the applicability of the ILs 
as reaction solvents for hydrogenations. Hydrogenation was then carried out using a 
variety of cinnamic compounds with varying functional groups (aldehyde, ester, acid, 
amide, nitrile). Features of the ILs were investigated, together with the applicability of 
the ILs as solvents for recycling procedures. The percentage selectivity (Equation 1) 
was calculated according to the following equation:11 
%% 100
%
product
selectivity x
products
=
∑
 
Equation 1 % Selectivity calculation 
The percentage conversion (Equation 2) was calculated according to the following 
equation: 
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% 100
products
conversion
substrate products
= ×
+
∑
∑
 
Equation 2 % Conversion calculation 
4.2 Trans-stilbene (220) 
The reduction of stilbene normally leads to one product, 1,2-diphenylethane (229) 
(Figure 4.3). Selective reduction of the double bond in trans-stilbene can be attributed 
to the fact that phenyl rings are notoriously difficult to reduce, with few exceptions.12 
trans-stilbene 1,2-diphenylethane
H2
IL
catalyst
220 229
 
Figure 4.3 Hydrogenation of trans-stilbene 
1,2-Diphenylethane (229) is desirable as a derivative for its anti-estrogenic properties.13 
For hydrogenation of trans-stilbene in the novel ILs, 1,2-diphenylethane was the only 
product observed. 80 ºC was chosen as the temperature for these reactions, however 110 
°C was necessary to dissolve the substrate in the [OctOSO3] ILs. The elevated 
temperature was used to facilitate the dissolution of the solid trans-stilbene in the ILs. 
The exception to this high temperature was with the 178d and 181d IL. Dissolution of 
the substrate was observed at 55 °C in these ILs. For hydrogenations carried out in the 
[OctOSO3] ILs, distillation under high vacuum was used to separate the product from 
the IL/catalyst system. Organic solvents (hexane, diethyl ether, acetonitrile, 
dichloromethane, chloroform, acetone, toluene, methanol, ethyl acetate, dioxane) were 
investigated as solvents for extraction, however all were at least partially soluble in the 
IL. The hydrogenation of this substrate in the ILs was examined according to various 
factors (IL anion, IL cation, recylability). 
4.2.1 Effect of IL anion on hydrogenation 
Concerning the IL of pentyl side chain, switching the anion from [NTf2] (178d) to 
[N(CN)2] (178e) significantly reduced the percentage conversion, from 100 to only 2 %. 
This drop in conversion is not noted for any of the other anions observed using the 
pentyl derivative (Table 4.1). 
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178 
Temp. (° C) Anion Conversion (%) 
55 NTf2 d 100 
N(CN)2 e 2 
PF6 c 98 
80 
BF4 b 74 
110 OctOSO3 f 100 
Table 4.1 Anion effect with 178 cation 
Also, using the propoxyethoxy side chain (181), the [OctOSO3] IL (181f) gave identical 
results to the [NTf2] IL (181d) albeit at a higher temperature (Table 4.2).  
181 
Anion Temp. (° C) Conversion (%) 
NTf2 d 55 100 
OctOSO3 f 110 100 
Table 4.2 Anion effect with 181 cation 
4.2.2 Effect of IL cation on hydrogenation 
4.2.2.1 IL side-chain 
Although an increase in temperature from 55 to 80 °C was necessary to facilitate 
dissolution of the trans-stilbene substrate in all [NTf2] ILs tested apart from the pentyl 
(178d) and propoxyethoxy derivative (181d), the effect of the side chain did not deliver 
major differences in terms of conversion (Table 4.3).  
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NTf2 ILs (d) 
Cation Temp. (° C) Conversion (%) 
178 55 100 
179 80 95 
180 80 100 
181 80 100 
183 80 93 
185 80 100 
Table 4.3 IL side-chain effect with [NTf2] ILs 
All ILs tested for the hydrogenation of trans-stilbene proved successful, however the 
lowest conversions were observed for the cation derivatives with the side chain 
terminating in an ethereal methyl group.  
4.2.3 Recyclability 
Using 178d the IL/catalyst system was reused 20 times with no reduction in selectivity 
(Table 4.4). The conversion did not fall below 100 % until the 18th recycle experiment, 
where the conversion was seen to drop to 93 %. Subsequent recycle experiments 
showed the conversion not to reach 100 % again, and thus the recycling experiment was 
terminated. It is noteworthy that the 1H NMR of the IL showed no degradation after all 
recycling experiments. The IL had undergone 576 hours in total of hydrogenation 
reactions at 55 °C.  
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178d 
Experiment/ 
Recycle 
Conversion 
(%) 
Time 
(h) 
Experiment/ 
Recycle 
Conversion 
(%) at 24 h 
91 5 R8 100 
100 24 R9 100 
E1 
100 48 R10 100 
59 5 R11 100 
100 24 R12 100 
R1 
100 48 R13 100 
75 5 R14 98 
100 24 R15 100 
R2 
100 48 R16 100 
R3 100 24 R17 100 
R4 97 24 R18 93 
R5 100 24 R19 94 
R6 98 24 R20 94 
R7 98 24   
Table 4.4 IL recyclability (178d) 
Changing the cation of the IL while using the same [NTf2] anion showed almost no 
effect on the recyclability up to 2 recycles. Using the [PF6] IL (178c), upon the 1st 
recycle no difference was seen. The [BF4] IL (178b) showed a significant decrease from 
74 to 60 % conversion upon 1st recycle and the [OctOSO3] IL (178f) showed the poorest 
result in terms of recyclability, a drop from 100 % to 0 % conversion upon the 1st 
recycle (Table 4.5).  
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Cation Anion Temp. 
(° C) 
Exp./ 
Recycle 
Conversion 
(%) 
E1 98 
R1 100 
179 NTf2 d 80 
R2 98 
E1 100 180 NTf2 d 80 
R1 100 
E1 100 181 NTf2 d 55 
R1 98 
E1 93 183 NTf2 d 80 
R1 100 
E1 98 PF6 c 80 
R1 98 
E1 74 BF4 b 80 
R1 60 
E1 100 
178 
OctOSO3 f 110 
R1 0 
Table 4.5 IL recyclability with various ILs 
4.2.4 NMR analysis 
The conversion of trans-stilbene (220) to 1,2-diphenylethane (229) can be easily 
monitored by the disappearance of the olefinic singlet representing two protons at ~ 7 
ppm on the 1H NMR spectrum. The appearance of another singlet more upfield, 
representing four equivalent protons at ~ 2.8 ppm appears as the double bond is 
hydrogenated. As can be seen from the 1H NMR spectrum of the substrate and the 
product, the two are easily distinguishable (Figure 4.4). 
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Figure 4.4 1H NMR spectrum of 220 and 229 
As the samples were monitored at 5 h and 24 h, a quick analysis by 1H NMR was 
possible while the substrate and products remained in the IL mixture. The 
hydrogenation of the substrate and subsequent conversion to product can be seen amidst 
the proton peaks of the IL (Figure 4.5). 
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Figure 4.5 1H NMR of substrate and product in IL 
4.3 Trans-cinnamaldehyde (94) 
The α,β-unsaturated aromatic aldehyde, trans-cinnamaldehyde (94) was hydrogenated 
in a broad range of achiral ILs. Due to its highly conjugated system, the hydrogenation 
of this α,β-unsaturated aldehyde not only leads to the reduction of the olefin moiety, but 
also the carbonyl group, yielding 3-phenylpropanol (97). Three main products however 
may be obtained from the reduction of this substrate; the saturation of the olefinic bond 
leads to the saturated aldehyde, hydrocinnamaldehyde (95), the reduction of the 
carbonyl group to yield the unsaturated alcohol, cinnamyl alcohol (96), and the 
reduction of both functionalities to yield the saturated alcohol, 3-phenylpropanol (97) 
(Figure 4.6). 
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Figure 4.6 Hydrogenation of trans-cinnamaldehyde 
As the resulting products of the hydrogenation of trans-cinnamaldehyde (94) are widely 
used in the fine chemical industry,14-16 it is desirable to selectively synthesise each 
product. The selectivity of the reduction of this substrate varies due to the two potential 
reducible functionalities in the compound, namely the alkene and carbonyl moiety. Due 
to the thermodynamically favoured reduction of the C=C bond over the C=O bond,17, 18 
the selectivity towards the unsaturated alcohol (96) is generally poor. This can be 
frustrating as 96 is used widely in the flavouring and perfume industries. 
Hydrocinnamaldehyde (95) however also deserves merit as it has uses in the perfumery 
industry and also in the important field of drug synthesis of anti-HIV compounds.19-21 
Nuithitikul and Winterbottom22 selectively reduced the olefin moiety of 
cinnamaldehyde using an aqueous solution of a rhodium (I) complex (chlorotris(meta-
trisulphonato triphenylphosphine). The reactions were carried out in a batch reactor (10 
– 40 atm. H2, 50 – 90 °C) and up to 99.9 % selectivity towards the saturated aldehyde 
was observed using a biphasic system (water/toluene). Reductions of cinnamaldehyde 
based on ruthenium catalysts were carried out by Hajek et al.23 and Qiu et al..24At 50 
atm. H2 using a 5 % Ru/Y catalyst (Y: alumosilicate zeolite used in petrochemistry), 
Hajek et al. achieved selectivity up to 70 % towards the unsaturated alcohol. Qiu et al. 
achieved similar selectivity (79.1 %), also towards the reduction of the carbonyl moiety, 
using a carbon nanotubes-supported Pd-Ru catalyst at 120 °C and 50 atm. H2 pressure. 
Better results were obtained using the combined metal system than with each metal 
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alone, speculated by the group to be due to a synergic effect or a promoting effect 
exerted by ruthenium. Our investigations using recyclable Pd/C catalysts in ILs at 1 
atm. H2 pressure to give selective reduction of the double bond in cinnamaldehdyde 
represent a significant result. 
Over the course of the reactions performed in the novel ILs, 96 was never observed, 
leading to the conclusion that the C=C double bond is reduced first, followed by the 
carbonyl group. The selectivity towards 95 was in every case much greater than that of 
3-phenylpropanol (97), the latter being formed mostly in minute quantities. Due to the 
viscosity of the ILs, the temperature chosen initially for these reactions was 55 ºC as it 
was not too high to speed up the degradation of the IL, or to significantly lower the 
solubility of the gas in the IL. This was seen to be the optimal temperature for most 
reactions carried out, as the IL became less viscous therefore facilitating easier stirring 
and dissolution of the substrate. The hydrogenation of this substrate in the ILs was 
investigated according to various factors (IL anion, IL cation, IL purification, reaction 
temperature, catalyst used, organic solvent comparison and recycling).  
4.3.1 Effect of IL anion on hydrogenation 
The most impressive results were achieved using the [NTf2] ILs, in comparison with the 
other four anions studied (Table 4.6).  
178 
Anion Conversion (%) Selectivity (%) 
NTf2 d 98 94 
BF4 b 0 - 
N(CN)2 e 12 100 
OctOSO3 f 25 100 
Table 4.6 Anion effect with 178 cation 
It was seen here that the [NTf2] salt (178d) gave a far superior result in terms of 
conversion and selectivity in comparison to the ILs of differing anions.  
The [NTf2] IL (181d) was again shown to give superior results in comparison with the 
[PF6] anion of the same IL (181c). This time a cation containing an oxygen atom was 
used as comparison for the two ILs (Table 4.7). 
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181 
Anion Conversion (%) Selectivity (%) 
NTf2 d 100 93 
PF6 c 77 100 
N(CN)2 e 5 100 
BF4 b 15 88 
OctOSO3 f 2 100 
Table 4.7 Anion effect with 181 cation 
Although 100 % selectivity was reached using the [PF6] analogue (181c), a compromise 
in conversion was observed (77 %). Therefore the [NTf2] IL (181d) is shown to be the 
superior IL, reaching 100 % conversion and 93 % selectivity within 48 hours.  
Once again, choosing a different cation (186), in comparison to the [BF4] analogue of 
the IL (186b), the [NTf2] IL (186d) shows superior results, albeit negligible. The result 
obtained with the 186d shows minimal conversion (Table 4.8).  
186 
Anion Conversion (%) Selectivity (%) 
NTf2 d 5 100 
BF4 b 0 0 
Table 4.8 Anion effect with 186 cation 
Overall, for all the ILs tested, the [N(CN)2] and [BF4] displayed the lowest percentage 
conversions. The [OctOSO3], although displaying poor activity in the second case, 
showed modest conversion in the case of the pentyl side-chain IL (178f). One [PF6] IL 
(169e) showed promising activity in comparison with the other IL anions.  
4.3.2 Effect of IL cation on hydrogenation 
4.3.2.1 Effect of side-chain  
Regarding side chain lengths and the number of ethereal oxygen atoms in the side chain, 
the number of oxygens seems to play a less significant role than the length of the 
terminal alkyl chain (Table 4.9).  
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NTf2 IL (d) 
Cation Conversion (%) Selectivity (%) 
178 98 94 
181 98 74 
182 13 100 
183 5 100 
185 97 88 
186 5 100 
Table 4.9 Side-chain effect with [NTf2] ILs 
In the case of the [NTf2] IL terminating with a propyl chain (181d and 185d), the results 
for hydrogenation increased dramatically in comparison with those of either a butyl or 
methyl terminating chain.  
Comparing differing side chains of the [N(CN)2] anion, little difference is observed, a 
slight decrease in conversion is observed with the addition of an oxygen atom to the 
side chain (Table 4.10). 
N(CN)2 ILs (e) 
Cation Conversion (%) Selectivity (%) 
178 12 100 
181 5 100 
Table 4.10 Side-chain effect with [N(CN)2] ILs 
In the case of the [OctOSO3] anion, a more marked difference can be seen, with 
acceptable conversion being obtained with the pentyl derivative (178f), but the addition 
of the oxygen to the side chain (181f) seeming to inhibit conversion altogether (Table 
4.11). 
 
OctOSO3 ILs (f) 
Cation Conversion (%) Selectivity (%) 
178 25 100 
181 2 100 
Table 4.11 Side-chain effect with [OctOSO3] ILs 
 136 
4.3.2.2 Imidazolium moiety 
The incorporation of a methyl group to the C2 position of the imidazolium moiety 
decreased product conversion by just over 50 % (Table 4.12). What was fascinating 
however in this particular case was that upon the 1st recycle of the IL/catalyst system, 
the conversion rose from a mere 36 % after 48 hours, to an impressive 100 %, thus 
suggesting that perhaps pre-treatement of the IL/catalyst system with hydrogen could 
prove beneficial for conversion results. 
NTf2 ILs (d) 
Cation Conversion (%) Selectivity (%) 
178 98 94 
189 36 100 
Table 4.12 1-methylimidazolium in comparison with 1,2-dimethylimidazolium moiety 
4.3.3 Effect of IL purification on hydrogenation 
4.3.3.1 Halide removal 
Table 4.13 displays the results from the effect of residual halide present in the IL. It can 
be seen that only a slight increase in conversion is evident when residual halide is 
removed from the IL. 
 
181b 
Halide  
(AgNO3 test) 
Exp. 
/Recycle 
Conversion (%) Selectivity (%) 
Positive E1 15 88 
E1 24 90 
R1 32 92 
Negative 
R2 16 84 
Table 4.13 Halide removal (181b) 
4.3.4 Effect of reaction temperature on hydrogenation 
In the following table (Table 4.14) eight experiments using four ILs are displayed, one 
carried out at RT, the others at 55 °C. 
 137 
 
NTf2 ILs (d) 
Cation 
 
Temp. (° C) Conversion (%) Selectivity (%) 
RT 100 67 178 
55 98 94 
RT 44 100 181 
55 98 74 
RT 14 82 182 
55 13 100 
RT 4 100 186 
55 5 100 
Table 4.14 Reaction temperature effect using [NTf2] ILs 
For the first two examples with ILs 178d and 181d, the increase in temperature from 
RT to 55 °C exerts a positive effect on the results obtained. Although in the case of 
181d, the selectivity decreases with temperature, the increase in conversion from 44 – 
100 % compensates for the small drop in selectivity. For ILs 182d and 186d, 
terminating with the butyl chain, the conversion is poor, and even when the temperature 
is increased, no significant increase in conversion can be viewed. 
4.3.5 Effect of catalyst used on hydrogenation 
The comparison of different palladium loadings (5 and 10 %) and the effect of 
switching from palladium to platinum catalyst are shown in Table 4.15. It is evident that 
the 10 % Pd/C (92) catalyst achieved a significantly increased conversion in comparison 
with its 5 % Pd/C (92) counterpart. The use of platinum on carbon (91) as a catalyst for 
this system is shown to be poorly active with a very low conversion rate being achieved.  
181d 
Catalyst Conversion (%) Selectivity (%) 
10% 92 100 93 
5% 92 91 74 
91 19 87 
Table 4.15 Varying catalysts with 181d 
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4.3.6 Comparison of novel ILs with organic solvent and conventional ILs 
The best results in terms of both conversion and selectivity obtained using the novel ILs 
were compared with results obtained using conventional ILs and an organic solvent 
(Table 4.16). Although 100 % conversion was reached with the conventional ILs and 
organic solvent, 100 % selectivity was only obtained using the novel ILs.  
Cation Exp./ 
Recycle 
Temp. 
(° C) 
Time 
(h) 
Conversion 
(%) 
Selectivity 
(%) 
[bmim][ NTf2] 107 E1 55 24 100 87 
[bmim][OctOSO3] 230 E1 55 24 100 69 
Toluene E1 RT 24 100 67 
5 35 100 
24 100 100 
185d R1 55 
48 100 88 
5 21 100 
24 100 100 
189d R1 55 
48 100 93 
Table 4.16 ILs/organic solvent/conventional ILs hydrogenation comparison 
After 24h, it can be seen that the novel ILs (185d and 189d) can display superior results 
to conventional ILs (107 and 230) or conventional organic solvents (toluene). 100 % 
conversion and selectivity were obtained upon the first recycle of two novel ILs after 
24h. 
4.3.7 Effect of recycling on hydrogenation 
IL 181d was recycled as reaction solvent 16 times (Table 4.17).  
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181d 
Exp./ 
Recycle 
Time 
(h) 
Conversion 
(%) 
Selectivity 
(%) 
Exp./ 
Recycle 
Time 
(h) 
Conversion 
(%) 
Selectivity 
(%) 
5 9 100 R9 5 - - 
24 65 100  24 - - 
E1 
48 100 93  48 48 79 
5 9 100 R10 5 - - 
24 22 100  24 - - 
R1 
48 48 80  48 59 83 
5 3 100 R11 5 - - 
24 8 100  24 - - 
R2 
48 30 56  48 19 78 
5 7 100 R12 5 - - 
24 8 100  24 - - 
R3 
48 28 79  48 12 79 
5 - - R13 5 - - 
24 - -  24 - - 
R4 
48 56 80  48 15 78 
5 9 100 R14 5 - - 
24 20 100  24 - - 
R5 
48 66 79  48 24 84 
5 - - R15 5 - - 
24 - -  24 - - 
R6 
48 23 80  48 13 67 
5 - - R16 5 - - 
24 - -  24 - - 
R7 
48 63 77  48 20 72 
5 13 80     
24 28 45     
R8 
48 55 80     
Table 4.17 Recycling of 181d 
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Samples were not taken at 5 and 25 hour intervals for each recycle procedure due to the 
small scale of the reaction and therefore the diminishing quantity of IL. It is evident 
from the results that the first reaction proved to be the most successful, with a dramatic 
reduction in conversion of product for the next reaction and indeed all following 
reactions (Figure 4.7). Something to note is the percentage conversion of the main 
product formed for the first 3 recycles and the subsequent increase upon recycle number 
4 and 5. This result may suggest that pre-treatment of the IL/catalyst system with H2 
may be beneficial for this particular system. Also worth noting is the fact that, even with 
the widely varying percentage conversion, the selectivity remains almost constant over 
the whole recycling procedure, never falling below 56 % (Figure 4.7).  
 
Figure 4.7 Recycling of 181d 
What is interesting to note is that, not all the best results were obtained on the first run, 
but on the second run (R1), thus suggesting in some cases the need for an initiating 
period for the catalyst with hydrogen and substrate for optimizing the conversion and 
selectivity (Table 4.18). One particular example is the case of the hydrogenation carried 
out in 189d. The conversion more than doubles upon recycling in Run 1 from 36 % to 
100 %. Optimum conversion and selectivity are thus observed on this run. For 
subsequent runs however after run 1, the conversion after 48 hours varies from 97 – 
100%. 
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189d 
Exp./Recycle Time (h) Conversion (%) Selectivity (%) 
5 2 100 
24 8 100 
E1 
48 36 100 
5 21 100 
24 100 100 
R1 
48 100 93 
5 19 100 
24 48 73 
R2 
48 97 98 
5 21 100 
24 79 99 
R3 
48 100 96 
5 22 100 
24 89 100 
R4 
48 97 100 
Table 4.18 Recycling of 189d 
Another example of substrate recycling can be seen in Table 4.19 using IL 185d. An 
increased conversion was achieved upon recycling on R1, from 32 % to 100 %, and 
then decreased from 100 % in increments of 15 % and 19 % respectively.  
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185d 
Exp./Recycle Time(h) Conversion (%) Selectivity (%) 
5 9 100 
24 32 100 
E1 
48 97 88 
5 35 100 
24 100 100 
R1 
48 100 88 
5 10 100 
24 31 100 
R2 
48 85 91 
5 9 100 
24 34 90 
R3 
48 64 93 
Table 4.19 Recycling of 185d 
Using the [BF4] IL (181b) which had been washed with water in order to remove excess 
halide, the conversion, albeit low (24 %) upon the first experiment, increased upon 
recycle 1 to 32 %. It decreased however again upon the subsequent recycle (Table 4.20).  
181b 
Exp./ Recycle Conversion (%) Selectivity (%) 
E1 24 90 
R1 32 92 
R2 16 84 
Table 4.20 Recycling of 181b 
Using the [PF6] IL (181c) a reduction in conversion was noted upon the first recycle. 
The selectivity however was not negatively affected, remaining at 100 % throughout the 
recycling procedure (Table 4.21).  
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181c 
Exp./Recycle Time (h) Conversion (%) Selectivity (%) 
5 4 100 
24 32 100 
E1 
48 77 100 
R1 48 58 100 
Table 4.21 Recycling of 169e 
4.3.8 NMR analysis 
Crude products were extracted from the respective ILs (distilled in the case of the 
[OctOSO3] ILs) and analysed by 1H NMR (Figure 4.8). Where there was still unreduced 
substrate, the olefinic doublet of doublets at ~ 6.7 ppm was integrated to one, therefore 
equal to one proton signal. As the hydrocinnamaldehyde was formed, the aldehydic 
triplet at ~ 9.8 ppm due also to 1 proton, allowed for the ratio of the substrate and this 
product to be evaluated. The aliphatic triplet, the signal due to the methylene protons 
adjacent to the hydroxyl group, at ~3.6 ppm was taken as a reference peak for the 
formation of 3-phenylpropanol. However, as this signal was due to 2 protons, the value 
of its integration was halved to allow for correct calculation of product ratios.  
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Figure 4.8 Crude product 
It was also proven that the identification and rough quantitation of the products could be 
obtained while still in the IL, as shown in the 1H NMR spectrum (Figure 4.9).  
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Figure 4.9 Crude product in IL 
Even while still present in the IL, a peak for each of the products and the starting 
material can be identified and subsequently used to determine the ratio of starting 
material to products.  
 145 
Impressive selectivity may be observed from the 1H NMR spectrum (Figure 4.10), 
showing a 24h sample taken before all the starting material had been converted to 
product. Although 100 % conversion was not yet reached, 100 % selectivity is 
observed.  
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Figure 4.10 1H NMR displaying selectivity to hydrocinnamaldehyde (95) 
In order to confirm that the integration of the NMR peaks correlated to the obtained 
isolated yields, 1H NMR peak ratios were in some cases confirmed by crude product 
extraction followed by column chromatography separation and subsequent calculation 
of isolated yield. Hydrocinnamaldehyde (95) was successfully separated from 3-
phenylpropanol (97) using column chromatography with a mobile phase of 30:70 ethyl 
acetate:hexane. For correct separation and correct calculation of product ratios, the 
column must be prepared and run immediately following termination of the reaction. It 
was noted that, as the crude product was allowed to stand in air, hydrocinnamaldehyde 
(95) was oxidised to hydrocinnamic acid (231). Although of inconvenience for correct 
calculation of isolated yield in these circumstances, oxidation of 3-phenylpropanol (97) 
is beneficial as an alternate route towards the synthesis of 3-phenylpropionic acid (231). 
In their patent, Castelijns et al. 25describe a similar route for the synthesis of this acid, 
covering the selective hydrogenation of cinnamaldehyde (94) to 3-phenylpropanal (95) 
followed by the subsequent oxidation of this intermediate to 3-phenylpropionic acid 
(231). Formation of this oxidised product occurred readily, even when 
hydrocinnamaldehyde (95) was stored in a sealed container. Three NMR samples were 
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taken to show the oxidation of the product, the 1st directly after the product was eluted 
from the column, the 2nd after storage in a sealed sample vial over 18h, and the 3rd after 
storage in the same vial after 20 h (Figure 4.11).  
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Figure 4.11 1H NMR spectra of 95 showing development of product 231 
After 20h an almost exact 50:50 ratio of hydrocinnamaldehyde (95) to hydrocinnamic 
acid (231) can be observed. Because of this oxidation process, in order to successfully 
quantify the amount of hydrocinnamaldehyde present, the column was always 
performed directly upon termination of the reaction.  
4.4 Trans-cinnamic acid (221) 
The hydrogenation of trans-cinnamic acid in the novel ILs resulted in formation of a 
single product, 3-phenylpropanoic acid (231) (Figure 4.12).  
H2
IL
catalystO
OH
trans-cinnamic acid
O
OH
3-phenylpropanoic acid
221 231
 
Figure 4.12 Hydrogenation of trans-cinnamic acid 
The hydrogenation of trans-cinnamic acid (221) in the novel ILs was examined 
according to the following factors: IL anion, IL cation, IL purification and recyclability. 
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4.4.1 Effect of IL anion on hydrogenation 
With the pentyl side chain ILs and differing anions, the [OctOSO3] IL (178f) shows the 
poorest conversion, with only 76 % being reached after 48 h in comparison with 100 % 
for the [NTf2] (178d) and [PF6] (178c) derivatives (Table 4.22). 
178 
Anion Time (h) Conversion (%) 
NTf2 d 48 100 
PF6 c 48 100 
OctOSO3 f 48 76 
Table 4.22 Anion effect with 178 cation 
However, regarding 181f, no compromise in conversion is evident using this IL in 
comparison with the [NTf2] derivative (181d). When the side chain length is increased 
to the propoxyethoxyethoxy derivative (185d and 185f), this statement also holds true 
(Table 4.23). 
Conversion = 100 % 
Cation Anion 
NTf2 d 181 
OctOSO3 f 
NTf2 d 185 
OctOSO3 f 
Table 4.23 Anion effect 
4.4.2 Effect of IL cation on hydrogenation 
4.4.2.1 Side-chain effect 
All side chains of the [NTf2] ILs tested were consistent with the double bond of 
cinnamic being hydrogenated within a 48 h period (Table 4.24). 
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NTf2 IL (d)  
Conversion = 100 % 
178 
179 
181 
182 
185 
Table 4.24 Side-chain effect with [NTf2] ILs 
4.4.2.2 Imidazolium moiety 
No difference can be seen in terms of conversion after 48 hours when the 1,2-
dimethylimidazolium derivative is used (Table 4.25). 
NTf2 IL (d)  
Conversion = 100% 
178 
189 
Table 4.25 ILs of 1-methylimidazolium and 1,2-dimethylimidazolium moiety 
4.4.3 Effect of IL purification on hydrogenation 
4.4.3.1 Colour removal 
Removal of colour from the 189d showed no difference in terms of conversion obtained 
after 48 hours (Table 4.26).  
NTf2 ILs (d)  
Conversion = 100 % 
Cation Appearance 
Yellow solid 189 
Colourless solid 
Table 4.26 Colour effect (189d) 
The same effect was noted with the [PF6] derivative of the IL (189c) (Table 4.27). 
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PF6 ILs (c)  
Conversion = 100 % 
Cation Appearance 
Yellow solid 189 
Colourless oil 
Table 4.27 Colour effect (189c) 
4.4.4 Effect of recycling on hydrogenation 
The IL/catalyst system was successfully recycled for the hydrogenation of trans-
cinnamic acid (221) with no decrease in conversion obtained after 48 hours (Table 
4.28). 
Conversion = 100% 
Solvent Anion Exp./ Recycle 
E1 
R1 
178 PF6 c 
R2 
E1 189 (colourless) NTf2 d 
R1 
E1 185 NTf2 d 
R1 
Table 4.28 Recycling effect 
For the reactions carried out in the [OctOSO3] ILs (f), vacuum distillation was not a 
viable method for separation of the product from the IL/catalyst mixture, as the boiling 
point was too high > 200 °C. In order to separate the product from the [OctOSO3] 
mixture, the mixture was filtered through a short plug of silica, the first spot eluting 
with 100 % DCM being the desired product.  
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4.5 Cinnamate esters 
4.5.1 Methyl cinnamate (222) 
Methyl cinnamate was selectively reduced to methyl 3-phenylpropanoate (232) (Figure 
4.13). Only one product was observed, that of methyl 3-phenylpropanoate (232). 
H2
IL
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O
O
methyl cinnamate
O
O
methyl 3-phenylpropanoate
222 232
 
Figure 4.13 Hydrogenation of methyl cinnamate 
Most hydrogenations carried out with methyl cinnamate (222) were found to have 
reached 100 % conversion by 24 h, therefore none were left any longer than this time. 
The temperature was increased from 55 to 80 °C for the [OctOSO3] hydrogenations in 
order to facilitate solubility of the substrate in the IL. The factors investigated while 
using this substrate included: IL anion, IL cation, purification and recyclability. 
4.5.1.1 Effect of anion on hydrogenation 
Changing the anion did not effect the conversion. Again, the only decrease in 
conversion from 100 % was observed when the [OctOSO3] derivative (178f) (Table 
4.29). 
Cation Anion Exp./ 
Recycle 
Time 
(h) 
Temp. 
(º C) 
Conversion 
(%) 
NTf2 d E1 24 55 100 
PF6 c E1 24 55 100 
BF4 b R1 24 55 100 
178 
OctOSO3 f E1 48 80 91 
PF6 c E1 24 55 100 185 
OctOSO3 f E1 48 80 100 
Table 4.29 Anion effect 
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4.5.1.2 Effect of IL cation on hydrogenation 
4.5.1.2.1 Side-chain effect  
It can be seen from the results obtained that the side chain did not affect the conversion 
from substrate to product concerning the [NTf2] and [PF6] ILs. In the case of the 
[OctOSO3] salt however, a modification in the side chain, notably the presence of extra 
oxygen atoms, resulted in a rise in conversion from 91 % to 100 %. 100 % conversion 
was obtained with all ILs tested except for 178f which gave a percentage conversion of 
91 % (Table 4.30). 
Conversion = 100 % 
Conditions Cation Anion 
24 h, 55 °C 178, 181, 180, 82, 183 d 
24 h, 55 °C 178, 185 c 
48 h, 80 °C 185, 181 f 
Table 4.30 Side-chain effect 
4.5.1.3 Effect of IL purification on hydrogenation 
4.5.1.3.1 Colour removal 
The colour was initially removed from the bromide salt (178a), and then colourless 
178a was reacted with KPF6 to give a colourless [PF6] IL (178c). The colour of the IL 
did not affect the conversion of methyl cinnamate (222). 100 % conversion was 
obtained with the coloured and colourless version of 178c. 
4.5.1.4 Effect of IL recycling on hydrogenation 
Three [NTf2] ILs (181d, 182d and 183d) with varying cations were recycled once, none 
showing any decrease in activity upon recycling.  
4.5.1.5 NMR analysis 
For the hydrogenations in [OctOSO3] ILs, it could be seen from the 1H NMR of the 
extracted product that the anion of the IL had degraded to 1-octanol. A simple column 
of mobile phase ethyl acetate: hexane (30:70) separated this unwanted impurity from the 
desired product, the desired reduced product eluting first from the column. Due to the 
distillation of the product from the IL at high temperature (~ 200 °C), a hydrolysis 
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product from cleavage of the ester moiety was also observed in the distillate. This was 
also separated from the desired product.  
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Figure 4.14 1H NMR spectrum of extract from hydrogenation in [OctOSO3] IL 
4.5.2 Ethyl trans-cinnamate (223) 
Ethyl trans-cinnamate was reduced selectively to the diydrocinnamic ester, ethyl 3-
phenyl propanoate (233) (Figure 4.15). 
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Figure 4.15 Hydrogenation of ethyl trans-cinnamate 
All reactions using ethyl trans-cinnamate (223) as the substrate showed 100 % 
conversion to 233 within 24h.  All reactions including the [OctOSO3] IL hydrogenations 
were run at 55 °C. The factors affecting hydrogenation in the novel ILs investigated 
included: IL anion, IL cation, purification and recyclability. 
4.5.2.1 Effect of IL anion on hydrogenation  
For the pentyl side chain of ILs (178) of various anions, both the [NTf2] and [PF6] 
derivatives gave 100 % conversion after just 5 h. The [BF4] and [OctOSO3] ILs of the 
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same side chain however were not complete, requiring more than 5 h to reach 100 % 
conversion; both however were successfully reduced upon 24 h (Table 4.31). 
178 
Anion Conversion (%) Time (h) 
50 5 BF4 b 
100 24 
PF6 c 100 5 
OctOSO3 f 100 24 
NTf2 d 100 5 
Table 4.31 Anion effect with 178 cation 
For the IL of longer side chain (185d), more than 5 hours was necessary but less than 24 
h for the total conversion of the substrate with [PF6] and the [OctOSO3] anion.  100 % 
conversion was achieved using 185c and 185f. 
4.5.2.2 Effect of IL cation on hydrogenation 
4.5.2.2.1 Side-chain length 
All tested [NTf2] ILs differing only in side chain length showed 100 % conversion after 
5 hours. It was in the case of ILs terminating with a butyl group that didn’t reach 100 % 
conversion after 5 h. Indeed in these cases, 100 % was reached upon 24 h (Table 4.32).  
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NTf2 ILs (d) 
Cation Time Conversion 
5 100 179 
24 100 
5 100 178 
24 100 
5 100 180 
24 100 
5 100 181 
24 100 
5 86 182 
24 100 
5 100 183 
24 100 
5 100 184 
24 100 
5 83 186 
24 100 
Table 4.32 Side-chain effect with [NTf2] ILs 
Using the [OctOSO3] ILs, upon increasing the length of the side chain or the number of 
oxygen atoms in the side chain, 100 % conversion was reached in all cases (178f, 181f 
and 185f) after 24h.  
In the case of the [PF6] ILs, increasing the side chain length meant an increase in the 
amount of time required to reach 100 % conversion (Table 4.33).  
 
PF6 ILs (c) 
Cation Time Conversion 
178 5 100 
5 55 185 
24 100 
Table 4.33 Side-chain effect with [PF6] ILs 
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4.5.2.2.2 Imidazolium moiety  
The dimethyl imidazolium derivative (189d) showed a decrease in conversion in 
comparison to the methyl imidazolium IL (178d) after 5 h. 188d does however show 
reaction completion with 100 % conversion reached within 24 h (Table 4.34).  
NTf2 ILs (d) 
Cation Time (h) Conversion 
(%) 
178 5 100 
5 91 189 
24 100 
Table 4.34 Imidazolium substitution effect 
4.5.2.3 Effect of IL purification on hydrogenation 
4.5.2.3.1 Colour removal 
The removal of colour from the IL is shown in this case to have a beneficial effect in 
terms of conversion (Table 4.35). After 5 hours using the colourless 189d, 100 % 
conversion was reached, however after the same period of time in the coloured IL, only 
91 % conversion was reached.  
 
NTf2 ILs (d) 
Solvent Appearance Time 
(h) 
Conversion 
(%) 
5 91 
24 100 
Dark yellow 
48 100 
5 100 
24 100 
 
 
189 
Pale yellow 
48 100 
Table 4.35 Colour effect with [NTf2] ILs 
4.5.2.4 Effect of IL recycling on hydrogenation 
The 179d IL system was successfully recycled five times with no loss in 100 % 
conversion after 24 h. 
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4.5.2.5 NMR Ananlysis 
Product ratios were obtained from 1H NMR spectra. The two distinct NMR signals of 
the substrate and product facilitated the calculation of starting material to product ratios 
from the crude 1H NMR. The two olefinic doublet signals at ~ 6.4 ppm and ~ 7.6 ppm 
are clearly separated from the signals of the hydrogenated product. The ethyl ester 
signals of both products are also clearly separate from each other (Figure 4.16).  
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Figure 4.16 1H NMR spectrum 
4.6 Benzyl cinnamate (224) – Hydrogenation v hydrogenolysis 
In order to achieve the selective hydrogenation of the olefin moiety of benzyl cinnamate 
without hydrogenolysis of the benzyl ester, elaborate conditions are often required.26-30  
224
Ph
O
O
Ph
benzyl cinnamate
H2
IL
Catalyst
Ph
O
O
Ph
Ph
O
OH
benzyl 3-phenylpropanoate
231234
3-phenylpropanoic 
acid
 
Figure 4.17 Hydrogenation of benzyl cinnamate 
For the hydrogenation reactions carried out in the [OctOSO3] ILs, vacuum distillation 
was not a viable method for separation of the product from the IL/catalyst mixture due 
to the high boiling point of the product > 200 °C. The mixture was therefore filtered 
through a short silica plug to separate the products from the mixture. When a mixture of 
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products, namely benzyl 3-phenylpropanoate (234) and 3-phenylpropanoic acid (231), 
were obtained, column chromatography (ethyl acetate: hexane, 4:1) was used to for their 
separation. The first spot eluted from the column using this mobile phase was 234, 
followed by 231. Except for the cases of ILs 178d, 181d, 178f, 181f, 181b and 181e, 
231 was the observed product in using the novel ILs as reaction solvents. Selectivity 
was quoted for non-hydrogenolysed product (234). The factors affecting hydrogenation 
in the novel ILs that were investigated included: IL anion, IL cation, IL purification, 
hydrogenolysis study and IL recyclability. 
4.6.1 Effect of IL anion on hydrogenation 
Using the [OctOSO3] and [NTf2] ILs (181d and 181f), 100 % conversion and selectivity 
were achieved.  With differing anions, the propoxyethoxy derivative (181) is successful 
in preventing hydrogenolysis in the case of the [BF4] IL. Good selectivity is also 
observed for this cation using the [N(CN)2] IL (Table 4.36). 
 
181 
Anion Time (h) Temp (º C) Conversion (%) Selectivity (%) 
N(CN)2 e 48 55 87 92 
BF4 b 48 55 100 100 
OctOSO3 f 48 60 100 100 
NTf2 d 48 55 100 100 
Table 4.36 Anion effect with 181 cation 
4.6.2 Imidazolium moiety 
With the 178d IL, no difference in selectivity or conversion is seen when a methyl 
group is added to the C2 position in the IL (189d) (Table 4.37).   
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NTf2 ILs (d) 
Solvent Time (h) Conversion (%) Selectivity (%) 
189 48 100 0 
5 100 0 
24 100 0 
178 
48 100 0 
Table 4.37 Effect of imidazolium substitution with [NTf2] ILs 
In the case of the [N(CN)2] ILs (e), little difference is evident between the two sets of 
results for differing cations(Table 4.38). 
N(CN)2 ILs (e) 
Solvent Conversion 
(%) 
Selectivity 
(%) 
182 87 92 
190 85 91 
Table 4.38 Effect of imidazolium substitution with [N(CN)2] ILs 
4.6.3 Effect of IL purification on hydrogenation 
4.6.3.1 Halide removal 
The removal of excess halide from 185c increases the selectivity from 30 % to 97 %, 
albeit with a compromise in percentage conversion (91 %) (Table 4.39). 
185c 
Halide (AgNO3 test) Conversion (%) Selectivity (%) 
Positive 100 30 
negative 91 97 
Table 4.39 Effect of halide removal (185c) 
4.6.4 Effect of selected IL on hydrogenolysis of substrate 
Using ILs 181d, 178f and 181f, it was found that hydrogenolysis of the benzyl ester did 
not occur after 48h of hydrogenation. A detailed study was launched to investigate this 
effect in similar ILs and to investigate various effects on this reaction. The effect of 
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catalyst loading, as well as the solvent effect was investigated during hydrogenations of 
benzyl cinnamate with various ILs (Table 4.40). 
Solvent Cat. 
Loading 
(g) 
Time 
(h) 
Conversion 
(%) 
Selectivity 
(%) 
 
0.01 24 100 0 178d 
 0.005 24 100 0 
0.01 24 100 0 
0.005 24 100 100 
0.005 24 100 100 
0.005 48 100 100 
181d 
 
0.0025 24 32 100 
0.01 24 100 53 
0.005 24 10 100 
0.0025 24 5 100 
0.005 48 19 100 
178f 
 
0.0025 48 0 0 
0.005 24 100 100 
0.01 48 100 56 
0.005 48 11 100 
181f 
 
0.0025 48 0 0 
[bmim][NTf2] 107 0.005 24 100 0 
[bmim][OctOSO3] 230 0.005 24 100 0 
THF 0.005 24 100 0 
Ethyl acetate 0.005 24 100 0 
methanol 0.005 24 100 0 
Table 4.40 Hydrogenolysis of benzyl cinnamate 
The least amount of catalyst effective in inducing 100 % conversion was 0.005g. Using 
half this value, only 32 % conversion was achieved after 24h with IL 181d. The 
[OctOSO3] ILs (178f and 181f) gave promising results in terms of selectivity; however 
this was only achieved when conversion was low for IL 178f, but with optimal 
conversion for IL 181f. The most compelling results from this data set are obtained 
using ILs 178d and 181f. Using 0.005 g catalyst, after 24 h, 100 % conversion and 
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selectivity were obtained. More surprising is the fact that the selectivity was retained up 
to 48h, thus suggesting that hydrogenolysis of the compound in this IL system only 
occurs with the unsaturated ester. More evidence is observed when the non-
hydrogenolysed reduced product (234) is further subjected to hydrogenation conditions 
using an increased amount of catalyst. No hydrogenolysis is observed (Table 4.41). The 
significance of this result is based on the fact that IL 181d completely prevents 
hydrogenolysis of the benzyl ester.  
Solvent Cat. Loading (g) Time (h) Conversion (%) Selectivity (%) 
181d 0.01 24 100 0 
Table 4.41 Hydrogenation of benzyl 3-phenylpropanoate 
4.6.5 Effect of IL recycling on hydrogenation 
The system used to obtain 100 % selectivity using IL 181d was recycled 8 times with 
no loss in activity (Table 4.42). 
181d 
Exp./Recycle Conversion (%) Selectivity (%) 
E1 100 100 
R1 100 100 
R2 100 100 
R3 100 100 
R4 100 100 
R5 97 100 
R6 91 100 
R7 91 100 
R8 81 100 
Table 4.42 Recycling of IL 181d system 
After the fourth recycle, the selectivity remains constant, but the conversion decreases 
slightly to 91 % upon recycle 7. It is only upon recycle 8 that a significant drop in 
conversion is observed (81 %).  
Varying catalytic amounts were tested for the hydrogenation of benzyl cinnamate using 
IL 181f (Table 4.43).  
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181f (24 h) 
Cat. Loading (g) Conversion (%) Selectivity (%) 
0.005 100 100 
0.006 100 68 
0.007 100 55 
0.008 100 26 
0.009 100 25 
Table 4.43 Varying catalytic amount for the hydrogenation of benzyl cinnamate in 181f 
As can be seen from the results displayed in Table 4.43, the increasing amount of 
catalyst favours hydrogenolysis with optimum conditions being observed using 0.005 g 
catalyst.  
The effect of cation chain length and the number of oxygens in the side chain was 
investigated to determine whether it was only the cation from ILs 181d and 181f that 
gave the best selectivity (Table 4.44). 
0.005 g catalyst, 24 h, 100 % conversion 
Solvent (d) Selectivity (%) 
179 7 
180 0 
182 34 
185 44 
187 0 
Table 4.44 Effect of ILs of differing cation on the selective reduction of benzyl 
cinnamate 
It is evident from the results obtained that any difference in the length of the side chain 
or the number of oxygens in it negatively affects the selectivity of the reaction. This 
reaction is therefore sensitive to changes in IL composition concerning the IL cation.  
4.6.6 NMR spectra 
From the crude 1H NMR spectrum, the ratio of 224 to 231 to 234 can be established 
(Figure 4.18).  
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Figure 4.18 Crude 1H NMR spectrum 
The doublet signals for the olefinic peaks of the substrate are separate from the singlet 
signal for the methylene group of 234. The two triplet signals in the aliphatic region of 
the spectrum comprise the signals for 234 and 231. The amount of acid can however be 
easily calculated by subtraction from the amount of 234 determined by its singlet peak 
at ~ 5.2 ppm. The crude product mixture of 231 and 234 can be separated using column 
chromatography with mobile phase ethyl acetate: hexane, 80:20. 234 elutes first from 
the column.  
4.7 Various substrates 
A short study of a variety of substrates with various functional groups was tested in four 
selected ILs (178d, 181d, 178f and 181f) (Table 4.45). For the case of the 
hydrogenation of allyl cinnamate (227), two products were observed, propyl 3-
phenylpropanoate (235) and propyl cinnamate (236); selectivity was quoted in terms of 
propyl cinnamate (235). For vinyl cinnamate (228), two products were observed, ethyl 
3-phenylpropoanoate (233) and ethyl cinnamate (223); selectivity was quoted in terms 
of the latter (223). Only one product was observed in the case of the hydrogenation of 
cinnamamide (226), 3-phenylpropanamide (237), and cinnamonitrile (225) that of 3-
phenylpropanenitrile (238). 
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Reaction [NTf2] ILs [OctOSO3] ILs 
 178 181 178 181 
Ph O
NH2
Ph O
NH2
226 237
 
 
100 % 
conversion 
 
100 % 
conversion 
 
100 % 
conversion 
 
100 % 
conversion 
Ph
N
Ph
N
225 238
 
100 % 
conversion 
100 % 
conversion 
100 % 
conversion 
98 % 
conversion 
Ph
O
O Ph
O
O Ph
O
O
227 236 235
 
100 % 
conversion 
0 % 
selective 
100 % 
conversion 
84 % 
selective 
100 % 
conversion 
0 % 
selective 
100 % 
conversion 
71 % 
selective 
Ph
O
O Ph
O
O Ph
O
O
228 223 233
 
100 % 
conversion 
0 % 
selective 
100 % 
conversion 
0 % 
selective 
100 % 
conversion 
0 % 
selective 
100 % 
conversion 
49 % 
selective 
Table 4.45 Study of various substrates 
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4.8 Conclusion 
A range of substrates were hydrogenated in the novel ILs. The ester functionality 
present in the ILs did not pose a problem, except when high temperatures were 
required for the separation of products from the [OctOSO3] ILs. In many cases, 
hydrolysis of this ester bond was evident, and the alcohol starting material was 
obtained together with the desired product. The reduction of the olefinic double bond 
was achieved selectively in the presence of other functional groups. 
Trans-stilbene was successfully used as a test substrate for these hydrogenations in 
the novel ILs. The effect of the anion of the IL used was shown to affect conversion, 
for which the lowest result was obtained with IL 178e. The cation side-chain however 
did not significantly alter results. The 178d system was recycled 20 times, thus 
demonstrating the robustness of the novel ILs in these hydrogenations. In the case of 
trans-cinnamaldehyde, the ILs of [BF4], [N(CN)2] and [OctOSO3] anions, displayed 
the poorest results, thus indicating that the anion again significantly influences the 
reaction. The side-chain of the IL cation was shown to have a marked influence on 
reaction results obtained. Only 5 % conversion was obtained with IL 186d, although 
100 % selectivity was obtained. The highest conversion obtained was using the ILs of 
propyl-terminating side-chains (181d and 185d). 178d gave both impressive 
conversion and selectivity (98 and 94 % respectively). Recycling was in some cases 
shown to demonstrate a positive effect on the reaction. 100 % selectivity was obtained 
using 185d and 189d upon the first recycle. Recycling of the 181d system 16 times 
showed the conversion to significantly decrease, however the selectivity remained 
relatively constant.  
Concerning trans-cinnamic acid and methyl and ethyl cinnamate, successful 
hydrogenation reactions were carried out in the novel ILs, with 100 % conversion 
being reached with a wide combination of IL cations and anions.  
Interesting IL effects on selectivity of hydrogenation reactions were observed using 
the benzyl cinnamate substrate. The cation side-chain of the IL was shown to, in some 
cases, positively influence reaction selectivity. Regardless of IL anion (b, d, e, f) side-
chain e was shown to give 100 % selectivity (ie no hydrogenolysis of the substrate). 
In comparison with commercially available [bmim] ILs, 181d, 178f and 181f 
prevented hydrogenolysis of the substrate. Recycling of the 181d system did not 
affect selectivity, however conversion decreased slightly over 8 recycling 
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experiments. Using IL 181f, the selectivity of the reaction was shown to be sensitive 
to the amount of palladium catalyst used. Increasing catalyst amounts led to 
decreasing selectivity. 100 % selectivity was obtained using 0.005 g 10 % Pd/C 
catalyst, however the selectivity dramatically decreased to 25 % using 0.009 g 
catalyst. The selectivity obtained was also sensitive to the cation side-chain used in 
the reaction. Only cations 178 and 181 led to 100 % selectivity being obtained.  
High percentage conversions for double bond reduction were observed using ILs 178 
and 181 d and f, using substrates, cinnamamide and cinnamonitrile. In the case of 
cinnamonitrile, the nitrile functionality was left unreduced after 48 hours of 
hydrogenation. The selective reduction of allyl cinnamate to propyl cinnamate was 
observed using ILs 181d and 181f (84 and 71 % selective respectively). Using vinyl 
cinnamate as substrate, selectivity of 49 % was only observed using IL 181f. 
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5 Hydrogenation in Chiral Ionic Liquids 
5.1 Introduction 
Chiral induction may originate from various sources including the reaction solvent.1 
The use of CILs as chiral induction solvent has been studied with promising results 
being obtained. Pegot et al.2 achieved reasonable enantioselectivity from their CIL 
(chirality originating from the cation) in the Baylis-Hillman reaction. A solvent-free 
method using microwave irradiation was used to synthesise CILs from (-)-N-
methylephedrine for subsequent use in the Baylis-Hillman reaction. The CILs were 
applied as reaction media for this asymmetric reaction between benzaldehyde and 
methyl acrylate (Figure 5.1). 
X
Ph H
O
OMe
O
DABCO
Ph
Z
N
R Ph
OH
OMe
O
R: C4H9, C8H17, C10H21, C16H33
X: OTf, PF6
Z: OH, OAc
 
Figure 5.1 Baylis-Hillman reaction of benzaldehyde with methyl acrylate 
Using DABCO as a Lewis base and CIL (R = C8H17, X = OTf, Z = OH) as reaction 
solvent, moderate yields (30 – 74 %) and moderate enantioselectivities (20 – 44 %) 
were obtained. Impressive enantioselectivity was obtained by Gausepohl et al.3 using 
their CIL with chirality originating from the anion. The aza-Baylis-Hillman reaction 
(Figure 5.2) was used with methyl vinyl ketone and N-(4-bromobenzylidene)-4-
toluenesulfonamide to furnish a chiral amine in modest conversions (34 – 39 %), 
however high enantioselectivities (71 – 84 %) were obtained.  
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Figure 5.2 aza-Baylis-Hillman reaction 
Preliminary testing of the novel CILs as reaction media was carried out using 
hydrogenation reactions as test systems. Using the available CILs, three substrates 
were briefly examined, dimethyl itaconate (144), tiglic acid (239) and α-methyl-trans-
cinnamaldehyde (240) (Figure 5.3).  
O
O
O
O
dimethyl itaconate
O
OH
tiglic acid
O
alpha-methyl trans-cinnamaldehyde
144
239
240
 
Figure 5.3 Investigated substrates 
Heterogeneous catalysis using the achiral catalysts, palladium on carbon (92) and 
Adams’ catalyst (241) was investigated. Homogeneous catalysis was also attempted 
using Wilkinson’s catalyst (119) and a rhodium catalyst with a Taniaphos ligand 
(242). The potential of the CILs as enantiomeric induction media was investigated, 
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the sole chiral source originating from the solvent or, alternatively when the chiral 
rhodium catalyst was used. Each substrate is taken individually and different factors 
affecting hydrogenation are examined. A discussion of enantiomeric excess 
determination is given in section 5.5. 
5.2 Dimethyl itaconate (144) 
The hydrogenation of dimethyl itaconate (144) in the novel ILs led to one product, 
namely dimethyl 2-methylsuccinate (157) (Figure 5.4). 
O
MeO
O
OMe
dimethyl itaconate
O
MeO
O
OMe
dimethyl 2-methylsuccinate
H2
IL
catalyst
144 157
 
Figure 5.4 Hydrogenation of dimethyl itaconate 
10 % Pd/C, Wilkinson’s catalyst (119) and a chiral rhodium catalyst were investigated 
as catalysts for the hydrogenation of this prochiral substrate in achiral and chiral ILs.  
5.2.1 10% Palladium on Carbon (92) 
After 24 hours, 100 % conversion was obtained using ethyl acetate and 178d 
respectively thus confirming the suitability of this catalyst for the reduction of 
dimethyl itaconate (144).  
5.2.1.1 Lactate ILs  
It is evident from the results obtained in this study that the propyl (216e and f) and 
pentyl (216i and j) side chains provided the best conversion, independent of their 
stereochemistry (Table 5.1). The ethereal oxygen present in the side chain displays a 
negative effect with only 50 % conversion reached after 24 hours.  
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Solvent Conversion (%) 
216f 100 
216e 100 
216h 80  
216j 100 
216i 100 
216l 50 
Table 5.1 Hydrogenation in lactate-based ILs 
5.2.1.2 Mandelate ILs 
The brief study of the mandelate ILs for this substrate revealed the combination of the 
ethereal oxygen in the side chain and the [OctOSO3] side chain to have a negative 
effect on substrate conversion (Table 5.2). 
Solvent Conversion (%) 
215c 100  
217l 25  
Table 5.2 Hydrogenation in mandelate-based ILs 
5.2.2 Wilkinson’s catalyst (119) 
Wilkinson’s catalyst was soluble in all CILs investigated. This catalyst was 
successfully immobilised in the ILs. The degree of leaching of the catalyst was 
examined by observation of the colour of the extract upon extraction of product from 
IL/catalyst mixture. A highly coloured extract indicated a greater degree of leaching, 
with a colourless extract being an indication of the catalyst’s immobilisation in the IL.  
5.2.2.1 Amount of catalyst used 
The amount of catalyst deemed to be sufficient in order to induce relatively good 
percentage conversion was 0.05 g (1.35 mol %). Initially 0.01 g (0.27 mol %) catalyst 
was used, with poor results being obtained. 0.05 g catalyst was therefore used as the 
quantity for all subsequent reactions using Wilkinson’s catalyst (Table 5.3). The 
extracts obtained from the ILs were slightly pale yellow indicating minimal catalyst 
leaching. 
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Solvent Catalyst (g) Conversion (%) 
216g 0.01 g 15  
0.01 g 21  215g 
0.05 g 100  
Table 5.3 Effect of amount of catalyst used 
5.2.2.2 Common Organic Solvents 
Using 0.05 g (1.35 mol %) of Wilkinson’s catalyst (119) in common organic solvents 
yielded poor percentage conversions (Table 5.4). 
Solvent Conversion (%) 
DCM 7 
Toluene 7 
MeOH 11 
Table 5.4 Hydrogenation in common organic solvents 
5.2.2.3 Recycling effect 
Using the racemic mandelate IL (215c), the recycling effect was investigated (Table 
5.5).  
215c 
Run Conversion 
(%) 
1 36  
2 56  
3 71  
4 75  
5 76  
6 85  
7 73  
8 73 
9 69  
10 64 
Table 5.5 Recycling effect (215c) 
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It was noted that an activation period for the catalyst in the IL was necessary in this 
case to achieve high conversion (Figure 5.5). 
 
Figure 5.5 Recycling experiment 
The conversion increases almost exponentially until run six, after which there is a 
sharp decrease by > 10 %. The conversion can then be seen to gradually decrease as 
far as run 10. It should be noted that upon investigation of the 1H NMR after 10 runs, 
the IL was not degraded. This CIL had been used for 240 hours at 55 °C. Leaching of 
the catalyst was estimated by observation of extract colour. What was observed was 
that the first two reactions showed the greatest degree of leaching, with the following 
extracts being almost colourless. 
5.2.2.4 CIL as additive 
The effect of CILs as additives were investigated. 215h as investigated as an additive 
with 178d achiral IL (Table 5.6).  
IL CIL (additive) 
178d 215h 
IL amount CIL amount Conversion (%) 
2 mL - 74  
- 2 mL 100  
1.8 mL 0.2 mL 74  
1.5 mL 0.5 mL 100  
Table 5.6 CILs as additives 
From the results displayed in Table 5.6 it is evident that the performance of the CIL in 
terms of conversion is superior to that of the IL. When 10 % CIL is added to the IL, 
the conversion remains the same as for the IL alone. However, 25 % CIL added is 
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enough to increase the conversion to 100 %. Thus, the potential of these CILs as 
additives has been demonstrated.  
5.2.3 Rh-Taniaphos (242) 
In order to test the feasibility of using the novel ILs with a chiral complex as catalyst, 
the Taniaphos ligand was used in conjunction with a rhodium norbornadiene complex 
(Figure 5.6). 
Fe P
N
H
P
(S)-1-diphenylphosphino-2-[(R)-alpha-(dimethylamino)-2-(diphenylphosphino)benzyl]ferrocene
Taniaphos
bis(norbornadiene)rhodium(I) tetrafluoroborate
 
Figure 5.6 Taniaphos chiral catalyst (242) 
 
Two achiral ILs and a racemic mandelate IL were used as test solvents (Table 5.7). 
[NTf2] ILs Conversion (%) 
178d 100 
181d 66 
215c 68 
Table 5.7 Hydrogenation using chiral catalyst 
 
All ILs tested were shown to be viable solvents for the hydrogenation using this 
catalyst. Although IL 178d gave the highest conversion, impressive conversion was 
seen also using ILs 181d and 215c. 
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5.2.4 1H NMR analysis 
The peaks for dimethyl itaconate (144) and its reduction product (157) in the 1H NMR 
spectrum were sufficiently separated that an accurate ratio of starting material to 
product could be obtained from a crude spectrum (Figure 5.7).  
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Figure 5.7 1H NMR spectrum of 144 and 157 
A determination of enantiomeric purity of a pure sample of dimethyl 2-succinate 
(157) was attempted using a europium chiral shift reagent, Eu(hfc)3 (243). (Figure 
5.8) 
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F2
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CF3
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3
 
Figure 5.8 Europium chiral shift reagent (243) 
Following addition of this chiral shift reagent to a pure sample of dimethyl 2-
succinate (157), the signal for protons of the terminal methyl group (circled below) 
was split into two signals (Figure 5.9). 
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Figure 5.9 1H NMR of effect of chiral shift reagent 
This method of enantiomeric determination could not be used however at this stage as 
the spectral resolution of the split signal was not sufficient and baseline separation 
was not achieved.  
5.3 Tiglic acid (239) 
The reduction of tiglic acid (239) led to the formation of 2-methylbutanoic acid (244) 
(Figure 5.10). 
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2-methylbutanoic acid
H2
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Figure 5.10 Hydrogenation of tiglic acid 
10 % Palladium on carbon (92), Wilkinson’s catalyst (119) and Adam’s catalyst (241) 
were used to investigate the hydrogenation of this substrate in the novel CILs.  
5.3.1 10 % Pd/C (92) 
All CILs displayed in Table 5.8 were tested under hydrogenation conditions using this 
catalyst, however no conversion was observed. Using the same amount of catalyst 
however, 100 % conversion was reached using ethyl acetate and achiral 178d 
subsequently. 
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Conversion = 100 % 
216d 
216f 
216h 
216j 
215c 
215e 
215l 
Table 5.8 Hydrogenation using palladium catalyst (92) 
Increasing the amount of catalyst used or the temperature gave however a higher 
conversion (Table 5.9).  
216d 
Catalyst (g) Temperature (° C) Conversion (%) 
0.05 g 55 0 
0.05 g 85 81 
0.15 g 55 93 
Table 5.9 Increasing amount of catalyst and reaction temperature 
5.3.2 Wilkinson’s catalyst (119) 
Using this catalyst similar conversions were obtained using common organic solvents 
as were obtained using the CILs (Table 5.10). 
Solvent Conversion (%) 
Methanol 26 
Ethyl acetate 8 
215d 22 
Table 5.10 Hydrogenation using 119 
5.3.3 Adam’s catalyst (241) 
Using 0.55 mol % of this catalyst, the reactions were successful, 100 % conversion 
was obtained for two CILs (Table 5.11). 
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Conversion = 100 % 
215d 
215a 
Table 5.11 Hydrogenation using Adam’s catalyst 
5.3.4 NMR analysis 
From the crude 1H NMR of a mixture of the starting material and the product, signals 
for each could be clearly identified, thus facilitating facile calculation of ratios of their 
peaks (Figure 5.11). 
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Figure 5.11 Crude 1H NMR spectrum 
5.4 α-methyl-trans-cinnamaldehyde (240) 
The hydrogenation of this substrate led to a mixture of products, namely 2-methyl-3-
phenylpropanal (245) and 2-methyl-3-phenylpropan-1-ol (246). (Figure 5.12). 
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Figure 5.12 Hydrogenation of α-methyl-trans-cinnamaldehyde (240) 
The hydrogenation of this substrate was initially attempted in the achiral ILs in order 
to establish the general ease of reduction of the sterically hindered double bond.  
5.4.1 10 % Pd/C (92) 
Achiral ILs were tested as reaction solvents using this catalyst. Selectivity is quoted 
for 245. Hydrogenation using this catalyst was also attempted in toluene for 
comparison purposes (Table 5.12).  
 
Solvent Temperature (° C) Selectivity (%) Conversion (%) 
Toluene RT 67 56 
178d 55 78 12 
178f 80 100 11 
181d 55 0 0 
181f 55 0 0 
Table 5.12 Hydrogenation using 10 % Pd/C catalyst (92) 
It can be seen that the influence of an ethereal oxygen in the side chain of the IL is of 
more significant influence than the anion. Using both the [NTf2] anion and [OctOSO3] 
anion with the pentyl side chain (178d and 178f), acceptable conversions are reached. 
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The addition of an ethereal oxygen to the side chain (181d and 181f) however reduces 
the conversion to 0 %.   
5.4.2 Adams catalyst (241) 
Although the selectivity obtained using the CILs was high (100 %) a compromise in 
percentage conversion was observed, 34 % being the highest conversion obtained 
using the CILs (Table 5.13).  
Solvent Selectivity (%) Conversion (%) 
178d 55 77 
216f 100 32 
216k 100 22 
215e 100 22 
215i 100 34 
215k 100 4 
Table 5.13 Hydrogenation using Adams catalyst (241) 
5.4.3 NMR analysis 
Analysis of a crude 1H NMR spectrum of the hydrogenation mixture of substrate and 
products was feasible due to the separation of the signals (Figure 5.13).  
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Figure 5.13 1H NMR spectra of 239, 244 and 245 
A 1H NMR spectrum of a mixture of the compounds shows that a ratio of signals 
could be used to determine percentage selectivity and conversion. This can be seen 
from an example of the crude spectrum (Figure 5.14). 
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Figure 5.14 1H NMR spectrum of crude reaction mixture 
5.5 Enantioselectivity 
5.5.1 Dimethyl 2-methylsuccinate (157) 
Chiral HPLC was used to analyse the possible enantiomeric excess of the products 
from the reactions. The retention time of (R)-dimethyl 2-methylsuccinate was shown 
to be approximately 5.3 minutes, followed by the (S)-enantiomer eluting at 
approximately 6.3 minutes (Figure 5.15).  This was confirmed by injection of a 
purchased (S)-dimethyl 2-methylsuccinate standard from Sigma-Aldrich.  
 
min
peak area: 1436.40137 peak area: 1439.04016
 
 
Figure 5.15 CHIRALPAK® IB column, 30 minutes isocratic, 98:2 heptane:ethanol, 1 
mL/min 
The optical rotation of the products was also determined. Using the (S)-dimethyl-2-
methylsuccinate standard (c, 3.0 in acetone), [α] 20D = + 4 ° was obtained. All 
subsequent products were measured at this concentration in acetone to give 0 – 0.2 ° 
optical rotation. Using chiral HPLC to determine enantioselectivity however led to 
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misleading results. Taking as controls, products obtained in 100 % conversion from 
an achiral reaction (achiral solvent/catalyst), ee values ranged from 1.3 – 2.0 % ee. 
Thus, an error was evidently observed using this method as the % ee should have been 
0 %. As the conversion decreased, an increased error in the method was observed. 
Again, testing products resulting from achiral reactions, an error range of 3.26 (R) – 
15.81 (S) % ee was obtained. However unsuccessful the HPLC measurements, a 
rough value could be estimated for products of 100 % conversion as the errors were 
lower than those products containing residual starting material. As values lower than 3 
% ee were obtained for products resulting from reactions carried out in optically pure 
solvents, and the optical purity obtained from optical rotation measurements was < 0.2 
°, the conclusion was drawn that chiral induction from chiral solvents used did not 
arise. Using the chiral catalyst however, with the product resulting from 100 % 
conversion, 30 (S) % ee was obtained using chiral HPLC, this result lying far outside 
the errors obtained. Using the polarimeter, 3.85 ° rotation was observed, thus 
confirming chiral induction from the reaction of the prochiral substrate. It is thus 
imperative that future work in this area should continue by development of an 
acceptable method for enantiomeric purity of the samples obtained.  
5.5.2 2-Methylbutanoic acid (244) 
 
The products obtained from the hydrogenation of tiglic acid were derivatized to the 
corresponding methyl ester (247) for subsequent analysis of enantiomer composition 
using chiral GC with an MS detector.  
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Figure 5.16 GC trace obtained using CP-Cyclodextrin-β-2,3,6-M-19 column 
Due to the similar retention times of both enantiomers on the chiral GC column, 
optical rotation was used as an investigative method to indicate if the final product 
was indeed a racemic mixture. Optical rotations were carried out in acetone and all 
reaction products furnished racemic mixtures. The optical rotation value for a 
standard, S-(+)-2-methylbutyric acid from Aldrich (245526), was [α] 20D = + 19 °, neat. 
Improved GC conditions need to be developed for future enantiomeric detection of 
this product. 
5.5.3 2-Methyl-3-phenylpropanal (245) and 2-methyl-3-phenylpropan-1-ol 
(246) 
As of yet, we have not developed a chiral GC/HPLC method for the enantiomeric 
measurement of the products obtained form the hydrogenation of α-methyl-trans-
cinnamaldehyde. Optical rotation was used thus far as a method for the determination 
of the optical activity of the compounds. Values obtained were < 0.2 ° with 246 
carried out in acetone (c = 4.2)4 and 245 also carried out in acetone (c = 1.25).5 
Future work will entail the development of a method for accurate determination of % 
ee obtained using chiral GC or HPLC. 
 184 
5.6 Conclusion 
Successful hydrogenation of three prochiral substrates was achieved in the novel 
achiral and chiral ILs. In the case of dimethyl itaconate, novel CILs were shown to be 
suitable solvents for its hydrogenation. Good conversion was obtained using the 
lactate ILs of alkyl terminating side-chain. The presence of an oxygen atom in the 
side-chain however showed the poorest conversion. This effect was also noted, albeit 
more pronounced, with mandelate ILs. Interestingly, using 1.35 mol % Wilkinson’s 
catalyst, superior results were obtained in the novel ILs in comparison with organic 
solvents. This homogeneous catalyst was also recycled numerous times in a novel IL 
with minimal leaching being observed. A chiral rhodium catalyst was also 
successfully used with 100 % conversion being obtained in a novel IL. Using tiglic 
acid as substrate, Adam’s catalyst was shown to have superior activity to Pd/C in the 
hydrogenation carried out in the novel ILs. 100 % conversion was obtained using this 
catalyst in a number of novel ILs. In the case of α-methyl-trans-cinnamaldehyde, 
Adams catalyst was shown to be not as active for this substrate. Although low 
conversions were obtained in the novel ILs using this catalyst, selectivity towards 245 
remained at an impressive 100 %.  
Although chiral induction did not arise from these novel chiral solvents, they showed 
promise as alternative reaction media. The fact that the CILs were sufficiently robust 
to endure elevated temperatures and reaction times with no indication of degradation 
displayed their possible future use. The CILs demonstrated potential as chiral 
additives as well as immobilizing media for homogeneous catalysts. In terms of 
selectivity, impressive results were obtained for the substrate α-methyl-trans-
cinnamaldehyde, even though conversion was poor.  
In order for satisfactory enantioselectivity results to be obtained, analytical method 
development is required in the future for the determination of possible chiral 
induction.  
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Experimental Section
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Experimental work 
Introduction 
Chemicals 
 
All chemicals were purchased from Aldrich, with the exception of LiNTf2, which was 
purchased from Solvionic. Methanol, ethanol, diethyl ether and triethylamine were 
dried over molecular sieves and distilled before use. 1-butanol, 1-pentanol, 1-octanol, 
1-decanol, 2-methoxyethanol, 2-ethoxyethanol, 2-propoxyethanol, 2-butoxyethanol, 
2- (2-methoxy ethoxy) ethanol, 2- (2-ethoxy ethoxy) ethanol, 2-(2-propoxyethoxy) 
ethanol, 2-(2-butoxyethoxy)ethanol, 2-(2-(2-methoxyethoxy)ethoxy)ethanol, and 1-
decanol were dried over molecular sieves and used without further purification. 1,2-
Dimethylimidazole was distilled before use. THF was dried over sodium wire, then 
sodium benzophenone, and distilled before use. DCM and ACN were dried over 
calcium hydride, and distilled before use. Acetone was dried over potassium 
carbonate then distilled before use.  
NMR Analysis 
All NMR analysis was carried out on a Bruker 400 MHz spectrometer, operating at 
400 MHz for 1H NMR and 100 MHz for 13C NMR, in deuterated chloroform, acetone, 
methanol or water. Chemical shifts are measured in parts per million (ppm) and 
coupling constants (J) are measured in Hertz (Hz). Numbering of specific protons and 
carbons of the compounds is assigned for all alkylating agents and bromide salts. 
Numbering is then assigned for the first outlined compound of each anion. For the 
chiral materials, numbering is performed on either the racemic version or an optically 
pure version of the compound.  
Splitting patterns are noted as follows: s: singlet; d: doublet; t: triplet; q: quartet; dd: 
doublet of doublets; tt: triplet of triplets; tq: triplet of quartets; br: broad 
LC/MS 
Liquid chromatography time-of-flight mass spectrometry was recorded on a Waters 
Corp. Liquid Chromatography-Time of flight mass spectrometer from Micromass MS 
Technologies Centre. High resolution mass spectrometry was obtained for all bromide 
ILs. Low resolution mass spectrometry was obtained for all ILs including bromide 
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salts. Mass spectrometry data for the starting materials was not obtained due to the 
reactivity of these compounds.  
GC/MS 
Gas chromatography mass spectrometry was carried out on a Hewlett Packard HP 
6890 Series GC System and a Hewlett Packard 5973 Mass Selective Detector. This 
analysis was carried out by Dilip Rai at UCD. 
IR analysis 
All IR analysis was carried out on a Perkin Elmer FT-IR spectrum GX spectrometer 
using a KBr disc or thin film on salt plates 
Optical Rotation 
All optical rotation measurements were carried out on a Perkin Elmer 343 Polarimeter 
in chloroform or acetone at 25 ºC. 
Melting point 
All melting point measurements were carried out on a Griffin melting point apparatus 
and values are expressed in degrees celcius (º C). 
 
X-Ray Crystallography 
This analysis was carried out by Helge Müller-Bunz at UCD. 
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Chapter 2 Experimental 
Achiral α-bromoestes 
Representative procedure for the preparation of achiral α bromoestes (butyl 2-
bromoacetate) (176a) 
To a stirred solution of DCM (350 mL), butanol 
(34.04 g, 460 mmol), and triethylamine (69.33 
mL, 500 mmol) under a nitrogen atmosphere at -
78 ºC was added dropwise bromoacetyl bromide (92.92 g, 460 mmol). After stirring 
at -78 ºC for 3 h, the reaction mixture was allowed warm up to -20 ºC and quenched 
by addition of water (60 mL). The organic phase was washed with distilled water (3 x 
60 mL), saturated ammonium chloride (3 x 60 mL), saturated sodium bicarbonate (3 x 
60 mL) and brine (2 x 60 mL). The organic phase was then dried over magnesium 
sulfate, filtered and solvents removed via rotary evaporation to yield the crude 
product. This crude product was then distilled under high vacuum to yield a pale 
yellow liquid in 68 % yield (60.95 g, 313 mmol). 
 
Molecular formula C6H11BrO2 
Molecular weight 195 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 4.10 (t, J = 6.7 Hz, 2H, H3), 3.75 (s, 2H, H1), 
1.60 (tt, J = 6.7, 7.2 Hz, 2H, H4), 1.36 (tq, J = 7.2, 7.4 Hz, 2H, H5), 0.95 (t, J = 7.4 
Hz, 3H, H6) 
13C NMR (100 MHz, CDCl3) δ ppm 167.38 (CO), 66.19 (OCH2), 30.42 (CH2), 26.00 
(CH2), 19.00 (CH2), 13.67 (CH3) 
 
1
2
3
4
5
6
Br
O
O
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Pentyl 2-bromoacetate (176b) 
1
2
3
4
5
6
7Br
O
O
 
Slightly pale yellow liquid 
 
The title compound was prepared from 
pentan-1-ol (44.00 g, 500 mmol) and 
bromoacetyl bromide (101.00 g, 500 mmol) 
according to the general procedure in 64 % 
yield (66.88 g, 320 mmol). 
Molecular formula C7H13BrO2 
Molecular weight 209 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 4.09 (t, J = 6.8 Hz, 2H, H3), 3.75 (s, 2H, H1), 
1.61-1.54 (m, 2H, H4), 1.28-1.23 (m, 4H, H’s 5 and 6), 0.84 (t, J = 7.0 Hz, 3H, H7) 
13C NMR (100 MHz, CDCl3) δ ppm 167.35 (CO), 66.45 (OCH2), 28.09 (CH2), 27.87 
(CH2), 26.01 (CH2), 22.27 (CH2), 13.94 (CH3) 
 
2-Methoxyethyl 2-bromoacetate (176c) 
1
2
3
4 5
Br
O
O
O
 
Pale yellow liquid 
 
The title compound was prepared from 
methoxyethanol (34.96 g, 460 mmol) and 
bromoacetyl bromide (92.92 g, 460 
mmol) according to the general procedure 
in 70 % yield (63.43 g, 322 mmol). 
Molecular formula C5H9BrO3 
Molecular weight 197 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 4.27 (t, J = 4.6 Hz, 2H, H3), 3.82 (s, 2H, H1), 
3.56 (t, J = 4.6 Hz, 2H, H4), 3.33 (s, 3H, H5) 
13C NMR (100 MHz, CDCl3) δ ppm 167.23 (CO), 69.99 (OCH2), 65.17 (CH2O), 
58.97 (CH3), 25.86 (CH2) 
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2-Ethoxyethyl 2-bromoacetate (176d) 
1
2
3
4 5
6Br
O
O
O
 
Pale yellow oily liquid 
 
The title compound was prepared from 
ethoxyethanol (45.00 g, 500 mmol) and 
bromoacetyl bromide (101.00, 500 mmol) 
according to the general procedure in 60 % 
yield (63.30 g, 300 mmol). 
Molecular formula C6H11BrO3 
Molecular weight 211 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 4.27 (t, J = 4.7 Hz, 2H, H3), 3.83 (s, 2H, H1), 
3.61 (t, J = 4.7 Hz, 2H, H4), 3.50 (q, J = 7.1 Hz, 2H, H5), 1.17 (t, J = 7.1 Hz, 3H, H6) 
13C NMR (100 MHz, CDCl3) δ ppm 167.34 (CO), 67.95 (OCH2), 66.75 (CH2O), 
65.47 (OCH2), 25.91 (CH2), 15.10 (CH3) 
 
2-Propoxyethyl 2-bromoacetate (176e) 
1
2
3
4 5
6
7
Br
O
O
O
 
Pale brown oily liquid 
 
The title compound was prepared from 
propoxyethanol (47.84 g, 460 mmol) and 
bromoacetyl bromide (92.92 g, 460 mmol) 
according to the general procedure in 83 
% yield (85.91 g, 382 mmol). 
Molecular formula C7H13BrO3 
Molecular weight 225 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 4.34 (t, J = 4.6 Hz, 2H, H3), 3.88 (s, 2H, H1), 
3.67 (t, J = 4.6 Hz, 2H, H4), 3.47 (t, J = 6.9 Hz, 2H, H5), 1.66 (tq, J = 6.9, 7.3 Hz, 2H, 
H6), 0.94 (t, J = 7.3 Hz, 3H, H7) 
13C NMR (100 MHz, CDCl3) δ ppm 167.31 (CO), 73.07 (OCH2), 68.10 (CH2O), 
65.42 (OCH2), 25.90 (CH2), 22.81 (CH2), 10.52 (CH3) 
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2-Butoxyethyl 2-bromoacetate (176f) 
 
1
2
3
4 5
6
7
8Br
O
O
O
 
Pale yellow liquid 
 
The title compound was prepared 
from butoxyethanol (54.28 g, 460 
mmol) and bromoacetyl bromide 
(92.92 g, 460 mmol) according to 
the general procedure in 75 % yield 
(82.46 g, 345 mmol). 
Molecular formula C8H15BrO3 
Molecular weight 239 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 4.32 (t, J = 4.6 Hz, 2H, H3), 3.88 (s, 2H, H1), 
3.65 (t, J = 4.6 Hz, 2H, H4), 3.47 (t, J = 6.8 Hz, 2H, H5), 1.61 (tt, J = 6.8, 7.1 Hz, 2H, 
H6), 1.43 (tq, J = 7.1, 7.4 Hz, 2H, H7), 0.92 (t, J = 7.4 Hz, 3H, H8) 
13C NMR (100 MHz, CDCl3) δ ppm 167.27 (CO), 71.19 (OCH2), 68.12 (CH2O), 
65.39 (OCH2), 31.57 (CH2), 25.87 (CH2), 19.20 (CH2), 13.88 (CH3) 
 
2-(2-Methoxyethoxy)ethyl 2-bromoacetate (176g) 
 
1
2
3
4 5
6 7Br
O
O
O
O
 
Colourless liquid 
 
The title compound was prepared 
from methoxyethoxyethanol (54.00 
g, 450 mmol) and bromoacetyl 
bromide (90.90 g, 450 mmol) 
according to the general procedure in 
62 % yield (67.24 g, 279 mmol). 
Molecular formula C7H13BrO4 
Molecular weight 241 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 4.31 (t, J = 4.6 Hz, 2H, H3), 3.86 (s, 2H, H1), 
3.71 (t, J = 4.6 Hz, 2H, H4), 3.63-3.62 (m, 2H, H5), 3.53-3.51 (m, 2H, H6), 3.34 (s, 
3H, H7) 
13C NMR (100 MHz, CDCl3) δ ppm 167.24 (CO), 71.81 (OCH2), 70.52 (CH2O), 
68.75 (OCH2), 65.27 (CH2O), 59.07 (OCH3), 25.91 (CH2) 
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2-(2-Ethoxyethoxy)ethyl 2-bromoacetate (176h) 
 
1
2
3
4 5
6 7
8
Br
O
O
O
O
 
Pale yellow liquid 
 
The title compound was prepared 
from ethoxyethoxyethanol (20.10 
g, 150 mmol) and bromoacetyl 
bromide (40.40 g, 200 mmol) 
according to the general 
procedure in 61 % yield (23.33 
g, 91.4 mmol). 
Molecular formula C8H15BrO4 
Molecular weight 255 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 4.34 (t, J = 4.6 Hz, 2H, H3), 3.88 (s, 2H, H1), 
3.74 (t, J = 4.6 Hz, 2H, H4), 3.66 (t, J = 4.0 Hz, 2H, H5), 3.60 (t, J = 4.0 Hz, 2H, H6), 
3.53 (q, J = 6.9 Hz, 2H, H7), 1.22 (t, J = 6.9 Hz, 3H, H8) 
13C NMR (100 MHz, CDCl3) δ ppm 167.27 (CO), 71.20 (OCH2), 70.45 (CH2O), 
69.90 (OCH2), 66.72 (CH2O), 65.32 (OCH2), 25.90 (CH2), 15.15 (CH3) 
 
2-(2-Propoxyethoxy)ethyl 2-bromoacetate (176i) 
 
1
2
3
4 5
6 7
8
9Br
O
O
O
O
 
Pale yellow oily liquid 
 
The title compound was 
prepared from propoxy 
ethoxyethanol (68.08 g, 460 
mmol) and bromoacetyl 
bromide (92.92 g, 460 
mmol) according to the 
general procedure in 73 % 
yield (90.33 g, 336 mmol). 
Molecular formula C9H17BrO4 
Molecular weight 269 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 4.36 (t, J = 4.2 Hz, 2H, H3), 3.89 (s, 2H, H1), 
3.77 (t, J = 4.2 Hz, 2H, H4), 3.70 (t, J = 4.4 Hz, 2H, H5), 3.63 (t, J = 4.4 Hz, 2H, H6), 
3.59 (t, J = 7.1 Hz, 2H, H7), 3.56 (tq, J = 7.1, 7.3 Hz, 2H, H8), 1.26 (t, J = 7.3 Hz, 3H, 
H9) 
13C NMR (100 MHz, CDCl3) δ ppm 167.27 (CO), 73.13 (OCH2), 70.67 (CH2O), 
70.56 (OCH2), 68.76 (CH2O), 65.36 (OCH2), 25.88 (CH2), 22.74 (CH2), 10.51 (CH3) 
 
 A-9 
2-(2-Butoxyethoxy)ethyl 2-bromoacetate (176j) 
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Pale yellow liquid 
 
The title compound was 
prepared from butoxy 
ethoxyethanol (72.9 g, 450 
mmol) and bromoacetyl 
bromide (90.9 g, 450 
mmol) according to the 
general procedure in 72 % 
yield (91.69 g, 324 mmol). 
Molecular formula C10H19BrO4 
Molecular weight 283 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 4.30 (t, J = 4.6 Hz, 2H, H3), 3.85 (s, 2H, H1), 
3.71 (t, J = 4.6 Hz, 2H, H4), 3.62-3.58 (m, 2H, H5), 3.56-3.51 (m, 2H, H6), 3.43 (t, J 
= 6.8 Hz, 2H, H7), 1.54 (tt, J = 6.8, 7.2 Hz 2H, H8), 1.34 (tq, J = 7.2, 7.5 Hz, 2H, 
H9), 0.89 (t, J = 7.5 Hz, 3H, H10) 
13C NMR (100 MHz, CDCl3) δ ppm 167.28 (CO), 71.32 (OCH2), 71.21 (CH2O), 
70.68 (OCH2), 68.76 (CH2O), 65.37 (OCH2), 31.68 (CH2), 25.89 (CH2), 19.24 (CH2), 
13.95 (CH3) 
 
2-(2-(2-Methoxyethoxy)ethoxy)ethyl 2-bromoacetate (176k) 
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Pale yellow liquid 
 
The title compound was 
prepared from methoxy 
ethoxyethoxyethanol (29.52 
g, 180 mmol) and 
bromoacetyl bromide (10.4 
g, 200 mmol) according to 
the general procedure in 58 
% yield (29.75 g, 104 
mmol). 
Molecular formula C9H17BrO5 
Molecular weight 285 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 4.28 (t, J = 4.6 Hz, 2H, H3), 3.81 (s, 2H, H1), 
3.68 (t, J = 4.6 Hz, 2H, H4), 3.62-3.57 (m, 6H, H’s 5,6 and 7), 3.50-3.43 (m, 2H, H8), 
3.32 (s, 3H, H9) 
 A-10 
13C NMR (100 MHz, CDCl3) δ ppm 167.25 (CO), 71.91 (OCH2), 70.64 (CH2O), 
70.57 (OCH2), 70.52 (CH2O), 68.74 (OCH2), 65.31 (CH2O), 59.04 (CH3), 25.84 
(CH2) 
 
Decyl 2-bromoacetate (176l) 
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Colourless liquid 
 
The title compound was 
prepared from decan-1-ol 
(71.10 g, 450 mmol) and 
bromoacetyl bromide 
(90.90 g, 450 mmol) 
according to the general 
procedure in 62 % yield 
(77.84 g, 279 mmol). 
Molecular formula C12H23BrO2 
Molecular weight 279 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 4.18 (t, J = 6.8 Hz, 2H, H3), 3.85 (s, 2H, H1), 
1.90 – 1.28 (m, 16H, H’s 4-11), 0.89 (t, J = 6.8 Hz, 3H, H12) 
13C NMR (100 MHz, CDCl3) δ ppm 167.37 (CO), 66.49 (OCH2), 63.05 (CH2), 34.09 
(CH2), 32.85 (CH2), 32.77 (CH2), 29.52 (CH2), 29.49 (CH2), 29.35 (CH2), 29.19 
(CH2), 22.69 (CH2), 14.13 (CH3) 
 
 A-11 
2-Bromo-N,N-bis(2-methoxyethyl)acetamide (199) 
 
1 2
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Pale yellow crystals 
 
The title compound was prepared from 
bis(2-methoxyethyl)amine (39.90 g, 300 
mmol) and bromoacetyl bromide (80.80 g, 
400 mmol) according to the general 
procedure in 49 % yield (37.33 g, 147 
mmol). Note: Purification can also be 
achieved by recrystallisation from diethyl 
ether. 
Molecular formula C18H26BrNO3 
Molecular weight 254 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 4.02 (s, 2H, H8), 3.66 (t, J = 5.1 Hz, 2H, H4), 
3.55 (br s, 4H, H’s 2 and 3), 3.53 (t, J = 5.1 Hz, 2H, H5), 3.33 (s, 6H, H’s 1 and 6) 
13C NMR (100 MHz, CDCl3) δ ppm 167.79 (CO), 70.74 (OCH2), 70.27 (CH2O), 
59.13 (CH2N), 58.94 (NCH2), 50.12 (CH3O), 46.90 (OCH3), 27.20 (CH2) 
 
2-Bromo-1-(pyrrolin-1-yl)ethanone (200) 
1
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Pale yellow crystals 
The title compound was prepared from 
pyrrolidine (33.50 g, 500 mmol) and 
bromoacetyl bromide (121.20 g, 600 mmol) 
according to the general procedure in 52 % 
yield (49.92 g, 260 mmol). 
Molecular formula C6H10BrNO 
Molecular weight 192 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 3.82 (s, 2H, H1), 3.55 (tt, J = 6.8, 6.8 Hz, 4H, H’s 
3 and 6), 2.00 (tt, J = 6.8, 6.8 Hz, 2H, H4), 1.92 (tt, J = 6.8, 6.8 Hz, 2H, H5) 
13C NMR (100 MHz, CDCl3) δ ppm 165.26 (CO), 47.15 (NCH2), 46.54 (NCH2), 
27.30 (CH2), 26.13 (CH2), 24.32 (CH2) 
 
 A-12 
2-Bromo-N-(2-methoxyethyl)acetamido (201) 
1 2
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Pale yellow crystals 
The title compound was prepared from 2-
methoxyethylamine (37.50 g, 500 mmol) 
and bromoacetyl bromide (111.10 g, 550 
mmol) according to the general procedure 
in 17 % yield (16.66 g, 85.0 mmol). 
Molecular formula C5H10BrNO2 
Molecular weight 196 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 6.80 (br s, 1H, H3), 3.90 (s, 2H, H1), 3.49 (s, 2H, 
H4), 3.48 (s, 2H, H5), 3.39 (s, 3H, H6) 
13C NMR (100 MHz, CDCl3) δ ppm 165.60 (CO), 70.68 (CH2O), 58.89 (OCH3), 
39.93 (NCH2), 29.12 (CH2) 
 
2-Bromo-N-(3-methoxypropyl)acetamido (202) 
1 2
3
4
5
6 7
O
N
H
Br
O
 
Pale yellow crystals 
The title compound was prepared from 3-
methoxypropan-1-amine (44.50 g, 500 mmol) 
and bromoacetyl bromide (111.10 g, 550 
mmol) according to the general procedure in 
51 % yield (53.55 g, 255 mmol). 
Molecular formula C6H12BrNO2 
Molecular weight 210 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.22 (br s, 1H, H3), 3.81 (s, 2H, H1), 3.45 (t, J = 
5.6 Hz, 2H, H6), 3.37 (q, J = 6.2 Hz, 2H, H4), 3.30 (s, 3H, H7), 1.78 (tt, J = 5.6, 6.2 
Hz, 2H, H5) 
13C NMR (100 MHz, CDCl3) δ ppm 165.39 (CO), 71.87 (CH2O), 58.86 (OCH3), 
39.21 (NCH2), 29.33 (CH2), 28.47 (CH2) 
 
 A-13 
Achiral bromide salts 
Representative method for the preparation of bromide salts (3-methyl-1-
(butoxycarbonylmethyl)imidazolium bromide) (177a) 
To a stirred solution of 1-
methylimidazole (45.0 mmol, 3.69 g, 
3.60 mL) in diethyl ether (60 mL) at 
-15 ºC under a nitrogen atmosphere 
was added dropwise butyl 2-bromoacetate (60.0 mmol, 11.70 g). The reaction mixture 
was stirred vigorously at -15 ºC for 1 h, then at RT for 24 h. The diethyl ether top 
phase was decanted and the IL washed with diethyl ether (2 x 20 mL), then residual 
solvent removed on the rotary evaporator. The product was dried under high vacuum 
for 8 h yielding a light orange viscous liquid in 82 % yield (10.17 g, 36.7 mmol).  
 
Molecular formula C10H17BrN2O2 
Molecular weight 277 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 10.20 (s, 1H, H2), 7.50 (t, J = 1.8 Hz, 1H, H4), 
7.37 (t, J = 1.8 Hz, 1H, H3), 5.42 (s, 2H, H5), 4.15 (t, J = 6.7 Hz, 2H, H7), 4.05 (s, 
3H, H1), 1.60 (tt, J = 6.7, 7.2 Hz 2H, H8), 1.31 (tq, J = 7.2, 7.4 Hz, 2H, H9), 0.87 (t, J 
= 7.4 Hz, 3H, H10)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.15 (CO), 138.65 (NCH2N), 123.70 
(NCH2), 122.82 (NCH2), 66.85 (OCH2), 50.30 (NCH2), 36.92 (NCH3), 30.33 (CH2), 
18.98 (CH2), 13.66 (CH3) 
IR (thin film on salt plate) (cm-1) 3099, 2961, 2930, 2861, 1751, 1569, 1558, 1495, 
1452, 1398, 1217, 1177 
MS m/z, Found 197.1278 [M-Br-]+, Calcd. C10H17N2O2 197.1290 
MS m/z, 197.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
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 A-14 
3-Methyl-1-(pentoxycarbonylmethyl)imidazolium bromide (178a) 
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Pale yellow viscous liquid 
The title compound was prepared 
from 1-methylimidazole (3.69g, 
45.0 mmol) and pentyl 2-
bromoacetate (54.0 mmol, 11.29 g) 
according to the general procedure 
in 97 % yield (12.76 g, 43.8 
mmol). 
Molecular formula C11H19BrN2O2 
Molecular weight 291 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.79 (s, 1H, H2), 7.30 (t, J = 1.8 Hz, 1H, H4), 
7.23 (t, J = 1.8 Hz, 1H, H3), 4.95 (s, 2H, H5), 4.16 (t, J = 6.8 Hz, 2H, H7), 3.90 (s, 
3H, H1), 1.65 (tt, J = 6.8, 7.2 Hz, 2H, H8), 1.30-1.23 (m, 4H, H’s 9 and 10), 0.86 (t, J 
= 7.0 Hz, 3H, H11) 
13C NMR (100 MHz, CDCl3) δ (ppm) 166.16 (CO), 138.39 (NCH2N), 123.79 
(NCH2), 123.08 (NCH2), 67.07 (OCH2), 50.30 (NCH2), 36.92 (NCH3), 28.00 (CH2), 
27.79 (CH2), 22.21 (CH2), 13.19 (CH3) 
IR (KBr disc) (cm-1) 3095, 2959, 2931, 1750, 1578, 1569, 1559, 1495, 1455, 1398, 
1230, 1177 
MS m/z, Found 211.1440 [M-Br-]+, Calcd. C11H19N2O2 211.1447  
MS m/z, 211.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
3-Methyl-1-(methoxyethoxycarbonylmethyl)imidazolium bromide (179a) 
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Pale brown solid 
 
The title compound was prepared from 
1-methylimidazole (120 mmol, 9.84 g) 
and 2-methoxyethyl 2-bromoacetate 
(150 mmol, 29.55 g) according to the 
general procedure in 89 % yield (29.92 
g, 107 mmol). 
Molecular formula C9H15BrN2O3 
Molecular weight 279 g/mol 
 A-15 
1H NMR (400 MHz, CDCl3) δ (ppm) 10.33 (s, 1H, H2), 7.57 (t, J = 1.8 Hz, 1H, H4), 
7.41 (t, J = 1.8 Hz, 1H, H3), 5.56 (s, 2H, H5), 4.39 (t, J = 4.6 Hz, 2H, H7), 4.10 (s, 
3H, H1), 3.66 (t, J = 4.6 Hz, 2H, H8), 3.40 (s, 3H, H9)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.18 (CO), 138.77 (NCH2N), 123.73 
(NCH2), 122.74 (NCH2), 69.84 (OCH2), 65.63 (NCH2), 59.03 (NCH3), 50.27 (OCH2), 
36.94 (OCH3) 
MP (°C) 53 – 55  
IR (KBr disc) (cm-1) 3438, 3111, 3152, 1751, 1223, 1199, 1177, 1124, 1090, 1026 
MS m/z, Found 199.1074 [M-Br-]+, Calcd. C9H15N2O3 199.1083  
MS m/z, 199.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
3-Methyl-1-(ethoxyethoxycarbonylmethyl)imidazolium bromide (180a) 
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Pale brown solid 
 
The title compound was prepared 
from 1-methylimidazole (25.0 
mmol, 2.05 g) and 2-ethoxyethyl 
2-bromoacetate (30.0 mmol, 6.33 
g) according to the general 
procedure in 93 % yield (6.81 g, 
23.2 mmol). 
Molecular formula C10H17BrN2O3 
Molecular weight 293 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 10.25 (s, 1H, H2), 7.61 (t, J = 1.8 Hz, 1H, H4), 
7.47 (t, J = 1.8 Hz, 1H, H3), 5.54 (s, 2H, H5), 4.37 (t, J = 4.8 Hz, 2H, H7), 4.10 (s, 
3H, H1), 3.68 (t, J = 4.8 Hz, 2H, H8), 3.56 (q, J = 7.1 Hz, 2H, H9), 1.22 (t, J = 7.1 
Hz, 3H, H10)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.31 (CO), 138.35 (NCH2N), 123.82 
(NCH2), 123.04 (NCH2), 67.74 (OCH2), 66.70 (NCH2), 65.78 (NCH3), 50.31 (OCH2), 
36.96 (OCH2), 15.11 (CH3) 
MP (°C) 24 – 26 
IR (KBr disc) (cm-1) 3437, 3157, 3101, 1751, 1567, 1493, 1452, 1389, 1219, 1177, 
1115, 1052 
MS m/z, Found 213.1231 [M-Br-]+, Calcd. C10H17N2O3 213.1239   
MS m/z, 213.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
 A-16 
3-Methyl-1-(propoxyethoxycarbonylmethyl)imidazolium bromide (181a) 
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Yellow solid 
 
The title compound was 
prepared from 1-
methylimidazole (65.0 mmol, 
5.33 g) and 2-propoxyethyl 2-
bromoacetate (78.0 mmol, 17.55 
g) according to the general 
procedure in 88 % yield (17.59 
g, 57.3 mmol). 
Molecular formula C11H19BrN2O3 
Molecular weight 307 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 10.25 (s, 1H, H2), 7.48 (t, J = 1.8 Hz, 1H, H4), 
7.35 (t, J = 1.8 Hz, 1H, H3), 5.46 (s, 2H, H5), 4.30 (t, J = 4.8 Hz, 2H, H7), 4.02 (s, 
3H, H1), 3.61 (t, J = 4.8 Hz, 2H, H8), 3.37 (t, J = 6.8 Hz, 2H, H9), 1.54 (tq, J = 6.8, 
7.5 Hz, 2H, H10), 0.85 (t, J = 7.5 Hz, 3H, H11)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.12 (CO), 138.74 (NCH2N), 123.68 (NCH2), 
122.77 (NCH2), 73.08 (OCH2-), 67.89 (NCH2), 65.87 (NCH3), 50.28 (OCH2), 36.93 
(OCH2), 22.75 (CH2), 10.50 (CH3) 
MP (°C) 25 – 27 
IR (KBr disc) (cm-1) 3099, 2967, 2927, 1751, 1578, 1568, 1558, 1539, 1495, 1452, 
1216, 1176 
MS m/z, Found 227.1410 [M-Br-]+, Calcd. C11H19N2O3 227.1396   
MS m/z, 227.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
3-Methyl-1-(butoxyethoxycarbonylmethyl)imidazolium bromide (182a) 
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Yellow solid 
 
The title compound was 
prepared from 1-
methylimidazole (160 mmol, 
13.12 g) and 2-butoxyethyl 2-
bromoacetate (190 mmol, 
45.41 g) according to the 
general procedure in 89 % 
yield (45.69 g, 142 mmol). 
Molecular formula C12H21BrN2O3 
 A-17 
Molecular weight 321 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 10.19 (s, 1H, H2), 7.60 (t, J = 1.8 Hz, 1H, H4), 
7.48 (t, J = 1.8 Hz, 1H, H3), 5.52 (s, 2H, H5), 4.36 (t, J = 4.6 Hz, 2H, H7), 4.10 (s, 
3H, H1), 3.67 (t, J = 4.6 Hz, 2H, H8), 3.47 (t, J = 6.8 Hz, 2H, H9), 1.59 (tt, J = 6.8, 
6.8 Hz, 2H, H10), 1.40 (tq, J = 6.8, 7.3 Hz, 2H, H11), 0.92 (t, J = 7.3 Hz, 3H, H12)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.16 (CO), 138.54 (NCH2N), 123.74 
(NCH2), 122.91 (NCH2), 71.24 (OCH2), 67.93 (NCH2), 65.82 (NCH3), 50.28 (OCH2), 
36.94 (OCH2), 31.58 (CH2), 19.22 (CH2), 13.94 (CH3) 
MP (°C) 28 – 30 
IR (KBr disc) (cm-1) 3094, 2957, 2933, 2866, 1751, 1575, 1569, 1558, 1539, 1495, 
1452, 1216, 1177, 1120 
MS m/z, Found 241.1539 [M-Br-]+, Calcd. C12H21N2O3 241.1552 
MS m/z, 241.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
3-Methyl-1-(methoxyethoxyethoxycarbonylmethyl)imidazolium bromide (183a) 
 
 
1
2
3
4
5
6
7
8 9
10 11N
N
Br-
O
O
O
O
 
White solid 
 
The title compound was 
prepared from 1-
methylimidazole (100 mmol, 
8.20 g) and 2-methoxy ethoxy 
ethyl 2-bromoacetate (120 
mmol, 28.92 g) according to 
the general procedure in 97 % 
yield (31.49 g, 97.5 mmol). 
Molecular formula C11H19BrN2O4 
Molecular weight 323 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 10.21 (s, 1H, H2), 7.53 (t, J = 1.7 Hz, 1H, H4), 
7.31 (t, J = 1.7 Hz, 1H, H3), 5.47 (s, 2H, H6), 4.32 (t, J = 4.6 Hz, 2H, H7), 4.02 (s, 
3H, H1), 3.68 (t, J = 4.6 Hz, 2H, H8), 3.59 (t, J = 4.8 Hz, 2H, H9), 3.50 (t, J = 4.8 Hz, 
2H, H10), 3.31 (s, 3H, H11)  
13C NMR (100 MHz, CDCl3) δ (ppm) 164.38 (CO), 136.93 (NCH2N), 122.06 
(NCH2), 120.93 (NCH2), 70.00 (OCH2), 68.69 (NCH2), 66.75 (NCH3), 63.87 (OCH2), 
57.24 (OCH2), 48.49 (OCH2), 35.13 (OCH3) 
MP (°C) 52 – 54 ºC 
 A-18 
IR (KBr disc) (cm-1) 3437, 3157, 3101, 2925, 1749, 1496, 1452, 1398, 1217, 1177, 
1102, 1049 
MS m/z, Found 243.1333 [M-Br-]+, Calcd. C11H19N2O4 243.1345  
MS m/z, 243.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
3-Methyl-1-(ethoxyethoxyethoxycarbonylmethyl)imidazolium bromide (184a) 
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Pale yellow solid 
 
The title compound was 
prepared from 1-
methylimidazole (59.0 
mmol, 4.84 g) and 2-
ethoxy ethoxyethyl 2-
bromoacetate (70.8 mmol, 
18.05 g) according to the 
general procedure in 92 % 
yield (18.28 g, 54.2 
mmol). 
Molecular formula C12H21BrN2O4 
Molecular weight 337 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 10.09 (s, 1H, H2), 7.61 (t, J = 1.8 Hz, 1H, H4), 
7.41 (t, J = 1.8 Hz, 1H, H3), 5.46 (s, 2H, H5), 4.31 (t, J = 4.6 Hz, 2H, H7), 4.02 (s, 
3H, H1), 3.68 (t, J = 4.6 Hz, 2H, H8), 3.59-3.57 (m, 2H, H9), 3.53-3.51 (m, 2H, H10), 
3.49 (q, J = 7.1 Hz, 2H, H11), 1.13 (t, J = 7.1 Hz, 3H, H12)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.24 (CO), 138.49 (NCH2N), 123.93 
(NCH2), 122.87 (NCH2), 70.65 (OCH2), 69.70 (NCH2), 68.55 (OCH2), 66.66 (OCH2), 
65.64 (OCH2), 50.27 (OCH2), 36.92 (NCH3), 15.18 (CH3) 
MP (°C) 28 – 30 
IR (KBr disc) (cm-1) 2026, 2862, 1751, 1568, 1558, 1539, 1495, 1451, 1217, 1175 
MS m/z, Found 257.1498 [M-Br-]+, Calcd. C12H21N2O4 257.1501   
MS m/z, 257.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
 A-19 
3-Methyl-1-(propoxyethoxyethoxycarbonylmethyl)imidazolium bromide (185a) 
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White solid 
 
The title compound was 
prepared from 1-
methylimidazole (50.0 
mmol, 4.10 g) and 2-
propoxyethoxyethyl 2-
bromoacetate (60.0 
mmol, 16.14 g) 
according to the general 
procedure in 98 % yield 
(17.16 g, 48.89 mmol). 
Molecular formula C13H23BrN2O4 
Molecular weight 351 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 10.13 (s, 1H, H2), 7.54, (t, J = 1.8 Hz, 1H, H4), 
7.34 (t, J = 1.8 Hz, 1H, H3), 5.45 (s, 2H, H5), 4.31 (t, J = 4.6 Hz, 2H, H7), 4.02 (s, 
3H, H1), 3.68 (t, J = 4.6 Hz, 2H, H8), 3.59-3.57 (m, 2H, H9), 3.53-3.50 (m, 2H, H10), 
3.35 (t, J = 6.9 Hz, 2H, H11), 1.53 (tq, J = 6.9, 7.3 Hz, 2H, H12), 0.84 (t, J = 7.3 Hz, 
3H, H13)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.21 (CO), 138.54 (NCH2N), 123.85 
(NCH2), 122.84 (NCH2), 73.10 (OCH2), 70.62 (OCH2), 69.92 (OCH2), 68.55 (OCH2), 
65.69 (NCH2), 50.29 (OCH2), 36.93 (NCH3), 22.76 (CH2), 10.52 (CH3) 
MP (°C) 32 – 34 ºC 
IR (KBr disc) (cm-1) 2959, 2926, 2859, 1751, 1558, 1639, 1495, 1452 
MS m/z, Found 271.1648 [M-Br-]+, Calcd. C13H23N2O4 271.1658  
MS m/z, 271.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
 A-20 
3-Methyl-1-(butoxyethoxyethoxycarbonylmethyl)imidazolium bromide (186a) 
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White solid 
 
The title compound was 
prepared from 1-
methylimidazole (220 
mmol, 18.04 g) and 2-
butoxyethoxyethyl 2-
bromoacetate (260 
mmol, 73.58 g) 
according to the general 
procedure in 94 % yield 
(75.65 g, 207 mmol) 
Molecular formula C14H25BrN2O4 
Molecular weight 365 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 10.40 (s, 1H, H2), 7.37 (t, J = 1.6 Hz, 1H, H4), 
7.19 (t, J = 1.6 Hz, 1H, H3), 5.42 (s, 2H, H5), 4.32 (t, J = 4.6 Hz, 2H, H7), 4.01 (s, 
3H, H1), 3.69 (t, J = 4.6 Hz, 2H, H8), 3.59-3.56 (m, 2H, H9), 3.54-3.51 (m, 2H, H10), 
3.40 (t, J = 6.8 Hz, 2H, H11), 1.50 (tt, J = 6.8 Hz, 7.2 Hz, 2H, H12), 1.30 (tq, J = 7.2 
Hz, 7.3 Hz, 2H, H13), 0.85 (t, J = 7.3 Hz, 3H, H14)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.23 (CO), 138.35 (NCH2N), 123.97 
(NCH2), 123.03 (NCH2), 71.20 (OCH2), 70.60 (OCH2), 69.94 (OCH2), 68.54 (OCH2), 
65.66 (OCH2), 50.27 (NCH2), 36.96 (NCH3), 31.62 (CH2), 19.23 (CH2), 13.94 (CH3) 
MP (°C) 48 – 50 ºC 
IR (KBr disc) (cm-1) 3445, 2927, 2861, 1553, 1494, 1453, 1086, 1051 
MS m/z, Found 285.1803 [M-Br-]+, Calcd. C14H25N2O4 285.1814 
MS m/z, 285.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
 A-21 
3-Methyl-1-(methoxyethoxyethoxyethoxycarbonylmethyl)imidazolium bromide 
(187a) 
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Pale brown solid 
 
The title compound was 
prepared from 1-
methylimidazole (90.0 
mmol, 7.38 g) and 2-(2-(2-
methoxyethoxy)ethoxy)eth
yl 2-bromoacetate (91.0 
mmol,  25.94 g) according 
to the general procedure in 
55 % yield (18.30 g, 49.86 
mmol). 
Molecular formula C13H23BrN2O5 
Molecular weight 367 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.92 (s, 1H, H2), 7.45 (t, J = 1.6 Hz, 1H, H4), 
7.60 (t, J = 1.6 Hz, 1H, H3), 5.47 (s, 2H, H5), 4.32 (t, J = 4.6 Hz, 2H, H7), 4.06 (s, 
3H, H1), 3.70 (t, J = 4.6 Hz, 2H, H8), 3.61-3.58 (m, 6H, H’s 9-11), 3.51-3.49 (m, 2H, 
H12), 3.31 (s, 3H, H13)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.33 (CO), 138.18 (NCH2N), 124.02 
(NCH2), 123.15 (NCH2), 71.77 (OCH2), 70.43 (OCH2), 70.39 (OCH2), 70.33 (OCH2), 
68.50 (OCH2), 65.44 (OCH2), 58.87 (OCH3), 50.20 (NCH2), 36.87 (NCH3) 
MP (°C) 59 – 61 
IR (KBr disc) (cm-1) 3150, 3095, 2925, 1751, 1635, 1575, 1569, 1558, 1494, 1451, 
1216, 1176 
MS m/z, Found 287.1605 [M-Br-]+, Calcd. C13H23N2O5 287.1607   
MS m/z, 287.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
 A-22 
3-Methyl-1-(decoxycarbonylmethyl)imidazolium bromide (188a) 
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White solid 
The title compound was 
prepared from 1-
methylimidazole (100 
mmol, 8.20 g) and decyl 2-
bromoacetate (110 mmol, 
30.69 g) according to the 
general procedure in 51 % 
yield (18.47 g, 51.2 
mmol). 
Molecular formula C16H29BrN2O2 
Molecular weight 361 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 10.36 (s, 1H, H2), 7.42 (t, J = 1.8 Hz, 1H, H4), 
7.28 (t, J = 1.8 H, 1H, H3), 5.40 (s, 2H, H5), 4.14 (t, J = 6.8 Hz, 2H, H7), 4.02 (s, 3H, 
H1), 1.62-1.59 (m, 2H, H8), 1.23-1.18 (m, 14H, H’s 9-15), 0.81 (t, J = 6.8 Hz, 3H, 
H16)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.07 (CO), 138.93 (NCH2N), 123.56 
(NCH2), 122.64 (NCH2), 67.23 (OCH2), 50.28 (NCH2), 36.89 (NCH3), 31.89 (CH2), 
29.54 (CH2), 29.48 (CH2), 29.31 (CH2), 29.19 (CH2), 28.35 (CH2), 25.73 (CH2), 22.70 
(CH2), 14.15 (CH3) 
MP (°C) 49 – 51 ºC 
IR (KBr disc) (cm-1) 3426, 2961, 1919, 2853, 1748, 1232, 1178, 1052 
MS m/z, Found 281.2228 [M-Br-]+, Calcd. C16H29N2O2 281.2229   
MS m/z, 281.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
 A-23 
2,3-Dimethyl-1-(butoxyethoxycarbonylmethyl)imidazolium bromide (190a) 
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Orange viscous liquid 
The title compound was 
prepared from 1,2-
dimethylimidazole (9.00 mmol, 
0.86 g) and 2-butoxyethyl 2-
bromoacetate (11.0 mmol, 2.63 
g) according to the general 
procedure in 92 % yield (2.78 
g, 8.30 mmol). 
Molecular formula C13H23BrN2O3 
Molecular weight 335 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.81 (d, J = 2.4 Hz, 1H, H5), 7.53 (d, J = 2.4 
Hz, 1H, H4), 5.42 (s, 2H, H6), 4.30 (t, J = 4.6 Hz, 2H, H8), 3.89 (s, 3H, H3), 3.61 (t, J 
= 4.6 Hz, 2H, H9), 3.47 (t, J = 6.7 Hz, 2H, H10), 2.56 (s, 3H, H1), 1.56 (tt, J = 6.7, 
7.2 Hz, 2H, H11), 1.36 (tq, J = 7.2, 7.5 Hz, 2H, H12), 0.93 (t, J  = 7.5 Hz, 3H, H13)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.30 (CO), 145.78 (NCHN), 123.02 (NCH2), 
122.34 (NCH2), 71.24 (OCH2), 67.98 (OCH2), 65.69 (OCH2), 50.02 (NCH2), 36.04 
(NCH3), 31.62 (CH2), 19.04 (CH2), 13.96 (NCH3), 11.27 (CH3) 
IR (thin film on salt plate) (cm-1) 2957, 2933, 2866, 1751, 1593, 1558, 1546, 1495, 
1451, 1216, 1120 
MS m/z, Found 255.1689 [M-Br-]+, Calcd. C13H23N2O3 255.1709   
MS m/z, 255.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
2,3-Dimethyl-1-(pentoxycarbonylmethyl)imidazolium bromide (189a) 
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Orange viscous liquid 
The title compound was 
prepared from 1,2-
dimethylimidazole (150 mmol, 
14.40 g) and pentyl 2-
bromoacetate (168 mmol, 35.11 
g) according to the general 
procedure in 81 % yield (36.91 
g, 121 mmol) 
Molecular formula C12H21BrN2O2 
Molecular weight 305 g/mol 
 A-24 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.74 (d, J = 2.0 Hz, 1H, H5), 7.46 (d, J = 2.0 
Hz, 1H, H4), 5.38 (s, 2H, H6), 4.13 (t, J = 6.8 Hz, 2H, H8), 3.89 (s, 3H, H3), 2.69 (s, 
3H, H1), 1.63-1.54 (m, 2H, H9), 1.27-1.20 (m, 4H, H’s 10 and 11), 0.85 (t, J = 7.0 
Hz, 3H, H12)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.31 (CO), 145.81 (NCHN), 122.98 (NCH2), 
122.22 (NCH2), 67.08 (OCH2), 50.12 (NCH2), 36.03 (NCH3), 28.06 (CH2), 27.83 
(CH2), 22.24 (CH2), 13.95 (CH2), 11.35 (NCH3) 
IR (thin film on salt plate) (cm-1) 2957, 2928, 2858, 1751, 1558, 1545, 1539, 1495, 
1452, 1238, 1210, 1176 
MS m/z, Found 225.1594 [M-Br-]+, Calcd. C12H21N2O2 225.1603  
MS m/z, 225.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
2,3-Dimethyl-1-(methoxyethoxyethoxycarbonylmethyl)imidazolium bromide 
(191a) 
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White powder 
 
The title compound was 
prepared from 1,2-
dimethylimidazole (150 mmol, 
14.40 g) and 2-(2-
methoxyethoxy) ethyl 2-
bromoacetate (171 mmol, 41.21 
g) according to the general 
procedure in 88 % yield (44.48 
g, 132 mmol). 
Molecular formula C12H21BrN2O4 
Molecular weight 337 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.69 (d, J = 2.0 Hz, 1H, H5), 7.34 (d, J = 2.0 
Hz, 1H, H4), 5.40 (s, 2H, H6), 4.32 (t, J = 4.7 Hz, 2H, H8), 3.86 (s, 3H, H3), 3.68 (t, J 
= 4.7 Hz, 2H, H9), 3.59 (t, J = 4.4 Hz, 2H, H10), 3.49 (t, J = 4.4 Hz, 2H, H11), 3.31 
(s, 3H, H1), 2.71 (s, 3H, H12)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.34 (CO), 145.77 (NCHN), 123.04 (NCH2), 
122.38 (NCH2), 71.79 (OCH2), 70.47 (OCH2), 68.55 (OCH2), 65.51 (OCH2), 59.02 
(OCH3), 49.96 (NCH2), 35.98 (NCH3), 11.25 (NCH3) 
MP (°C) 74 – 75  
IR (KBr disc) (cm-1) 3426, 2925, 2868, 1747, 1453, 1248, 1214, 1135, 1099, 1026 
 A-25 
MS m/z, Found 257.1492 [M-Br-]+, Calcd. C12H21N2O4 257.1501  
MS m/z, 257.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
3-Methyl-1-[(bis-1-methoxyethyl)carbamylmethyl]imidazolium bromide (205a) 
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White powder 
The title compound was prepared from 
1-methylimidazole (45.0 mmol, 3.69 g) 
and 2-bromo-N,N-bis-(2-methoxy ethyl) 
acetamide (50.0 mmol, 12.70 g) 
according to the general procedure in 91 
% yield (13.76 g, 41.0 mmol). 
 
Molecular formula C12H22BrN3O3 
Molecular weight 336 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.91 (s, 1H, H2), 7.44 (t, J = 1.8 Hz, 1H, H4), 
7.42 (t, J = 1.8 Hz, 1H, H3), 5.66 (s, 2H, H5), 4.07 (s, 3H, H1), 3.70 (t, J = 4.8 Hz, 
2H, H7), 3.57-3.55 (m, 4H, H’s 8 and 11), 3.50-3.47(m, 2H, H10), 3.36 (s, 3H, H9), 
3.31 (s, 3H, H12) 
13C NMR (100 MHz, CDCl3) δ (ppm) 165.46 (CO), 138.30 (NCH2N), 124.14 
(NCH2), 122.31 (NCH2), 70.51 (OCH2), 70.05 (OCH2), 59.25 (OCH3), 58.92 (OCH3), 
50.63 (NCH2), 48.82 (NCH2), 46.83 (NCH2), 36.75 (NCH3) 
MP (°C) 68 – 70  
IR (KBr disc) (cm-1) 3441, 3108, 2940, 1654, 1576, 1474, 1427, 1178, 1116, 1015 
MS m/z, Found 256.1653 [M-Br-]+, Calcd. C12H22N3O3 256.1661 
MS m/z, 256.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 A-26 
3-Methyl-1-(pyrrolidinylcarbonylmethyl)imidazolium bromide (197a) 
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White powder 
The title compound was prepared 
from 1-methylimidazole (36.0 
mmol, 2.95 g) and 2-bromo-1- 
(pyrrolidin-1-yl) ethanone (39.0 
mmol, 7.49 g) according to the 
general procedure in 56 % yield 
(5.52 g, 20.15 mmol). 
Molecular formula C10H16BrN3O 
Molecular weight 274 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.80 (s, 1H, H2), 7.71 (t, J = 1.8 Hz, 1H, H4), 
7.46 (t, J = 1.8 Hz, 1H, H3), 5.58 (s, 2H, H5), 4.02 (s, 3H, H1), 3.65 (t, J = 6.8 Hz, 
2H, H7), 3.42 (t, J = 6.8 Hz, 2H, H8), 2.04 (tt, J = 6.8, 7.2 Hz, 2H, H9), 1.86 (tt, J = 
6.8, 7.2 Hz, 2H, H10) 
13C NMR (100 MHz, CDCl3) δ (ppm) 162.63 (CO), 137.95 (NCH2N), 124.41 
(NCH2), 122.32 (NCH2), 51.09 (NCH2), 46.55 (NCH2), 46.11 (NCH2), 36.76 (NCH3), 
25.98 (CH2), 24.04 (CH2) 
MP (°C) 109 – 111 
IR (KBr disc) (cm-1) 3443, 1656, 1573, 1424, 1343, 1176, 1042 
MS m/z, 194.1289 [M-Br-]+, Calcd. C10H16N3O 194.1293 
MS m/z, 194.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
2,3-Dimethyl-1-(pyrrolidinylcarbonylmethyl)imidazolium bromide (198a) 
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White powder 
The title compound was prepared from 
1,2-dimethylimidazole (40.0 mmol, 3.84 
g) and 2-bromo-1-(pyrrolidin-1-yl) 
ethanone (42.0 mmol, 8.06 g) according to 
the general procedure in 82 % yield (9.41 
g, 32.8 mmol). 
Molecular formula C11H18BrN3O 
Molecular weight 288 g/mol 
 A-27 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.84 (d, J = 2.2 Hz, 1H, H5), 7.47 (d, J = 2.2 
Hz, 1H, H4), 5.66 (s, 2H, H6), 3.91 (s, 3H, H3), 3.76 (t, J = 6.8 Hz, 2H, H8), 3.46 (t, J 
= 6.8 Hz, 2H, H9), 2.72 (s, 3H, H1), 2.05 (tt, J = 6.8, 6.4 Hz, 2H, H10), 1.92 (tt, J = 
6.8, 6.4 Hz, 2H, H11) 
13C NMR (100 MHz, CDCl3) δ (ppm) 162.51 (CO), 146.06 (NCHN), 123.04 (NCH2), 
121.70 (NCH2), 51.16 (NCH2), 46.50 (NCH2), 46.18 (NCH2), 35.80 (NCH3), 26.01 
(NCH3), 24.05 (CH2), 11.15 (CH2-) 
MP (°C) 142 – 144  
IR (KBr disc) (cm-1) 3406, 3141, 1646, 1478, 1420, 1337, 1165 
MS m/z, 208.1441 [M-Br-]+, Calcd. C11H18N3O 208.1450 
MS m/z, 208.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
3-Methyl-1-(methoxyethylcarbamylmethyl)imidazolium bromide (203a) 
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Yellow viscous liquid 
 
The title compound was prepared 
from 1-methylimidazole (50.0 
mmol, 4.10 g) and 2-bromo-N- (2-
methoxyethyl) acetamide (56.0 
mmol, 10.98 g) according to the 
general procedure in 97 % yield 
(13.48 g, 48.5 mmol). 
Molecular formula C9H16BrN3O2 
Molecular weight 278 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.76 (s, 1H, H2), 8.55 (t, J = 5.2 Hz, 1H, H7), 
7.65 (t, J = 1.6 Hz, 1H, H4), 7.31 (t, J = 1.6 Hz, 1H, H3), 5.39 (s, 2H, H5), 4.05 (s, 
3H, H1), 3.56-3.53 (m, 2H, H8), 3.48-3.44 (m, 2H, H9), 3.36 (s, 3H, H10) 
13C NMR (100 MHz, CDCl3) δ (ppm) 164.74 (CO), 137.73 (NCH2N), 123.90 
(NCH2), 122.44 (NCH2), 70.40 (OCH2), 58.69 (OCH3), 51.75 (NCH2), 39.51 (NCH3), 
36.80 (NCH2) 
IR (thin film on salt plate) (cm-1) 3064, 1683, 1559, 1456, 1261, 1177, 1122, 1022 
MS m/z, 198.1238 [M-Br-]+, Calcd. C9H16N3O2 198.1243 
MS m/z, 198.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
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3-Methyl-1-(methoxypropylcarbamylmethyl)imidazolium bromide (204a) 
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Beige solid 
 
The title compound was prepared from 1-
methylimidazole (43.0 mmol, 3.53 g) and 
2-bromo-N-(3-methoxypropyl) acetamide 
(46.0 mmol, 9.66 g) according to the 
general procedure in 91 % yield (11.43 g, 
39.1 mmol). 
Molecular formula C10H18BrN3O2 
Molecular weight 292 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.66 (s, 1H, H2), 8.53 (t, J = 5.4 Hz, 1H, H7), 
7.65 (t, J = 1.8 Hz, 1H, H4), 7.41 (t, J = 1.8 Hz, 1H, H3), 5.33 (s, 2H, H5), 4.04 (s, 
3H, H1), 3.42 (t, J = 6.3 Hz, 2H, H8), 3.34-3.26 (m, 5H, H’s 10 and 11), 1.83 (tt, J = 
6.3, 6.8 Hz, 2H, H9) 
13C NMR (100 MHz, CDCl3) δ (ppm) 164.43 (CO), 137.49 (NCH2N), 123.77 
(NCH2), 122.76 (NCH2), 70.16 (OCH2), 58.62 (OCH3), 51.73 (NCH2), 37.25 (NCH2), 
36.83 (NCH3), 29.08 (CH2) 
MP (°C) 75 – 77 
IR (KBr disc) (cm-1) 3440, 3081, 2939, 1684, 1567, 1447, 1264, 1178, 1112 
MS m/z, 212.1395 [M-Br-]+, Calcd. C10H18N3O2 212.1399 
MS m/z, 212.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 A-29 
Achiral NTf2 salts 
Representative method for the preparation of NTf2 salts (3-methyl-1-
(butoxycarbonylmethyl)imidazolium NTf2) (177d) 
A flask was charged with 3-
methyl-1-(butoxy carbonylmethyl) 
imidazolium bromide 177a (3.05 
g, 11.0 mmol) and distilled water 
(10 mL). LiNTf2 (4.89 g, 17.0 
mmol) in distilled water (3 mL) was added in one portion and the suspension was 
stirred vigorously for 6 h at RT. The top aqueous layer was removed and the IL was 
washed with distilled water (3 x 10 mL). The solvent was then removed on the rotary 
evaporator and the product was dried under high vacuum for 3 h to give a pale yellow 
oil in 86 % yield (4.49 g, 9.41 mmol). 
 
Molecular formula C12H17F6N3O6S2 
Molecular weight 477 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.78 (s, 1H, H2), 7.30 (t, J = 1.8 Hz, 1H, H4), 
7.24 (t, J = 1.8 Hz, 1H, H3), 4.95 (s, 2H, H5), 4.15 (t, J = 6.7 Hz, 2H, H7), 3.89 (s, 
3H, H1), 1.59 (tt, J = 6.7, 7.4 Hz, 2H, H8), 1.31 (tq, J = 7.4, 7.2 Hz, 2H, H9), 0.87 (t, 
J = 7.2 Hz, 3H, H10)  
13C NMR (100 MHz, CDCl3) δ (ppm) 165.75 (COO), 137.69 (NCHN), 123.79 
(NCH2), 123.16 (NCH2), 122.03 (q, J = 320 Hz, 2CF3’s), 66.97 (OCH2-), 49.93 
(NCH2), 36.56 (CH2), 30.03 (CH2), 18.87 (CH2), 13.55 (CH3) 
IR (thin film on salt plate) (cm-1) 3164, 3125, 2966, 2937, 2876, 1750, 1580, 1569, 
1559, 1495, 1457, 1354, 1197, 1136 
MS m/z, 197.1 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-]   
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 A-30 
3-Methyl-1-(pentoxycarbonylmethyl)imidazolium NTf2 (178d) 
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Yellow slightly viscous oil 
 
The title compound was prepared from 3-
methyl-1-(pentoxy carbonyl methyl) 
imidazolium bromide 178a (19.15 g, 39.0 
mmol) and LiNTf2 (13.49 g, 47.0 mmol) 
according to the general procedure in 93 
% yield (17.78 g, 36.2 mmol). 
Molecular formula C13H19F6N3O2S2 
Molecular weight 491 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.67 (s, 1H), 7.32 (t, J = 1.6 Hz, 1H), 7.27 (t, J = 
1.6 Hz, 1H), 4.91 (s, 2H), 4.11 (t, J = 6.8 Hz, 2H), 3.85 (s, 3H), 1.65-1.57 (m, 2H), 
1.24-1.23 (m, 4H), 0.82 (t, J = 6.8 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 165.76, 137.52, 123.85, 123.25, 122.20 (q, J = 
319 Hz, 2CF3’s ), 67.20, 49.88, 36.48, 27.91, 27.73, 22.18, 13.82 
IR (thin film on salt plate) (cm-1) 3164, 3124, 2963, 2928, 2862, 1750, 1582, 1569, 
1558, 1495, 1455, 1354, 1197, 1136 
MS m/z, 211.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
3-Methyl-1-(methoxyethoxycarbonylmethyl)imidazolium NTf2 (179d) 
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Pale brown viscous liquid 
 
The title compound was prepared from 3-
methyl-1-(methoxy ethoxyoxy carbonylmethyl) 
imidazolium bromide 179a (1.74 g, 6.26 mmol) 
and LiNTf2 (2.16 g, 7.51 mmol) according to the 
general procedure in 91 % yield (2.73 g, 5.70 
mmol). 
Molecular formula C11H15F6N3O7S2 
Molecular weight 479 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.85 (s, 1H), 7.39 (t, J = 1.8 Hz, 1H), 7.33 (t, J = 
1.8 Hz, 1H), 5.07 (s, 2H), 4.40 (t, J = 4.6 Hz, 2H), 3.98 (s, 3H), 3.66 (t, J = 4.6 Hz, 
2H), 3.40 (s, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 165.73, 137.75, 123.78, 123.18, 119.70 (q, J = 
319 Hz, 2CF3’s ), 69.75, 65.72, 63.24, 58.89, 49.93 
IR (thin film on salt plate) (cm-1) 2926, 2855, 1750, 1636, 1558, 1539, 1495, 1452, 
1365, 1204, 1129 
 A-31 
MS m/z, 199.1 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
3-Methyl-1-(ethoxyethoxycarbonylmethyl)imidazolium NTf2 (180d) 
 
N
N
O
O
O
NTf2-
 
Orange liquid 
 
The title compound was prepared from 
3-methyl-1-(ethoxy ethoxy carbonyl 
methyl) imidazolium bromide 180a 
(2.93 g, 10.0 mmol) and LiNTf2 (4.59 
g, 16.0 mmol) according to the general 
procedure in 90 % yield (4.42 g, 8.97 
mmol).  
Molecular formula C12H17F6N3O7S2 
Molecular weight 493 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.82 (s, 1H), 7.39 (t, J = 1.8 Hz, 1H), 7.34 (t, J = 
1.8 Hz, 1H), 5.06 (s, 2H), 4.38 (t, J = 4.6 Hz, 2H), 3.97 (s, 3H), 3.68 (t, J = 4.6 Hz, 
2H), 3.56 (q, J = 7.1 Hz, 2H), 1.22 (t, J = 7.1 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 165.76, 137.63, 123.80, 123.25, 119.70 (q, J = 
319 Hz, 2CF3’s), 67.62, 66.67, 65.97, 49.92, 36.56, 15.01 
IR (thin film on salt plate) (cm-1) 3169, 3116, 2967, 2927, 2859, 1751, 1581, 1569, 
1558, 1495, 1452, 1352, 1196, 1135 
MS m/z, 213.1 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
3-Methyl-1-(propoxyethoxycarbonylmethyl)imidazolium NTf2 (181d) 
 
 
N
N
O
O
O
NTf2-
 
Slightly viscous yellow oil 
 
The title compound was prepared from 3-
methyl-1-(propoxy ethoxy carbonyl 
methyl) imidazolium bromide 181a (3.55 
g, 7.00 mmol) and LiNTf2 (2.15 g, 7.50 
mmol) according to the general procedure 
in 68 % yield (2.43 g, 4.79 mmol). 
Molecular formula C13H19F6N3O7S2 
Molecular weight 507 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.78 (s, 1H), 7.39 (t, J = 1.8 Hz, 1H), 7.36 (t, J = 
1.8 Hz, 1H), 5.04 (s, 2H), 4.37 (t, J = 4.8 Hz, 2H), 3.95 (s, 3H), 3.67 (t, J = 4.8 Hz, 
2H), 3.43 (t, J = 6.7 Hz, 2H), 1.61 (tq, J = 6.7, 7.3 Hz, 2H), 0.92 (t, J = 7.3 Hz, 3H)  
 A-32 
13C NMR (100 MHz, CDCl3) δ (ppm) 165.76, 137.50, 123.82, 123.34, 119.09 (q, J = 
319 Hz, 2CF3’s), 72.99, 67.79, 65.91, 49.87, 56.49, 22.68, 10.37 
IR (thin film on salt plate) (cm-1) 3164, 3117, 2968, 2927, 2862, 1751, 1569, 1558, 
1539, 1495, 1452, 1353, 1198, 1135 
MS m/z, 227.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
3-Methyl-1-(butoxyethoxycarbonylmethyl)imidazolium NTf2 (182d) 
 
N
N
O
O
O
NTf2-
 
Pale yellow oil 
 
The title compound was prepared from 3-
methyl-1-(butoxy ethoxy carbonyl 
methyl) imidazolium bromide 182a (1.85 
g, 5.77 mmol) and LiNTf2 (1.99 g, 6.92 
mmol) according to the general procedure 
in 84 % yield (2.73 g, 4.82 mmol). 
Molecular formula C14H21F6N3O7S2 
Molecular weight 521 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.71 (s, 1H), 7.38 (t, J = 1.8 Hz, 1H), 7.36 (t, J = 
1.8 Hz, 1H), 5.00 (s, 2H), 4.32 (t, J = 4.8 Hz, 2H), 3.91 (s, 3H), 3.64 (t, J = 4.8 Hz, 
2H), 3.44 (t, J = 6.7 Hz, 2H), 1.54 (tt, J = 6.7, 7.2 Hz, 2H), 1.34 (tq, J  = 7.2, 7.5 Hz, 
2H), 0.89 (t, J = 7.5 Hz, 3 H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 165.78, 137.32, 123.83, 123.40, 122.33 (q, J = 
319 Hz, 2CF3’s), 71.09, 67.78, 65.81, 49.78, 36.37, 31.50, 19.11, 13.78 
IR (thin film on salt plate) (cm-1) 3164, 3123, 2959, 2934, 2864, 1756, 1582, 1569, 
1558, 1495, 1453, 1354, 1197, 1135 
MS m/z, 241.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
 A-33 
3-Methyl-1-(methoxyethoxyethoxycarbonylmethyl)imidazolium NTf2 (183d) 
 
 
N
N
O
O
O
NTf2-
O
 
Yellow oil 
 
The title compound was prepared from 3-
methyl-1-(methoxy ethoxy ethoxy 
carbonylmethyl) imidazolium bromide 
183a (1.01 g, 3.13 mmol) and LiNTf2 
(1.09 g, 3.80 mmol) according to the 
general procedure in 91 % yield (1.49 g, 
2.85 mmol). 
Molecular formula C13H19F6N3O8S2 
Molecular weight 523 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.80 (s, 1H), 7.42 (t, J = 1.8 Hz, 1H), 7.36 (t, J = 
1.8 Hz, 1H), 5.05 (s, 2H), 4.38 (t, J = 4.7 Hz, 2H), 3.96 (s, 3H), 3.74 (t, J = 4.7 Hz, 
2H), 3.65-3.60 (m, 2H), 3.56-3.53 (m, 2H), 3.37 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 165.81, 137.55, 123.89, 123.28, 119.15 (q, J = 
319 Hz, 2CF3’s), 71.69, 70.35, 68.38, 65.65, 58.88, 49.86, 36.48 
IR (thin film on salt plate) (cm-1) 3162, 3123, 2962, 2926, 2861, 1751, 1580, 1569, 
1558, 1495, 1452, 1354, 1198, 1136 
MS m/z, 243.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
3-Methyl-1-(ethoxyethoxyethoxycarbonylmethyl)imidazolium NTf2 (184d) 
 
 
N
N
O
O
O
NTf2-
O
 
Yellow slightly viscous liquid 
 
The title compound was prepared from 3-
methyl-1-(ethoxy ethoxy ethoxy 
carbonylmethyl) imidazolium bromide 
183a (1.88 g, 5.59 mmol) and LiNTf2 (1.92 
g, 6.70 mmol) according to the general 
procedure in 87 % yield (2.61g, 4.86 
mmol). 
Molecular formula C14H21F6N3O8S2 
Molecular weight 537 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.82 (s, 1H), 7.42 (t, J = 1.8 Hz, 1H), 7.35 (t, J = 
1.8 Hz, 1H), 5.05 (s, 2H), 4.38 (t, J = 4.8 Hz, 2H), 3.97 (s, 3H), 3.74 (t, J = 4.8 Hz, 
2H), 3.66 (t, J = 4.4 Hz, 2H), 3.61 (t, J = 4.4 Hz, 2H), 3.58 (q, J = 7.0 Hz, 2H), 1.21 
(t, J = 7.0 Hz, 3H)  
 A-34 
13C NMR (100 MHz, CDCl3) δ (ppm) 165.79, 137.59, 123.90, 123.27, 119.69 (q, J = 
319 Hz, 2CF3’s), 70.56, 69.61, 68.40, 66.62, 65.71, 49.89, 36.52, 15.09 
IR (thin film on salt plate) (cm-1) 3162, 3123, 2969, 2926, 2865, 1752, 1582, 1558, 
1495, 1452, 1354, 1197, 1135 
MS m/z, 257.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
3-Methyl-1-(propoxyethoxyethoxycarbonylmethyl)imidazolium NTf2 (185d) 
 
 
N
N
O
O
O
NTf2-
O
 
Slightly viscous yellow liquid 
 
The title compound was prepared 
from 3-methyl-1-(methoxy ethoxy 
ethoxy carbonylmethyl) imidazolium 
bromide 185a (1.91 g, 5.45 mmol) 
and LiNTf2 (1.88 g, 6.54 mmol) 
according to the general procedure in 
82 % yield (2.46 g, 4.46 mmol). 
Molecular formula C15H23F6N3O8S2 
Molecular weight 551 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.92 (s, 1H), 7.40 (t, J = 1.7 Hz, 1H), 7.31 (t, J = 
1.7 Hz, 1H), 5.08 (s, 2H), 4.41 (t, J = 4.8 Hz, 2H), 4.00, (s, 3H), 3.77 (t, J = 4.8 Hz, 
2H), 3.67 (t, J = 4.8, 2H), 3.61 (t, J = 4.8 Hz, 2H), 3.44 (t, J = 6.8 Hz, 2H), 1.61 (tq, J 
= 6.8, 7.2 Hz, 2H), 0.93 (t, J = 7.2 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 165.71, 137.92, 123.80, 123.07, 122.00 (q, J = 
319 Hz, 2CF3’s), 73.09, 70.58, 69.89, 68.42, 65.86, 50.02, 36.66, 22.76, 10.47 
IR (thin film on salt plate) (cm-1) 3164, 3119, 2966, 2927, 2865, 1751, 1568, 1558, 
1495, 1452, 1353, 1198, 1135 
MS m/z, 271.3 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
 A-35 
3-Methyl-1-(butoxyethoxyethoxycarbonylmethyl)imidazolium NTf2 (186d) 
 
 
N
N
O
O
O
NTf2-
O
Slightly viscous yellow liquid 
 
The title compound was prepared 
from 3-methyl-1-(methoxy ethoxy 
ethoxycarbonylmethyl) imidazolium 
bromide 186a (2.34 g, 6.40 mmol) 
and LiNTf2 (2.20 g, 7.68 mmol) 
according to the general procedure in 
86 % yield (3.10 g, 5.48 mmol). 
Molecular formula C16H25F6N3O8S2 
Molecular weight 555 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.73 (s, 1H), 7.34 (t, J = 1.6 Hz, 1H), 7.27 (t, J = 
1.6 Hz, 1H), 4.96 (s, 2H), 4.31 (t, J = 4.8 Hz, 2H), 3.88 (s, 3H), 3.67 (t, J = 4.8 Hz, 
2H), 3.56-3.55 (m, 2H), 3.52-3.49 (m, 2H), 3.40 (t, J = 6.8 Hz, 2H), 1.51 (tt, J = 6.8, 
7.2 Hz, 2H), 1.33 (tq, J = 7.2, 7.3 Hz, 2H), 0.86 (t, J = 7.4 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 165.74, 137.60, 123.88, 123.28, 119.71 (q, J = 
319 Hz, 2CF3’s), 71.17, 70.54, 69.90, 68.39, 65.75, 49.90, 36.52, 31.62, 19.95, 13.87 
IR (thin film on salt plate) (cm-1) 3163, 3123, 2957, 2934, 2868, 1756, 1569, 1558, 
1539, 1495, 1455, 1354, 1197, 1135 
MS m/z, 285.3 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
3-Methyl-1-(methoxyethoxyethoxyethoxycarbonylmethyl)imidazolium NTf2 
(187d) 
 
 
N
N
O
O
O
NTf2-
O
O
Brown liquid 
 
The title compound was prepared 
from 3-methyl-1-(methoxy ethoxy 
ethoxy ethoxy carbonylmethyl) 
imidazolium bromide 187a (2.20 g, 
6.00 mmol) and LiNTf2 (2.01 g, 
7.00 mmol) according to the general 
procedure in 93 % yield (3.17 g, 
5.60 mmol). 
Molecular formula C15H23F6N3O9S2 
Molecular weight 567 g/mol 
 A-36 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.78 (s, 1H), 7.37 (t, J = 1.6 Hz, 1H), 7.26 (t, J = 
1.6 Hz, 1H), 4.99 (s, 2H), 4.31 (t, J = 4.6 Hz, 2H), 3.89 (s, 3H), 3.66 (t, J = 4.6 Hz, 
2H), 3.57-3.54 (m, 6H), 3.49-3.47 (m, 2H), 3.28 (s, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 165.78, 137.75, 123.96, 123.18, 119.7 (q, J = 
319 Hz, 2CF3’s), 71.79, 70.42, 70.38, 70.32, 68.35, 65.57, 58.82, 49.92, 36.53 
IR (thin film on salt plate) (cm-1) 3161, 3116, 2925, 2859, 1751, 1569, 1558, 1539, 
1495, 1452, 1354, 1198, 1135 
MS m/z, 287.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
3-Methyl-1-(decoxycarbonylmethyl)imidazolium NTf2 (188d) 
 
 
N
N
O
O
NTf2-
Yellow oil 
 
The title compound was prepared 
from 3-methyl-1-(decoxy carbonyl 
methyl) imidazolium bromide 188a 
(3.03 g, 8.40 mmol ) and LiNTf2 
(2.73 g, 9.51 mmol) according to the 
general procedure in 95 % (4.46 g, 
7.94 mmol).   
Molecular formula C18H29F6N3O6S2 
Molecular weight 561 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.76 (s, 1H), 7.30 (t, J = 1.6 Hz, 1H), 7.24 (t, J = 
1.6 Hz, 1H), 4.94 (s, 2H), 4.16 (t, J = 7.0 Hz, 2H), 3.89 (s, 3H), 1.63-1.55 (m, 2H), 
1.24-1.95 (m, 14H), 0.83 (t, J = 6.8 Hz, 3H).  
13C NMR (100 MHz, CDCl3) δ (ppm) 165.75, 137.54, 123.83, 123.26, 119.71 (q, J = 
319 Hz, 2CF3’s), 67.24, 49.89, 36.49, 29.62, 29.56, 29.51, 29.44, 29.29, 28.24, 25.74, 
22.67, 14.10 
IR (thin film on salt plate) (cm-1) 3171,3120, 2957, 2926, 2859, 1751, 1558, 1539, 
1497, 1452, 1354, 1198, 1134 
MS m/z, 281.3 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
 A-37 
2,3-Dimethyl-1-(butoxyethoxycarbonylmethyl)imidazolium NTf2 (190d) 
 
N
N
O
O
O
NTf2-
 
Brown liquid 
 
The title compound was prepared from 
2,3-dimethyl-1-(butoxy carbonyl methyl) 
imidazolium bromide 190a (3.69 g, 11.0 
mmol) and LiNTf2 (4.59 g, 16.0 mmol) 
according to the general procedure in 83 
% yield (4.88 g, 9.12 mmol). 
Molecular formula C15H23F6N3O7S2 
Molecular weight 535 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.26 (dd, J = 1.8, 1.8 Hz, 2H), 4.95 (s, 2H), 4.37 
(t, J = 4.6 Hz, 2H), 3.83 (s, 3H), 3.67 (t, J = 4.6 Hz, 2H), 3.48 (t, J = 6.7 Hz, 2H), 1.57 
(tt, J = 6.7, 7.2 Hz, 2H), 1.36 (tq, J = 7.2, 7.5 Hz, 2H), 0.93 (t, J = 7.5 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 165.72, 145.53, 122.39, 122.36, 119.7 (q, J = 
320 Hz, 2CF3’s), 71.16, 67.83, 65.87, 49.16, 35.50, 31.56, 19.18, 13.86, 9.74 
IR (thin film on salt plate) (cm-1) 3151, 2962, 2934, 2865, 1751, 1595, 1558, 1539, 
1495, 1452, 1352, 1198, 1136 
MS m/z, 255.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
2,3-Dimethyl-1-(pentoxycarbonylmethyl)imidazolium NTf2 (189d) 
 
N
N
O
O
NTf2-
 
Yellow liquid 
 
The title compound was prepared from 
2,3- dimethyl-1- (pentoxy carbonyl 
methyl) imidazolium bromide 189a (3.36 
g, 11.0 mmol) and LiNTf2 (4.59 g, 16.0 
mmol) according to the general procedure 
in 95 % yield (5.30 g, 10.5 mmol). 
Molecular formula C14H21F6N3O6S2 
Molecular weight 505 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.28 (d, J = 2.2 Hz, 1H), 7.26 (d, J = 2.2 Hz, 
1H), 4.93 (s, 2H), 4.21 (t, J = 6.8 Hz, 2H), 3.82 (s, 3H), 2.56 (s, 3H), 1.68-1.60 (m, 
2H), 1.34-1.27 (m, 4H), 0.92 (t, J = 7.0 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 165.78, 145.45, 122.38, 122.37, 119.7 (q, J = 
321 Hz, 2CF3’s), 67.21, 49.17, 35.48, 27.93, 27.75, 22.18, 13.85, 9.75 
 A-38 
IR (thin film on salt plate) (cm-1) 3154, 2962, 2930, 2862, 1751, 1595, 1558, 1546, 
1539, 1495, 1452, 1354, 1197, 1137 
MS m/z, 225.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
2,3-Dimethyl-1-(methoxyethoxyethoxycarbonylmethyl)imidazolium NTf2 (191d) 
 
N
N
O
O
O
NTf2-
O
 
Brown slightly viscous oil 
 
The title compound was prepared from 
2,3-dimethyl-1-(methoxy ethoxy ethoxy 
carbonylmethyl) imidazolium bromide 
191d (2.70 g, 8.00 mmol) and LiNTf2 
(2.44 g, 8.50 mmol) according to the 
general procedure in 96 % yield (4.12 g, 
7.67 mmol). 
Molecular formula C14H21F6N3O8S2 
Molecular weight 537 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.29 (d, J = 2.2 Hz, 1H), 7.26 (d, J = 2.2 Hz, 
1H), 4.96 (s, 2H), 4.39 (t, J = 4.8 Hz, 2H), 3.82 (s, 3H), 3.74 (t, J = 4.8 Hz, 2H), 3.65-
3.63 (m, 2H), 3.56-3.54 (m, 2H), 3.37 (s, 3H), 2.56 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 165.76, 145.61, 122.42, 122.35, 119.70 (q, J = 
319 Hz, 2CF3’s), 71.72, 70.39, 68.38, 65.71, 58.97, 49.20, 35.53, 9.79 
IR (thin film on salt plate) (cm-1) 3150, 2962, 2857, 1751, 1558, 1539, 1495, 1452, 
1354, 1198, 1136 
MS m/z, 257.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 A-39 
Achiral BF4 salts 
Representative method for the preparation of BF4 salts (3-methyl-1-
(butoxycarbonylmethyl)imidazolium BF4) (177b) 
To a flask charged with 3-methyl-  
1-(butoxy carbonyl methyl) 
imidazolium bromide 177a (2.94 
g, 10.60 mmol) in acetone (10 
mL), was added NaBF4 (1.40, 
12.7 mmol). The reaction was stirred under reflux for 4 days. The fine white 
precipitate was filtered and washed with acetone (3 x 5 mL). The filtrate and washings 
were combined and dried via rotary evaporation. The product was then dried under 
high vacuum for 8 h to give a yellow viscous liquid in 97 % yield (2.92 g, 10.28 
mmol). 
 
Molecular formula C10H17BF4N2O2 
Molecular weight 284 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.94 (s, 1H, H2), 7.66 (t, J = 1.6 Hz, 1H, H4), 
7.63 (t, J = 1.6 Hz, 1H, H3), 5.23 (s, 2H, H5), 4.10 (t, J = 6.6 Hz, 2H, H7), 3.98 (s, 
3H, H1), 1.54 (tt, J = 6.6, 7.2 Hz, 2H, H8), 1.30 (tq, J = 7.2, 7.4 Hz, 2H, H9), 0.80 (t, 
J = 7.4 Hz, 3H, H10) 
13C NMR (100 MHz, CDCl3) δ (ppm) 167.50 (COO), 138.91 (NCHN), 124.93 
(NCH2), 124.50 (NCH2), 66.64 (OCH2), 50.63 (NCH2), 36.84 (CH2), 31.20 (CH2), 
19.60 (CH2), 13.92 (CH3) 
IR (thin film on salt plate) (cm-1) 3167, 3126, 2964, 2932, 2972, 1750, 1582, 1569, 
1558, 1495, 1455,  1398, 1217, 1181 
MS m/z, 197.1 [M-BF4-]+; MS: m/z, 87.0 [BF4-] 
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 A-40 
3-Methyl-1-(pentoxycarbonylmethyl)imidazolium BF4 (178b) 
 
N
N
O
O
BF4-
 
Viscous yellow liquid 
 
The title compound was prepared from 3-
methyl-1-(pentoxy carbonyl methyl) 
imidazolium bromide 178a (3.11 g, 10.1 
mmol) and NaBF4 (1.33 g, 12.1 mmol) 
according to the general procedure in 95 
% yield (2.86 g, 9.60 mmol). 
Molecular formula C11H19BF4N2O2 
Molecular weight 298 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.08 (s, 1H), 7.45 (t, J = 1.8 Hz, 1H), 7.39 (s, J 
= 1.8 Hz, 1H), 5.14 (s, 2H), 4.22 (t, J = 6.8 Hz, 2H), 3.97 (s, 3H), 1.72 (tt, J = 6.8, 7.1 
Hz, 2H), 1.38-1.27 (m, 4H), 0.93 (t, J = 7.1 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.24, 137.73, 123.73, 123.27, 66.99, 49.86, 
36.37, 27.97, 27.76, 22.22, 13.98 
IR (thin film on salt plate) (cm-1) 3167, 3124, 2961, 2931, 2860, 1750, 1582, 1569, 
1559, 1495, 1455, 1398, 1230, 1178 
MS m/z, 211.2 [M-BF4-]+; MS: m/z, 87.0 [BF4-] 
 
3-Methyl-1-(methoxyethoxycarbonylmethyl)imidazolium BF4 (179b) 
 
N
N
O
O
O
BF4-
 
Brown viscous liquid 
 
The title compound was prepared from 3-
methyl-1-(methoxy ethoxy carbonyl 
methyl) imidazolium bromide 179a (2.93 
g, 10.5 mmol) and NaBF4 (1.39 g, 12.6 
mmol) according to the general procedure 
in 95 % yield (2.86 g, 10.0 mmol). 
Molecular formula C9H15BF4N2O3 
Molecular weight 286 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.71 (s, 1H), 7.43 (s, 2H), 5.11 (s, 2H), 4.33 (t, J 
= 4.4 Hz, 2H), 3.85 (s, 3H), 3.66 (t, J = 4.4 Hz, 2H), 3.31 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 170.52, 139.95, 126.08, 125.99, 67.81, 60.59, 
52.22, 38.42, 32.74 
IR (thin film on salt plate) (cm-1) 3167, 3123, 2961, 2927, 1751, 1583, 1569, 1558, 
1495, 1452, 1382, 1226, 1181 
MS m/z, 199.1 [M-BF4-]+; MS: m/z, 87.0 [BF4-] 
 A-41 
3-Methyl-1-(ethoxyethoxycarbonylmethyl)imidazolium BF4 (180b) 
 
N
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O
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O
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Dark orange liquid 
 
The title compound was prepared from 3-
methyl-1-(ethoxy ethoxy carbonyl 
methyl) imidazolium bromide 180a (2.93 
g, 10.0 mmol) and NaBF4 (1.32 g, 12.0 
mmol) according to the general procedure 
in 96 % yield (2.87 g, 9.57 mmol). 
Molecular formula C10H17BF4N2O3 
Molecular weight 300 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.69 (s, 1H), 7.35 (t, J = 1.8 Hz, 1H), 7.32 (t, J = 
1.8 Hz, 1H), 4.99 (s, 2H), 4.27 (t, J = 4.6 Hz, 2H), 3.84 (s, 3H), 3.60 (t, J = 4.6 Hz, 
2H), 3.48 (q, J = 6.9 Hz, 2H), 1.13 (t, J = 6.9 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 166.36, 137.70, 123.75, 123.33, 67.72, 66.59, 
65.76,  49.76, 36.37,15.07 
IR (thin film on salt plate) (cm-1) 3167, 3119, 2977, 2937, 2865, 1751, 1582, 1569, 
1558, 1495, 1451, 1227, 1217, 1180 
MS m/z, 213.1 [M-BF4-]+; MS: m/z, 87.0 [BF4-] 
 
3-Methyl-1-(propoxyethoxycarbonylmethyl)imidazolium BF4 (181b) 
 
N
N
O
O
O
BF4-
 
Dark yellow viscous liquid 
 
The title compound was prepared from 3-
methyl-1-(propoxy ethoxy carbonyl 
methyl) imidazolium bromide 181a (2.93 
g, 9.56 mmol) and NaBF4 (1.26g, 11.5 
mmol) according to the general procedure 
in 97 % yield (2.92 g, 9.30 mmol) 
Molecular formula C11H19BF4N2O3 
Molecular weight 314 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.94 (s, 1H), 7.66 (t, J = 1.8 Hz, 1H), 7.64 (t, J = 
1.8 Hz, 1H), 5.24 (s, 2H), 4.21 (t, J = 4.7 Hz, 2H), 3.98 (s, 3H), 3.53 (t, J = 4.7 Hz, 
2H), 3.28 (t, J = 6.5 Hz, 2H), 1.46 (tq, J = 6.5, 7.5  Hz, 2H), 0.77 (t, J = 7.5 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 167.52, 138.92, 123.93, 124.52, 73.23, 68.74, 
66.27, 50.62, 36.86, 23.54, 10.83 
IR (thin film on salt plate) (cm-1) 3167, 3124, 2966, 2930, 2876, 1751, 1581, 1569, 
1558, 1495, 1452, 1394, 1224, 1181 
 A-42 
MS m/z, 227.2 [M-BF4-]+; MS: m/z, 87.0 [BF4-] 
 
3-Methyl-1-(butoxyethoxycarbonylmethyl)imidazolium BF4 (182b) 
 
N
N
O
O
O
BF4-
 
Pale yellow viscous liquid 
 
The title compound was prepared from 3-
methyl-1-(butoxy ethoxy carbonyl 
methyl) imidazolium bromide 182a (2.94 
g, 9.15 mmol) and NaBF4 (1.21g, 11.0 
mmol) according to the general procedure 
in 96 % yield (2.88 g, 8.78 mmol).   
Molecular formula C12H21BF4N2O3 
Molecular weight 328 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.83 (s, 1H), 7.42 (t, J = 1.8 Hz, 1H), 7.39 (t, J = 
1.8 Hz, 1H), 5.08 (s, 2H), 4.36 (t, J = 4.7 Hz, 2H), 3.94 (s, 3H), 3.68 (t, J = 4.7 Hz, 
2H), 3.49 (t, J = 6.8 Hz, 2H), 1.59 (tt, J = 6.8, 7.2 Hz, 2H), 1.41 (tq, J = 7.2, 7.4 Hz, 
2H), 0.94 (t, J = 7.4 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.28, 137.78, 123.70, 123.29, 71.15, 67.94, 
65.74, 49.81, 36.41, 31.58, 19.20, 13.90 
IR (thin film on salt plate) (cm-1) 3167, 3126, 2961 , 2935, 1750, 1582, 1569, 1558, 
1495, 1456, 1451, 1218, 1181 
MS m/z, 241.2 [M-BF4-]+; MS: m/z, 87.0 [BF4-] 
 
 A-43 
3-Methyl-1-(methoxyethoxyethoxycarbonylmethyl)imidazolium BF4 (183b) 
 
 
N
N
O
O
O
BF4-
O
 
Orange liquid 
 
The title compound was prepared 
from 3-methyl-1-(methoxy ethoxy 
ethoxycarbonylmethyl) imidazolium 
bromide 183a (2.95g, 9.12 mmol) 
and NaBF4 (1.20 g, 10.9 mmol) 
according to the general procedure 
in 94 % yield (2.84g, 8.61 mmol). 
Molecular formula C11H19BF4N2O4 
Molecular weight 330 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.71 (s, 1H), 7.38 (d, J = 1.6 Hz, 1H) 7.34 (d, J 
= 1.6 Hz, 1H), 4.99 (s, 2H), 4.77 (t, J = 4.6 Hz, 2H), 3.86 (s, 3H), 3.66 (t, J = 4.6 Hz, 
2H), 3.57 (t, J = 4.4 Hz, 2H), 3.48 (t, J = 4.4 Hz, 2H), 3.28 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 166.46, 137.67, 123.82, 123.36, 71.69, 70.26, 
68.49, 65.50, 58.81, 49.69, 36.31 
IR (thin film on salt plate) (cm-1) 3166, 3123, 1750, 1581, 1575, 1569, 1558, 1495, 
1451, 1221, 1181 
MS m/z, 243.2 [M-BF4-]+; MS: m/z, 87.0 [BF4-] 
 
3-Methyl-1-(ethoxyethoxyethoxycarbonylmethyl)imidazolium BF4 (184b) 
 
 
N
N
O
O
O
BF4-
O
 
Orange viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(ethoxy ethoxy 
ethoxy carbonylmethyl)imidazolium 
bromide 184a (2.94 g, 8.73 mmol) 
and NaBF4 (1.15g, 10.48 mmol) 
according to the general procedure 
in 96 % yield (2.89 g, 8.40 mmol). 
Molecular formula C12H21BF4N2O4 
Molecular weight 344 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.94 (s, 1H), 7.66 (t, J = 1.8 Hz, 1H) 7.63 (t, J = 
1.8 Hz, 1H), 5.23 (s, 2H), 4.21 (t, J = 4.7 Hz, 2H), 3.98 (s, 3H), 3.59 (t, J = 4.7 Hz, 
2H), 3.48-3.45 (m, 2H), 3.41-3.39 (m, 2H), 3.36 (q, J = 7.0 Hz, 2H), 1.02 (t, J = 7.0 
Hz, 3H) 
 A-44 
13C NMR (100 MHz, CDCl3) δ (ppm) 167.54, 138.92, 124.94, 124.51, 71.22, 70.56, 
69.22, 66.83, 66.27, 50.63, 46.85, 15.59 
IR (thin film on salt plate) (cm-1) 3167, 3121, 2970, 2926, 2862, 1756, 1582, 1569, 
1558, 1495, 1451, 1218, 1181 
MS m/z, 257.2 [M-BF4-]+; MS: m/z, 87.0 [BF4-] 
 
3-Methyl-1-(propoxyethoxyethoxycarbonylmethyl)imidazolium BF4 (185b) 
 
 
N
N
O
O
O
BF4-
O
Orange liquid 
 
The title compound was prepared 
from 3-methyl-1-(propoxy ethoxy 
ethoxy carbonylmethyl) imidazolium 
bromide 185a (2.94 g, 8.38 mmol) 
and NaBF4 (1.11g, 10.1 mmol) 
according to the general procedure in 
93 % yield (2.79 g, 7.79 mmol). 
Molecular formula C13H23BF4N2O4 
Molecular weight 358 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.95 (s, 1H), 7.45 (t, J = 1.8 Hz, 1H), 7.37 (t, J = 
1.8 Hz, 1H), 5.12 (s, 2H), 4.38 (t, J = 4.7 Hz, 2H), 3.97 (s, 3H), 3.75 (t, J = 4.7 Hz, 
2H), 3.67 (t, J = 3.2 Hz, 2H), 3.60 (t, J = 3.2 Hz, 2H), 3.44 (t, J = 6.8 Hz, 2H), 1.64 
(tq, J = 6.8, 7.6 Hz, 2H), 0.94 (t, J = 7.6 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.23, 137.96, 123.79, 123.13, 73.06, 70.54, 
69.89, 68.54, 65.66, 49.85, 36.52, 22.75, 10.49 
IR (thin film on salt plate) (cm-1) 3166, 3121, 2964, 2927, 2866, 1750, 1581, 1574, 
1569, 1558, 1495, 1452, 1220, 1181 
MS m/z, 271.3 [M-BF4-]+; MS: m/z, 87.0 [BF4-] 
 
 A-45 
3-Methyl-1-(butoxyethoxyethoxycarbonylmethyl)imidazolium BF4 (186b) 
 
 
N
N
O
O
O
BF4-
O
Yellow viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(butoxy ethoxy 
ethoxy carbonylmethyl) imidazolium 
bromide 186a (2.94 g, 8.06 mmol) 
and NaBF4 (1.06 g, 9.68 mmol) 
according to the general procedure in 
92 % yield (2.79 g, 7.50 mmol). 
Molecular formula C14H25BF4N2O4 
Molecular weight 372 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.09 (s, 1H), 7.80 (t, J = 1.8 Hz, 1H), 7.77 (t, J = 
1.8 Hz, 1H), 5.38 (s, 2H), 4.35 (t, J = 4.7 Hz, 2H), 4.11 (s, 3H), 3.74 (t, J = 4.7 Hz, 
2H), 3.62-3.59 (m, 2H), 3.56-3.53 (m, 2H), 3.46 (t, J = 6.4 Hz, 2H), 1.54 (tt, J = 6.4, 
6.8 Hz, 2H), 1.39 (tq, J = 6.8, 7.2 Hz, 2H), 0.92 (t, J = 7.2 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 167.39, 166.33, 137.74, 123.78, 123.30, 72.48, 
71.05, 70.18, 68.53, 61.86, 49.74, 30.96, 19.23, 13.92 
IR (thin film on salt plate) (cm-1) 3167‚ 3120, 2956, 2930, 2863, 1751, 1581, 1569, 
1558, 1495, 1455, 1217, 1181 
MS m/z, 285.3 [M-BF4-]+; MS: m/z, 87.0 [BF4-] 
 
3-Methyl-1-(methoxyethoxyethoxyethoxycarbonylmethyl)imidazolium BF4 
(187b) 
 
 
N
N
O
O
O
BF4-
O
O
Brown viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(methoxy ethoxy 
ethoxy ethoxy carbonyl methyl) 
imidazolium bromide 187a (1.47 
g, 4.00 mmol) and NaBF4 (0.55 g, 
5.00 mmol) according to the 
general procedure in 94 % yield 
(1.41 g, 3.77 mmol). 
Molecular formula C13H23BF4N2O5 
Molecular weight 374 g/mol 
 A-46 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.79 (s, 1H), 7.47 (s, 1H), 7.40 (s, 1H), 5.08 (s, 
2H), 4.34 (t, J = 4.6 Hz, 2H), 3.92 (s, 3H), 3.73 (t, J = 4.6 Hz, 2H), 3.63-3.58 (m, 6H), 
3.55-3.45 (m, 2H), 3.39 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 166.49, 137.71, 123.83, 123.36, 71.74, 70.32, 
70.28, 70.22, 68.49, 65.41, 58.79, 49.69, 36.29 
IR (thin film on salt plate) (cm-1) 3165, 3122, 2925, 1751, 1582, 1569, 1558, 1495, 
1452, 1217, 1181 
MS m/z, 287.1 [M-BF4-]+; MS: m/z, 86.9 [BF4-] 
 
2,3-Dimethyl-1-(butoxyethoxycarbonylmethyl)imidazolium BF4 (190b) 
 
N
N
O
O
O
BF4-
 
Orange viscous liquid 
 
The title compound was prepared 
from 2,3-dimethyl-1-(butoxy carbonyl 
methyl) imidazolium bromide 190a 
(2.94 g, 8.78 mmol) and NaBF4 
(1.16g, 10.5 mmol) according to the 
general procedure in 95 % yield (2.85 
g, 8.33 mmol). 
Molecular formula C13H23BF4N2O3 
Molecular weight 342 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.32 (d, J = 2.0 Hz, 1H), 7.31 (d, J = 2.0 Hz, 
1H), 4.98 (s, 2H), 4.36 (t, J = 4.8 Hz, 2H), 3.80 (s, 3H), 3.68 (t, J = 4.8 Hz, 2H), 3.49 
(t, J = 6.8 Hz, 2H), 2.53 (s, 3H), 1.59 (tt, J = 6.8, 7.2 Hz, 2H), 1.41 (tq, J = 7.2, 7.4 
Hz, 2H), 0.95 (t, J = 7.4 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 166.26, 145.68, 122.41, 122.35, 71.13, 67.96, 
65.61, 48.90, 35.26, 31.59, 19.20, 13.90, 9.49 
IR (thin film on salt plate) (cm-1) 3157, 2962, 2933, 1750, 1595, 1558, 1544, 1495, 
1451, 1391, 1248, 1217 
MS m/z, 255.2 [M-BF4-]+; MS: m/z, 87.0 [BF4-] 
 
 A-47 
2,3-Dimethyl-1-(pentoxycarbonylmethyl)imidazolium BF4 (189b) 
 
N
N
O
O
BF4-
 
Yellow viscous liquid 
 
The title compound was prepared 
from 2,3-dimethyl-1-(pentoxy 
carbonyl methyl) imidazolium 
bromide 189a (2.93 g, 9.62 mmol) 
and NaBF4 (1.28 g, 11.6 mmol) 
according to the general procedure in 
93 % yield (2.79 g, 8.94 mmol) 
Molecular formula C12H21BF4N2O2 
Molecular weight 312 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.21 (s, 2H), 4.89 (s, 2H), 4.15 (t, J = 6.8 Hz, 
2H), 3.61 (s, 3H), 2.98 (s, 3H), 1.65-1.60 (m, 2H), 1.30-1.28 (m, 4H), 0.86 (t, J = 6.8 
Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.24, 145.70, 122.39, 122.29, 67.06, 49.10, 
35.38, 28.02, 27.80, 22.22, 13.91, 9.73 
IR (thin film on salt plate) (cm-1) 3440, 3148, 2958, 2930, 2860, 1748, 1546, 1454, 
1399, 1225, 1049, 1035 
MS m/z, 225.2 [M-BF4-]+; MS: m/z, 87.0 [BF4-] 
 
2,3-Dimethyl-1-(methoxyethoxyethoxycarbonylmethyl)imidazolium BF4 (191b) 
 
N
N
O
O
O
BF4-
O
 
Orange viscous liquid 
 
The title compound was prepared 
from 2,3-dimethyl-1-(methoxy ethoxy 
carbonylmethyl)imidazolium bromide 
191a (2.94 g, 8.73 mmol) and NaBF4 
(1.16g, 10.5 mmol) according to the 
general procedure in 94 % yield (2.82 
g, 8.20 mmol). 
Molecular formula C12H21BF4N2O4 
Molecular weight 344 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.64 (s, 2H), 5.30 (s, 2H), 4.36 (t, J = 4.7 Hz, 
2H), 3.99 (s, 3H), 3.73 (t, J = 4.7 Hz, 2H), 3.62 (t, J = 4.6 Hz, 2H), 3.51 (t, J = 4.6 Hz, 
2H), 3.31 (s, 3H), 2,73 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 171.66, 151.56, 127.67, 127.57, 76.85, 75.22, 
72.50, 70.48, 63.13, 53.96, 40.65, 14.68 
 A-48 
IR (thin film on salt plate) (cm-1) 3154, 2926, 2862, 1750, 1558, 1546, 1539, 1495, 
1451, 1247, 1217 
MS m/z, 257.2 [M-BF4-]+; MS: m/z, 87.0 [BF4-] 
 
Achiral PF6 salts 
Representative method for the preparation of PF6 salts (3-methyl-1-
(butoxycarbonylmethyl)imidazolium PF6) (177c) 
To a flask charged with 3-methyl-
1-(butoxy carbonyl methyl) 
imidazolium bromide 177a (2.02 
g, 7.31 mmol) in acetone (10 mL), 
was added KPF6 (1.61 g, 8.77 mmol). The reaction was stirred under reflux for 4 days. 
The fine white precipitate was filtered and washed with acetone (3 x 5 mL). The 
filtrate and washings were combined and dried via rotary evaporation. The product 
was then dried under high vacuum for 8 h to give a brown viscous liquid in 93 % 
yield (2.33 g, 6.81 mmol). 
 
Molecular formula C10H17PF6N2O2 
Molecular weight 342 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.06 (s, 1H, H2), 7.79 (t, J = 1.8 Hz, 1H, H4), 
7.77 (t, J =  1.8 Hz, 1H, H3), 5.37 (s, 2H, H5), 4.24 (t, J = 6.5 Hz, 2H, H7), 4.14 (s, 
3H, H1), 1.67 (tt, J = 6.5, 6.8 Hz, 2H, H8), 1.42 (tq, J = 6.8, 7.3 Hz, 2H, H9), 0.94 (t, 
J = 7.3 Hz, 3H, H10) 
13C NMR (100 MHz, CDCl3) δ (ppm) 167.41 (COO), 138.73 (NCHN), 124.97 
(NCH2), 124.56 (NCH2), 67.01 (OCH2), 50.70 (NCH2), 36.90 (CH2), 28.86 (CH2), 
28.58 (CH2), 14.22 (CH3) 
IR (thin film on salt plate) (cm-1) 3178, 3127, 2966, 2871, 1751, 1582, 1569, 1559, 
1495, 1452, 1398, 1218, 1181 
MS m/z, 197.1 [M-PF6-]+; MS: m/z, 145.0 [PF6-] 
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 A-49 
3-Methyl-1-(pentoxycarbonylmethyl)imidazolium PF6 (178c) 
 
N
N
O
O
PF6-
 
Brown viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(pentoxy carbonyl 
methyl) imidazolium bromide 178a 
(2.44 g, 8.40 mmol) and KPF6 (1.86 g, 
10.1 mmol) according to the general 
procedure in 98 % yield (2.94 g, 8.26 
mmol). 
Molecular formula C11H19PF6N2O2 
Molecular weight 356 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.01 (s, 1H), 7.80 (t, J = 1.8 Hz, 1H), 7.77 (t, J = 
1.8 Hz, 1H), 5.40 (s, 2H), 4.32 (t, J = 4.8 Hz, 2H), 4.12 (s, 3H), 1.73-1.64 (m, 2H), 
1.40-1.31 (m, 4H), 0.95 (t, J = 7.0 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 167.41, 138.73, 124.97, 124.56, 67.01, 50.70, 
30.08, 29.51, 29.31, 28.86, 14.22 
IR (thin film on salt plate) (cm-1) 3179, 3133, 2962, 2933, 2864, 1751, 1582, 1569, 
1559, 1495, 1456, 1398, 1232, 1181 
MS m/z, 211.2 [M-PF6-]+; MS: m/z, 145.0 [PF6-] 
 
3-Methyl-1-(methoxyethoxycarbonylmethyl)imidazolium PF6 (179c) 
 
N
N
O
O
O
PF6-
 
Brown solid 
 
The title compound was prepared 
from 3-methyl-1-(methoxy ethoxy 
carbonylmethyl)imidazolium bromide 
179a (2.43 g, 8.72 mmol) and KPF6 
(1.93 g, 10.5 mmol) according to the 
general procedure in 96 % yield (2.88 
g, 8.37 mmol). 
Molecular formula C9H15PF6N2O3 
Molecular weight 344 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.89 (s, 1H), 7.64 (t, J = 1.8 Hz, 1H), 7.61 (t, J = 
1.8 Hz, 1H), 5.23 (s, 2H), 4.21 (t, J = 4.6 Hz, 2H), 3.99 (s, 3H), 3.48 (t, J = 4.6 Hz, 
2H), 3.18 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 167.47, 138.74, 124.96, 124.56, 70.55, 66.08, 
58.78,50.64, 36.89 
 A-50 
MP (°C) 58 – 60 
IR (KBr disc) (cm-1) 3174, 1752, 1581, 1453, 1255, 1182, 1096, 1041 
MS m/z, 199.1 [M-PF6-]+; MS: m/z, 145.0 [PF6-] 
 
3-Methyl-1-(ethoxyethoxycarbonylmethyl)imidazolium PF6 (180c) 
 
N
N
O
O
O
PF6-
 
Yellow viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(ethoxy ethoxy 
carbonylmethyl)imidazolium bromide 
180a (2.46 g, 8.38 mmol) and KPF6 
(1.86 g, 10.1 mmol) according to the 
general procedure in 98 % yield (2.94 
g, 8.21 mmol). 
Molecular formula C10H17PF6N2O3 
Molecular weight 358 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.91 (s, 1H), 7.66 (t, J = 1.8 Hz, 1H), 7.63 (t, J = 
1.8 Hz, 1H), 5.24 (s, 2H), 4.20 (t, J = 4.7 Hz, 2H), 4.00 (s, 3H), 3.53 (t, J = 4.7 Hz, 
2H), 3.38 (q, J = 7.1 Hz, 2H), 1.02 (t, J = 7.1 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 167.49, 138.76, 124.98, 124.58, 68.51, 66.56, 
66.36, 50.67, 36.91, 15.48 
IR (thin film on salt plate) (cm-1) 3179, 3131, 2972, 2927, 2865, 1751, 1579, 1569, 
1559, 1495, 1451, 1398, 1225, 1180, 1117 
MS m/z, 213.1 [M-PF6-]+; MS: m/z, 145.0 [PF6-] 
 
3-Methyl-1-(propoxyethoxycarbonylmethyl)imidazolium PF6 (181c) 
 
 
N
N
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O
PF6-
Yellow viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(propoxy ethoxy 
carbonyl methyl) imidazolium 
bromide 181a (2.47 g, 8.06 mmol) 
and KPF6 (1.78 g, 9.68 mmol) 
according to the general procedure 
in 97 % yield (2.91 g, 7.82 mmol). 
Molecular formula C11H19PF6N2O3 
Molecular weight 372 g/mol 
 A-51 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.08 (s, 1H), 7.81 (t, J = 1.8 Hz, 1H), 7.76 (t, J = 
1.8 Hz, 1H), 5.44 (s, 2H), 4.35 (t, J = 4.8 Hz, 2H), 4.13 (s, 3H), 3.63 (t, J = 4.8 Hz, 
2H), 3.41 (t, J = 4.8 Hz, 2H), 1.60 (tq, J = 4.8, 7.0 Hz, 2H), 0.90 (t, J = 7.0 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 167.45, 138.75, 124.10, 124.58, 73.23, 68.72, 
66.33, 50.68, 36.92, 23.53, 10.82 
IR (thin film on salt plate) (cm-1) 3179, 3125, 2970, 2931, 2877, 1751, 1582, 1569, 
1559, 1495, 1451, 1398, 1218, 1181, 1113 
MS m/z, 227.2 [M-PF6-]+; MS: m/z, 145.0 [PF6-] 
 
3-Methyl-1-(butoxyethoxycarbonylmethyl)imidazolium PF6 (182c) 
 
 
N
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O
O
PF6-
Yellow viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(butoxy ethoxy 
carbonyl methyl) imidazolium 
bromide 182a (2.49 g, 7.77 mmol) 
and KPF6 (1.70 g, 9.24 mmol) 
according to the general procedure 
in 95 % yield (2.85 g, 7.38 mmol). 
Molecular formula C12H21PF6N2O3 
Molecular weight 386 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.46 (s, 1H), 7.34 (t, J = 1.8 Hz, 1H), 7.32 (t, J = 
1.8 Hz, 1H), 4.96 (s, 2H), 4.35 (t, J = 4.6 Hz, 2H), 3.88 (s, 3H), 3.67 (t, J = 4.8 Hz, 
2H), 3.49 (t, J = 6.8 Hz, 2H), 1.58 (tt, J = 6.8, 7.2 H, 2H), 1.40 (tq, J = 7.2, 7.5 Hz, 
2H), 0.94 (t, J = 7.5 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.05, 137.24, 123.63, 123.37, 71.09, 67.87, 
65.78, 49.67, 36.26, 31.55, 19.16, 13.86 
IR (thin film on salt plate) (cm-1) 3178, 3127, 2961, 2934, 2870, 1751, 1582, 1569, 
1559, 1495, 1451, 1393, 1217, 1180 
MS m/z, 241.2 [M-PF6-]+; MS: m/z, 145.0 [PF6-] 
 
 A-52 
3-Methyl-1-(methoxyethoxyethoxycarbonylmethyl)imidazolium PF6 (183c) 
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Orange viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(methoxy ethoxy 
ethoxy carbonyl methyl) 
imidazolium bromide 183a (3.55 
g, 11.0 mmol) and KPF6 (3.31 g, 
18.0 mmol) according to the 
general procedure in 91 % yield 
(3.87 g, 9.97 mmol).   
Molecular formula C11H19PF6N2O4 
Molecular weight 388 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.60 (s, 1H), 7.53 (tt, J = 1.8, 1.8 Hz, 2H), 5.59 
(s, 2H), 4.45 (t, J = 4.6 Hz, 2H), 4.00 (s, 3H), 3.82 (t, J = 4.6 Hz, 2H), 3.72 (t, J = 4.6 
Hz, 2H), 3.62 (t, J = 4.6 Hz, 2H), 3.44 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 165.98, 136.76, 123.33, 123.17, 71.16, 69.69, 
67.85, 65.23, 57.54, 49.44, 35.84 
IR (thin film on salt plate) (cm-1) 3172, 3124, 2926, 1751, 1580, 1569, 1559, 1495, 
1457, 1218, 1181, 1106 
MS m/z, 243.2 [M-PF6-]+; MS: m/z, 145.0 [PF6-] 
 
3-Methyl-1-(ethoxyethoxyethoxycarbonylmethyl)imidazolium PF6 (184c) 
 
 
N
N
O
O
O
PF6-
O
Orange viscous liquid 
 
The title compound was 
prepared from 3-methyl-1-
(ethoxyethoxyethoxycarbonylm
ethyl) imidazolium bromide 
184a (2.51 g, 7.46 mmol) and 
KPF6 (1.65 g, 8.95 mmol) 
according to the general 
procedure in 96 % yield (2.88 g, 
7.16 mmol). 
Molecular formula C12H21PF6N2O4 
Molecular weight 402 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.65 (s, 1H), 7.39 (t, J = 1.6 Hz, 1H), 7.31 (t, J = 
1.6 Hz, 1H), 5.02 (s, 2H), 4.41 (t, J = 4.6 Hz, 2H), 3.96 (s, 3H), 3.78 (t, J = 4.6 Hz, 
 A-53 
2H), 3.68-3.66 (m, 2H), 3.62-3.60 (m, 2H), 3.57 (q, J = 7.0 Hz, 2H), 1.23 (t, J = 7.0 
Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 166.30, 137.56, 123.81, 123.40, 70.06, 69.34, 
68.03, 65.68, 65.18, 49.51, 35.74, 14.44 
IR (thin film on salt plate) (cm-1) 3175, 3123, 2966, 2926, 2869, 1751, 1582, 1569, 
1559, 1495, 1451, 1215, 1180, 1105 
MS m/z, 257.1 [M-PF6-]+; MS: m/z, 145.0 [PF6-]   
 
3-Methyl-1-(propoxyethoxyethoxycarbonylmethyl)imidazolium PF6 (185c) 
 
 
N
N
O
O
O
PF6-
O
Yellow viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(propoxy ethoxy 
ethoxycarbonylmethyl) imidazolium 
bromide 185a (2.53 g, 7.21 mmol) 
and KPF6 (1.59 g, 8.65 mmol) 
according to the general procedure 
in 91 % yield (2.72 g, 6.54 mmol). 
Molecular formula C13H23PF6N2O4 
Molecular weight 416 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.51 (s, 1H), 7.29 (s, 1H), 7.22 (s, 1H), 4.91 (s, 
2H), 4.31 (t, J = 4.6 Hz, 2H), 3.86 (s, 3H), 3.68 (t, J = 4.6 Hz, 2H), 3.59 (t, J = 4.8 Hz, 
2H), 3.53 (t, J = 4.8 Hz, 2H), 3.36 (t, J = 6.8 Hz, 2H), 1.54 (m, 2H), 0.85 (t, J = 7.4 
Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 166.01, 137.45, 123.75, 123.29, 73.02, 70.49, 
69.85, 68.47, 65.70, 49.76, 36.43, 22.73, 10.47 
IR (thin film on salt plate) (cm-1) 3178, 3126, 2962, 2927, 2873, 1751, 1581, 1569, 
1559, 1495, 1452, 1400, 1218, 1180 
MS m/z, 271.3 [M-PF6-]+; MS: m/z, 145.0 [PF6-] 
 
 A-54 
3-Methyl-1-(butoxyethoxyethoxycarbonylmethyl)imidazolium PF6 (186c) 
 
 
N
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O
PF6-
O
Brown viscous liquid 
 
The title compound was 
prepared from 3-methyl-1-
(butoxyethoxyethoxycarbonyl
methyl) imidazolium bromide 
186a (2.96 g, 8.10 mmol) and 
KPF6 (2.21 g, 12.0 mmol) 
according to the general 
procedure in 79 % yield (2.75 
g, 6.40 mmol). 
Molecular formula C14H25PF6N2O4 
Molecular weight 430 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.47 (s, 1H), 7.29 (s, 1H), 7.23 (s, 1H), 4.90 (s, 
2H), 4.30 (t, J = 4.6 Hz, 2H), 3.85 (s, 3H), 3.67 (t, J = 4.6 Hz, 2H), 3.58-3.56 (m, 2H), 
3.52-3.50 (m, 2H), 3.40 (t, J = 6.8 Hz, 2H), 1.51 (tt, J = 6.8, 7.2 Hz, 2H), 1.28 (tq, J = 
7.2, 7.5 Hz, 2H), 0.86 (t, J = 7.5 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 165.95, 137.48, 123.75, 123.22, 71.18, 70.52, 
69.91, 68.48, 65.73, 49.75, 36.44, 19.24, 13.93 
IR (thin film on salt plate) (cm-1) 3179, 3125, 2957, 2933, 2866, 1756, 1580, 1569, 
1559, 1495, 1452, 1218, 1181, 1106 
MS m/z, 285.3 [M-PF6-]+; MS: m/z, 145.0 [PF6-] 
 
3-Methyl-1-(methoxyethoxyethoxyethoxycarbonylmethyl)imidazolium PF6 (187c) 
 
 
N
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O
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O
O
Brown viscous liquid 
 
The title compound was 
prepared from 3-methyl-1-
(methoxy ethoxy ethoxy ethoxy 
carbonylmethyl) imidazolium 
bromide 187a (1.47 g, 4.00 
mmol) and KPF6 (0.92 g, 5.00 
mmol) according to the general 
procedure in 57 % yield (0.98 g, 
2.27 mmol). 
Molecular formula C13H23PF6N2O5 
Molecular weight 432 g/mol 
 A-55 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.54 (s, 1H), 7.40 (t, J = 1.8 Hz, 1H), 7.35 (t, J = 
1.8 Hz, 1H), 5.32 (s, 2H), 4.33 (t, J = 4.5 Hz, 2H), 3.89 (s, 3H), 3.72 (t, J = 4.5 Hz, 
2H), 3.64-3.59 (m, 6H), 3.55 (t, J = 4.6 Hz, 2H), 3.33 (s, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.24, 137.38, 123.75, 123.37, 71.69, 70.27, 
70.23, 70.17, 68.41, 65.47, 58.69, 49.59, 36.20 
IR (thin film on salt plate) (cm-1) 3176, 3121, 2926, 2862, 1751, 1582, 1569, 1559, 
1495, 1452, 1402, 1224, 1180 
MS m/z, 287.3 [M-PF6-]+; MS: m/z, 145.0 [PF6-] 
 
2,3-Dimethyl-1-(butoxyethoxycarbonylmethyl)imidazolium PF6 (190c) 
 
N
N
O
O
O
PF6-
 
Brown viscous liquid 
 
The title compound was prepared 
from 2,3-dimethyl-1-(butoxy ethoxy 
carbonyl methyl) imidazolium 
bromide 190a (2.51 g, 7.50 mmol) 
and KPF6 (1.66 g, 9.00 mmol) 
according to the general procedure in 
97 % yield (2.91 g, 7.28 mmol). 
Molecular formula C13H23PF6N2O3 
Molecular weight 400 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.25 (d, J = 2.4Hz, 1H), 7.22 (d, J = 2.4 Hz, 
1H), 4.89 (s, 2H), 4.35 (t, J = 4.8 Hz, 2H), 3.77 (s, 3H), 3.67-3.65 (m, 2H), 3.49 (t, J = 
6.6 Hz, 2H), 2.51 (s, 3H), 1.59-1.52 (m, 2H), 1.41-1.32 (m, 2H), 0.94 (t, J = 7.4 Hz, 
3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 165.98, 145.59, 122.38, 122.21, 71.09, 67.90, 
65.70, 48.80, 35.18, 31.59, 19.19, 13.88, 9.24 
IR (thin film on salt plate) (cm-1) 3163, 2962, 2931, 2867, 1751, 1596, 1559, 1539, 
1495, 1451, 1392, 1245, 1218, 1123 
MS m/z, 255.2 [M-PF6-]+; MS: m/z, 145.0 [PF6-] 
 
 A-56 
2,3-Dimethyl-1-(pentoxycarbonylmethyl)imidazolium PF6 (189c) 
 
N
N
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O
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Yellow solid 
 
The title compound was prepared 
from 2,3-dimethyl-1-(pentoxy 
carbonyl methyl) imidazolium 
bromide 189a (2.47 g, 8.11 mmol) 
and KPF6 (1.79 g, 9.73 mmol) 
according to the general procedure in 
97 % yield (2.91 g, 7.86 mmol). 
Molecular formula C12H21PF6N2O2 
Molecular weight 370 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.61 (s, 2H), 5.28 (s, 2H), 4.23 (t, J = 6.6 Hz, 
2H), 4.0 (s, 3H), 3.73 (s, 3H), 1.71-1.64 (m, 2H), 1.37-1.31 (m, 4H), 0.92 (t, J = 7.0 
Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 167.27, 147.15, 123.39, 123.26, 67.08, 49.46, 
35.76, 28.83, 28.58, 22.91, 74.24, 9.73 
MP (°C) 40 – 42 
IR (KBr disc) (cm-1) 3165, 2956, 2930, 1752, 1399, 1253, 1231, 1212, 1049 
MS m/z, 225.2 [M-PF6-]+; MS: m/z, 145.0 [PF6-] 
 
2,3-Dimethyl-1-(methoxyethoxyethoxycarbonylmethyl)imidazolium PF6 (191c) 
 
N
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O
O
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Orange viscous liquid 
 
The title compound was prepared 
from 2,3-dimethyl-1-(methoxy ethoxy 
ethoxy carbonylmethyl) imidazolium 
bromide 191a (2.51 g, 7.46 mmol) 
and KPF6 (1.65 g, 8.95 mmol) 
according to the general procedure in 
95 % yield (2.84 g, 7.06 mmol). 
Molecular formula C12H21PF6N2O4 
Molecular weight 402 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.59 (s, 2H), 5.27 (s, 2H), 4.38 (t, J = 4.6 Hz, 
2H), 3.98 (s, 3H), 3.73 (t, J = 4.6 Hz, 2H), 3.63 (t, J = 4.6 Hz, 2H), 3.52 (t, J = 4.6 Hz, 
2H), 3.12 (s, 3H), 2.72 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 167.27, 147.21, 123.38, 123.22, 72.46, 70.88, 
69.20, 66.23, 58.81, 49.65, 35.74, 9.70 
 A-57 
IR (thin film on salt plate) (cm-1) 3160, 2926, 2861, 1751, 1596, 1559, 1539, 1495, 
1452, 1400, 1245, 1217, 1106 
MS m/z, 257.2 [M-PF6-]+; MS: m/z, 145.0 [PF6-] 
 
Achiral N(CN)2 salts 
Representative method for the preparation of N(CN)2 salts (3-methyl-1-
(butoxycarbonylmethyl)imidazolium N(CN)2) (177e) 
A dry flask was charged with 3-
methyl-1-(butoxy carbonyl methyl) 
imidazolium bromide 177a (3.05 g, 
11.00 mmol) and acetonitrile (10 
mL) under a nitrogen atmosphere. 
NaN(CN)2 (1.42 g, 16.0 mmol) was 
added in one portion and the suspension was stirred vigorously for 4 days at RT. The 
fine white precipitate was filtered quickly in air and washed with dry acetonitrile (3 x 
5 mL). The filtrate and washings were combined, solvent removed by rotary 
evaporation and then under high vacuum to give a yellow oil in 87 % yield (2.51 g, 
9.54 mmol). 
 
Molecular formula C12H17N5O2 
Molecular weight 263 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.82 (s, 1H, H2), 7.56 (t, J = 1.8 Hz, 1H, H4), 
7.46 (t, J = 1.8 Hz, 1H, H3), 5.32 (s, 2H, H5), 4.15 (t, J = 6.8 Hz, 2H, H7), 4.02 (s, 
3H, H1), 1.61 (tt, J = 6.8, 7.2 Hz, 2H, H8), 1.33 (tq, J = 7.2, 7.5 Hz, 2H, H9), 0.87 (t, 
J = 7.5 Hz, 3H, H10)  
13C NMR (100 MHz, CDCl3) δ (ppm) 164.10 (COO), 136.12 (NCHN), 121.89 
(NCH2), 121.18 (NCH2), 64.85 (OCH2), 48.22 (NCH2), 34.87 (CH2), 28.31 (CH2), 
16.96 (CH2), 11.67 (CH3) Note: C’s from anion are not visible in 13C NMR 
IR (thin film on salt plate) (cm-1) 2962, 2931, 2861, 2241, 2139, 1750, 1569, 1558, 
1539, 1495, 1452, 1217, 1177 
MS m/z, 197.1 [M-N(CN)2-]+; MS: m/z, 66.0 [N(CN)2-] 
 
 
N
N
O
O
9
8
7
6
5
4
3
2
1
10
N
N
N
 A-58 
3-Methyl-1-(pentoxycarbonylmethyl)imidazolium N(CN)2 (178e) 
 
N
N
O
O
N(CN)2-
 
Bright yellow oil 
 
The title compound was prepared 
from 3-methyl-1-(pentoxy carbonyl 
methyl) imidazolium bromide 178a 
(3.20 g, 11.0 mmol) and NaN(CN)2 
(1.34 g, 15.0 mmol) according to the 
general procedure in 98 % yield (3.00 
g, 10.8 mmol). 
Molecular formula C13H19N5O2 
Molecular weight 277 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.66 (s, 1H), 7.63 (t, J = 1.8 Hz, 1H), 7.56 (t, J = 
1.8 Hz, 1H), 5.29 (s, 2H), 4.13 (t, J = 6.8 Hz, 2H), 4.02 (s, 3H), 1.62-1.59 (m, 2H), 
1.26-1.22 (m, 4H), 0.84 (t, J = 6.8 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 164.05, 135.78, 121.97, 121.34, 65.02, 48.12, 
34.78, 25.94, 25.74, 20.16, 11.90 Note: C’s from anion are not visible in 13C NMR 
IR (thin film on salt plate) (cm-1) 2958, 2933, 2861, 2240, 2138, 1750, 1569, 1558, 
1495, 1457, 1229, 1177 
MS m/z, 211.2 [M-N(CN)2-]+; MS: m/z, 66.0 [N(CN)2-] 
 
3-Methyl-1-(methoxyethoxycarbonylmethyl)imidazolium N(CN)2 (179e) 
 
 
N
N
O
O
O
N(CN)2-
 
Brown oil 
 
The title compound was prepared 
from 3-methyl-1-(methoxy ethoxy 
carbonyl methyl) imidazolium 
bromide 179a (3.35 g, 12.0 mmol) 
and NaN(CN)2 (1.78 g, 20.0 mmol) 
according to the general procedure in 
80 % yield (2.55 g, 9.62 mmol). 
Molecular formula C11H15N5O3 
Molecular weight 265 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.81 (s, 1H), 7.66 (t, J = 1.8 Hz, 1H), 7.55 (t, J = 
1.8 Hz, 1H), 5.44 (s, 2H), 4.35 (t, J = 4.5 Hz, 2H), 4.06 (s, 3H), 3.63 (t,  J = 4.5 Hz, 
2H), 3.37 (s, 3H)  
 A-59 
13C NMR (100 MHz, CDCl3) δ (ppm) 164.30, 136.09, 121.94, 121.24, 67.86, 63.55, 
56.95, 48.22, 34.91 Note: C’s from anion are not visible in 13C NMR 
IR (thin film on salt plate) (cm-1) 3099, 2928, 2857, 1750, 1636, 1574, 1558, 1495, 
1452, 1378, 1216, 1176 
MS m/z, 199.1 [M-N(CN)2-]+; MS: m/z, 66.0 [N(CN)2-] 
 
3-Methyl-1-(ethoxyethoxycarbonylmethyl)imidazolium N(CN)2 (180e) 
 
N
N
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O
O
N(CN)2-
 
Brown viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(ethoxy ethoxy 
carbonylmethyl)imidazolium bromide 
180a (2.84 g, 9.70 mmol) and 
NaN(CN)2 (0.98 g, 11.0 mmol) 
according to the general procedure in 
99 % yield (2.68 g, 9.61 mmol). 
Molecular formula C12H17N5O3 
Molecular weight 279 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.95 (s, 1H), 7.60 (t, J = 1.6 Hz, 1H), 7.50 (t, J = 
1.6 Hz, 1H), 5.45 (s, 2H), 4.37 (t, J = 4.6 Hz, 2H), 4.09 (s, 2H), 3.68 (t, J = 4.6 Hz, 
2H), 3.55 (q, J = 7.0 Hz, 2H), 1.21 (t, J = 7.0 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.20, 138.22, 123.86, 123.14, 67.72, 66.69, 
65.85, 50.23, 36.91, 15.12 Note: C’s from anion are not visible in 13C NMR 
IR (thin film on salt plate) (cm-1) 2974, 2928, 2862, 2139, 1750, 1633, 1569, 1558, 
1495, 1451, 1217, 1177, 1115 
MS m/z, 213.1 [M-N(CN)2-]+; MS: m/z, 66.0 [N(CN)2-] 
 
 
 A-60 
3-Methyl-1-(propoxyethoxycarbonylmethyl)imidazolium N(CN)2 (181e) 
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Pale brown viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(propoxy ethoxy 
carbonylmethyl)imidazolium bromide 
181a (3.38 g, 11.0 mmol) and 
NaN(CN)2 (1.42 g, 16.0 mmol) 
according to the general procedure in 
91 % yield (2.93 g, 10.0 mmol). 
Molecular formula C13H19N5O3 
Molecular weight 293 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.82 (s, 1H), 7.61 (t, J = 1.8 Hz, 1H), 7.53 (t, J = 
1.8 Hz, 1H), 5.41 (s, 2H), 4.35 (t, J = 4.6 Hz, 2H), 4.07 (s, 3H), 3.66 (t, J = 4.6 Hz, 
2H), 3.42 (t, J = 6.8 Hz, 2H), 1.59 (tq, J = 6.8, 7.4 Hz, 2H), 0.90 (t, J  = 7.4 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.16, 138.13, 123.86, 123.22, 73.02, 67.89, 
65.83, 50.22, 36.90, 22.72, 10.49 Note: C’s from anion are not visible in 13C NMR 
IR (thin film on salt plate) (cm-1) 2962, 2927, 2861, 2139, 1751, 1636, 1558, 1539, 
1495, 1452, 1216, 1175, 1106 
MS m/z, 227.2 [M-N(CN)2-]+; MS: m/z, 66.0 [N(CN)2-] 
 
3-Methyl-1-(butoxyethoxycarbonylmethyl)imidazolium N(CN)2 (182e) 
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Dark yellow oil 
 
The title compound was prepared 
from 3-methyl-1-(butoxy ethoxy 
carbonylmethyl)imidazolium bromide 
182a (3.85 g, 12.0 mmol) and 
NaN(CN)2 (1.78 g, 20.0 mmol) 
according to the general procedure in 
51 % yield (1.87 g, 6.09 mmol). 
Molecular formula C14H21N5O3 
Molecular weight 307 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.87 (s, 1H), 7.58 (t, J = 1.8 Hz, 1H), 7.50 (t, J = 
1.8 Hz, 1H), 5.41 (s, 2H), 4.36 (t, J = 4.8 Hz, 2H), 4.08 (s, 3H), 3.67 (t, J = 4.8 Hz, 
2H), 3.46 (t, J = 6.8 Hz, 2H), 1.55 (tt, J = 6.8, 7.2 Hz, 2H), 1.35 (tq, J = 7.2, 7.5 Hz, 
2H), 0.91 (t, J = 7.5 Hz, 3H)  
 A-61 
13C NMR (100 MHz, CDCl3) δ (ppm) 166.10, 138.21, 123.83, 123.14, 71.22, 67.92, 
65.87, 50.23, 36.91, 31.57, 19.21, 13.94 Note: C’s from anion are not visible in 13C 
NMR 
IR (thin film on salt plate) (cm-1) 2960, 2933, 2865, 2139, 1751, 1633, 1569, 1558, 
1495, 1452, 1215, 1177, 1117 
MS m/z, 241.2 [M-N(CN)2-]+; MS: m/z, 66.0 [N(CN)2-] 
 
3-Methyl-1-(methoxyethoxyethoxycarbonylmethyl)imidazolium N(CN)2 (183e) 
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Orange viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(methoxy ethoxy 
ethoxy carbonylmethyl) imidazolium 
bromide 183a (2.91 g, 9.00 mmol) 
and NaN(CN)2 (0.89 g, 10.0 mmol) 
according to the general procedure in 
94 % yield (2.59 g, 8.38 mmol). 
Molecular formula C14H19N5O4 
Molecular weight 309 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.95 (s, 1H), 7.49 (t, J = 1.6 Hz, 1H), 7.30 (t, J = 
1.6 Hz, 1H), 5.38 (s, 2H), 4.33 (t, J = 4.6 Hz, 2H), 4.01 (s, 3H), 3.68 (t, J = 4.6 Hz, 
2H), 3.59-3.53 (m, 2H), 3.50-3.44 (m, 2H), 3.31 (s, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.14, 138.63, 123.85, 122.81, 71.97, 70.47, 
68.53, 65.70, 59.03, 50.26, 36.90 Note: C’s from anion are not visible in 13C NMR 
IR (thin film on salt plate) (cm-1) 2926, 2859, 2139, 1750, 1566, 1558, 1495, 1452, 
1217, 1175, 1104 
MS m/z, 243.2 [M-N(CN)2-]+; MS: m/z, 66.0 [N(CN)2-] 
 
 A-62 
3-Methyl-1-(ethoxyethoxyethoxycarbonylmethyl)imidazolium N(CN)2 (184e) 
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Brown viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(ethoxy ethoxy 
ethoxy carbonylmethyl) imidazolium 
bromide 184a (2.53 g, 7.50 mmol) 
and NaN(CN)2 (0.76 g, 8.50 mmol) 
according to the general procedure in 
99 % yield (2.40 g, 7.43 mmol). 
Molecular formula C14H21N5O4 
Molecular weight 323 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 10.01 (s, 1H), 7.61 (t, J = 1.8 Hz, 1H), 7.43 (t, J 
= 1.8 Hz, 1H), 5.46 (s, 2H), 4.40 (t, J = 4.8 Hz, 2H), 4.09 (s, 3H), 3.76 (t, J = 4.8 Hz, 
2H), 3.67-3.65 (m, 2H), 3.62-3.59 (m, 2H), 3.55 (q, J = 7.0 Hz, 2H), 1.21 (t, J = 7.0 
Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 166.16, 138.47, 123.92, 122.91, 70.65, 69.70, 
68.53, 66.67, 65.71, 50.94, 36.90, 15.18 Note: C’s from anion are not visible in 13C 
NMR 
IR (thin film on salt plate) (cm-1) 2927, 2868, 2139, 1750, 1636, 1569, 1558, 1495, 
1451, 1215, 1177, 1105  
MS m/z, 257.2 [M-N(CN)2-]+; MS: m/z, 66.0 [N(CN)2-] 
 
3-Methyl-1-(propoxyethoxyethoxycarbonylmethyl)imidazolium N(CN)2 (185e) 
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Yellow viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(propoxy ethoxy 
ethoxy carbonylmethyl) imidazolium 
bromide 185a (2.70 g, 7.70 mmol) 
and NaN(CN)2 (0.80 g, 9.00 mmol) 
according to the general procedure in 
85 % yield (2.20 g, 6.53 mmol). 
Molecular formula C15H23N5O4 
Molecular weight 337 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 10.03 (s, 1H), 7.61 (t, J = 1.8 Hz, 1H), 7.43 (t, J 
= 1.8 Hz, 1H), 5.46 (s, 2H), 4.39 (t, J = 4.6 Hz, 2H), 4.09 (s, 3H), 3.76 (t, J = 4.6 Hz, 
 A-63 
2H), 3.66-3.64 (m, 2H), 3.60-3.57 (m, 2H), 3.43 (t, J = 6.9 Hz, 2H), 1.61 (tq, J = 6.9, 
7.6 Hz, 2H), 0.92 (t, J = 7.6 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.15, 138.47, 123.90, 122.90, 73.09, 70.61, 
69.92, 68.53, 65.74, 50.23, 36.90, 22.77, 10.53 Note: C’s from anion are not visible in 
13C NMR 
IR (thin film on salt plate) (cm-1) 2963, 2927, 2863, 2139, 1751, 1635, 1568, 1558 , 
1495, 1452, 1217, 1175, 1105 
MS m/z, 271.3 [M-N(CN)2-]+; MS: m/z, 66.0 [N(CN)2-] 
 
3-Methyl-1-(butoxyethoxyethoxycarbonylmethyl)imidazolium N(CN)2 (186e) 
 
 
N
N
O
O
O
N(CN)2-
O
Pale brown solid 
 
The title compound was 
prepared from 3-methyl-1-
(butoxy ethoxy ethoxy carbonyl 
methyl) imidazolium bromide 
186a (2.92 g, 8.00 mmol) and 
NaN(CN)2 (0.80 g, 9.00 mmol) 
according to the general 
procedure in 98 % yield (2.75 g, 
7.83 mmol). 
Molecular formula C16H25N5O4 
Molecular weight 351 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 10.23 (s, 1H), 7.41 (t, J = 1.8 Hz, 1H), 7.23 (t, J 
= 1.8 Hz, 1H), 5.40 (s, 2H), 4.32 (t, J = 4.6 Hz, 2H), 4.01 (s, 3H), 3.68 (t, J = 4.6 Hz, 
2H), 3.58-3.55 (m, 2H), 3.54-3.50 (m, 2H), 3.39 (t, J = 6.7 Hz, 2H), 1.49 (tt, J = 6.7, 
7.6 Hz, 2H), 1.28 (tq, J = 7.6, 7.2 Hz, 2H), 0.85 (t, J = 7.2 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 164.19, 136.12, 122.00, 121.91, 69.19, 68.58, 
67.93, 66.53, 63.70, 48.20, 34.89, 29.63, 17.24, 11.96 Note: C’s from anion are not 
visible in 13C NMR 
Mp (°C) 34 – 36 ºC 
IR (KBr disc) (cm-1) 3435, 2958, 2867, 2140, 1752, 1635, 1222, 1177, 1100 
MS m/z, 285.3 [M-N(CN)2-]+; MS: m/z, 66.0 [N(CN)2-] 
 
 
 
 A-64 
3-Methyl-1-(methoxyethoxyethoxyethoxycarbonylmethyl)imidazolium N(CN)2 
(187e) 
 
 
 
N
N
O
O
O
N(CN)2-
O
O
Amber viscous liquid 
 
The title compound was 
prepared from 3-methyl-1-
(methoxy ethoxy ethoxy ethoxy 
carbonylmethyl) imidazolium 
bromide 187a (2.94 g, 8.00 
mmol) and NaN(CN)2 (0.80 g, 
9.00 mmol) according to the 
general procedure in 75 % yield 
(2.12 g, 6.01 mmol). 
Molecular formula C15H23N5O5 
Molecular weight 353 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.72 (s, 1H), 7.67 (d, J = 1.6 Hz, 1H), 7.50 (d, J 
= 1.6 Hz, 1H), 5.40 (s, 2H), 4.38 (t, J = 4.6 Hz, 2H), 4.07 (s, 3H), 3.74 (t, J = 4.6 Hz, 
2H), 3.65-3.60 (m, 6H), 3.56-3.53 (m, 2H), 3.37 (s, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.18, 138.18, 124.06, 123.14, 71.79, 70.45, 
70.42, 70.35, 68.49, 65.56, 58.88, 50.17, 36.82 Note: C’s from anion are not visible in 
13C NMR 
IR (thin film on salt plate) (cm-1) 2925, 2859, 2242, 2139, 1751, 1635, 1566, 1558, 
1495, 1452, 1217, 1176 
MS m/z, 287.2 [M-N(CN)2-]+; MS: m/z, 66.0 [N(CN)2-] 
 
2,3-Dimethyl-1-(butoxyethoxycarbonylmethyl)imidazolium N(CN)2 (190e) 
 
N
N
O
O
O
N(CN)2-
 
Brown viscous liquid 
 
The title compound was prepared 
from 2,3-dimethyl-1-(butoxy ethoxy 
carbonyl methyl) imidazolium 
bromide 190a (3.02 g, 9.00 mmol) 
and NaN(CN)2 (1.07 g, 12.0 mmol) 
according to the general procedure 
in 78 % yield (2.25 g, 7.01 mmol). 
Molecular formula C15H23N5O3 
Molecular weight 321 g/mol 
 A-65 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.71 (d, J = 2.0 Hz, 1H), 7.53 (d, J = 2.0 Hz, 
1H), 5.36 (s, 2H), 4.37 (t, J = 4.6 Hz, 2H), 3.95 (s, 3H), 3.67 (t, J = 4.6 Hz, 2H), 3.47 
(t, J = 6.7 Hz, 2H), 2.71 (s, 3H), 1.57 (tt, J = 6.7, 7.2 Hz, 2H), 1.37 (tq, J = 7.2, 7.5 
Hz, 2H), 0.93 (t, J = 7.5s Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 166.13, 145.69, 122.87, 122.47, 71.22, 67.95, 
65.78, 49.79, 35.97, 31.60, 19.23, 13.94, 10.78 Note: C’s from anion are not visible in 
13C NMR 
IR (thin film on salt plate) (cm-1) 2957, 2933, 2864, 2139, 1751, 1635, 1558, 1539, 
1495, 1452, 1217, 1120 
MS m/z, 255.2 [M-N(CN)2-]+; MS: m/z, 66.0 [N(CN)2-] 
 
2,3-Dimethyl-1-(pentoxycarbonylmethyl)imidazolium N(CN)2 (189e) 
 
 
N
N
O
O
N(CN)2-
 
Yellow oil 
 
The title compound was prepared 
from 2,3-dimethyl-1-(pentoxy 
carbonyl methyl) imidazolium 
bromide 189a (3.66 g, 12.0 mmol) 
and NaN(CN)2 (1.78 g, 20.0 mmol) 
according to the general procedure 
in 85 % yield (2.96 g, 10.2 mmol). 
Molecular formula C14H21N5O2 
Molecular weight 291 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.70 (d, J = 2.0 Hz, 1H), 7.55 (d, J = 2.0 Hz, 
1H), 5.32 (s, 2H), 4.21 (t, J = 7.0 Hz, 2H), 3.95 (s, 3H), 2.71 (s, 3H), 1.68-1.65 (m, 
2H), 1.34-1.30 (m, 4H), 0.91 (t, J = 7.0 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.15, 145.60, 122.84, 122.47, 67.13, 49.82, 
33.99, 28.04, 27.80, 22.23, 13.95, 10.84 Note: C’s from anion are not visible in 13C 
NMR 
IR (thin film on salt plate) (cm-1) 2959, 2933, 2862, 2136, 1751, 1635, 1558, 1539, 
1495, 1456, 1228, 1217, 1168 
MS m/z, 225.2 [M-N(CN)2-]+; MS: m/z, 66.0 [N(CN)2-] 
 
 A-66 
2,3-Dimethyl-1-(methoxyethoxyethoxycarbonylmethyl)imidazolium N(CN)2 
(191e) 
 
 
N
N
O
O
O
N(CN)2-
O
 
Pale brown slightly viscous liquid 
 
The title compound was prepared 
from 2,3-dimethyl-1-(methoxy 
ethoxy ethoxy carbonyl methyl) 
imidazolium bromide 191a (2.90 g, 
8.48 mmol) and NaN(CN)2 (0.84 g, 
9.40 mmol) according to the general 
procedure in 99 % yield (2.74 g, 
8.48 mmol). 
Molecular formula C14H21N5O4 
Molecular weight 323 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.69 (d, J = 2.2 Hz, 1H), 7.51 (d, J = 2.2 Hz, 
1H), 3.34 (s, 2H), 4.40 (t, J = 4.6 Hz, 2H), 3.95 (s, 3H), 3.75 (t, J  = 4.6 Hz, 2H), 3.66-
3.63 (m, 2H), 3.57-3.55 (m, 2H), 3.38 (s, 3H), 2.72 (s, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.09, 145.74, 122.87, 122.46, 71.78, 70.45, 
68.45, 65.66, 59.02, 49.73, 35.92, 10.67 Note: C’s from anion are not visible in 13C 
NMR 
IR (thin film on salt plate) (cm-1) 2953, 2926, 2859, 2239, 2139, 1751, 1558, 1539, 
1495, 1452, 1216, 1103 
MS m/z, 257.2 [M-N(CN)2-]+; MS: m/z, 66.0 [N(CN)2-] 
 
Achiral OctOSO3 salts 
Representative method for the preparation of OctOSO3 salts (3-methyl-1-
(butoxycarbonylmethyl)imidazolium OctOSO3) (177f) 
To a solution of 3-methyl-1-
(butoxy carbonyl methyl) 
imidazolium bromide 177a 
(2.58 g, 9.30 mmol) in distilled 
water (20 mL) was added in 
one portion sodium octyl sulfate (1.93 g, 8.30 mmol) and stirred at 60 ºC for 2 h. The 
water was then slowly removed under vacuum. The precipitate was dissolved in DCM 
(5 mL) and washed with distilled water (2 x 3 mL). The product remaining was dried 
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 A-67 
on the rotary evaporator and then under high vacuum for 8 h to give a colourless 
grease in 61 % yield (2.07 g, 5.09 mmol). 
 
Molecular formula C18H34N2O6S 
Molecular weight 406 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.40 (s, 1H, H2), 7.38 (t, J = 1.8 Hz, 1H, H4), 
7.29 (t, J = 1.8 Hz, 2H, H3), 5.14 (s, 2H, H5), 4.14 (t, J = 6.6 Hz, 2H, H7), 3.93 (s, 
3H, H1), 1.63-1.55 (m, 4H, H’s 11 and 8), 1.36-1.14 (m, 14H, H’s 9 and 12-17), 0.89 
(t, J = 7.2 Hz, 3H, H10), 0.82 (t, J = 6.8 Hz, 3H, H18)  
13C NMR (100 MHz, CDCl3) δ (ppm) 165.40 (COO), 138.97 (NCHN), 123.63 
(NCH2), 122.95 (NCH2), 68.07 (OCH2), 66.71 (OCH2), 49.95 (NCH2), 36.60 (CH2), 
31.83 (CH2), 30.34 (CH2), 29.47 (CH2), 29.35 (CH2), 29.26 (CH2), 25.86 (CH2), 22.66 
(CH2), 18.96 (CH2), 14.12 (CH3), 13.65 (CH3) 
IR (thin film on salt plate) (cm-1) 3460, 3115, 2926, 1752, 1569, 1468, 1227, 1060 
MS m/z, 197.1 [M-OctOSO3-]+; MS: m/z, 209.0 [OctOSO3-] 
 
3-Methyl-1-(pentoxycarbonylmethyl)imidazolium OctOSO3 (178f) 
 
 
N
N
O
O
OctOSO3-
 
Pale yellow grease 
 
The title compound was prepared 
from 3-methyl-1-(pentoxy carbonyl 
methyl) imidazolium bromide 178a 
(2.62 g, 9.00 mmol) and sodium 
octyl sulfate (1.62 g, 7.00 mmol) 
according to the general procedure 
in 96 % yield (2.82 g, 6.70 mmol). 
Molecular formula C19H36N2O6S 
Molecular weight 420 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.51 (s, 1H), 7.36 (t, J = 1.6 Hz, 1H), 7.27 (t, J = 
1.6 Hz, 1H), 5.15 (s, 2H), 4.13 (t, J = 7.0 Hz, 2H), 3.94 (m, 5H), 1.61-1.57 (m, 4H), 
1.25-1.20 (m, 14H), 0.83-0.78 (m, 6H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.28, 139.22, 123.56, 122.86, 68.01, 67.00, 
50.01, 36.60, 31.81, 29.50, 29.33, 29.23, 28.03, 27.81, 25.85, 22.63, 20.01, 14.06, 
13.87 
IR (thin film on salt plate) (cm-1) 2957, 2926, 2858, 1751, 1558, 1539, 1495, 1452 
 A-68 
MS m/z, 211.2 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
 
3-Methyl-1-(methoxyethoxycarbonylmethyl)imidazolium OctOSO3 (179f) 
 
 
N
N
O
O
O
OctOSO3-
 
Brown grease 
 
The title compound was prepared 
from 3-methyl-1-(methoxy ethoxy 
carbonyl methyl) imidazolium 
bromide 179a (2.65g, 9.50 mmol) 
and sodium octyl sulfate (1.97 g, 
8.50 mmol) according to the general 
procedure in 95 % yield (3.30 g, 
8.07 mmol). 
Molecular formula C17H32N2O7S 
Molecular weight 408 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.51 (s, 1H), 7.44 (s, 1H), 7.33 (s, 1H), 5.25 (s, 
2H), 4.30 (t, J = 4.6 Hz, 2H), 3.95 (m, 5H), 3.57 (t, J = 4.6 Hz, 2H), 3.31 (s, 3H), 1.60 
(tt, J = 6.8, 7.4 Hz, 2H), 1.29-1.19 (m, 10H), 0.82 (t, J = 6.8 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 166.43, 138.75, 123.75, 122.99, 69.87, 68.10, 
65.47, 58.95, 50.05, 36.73, 31.83, 29.45, 29.34, 29.26, 25.85, 22.67, 14.13 
IR (thin film on salt plate) (cm-1) 2952, 2925, 2857, 1751, 1558, 1539, 1495, 1452, 
1257, 1217, 1176 
MS m/z, 199.2 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
 
3-Methyl-1-(ethoxyethoxycarbonylmethyl)imidazolium OctOSO3 (180f) 
 
 
N
N
O
O
O
OctOSO3-
 
Brown grease 
 
The title compound was prepared 
from 3-methyl-1-(ethoxy ethoxy 
carbonyl methyl) imidazolium 
bromide 180a (2.93 g, 10.0 mmol) 
and sodium octyl sulfate (1.86 g, 
8.00 mmol) according to the general 
procedure in 96 % yield (3.24 g, 
7.66 mmol). 
Molecular formula C18H34N2O7S 
Molecular weight 422 g/mol 
 A-69 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.42 (s, 1H), 7.37 (s, 1H), 7.28 (s, 1H), 5.17 (s, 
2H), 4.29 (t, J = 4.7 Hz, 2H), 3.94 (m, 5H), 3.60 (t, J = 4.7 Hz, 2H), 3.48 (q, J = 7.1 
Hz, 2H), 1.63 (tt, J = 6.8, 7.2 Hz, 2H), 1.29-1.15 (m, 10H), 1.15 (t, J = 7.1 Hz, 3H), 
0.82 (t, J = 6.8 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.45, 138.89, 123.67, 122.98, 68.23, 67.76, 
66.72, 65.70, 49.96, 36.62, 31.83, 29.43, 29.34, 29.26, 25.83, 22.67, 15.07, 14.13 
IR (thin film on salt plate) (cm-1) 2955, 2926, 2858, 1751, 1558, 1539, 1495, 1452, 
1402, 1217, 1176, 1107 
MS m/z, 213.2 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
 
3-Methyl-1-(propoxyethoxycarbonylmethyl)imidazolium OctOSO3 (181f) 
 
 
N
N
O
O
O
OctOSO3-
 
Dark yellow grease 
 
The title compound was prepared 
from 3-methyl-1-(propoxy ethoxy 
carbonyl methyl) imidazolium 
bromide 181a (3.68 g, 12.0 mmol) 
and sodium octyl sulfate (2.09 g, 
9.00 mmol) according to the general 
procedure in 85 % yield (3.33 g, 
7.62 mmol). 
Molecular formula C19H36N2O7S 
Molecular weight 436 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.45 (s, 1H), 7.48 (t, J = 1.6 Hz, 1H), 7.41 (t, J = 
1.6 Hz, 1H), 5.25 (s, 2H), 4.36 (t, J = 4.7 Hz, 2H), 4.01 (m, 5H), 3.67 (t, J = 4.7 Hz, 
2H), 3.43 (t, J = 6.8 Hz, 2H), 1.63-1.58 (m, 4H), 1.56-1.29 (m, 10H), 0.92-0.86 (m, 
6H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.45, 138.89, 123.71, 123.06, 73.04, 67.92, 
67.89, 65.67, 49.91, 36.58, 31.83, 29.50, 29.36, 29.26, 25.87, 22.73, 22.66, 14.13, 
10.47 
IR (thin film on salt plate) (cm-1) 3118, 2958, 2927, 2855, 1750, 1569, 1558, 1539, 
1495, 1455, 1217, 1178, 1108 
MS m/z, 227.1 [M-OctOSO3-]+; MS: m/z, 209.0 [OctOSO3-] 
 
 A-70 
3-Methyl-1-(butoxyethoxycarbonylmethyl)imidazolium OctOSO3 (182f) 
 
 
N
N
O
O
O
OctOSO3-
 
Pale yellow viscous liquid/grease 
 
The title compound was prepared 
from 3-methyl-1-(butoxy ethoxy 
carbonyl methyl) imidazolium 
bromide 182a (3.15 g, 9.80 mmol) 
and sodium octyl sulfate (1.81 g, 
7.80 mmol) according to the general 
procedure in 93 % yield (3.27 g, 
7.25 mmol). 
Molecular formula C20H38N2O7 
Molecular weight 450 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.49 (s, 1H), 7.36 (t, J = 1.6 Hz, 1H), 7.28 (t, J = 
1.6 Hz, 1H), 5.24 (s, 2H), 4.28 (t, J = 4.8 Hz, 2H), 3.94 (m, 5H), 3.59 (t, J = 4.8 Hz, 
2H), 3.40 (t, J = 6.8 Hz, 2H), 1.51 (tt, J = 6.8, 6.8 Hz, 2H), 1.28 (tq, J = 6.8, 7.1 Hz, 
2H), 1.34-1.14 (m, 12H), 0.86 (t, J = 7.1 Hz, 3H), 0.80 (t, J = 7.2 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.32, 139.12, 123.59, 122.92, 71.25, 67.99, 
67.95, 65.78, 49.96, 36.65, 31.84, 31.60, 29.49, 29.36, 29.28, 25.87, 22.68, 19.24, 
14.15, 13.95 
IR (thin film on salt plate) (cm-1) 3114, 2954, 2927, 2858, 1751, 1567, 1558, 1539, 
1495, 1455, 1217, 1112 
MS m/z, 241.2 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
 
3-Methyl-1-(methoxyethoxyethoxycarbonylmethyl)imidazolium OctOSO3 (183f) 
 
 
N
N
O
O
O
OctOSO3-
O
 
Yellow grease 
 
The title compound was prepared 
from 3-methyl-1-(methoxy ethoxy 
ethoxy carbonylmethyl)imidazolium 
bromide 183a (3.23 g, 10.0 mmol) 
and sodium octyl sulfate (2.09 g, 
9.00 mmol) according to the general 
procedure in 82 % yield (3.34 g, 
7.37 mmol). 
Molecular formula C19H36N2O8 
Molecular weight 452 g/mol 
 A-71 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.23 (s, 1H), 7.47 (t, J = 1.8 Hz, 1H), 7.36 (t, J = 
1.8 Hz, 1H), 5.17 (s, 2H), 4.38 (t, J = 4.6 Hz, 2H), 3.92 (m, 5H), 3.67 (t, J = 4.6 Hz, 
2H), 3.58-3.53 (m, 2H), 3.49-3.44 (m, 2H), 3.30 (s, 3H), 1.60 (tt, J = 6.8, 7.4 Hz, 2H), 
1.27-1.14 (m, 10H), 0.82 (t, J = 7.0 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.67, 138.55, 123.87, 123.14, 71.71, 70.32, 
68.58, 68.06, 65.43, 58.96, 49.90, 36.55, 31.84, 29.45, 29.37, 29.27, 25.85, 22.66, 
14.13 
IR (thin film on salt plate) (cm-1) 2954, 2926, 2859, 1750, 1558, 1539, 1495, 1455, 
1401, 1364, 1203, 1174, 1102 
MS m/z, 243.2 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
 
3-Methyl-1-(ethoxyethoxyethoxycarbonylmethyl)imidazolium OctOSO3 (184f) 
 
 
N
N
O
O
O
OctOSO3-
O
 
Yellow grease 
 
The title compound was prepared 
from 3-methyl-1-(ethoxy ethoxy 
ethoxy carbonylmethyl)imidazolium 
bromide 184a (3.20 g, 9.50 mmol) 
and sodium octyl sulfate (1.86 g, 
8.00 mmol) according to the general 
procedure in 93 % yield (3.47 g, 
7.21 mmol). 
Molecular formula C20H38N2O8S 
Molecular weight 466 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.44 (s, 1H), 7.52 (s, 1H), 7.40 (s, 1H), 5.23 (s, 
2H), 4.37 (t, J = 4.8 Hz, 2H), 4.02 (m, 5H), 3.75 (t, J = 4.8 Hz, 2H), 3.66-3.63 (m, 
2H), 3.61-3.57 (m, 2H), 3.55 (q, J = 7.1 Hz, 2H), 1.70 (tt, J = 6.8, 7.4 Hz, 2H), 1.38-
1.27 (m, 10H), 1.23 (t, J = 7.1 Hz, 3H), 0.89 (t, J = 6.8 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.46, 138.86, 123.82, 123.01, 70.61, 69.71, 
68.57, 68.04, 66.66, 65.63, 49.88, 36.57, 31.82, 29.47, 29.35, 29.26, 25.85, 22.66, 
15.15, 14.12 
IR (thin film on salt plate) (cm-1) 2957, 2927, 2858, 1751, 1558, 1639, 1495, 1452, 
1399, 1260, 1217, 1178, 1106 
MS m/z, 257.1 [M-OctOSO3-]+; MS: m/z, 209.0 [OctOSO3-] 
 
 A-72 
3-Methyl-1-(propoxyethoxyethoxycarbonylmethyl)imidazolium OctOSO3 (185f) 
 
 
N
N
O
O
O
OctOSO3-
O
 
Pale yellow viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(propoxy ethoxy 
ethoxy carbonylmethyl)imidazolium 
bromide 185a (0.78 g, 2.23 mmol) 
and sodium octyl sulfate (0.42 g, 
1.80 mmol) according to the general 
procedure in 98 % yield (0.85 g, 
1.77 mmol). 
Molecular formula C21H40N2O8 
Molecular weight 480 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.41 (s, 1H), 7.45 (t, J = 1.8 Hz, 1H), 7.33 (t, J = 
1.8 Hz, 1H), 5.17 (s, 2H), 4.29 (t, J = 4.8 Hz, 2H), 3.94-3.91 (m, 5H), 3.67 (t, J = 4.8 
Hz, 2H), 3.58-3.54 (m, 2H), 3.53-3.49 (m, 2H), 3.35 (t, J = 6.8 Hz, 2H), 1.62-1.48 (m, 
14H), 0.85-0.80 (m, 6H)   
13C NMR (100 MHz, CDCl3) δ (ppm) 166.46, 138.88, 123.82, 123.00, 73.10, 70.58, 
70.46, 70.14, 69.93, 67.92, 65.56, 61.82, 36.59, 31.83, 29.49, 29.36, 29.27, 25.87, 
22.76, 22.67, 14.13 
IR (thin film on salt plate) (cm-1) 2956, 2927, 2859, 1751, 1558, 1539, 1495, 1455, 
1217, 1106 
MS m/z, 271.3 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
 
3-Methyl-1-(butoxyethoxyethoxycarbonylmethyl)imidazolium OctOSO3 (186f) 
 
 
N
N
O
O
O
OctOSO3-
O
Pale yellow viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(butoxy ethoxy 
ethoxy carbonyl methyl) 
imidazolium bromide 186a (2.19 
g, 6.00 mmol) and sodium octyl 
sulfate (1.16 g, 5.00 mmol) 
according to the general procedure 
in 92 % yield (2.28 g, 4.61 mmol). 
Molecular formula C22H42N2O8S 
Molecular weight 494 g/mol 
 A-73 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.34 (s, 1H), 7.50 (t, J = 1.8 Hz, 1H), 7.41 (t, J = 
1.8 Hz, 1H), 5.15 (s, 2H), 4.28 (t, J = 4.8 Hz, 2H), 3.93 (m, 5H), 3.67 (t, J = 4.8 Hz, 
2H), 3.57-3.53 (m, 2H), 3.52-3.48 (m, 2H), 3.38 (t, J = 6.8 Hz, 2H), 1.52 (tt, J = 6.8, 
7.2 Hz, 2H), 1.28 (tq, J = 7.2, 6.8 Hz, 2H), 1.32-1.12 (m, 12H), 0.86-0.78 (m, 6H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.48, 138.71, 123.91, 123.16, 71.25, 71.20, 
70.56, 68.55, 67.77, 65.52, 49.79, 36.51, 31.81, 31.62, 29.50, 29.35, 29.25, 25.87, 
22.64, 19.23, 14.10, 13.93 
IR (thin film on salt plate) (cm-1) 2953, 2927, 2859, 1750, 1558, 1539, 1495, 1455, 
1217, 1110 
MS m/z, 285.2 [M-OctOSO3-]+; MS: m/z, 209.0 [OctOSO3-] 
 
3-Methyl-1-(methoxyethoxyethoxyethoxycarbonylmethyl)imidazolium OctOSO3 
(187f) 
 
 
N
N
O
O
O
OctOSO3-
O
O
Pale brown viscous liquid 
 
The title compound was prepared 
from 3-methyl-1-(methoxy ethoxy 
ethoxy ethoxy carbonyl methyl) 
imidazolium bromide 187a (2.20 
g, 6.00 mmol) and sodium octyl 
sulfate (1.62 g, 7.00 mmol) 
according to the general procedure 
in 84 % yield (2.51 g, 5.05 mmol). 
Molecular formula C21H40N2O9S 
Molecular weight 496 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.36 (s, 1H), 7.44 (t, J = 1.6 Hz, 1H), 7.28 (t, J = 
1.6 Hz, 1H), 5.23 (s, 2H), 4.31 (t, J = 4.6 Hz, 2H), 3.96-3.90 (m, 5H), 3.67-3.61 (m, 
2H), 3.59-3.53 (m, 6H), 3.29 (s, 3H), 1.61 (tt, J = 6.8, 7.4 Hz, 2H), 1.29-1.19 (m, 
12H), 0.82 (t, J = 6.8 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.77, 138.37, 123.91, 123.25, 70.34, 70.31, 
70.26, 70.14, 68.56, 68.04, 65.30, 58.88, 49.86, 36.47, 31.82, 29.42, 29.35, 29.25, 
25.83, 22.64, 14.10 
IR (thin film on salt plate) (cm-1) 2951, 2926, 2859, 1751, 1566, 1558, 1539, 1495, 
1456, 1399, 1217, 1106 
MS m/z, 287.2 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
 
 A-74 
 
2,3-Dimethyl-1-(butoxyethoxycarbonylmethyl)imidazolium OctOSO3 (190f) 
 
N
N
O
O
O
OctOSO3-
 
Beige fluffy solid 
 
The title compound was prepared 
from 2,3-dimethyl-1-(butoxy 
carbonyl methyl) imidazolium 
bromide 190a (2.51 g, 7.50 mmol) 
and sodium octyl sulfate (1.51 g, 
6.50 mmol) according to the general 
procedure in 84 % yield (2.53 g, 
5.44 mmol). 
Molecular formula C21H40N2O7S 
Molecular weight 464 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.49 (d, J = 2.2 Hz, 1H), 7.43 (d, J = 2.2 Hz, 
1H), 5.20 (s, 2H), 4.36 (t, J = 4.7 Hz, 2H), 3.88 (m, 5H), 3.67 (t, J = 4.7 Hz, 2H), 3.48 
(t, J = 6.8 Hz, 2H), 2.63 (s, 3H), 1.68-1.55 (m, 4H), 1.42-1.27 (m, 12H), 0.96 (t, J = 
7.4 Hz, 3H), 0.90 (t, J = 7.0 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.52, 145.81, 122.70, 122.40, 71.22, 67.99, 
67.82, 65.57, 49.37, 35.57, 31.84, 31.62, 29.49, 29.36, 29.28, 25. 87, 22.67, 19.24, 
14.13, 13.94, 10.20 
Mp (°C) 50 – 52  
IR (KBr disc) (cm-1) 2959, 2927, 2861, 1751, 1558, 1546, 1539, 1495, 1455, 1256, 
1217, 1121 
MS m/z, 255.3 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
 
2,3-Dimethyl-1-(pentoxycarbonylmethyl)imidazolium OctOSO3 (189f) 
 
 
N
N
O
O
OctOSO3-
 
Off-white solid 
 
The title compound was prepared 
from 2,3-dimethyl-1-(pentoxy 
carbonyl methyl) imidazolium 
bromide 189a (2.47 g, 8.10 mmol) 
and sodium octyl sulfate (1.65 g, 
7.10 mmol) according to the general 
procedure in 86 % yield (2.66 g, 
6.11 mmol). 
Molecular formula C20H38N2O6 
 A-75 
Molecular weight 434 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.44 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 2.4 Hz, 
1H), 5.13 (s, 2H), 4.12 (t, J = 6.8 Hz, 2H), 3.88 (t, J = 7.0 Hz, 2H), 3.81 (s, 3H), 2.57 
(s, 3H), 1.64-1.53 (m, 4H), 1.28-1.18 (m, 14H), 0.86 (t, J = 7.0 Hz, 3H), 0.82 (t, J = 
7.0 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 166.55, 145.82, 122.71, 122.31, 67.59, 66.93, 
49.55, 35.64, 31.84, 29.54, 29.37, 29.28, 28.07, 27.83, 25.90, 22.67, 22.24, 14.13, 
13.94, 10.45 
Mp (°C) 63 – 65  
IR (KBr disc) (cm-1) 2956, 2927, 1751, 1452, 1398, 1251, 1219, 1052 
MS m/z, 225.2 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
 
2,3-Dimethyl-1-(methoxyethoxyethoxycarbonylmethyl)imidazolium OctOSO3 
(191f) 
 
 
N
N
O
O
O
OctOSO3-
O
 
Yellow grease 
 
The title compound was prepared 
from 2,3-dimethyl-1-(methoxy 
ethoxy ethoxy carbonyl methyl) 
imidazolium bromide 191a (2.56 g, 
7.60 mmol) and sodium octyl 
sulfate (1.62 g, 7.00 mmol) 
according to the general procedure 
in 94 % yield (3.07 g, 6.57 mmol). 
Molecular formula C20H38N2O8S 
Molecular weight 466 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.48 (d, J = 2.0 Hz, 1H), 7.36 (d, J = 2.0 Hz, 
1H), 5.16 (s, 2H), 4.30 (t, J = 4.7 Hz, 2H), 3.91 (t, J = 7.0 Hz, 2H), 3.81 (s, 3H), 3.67 
(t, J = 4.7 Hz, 2H), 3.58-3.52 (m, 2H), 3.48-3.44 (m, 2H), 3.31 (s, 3H), 2.68 (s, 3H), 
1.58 (tt, J = 6.8, 7.6 Hz, 2H), 1.29-1.15 (m, 10H), 0.82 (t, J = 7.0 Hz, 3H)  
13C NMR (100 MHz, CDCl3) δ (ppm) 166.55, 145.86, 122.79, 122.35, 71.78, 70.42, 
68.56, 67.65, 65.44, 59.04, 49.40, 35.59, 31.83, 29.53, 29.37, 29.28, 25.89, 22.67, 
14.13, 10.28 
IR (thin film on salt plate) (cm-1) 2955, 2926, 2858, 1751, 1558, 1545, 1539, 1495, 
1452, 1217, 1105 
MS m/z, 257.2 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
 A-76 
3-Methyl-1-[bis-1-methoxyethyl]carbamylmethyl)imidazolium OctOSO3 (205f) 
 
N
N
N
OOctOSO3-
O
O
 
Yellow grease 
 
The title compound was prepared 
from 3-methyl-1-[(bis-1-methoxy 
ethyl)carbamylmethyl] imidazolium 
bromide (1.38 g, 4.12 mmol) 205a 
and sodium octyl sulfate (4.01 
mmol, 0.93 g) according to the 
general procedure in 92 % yield 
(1.71 g, 3.67 mmol). 
Molecular formula C20H39N3O7S 
Molecular weight 465 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.34 (s, 1H), 7.25 (t, J = 1.6 Hz, 1H), 7.20 (t, J = 
1.6 Hz, 1H), 5.30 (s, 2H), 3.98 (t, J = 6.8 Hz, 2H), 3.91 (s, 3H), 3.60 (t, J = 4.8 Hz, 
2H), 3.51-3.43 (m, 6H), 3.30 (s, 3H), 3.26 (s, 3H), 1.63 (tt, J = 6.8, 7.2 Hz, 2H), 1.30-
1.19 (m, 10H), 0.82 (t, J = 6.8 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 165.64, 139.03, 124.03, 122.17, 70.54, 70.03, 
67.91, 59.17, 58.91, 50.43, 48.62, 46.77, 36.47, 31.83, 29.51, 29.36, 29.27, 25.87, 
22.67, 14.13 
IR (thin film on salt plate) (cm-1) 3480, 3112, 2926, 1653, 1575, 1472, 1428, 1220, 
1119, 1016 
MS m/z, 256.1 [M-OctOSO3-]+; MS: m/z, 209.0 [OctOSO3-] 
 
3-Methyl-1 (pyrrolidinecarbonylmethyl)imidazolium bromide OctOSO3 (197f) 
N
N
N
OOctOSO3-
 
White grease 
 
The title compound was prepared 
from 3-methyl-1-(pyrrolidinyl 
carbonyl methyl) imidazolium 
bromide 197a (7.70 mmol, 2.11 g) 
and sodium octyl sulfate (8.02 
mmol, 1.86 g) according to the 
general procedure in 97 % yield 
(3.02 g, 7.48 mmol). 
Molecular formula C18H33N3O5S 
Molecular weight 403 g/mol 
 A-77 
1H NMR (400 MHz, CDCl3) δ (ppm) 9.53 (s, 1H), 7.45 (t, J = 1.8 Hz, 1H), 7.20 (t, J = 
1.8 Hz, 1H), 5.34 (s, 2H), 3.92 (m, 5H), 3.57 (t, J = 6.8 Hz, 2H), 3.40 (t, J = 6.8 Hz, 
2H), 1.99 (tt, J = 6.8, 6.8 Hz, 2H), 1.86 (tt, J = 6.8, 6.8 Hz, 2H), 1.61 (tt, J = 6.8, 7.4 
Hz, 2H), 1.29-1.19 (m, 10H), 0.82 (t, J = 7.0 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 162.66, 138.56, 124.32, 122.10, 67.97, 50.84, 
46.57, 46.02, 36.58, 31.83, 29.51, 29.36, 29.27, 26.03, 25.87, 24.07, 22.67, 14.14 
IR (thin film on salt plate) (cm-1) 3460, 2922, 1652, 1471, 1218, 1089, 979 
MS m/z, 194.2 [M-OctOSO3-]+; MS: m/z, 209.0 [OctOSO3-] 
 
2,3-Dimethyl-1 (pyrrolidinecarbonylmethyl)imidazolium OctOSO3 (198f) 
N
N
N
OOctOSO3-
 
Yellow grease 
 
The title compound was prepared from 
2,3-dimethyl-1-(pyrrolidinyl carbonyl 
methyl) imidazolium bromide 198a 
(7.46 mmol, 2.15 g) and sodium octyl 
sulfate (8.02 mmol, 1.86 g) according to 
the general procedure in 98 % yield 
(3.06 g, 7.34 mmol). 
Molecular formula C19H35N3O5S 
Molecular weight 417 g/mol 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.52 (d, J = 2.0 Hz, 1H), 7.31 (d, J = 2.0 Hz, 
1H), 5.32 (s, 2H), 3.62 (t, J = 6.8 Hz, 2H), 3.82 (s, 3H), 3.38 (t, J = 6.8 Hz, 2H), 3.40 
(t, J = 7.0 Hz, 2H), 2.65 (s, 3H), 1.20 (tt, J = 6.8, 7.2 Hz, 2H), 1.85 (tt, J = 6.8, 7.2 Hz, 
2H), 1.60 (tt, J = 6.8, 7.4 Hz, 2H), 1.26-1.15 (m, 10H), 0.82 (t, J = 6.8 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ (ppm) 162.79, 145.99, 122.88, 121.79, 67.75, 50.58, 
46.47, 45.92, 35.50, 31.82, 29.53, 29.37, 29.27, 26.03, 25.89, 24.07, 22.66, 14.13, 
10.52 
IR (thin film on salt plate) (cm-1) 3460, 2920, 2853, 1651, 1468, 1216, 1116, 1085 
MS m/z, 208.1 [M-OctOSO3-]+; MS: m/z, 209.0 [OctOSO3-] 
 A-78 
Chapter 3 Experimental 
Chiral alcohols 
Representative procedure for the preparation of chiral alcohols (RS - methyl 
mandelate) (209o) 
A solution of RS – mandelic acid (5.32 g, 35.0 mmol) 
in methanol (11.20 g, 350 mmol) was stirred 
vigorously under reflux for 6 hours. The progress of 
the reaction was monitored by TLC. The reaction was 
cooled and 10 mL of water was added. The product 
was then extracted with DCM (3 x 5 mL). The product was then dried to give a 
colourless liquid at RT in 99 % yield (5.75 g, 34.6 mmol). 
 
Molecular formula C9H10O3 
Molecular weight 166 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.35-7.24 (m, 5H, H’s 1-5), 5.10 (s, 1H, H7), 3.66 
(s, 3H, H10), 3.59 (br, 1H, H8) 
13C NMR (100 MHz, CDCl3) δ ppm 174.16 (CO), 138.24 (ArC), 128.65 (ArC), 
128.55 (ArC), 126.63 (ArC), 72.93 (COH), 53.05 (OCH3) 
 
RS - Ethyl mandelate (209c) 
1
2
3
4
5
6 7
8
9
10
11O
OH
O
 
Colourless liquid 
The title compound was prepared from 
RS – mandelic acid (7.81 g, 51.0 mmol) 
and ethanol (18.4 g, 400 mmol) 
according to the general procedure in 
100 % yield (9.17 g, 51.0 mmol) 
Molecular formula C10H12O3 
Molecular weight 180 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.46 (m, 5H, H’s 1-5), 5.19 (s, 1H, H7), 4.33-4.15 
(m, 2H, H10), 3.50 (br, 1H, H8), 1.25 (t, J = 7.0 Hz, 3H, H11) 
13C NMR (100 MHz, CDCl3) δ ppm 173.72 (CO), 138.40 (ArC), 138.71 (ArC), 
128.42 (ArC), 126.54 (ArC), 72.89 (COH), 62.28 (OCH2), 14.03 (CH3) 
1
2
3
4
5
6 7
8
9 10
O
OH
O
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R - Ethyl mandelate (209a) 
O
OH
O
 
Colourless liquid 
The title compound was prepared from R 
– mandelic acid (5.32 g, 35.0 mmol) and 
ethanol (18.4 g, 400 mmol) according to 
the general procedure in 98 % yield (6.15 
g, 34.2 mmol) 
Molecular formula C10H12O3 
Molecular weight 180 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.48-7.43 (m, 5H), 5.18 (s, 1H,), 4.33-4.15 (m, 
2H), 3.45 (br, 1H), 1.27 (t, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 173.72, 138.40, 238.68, 128.58, 126.65, 72.89, 
62.29, 14.03 
[α] 20D  -141.8º (0.7 c, CHCl3) 
 
S - Ethyl mandelate (209b) 
O
OH
O
 
Colourless liquid 
The title compound was prepared from S – 
mandelic acid (7.90 g, 52.0 mmol) and 
ethanol (7.89 g, 172 mmol) according to the 
general procedure in 84 % yield (7.85 g, 
43.6 mmol) 
Molecular formula C10H12O3 
Molecular weight 180 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.49-7.42 (m, 5H), 5.18 (s, 1H), 4.33-4.16 (m, 
2H), 3.50 (br, 1H), 1.27 (t, J = 7.0 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 173.72, 138.40, 128.63, 128.58, 126.65, 72.90, 
62.28, 14.03 
[α] 20D  +138º (0.7 c, CHCl3) 
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RS - Butyl mandelate (209f) 
1
2
3
4
5
6 7
8
9
10
11
12
13O
OH
O
 
Pale yellow liquid 
The title compound was prepared 
from RS – mandelic acid (7.60 g, 
50.0 mmol) and butanol (10.21 g. 
138 mmol) according to the general 
procedure in 100 % yield (10.38 g, 
49.9 mmol) 
Molecular formula C12H16O3 
Molecular weight 208 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.56-7.50 (m, 2H, H’s 1 and 5), 7.39-7.31 (m, 3H, 
H’s 2-4), 5.19 (s, 1H, H7), 4.23-4.15 (m, 2H, H10), 3.51 (br, 1H, H8), 1.62 (tt, J = 7.2 
Hz, 7.4 Hz, 2H, H11), 1.31 (tq, J =7.4 Hz, 7.5 Hz, 2H, H12), 0.89 (t, J = 7.5 Hz, 3H, 
H13) 
13C NMR (100 MHz, CDCl3) δ ppm 173.81 (CO), 138.47 (ArC), 128.39 (ArC), 
128.41 (ArC), 126.00 (ArC), 72.88 (COH), 66.03 (OCH2), 30.40 (CH2), 18.85 (CH2), 
13.56 (CH3) 
 
R - Butyl mandelate (209d) 
O
OH
O
 
Colourless liquid 
The title compound was prepared 
from R – mandelic acid (8.82 g, 
58.0 mmol) and butanol (10.21 g. 
138 mmol) according to the general 
procedure in 100 % yield (12.01 g, 
57.7 mmol) 
Molecular formula C12H16O3 
Molecular weight 208 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.46-7.32 (m, 5H), 5.18 (s, 1H), 4.22-4.12 (m, 
2H), 2.99 (s, 1H), 1.62 (tt, J = 7.0 Hz, 7.2 Hz, 2H), 1.27 (tq, J =7.2 Hz, 7.2 Hz, 2H), 
0.85 (t, J =7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 173.83, 138.42, 128.55, 128.41, 126.50, 72.85, 
66.08, 30.39, 18.85, 13.56 
[α] 20D  -100.3º (0.6 c, CHCl3) 
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S - Butyl mandelate (209e) 
O
OH
O
 
Colourless liquid 
The title compound was prepared 
from S – mandelic acid (8.51 g, 56.0 
mmol) and butanol (10.21 g. 138 
mmol) according to the general 
procedure in 98 % yield (11.40 g, 
54.8 mmol) 
Molecular formula C12H16O3 
Molecular weight 208 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.46-7.41 (m, 2H), 7.39-7.31 (m, 3H), 5.18 (s, 
1H), 4.18-4.08 (m, 2H), 3.32 (s, 1H), 1.58 (tt, J = 7.2 Hz, 7.4 Hz, 2H), 1.25 (tq, J =7.4 
Hz, 7.4 Hz, 2H), 0.89 (t, J =7.4 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 173.82, 138.44, 128.60, 128.54, 126.51, 72.87, 
62.74, 30.39, 18.85, 13.55 
[α] 20D  +88.3º (0.6 c, CHCl3) 
 
RS - Pentyl mandelate (209i) 
1
2
3
4
5
6 7
8
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14
O
OH
O
 
Pale yellow liquid 
The title compound was prepared 
from RS – mandelic acid (7.75 g, 
51.0 mmol) and pentanol (13.2 g, 
150 mmol) according to the general 
procedure in 98 % yield (11.1 g, 
51.0 mmol) 
Molecular formula C13H18O3 
Molecular weight 222 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.45-7.42 (m, 2H, H’s 1 and 5), 7.38-7.33 (m, 3H, 
H’s 2 and 4), 5.18 (s, 1H, H7), 4.17-4.14 (t, J = 6.6 Hz, 2H, H10), 2.73 (br, 1H, H8), 
1.63 (tt, J = 6.6 Hz, 7.0 Hz, 2H, H11), 1.23-1.18 (m, 4H, H’s 12 and 13), 0.87 (t, J 
=7.0 Hz, 3H, H14) 
13C NMR (100 MHz, CDCl3) δ ppm 173.81 (CO), 138.48 (ArC), 128.39 (ArC), 
126.51 (ArC), 72.87 (ArC), 66.28 (COH), 63.04 (OCH2), 32.44 (CH2), 27.73 (CH2), 
22.14 (CH2), 13.88 (CH3) 
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R - Pentyl mandelate (209g) 
O
OH
O
 
Pale yellow liquid 
The title compound was prepared 
from R – mandelic acid (7.60 g, 
50.0 mmol) and pentanol (13.2 g, 
150 mmol) according to the general 
procedure in 95 % yield (10.6 g, 
47.7 mmol) 
Molecular formula C13H18O3 
Molecular weight 222 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.46-7.43 (m, 2H), 7.39-7.32 (m, 3H), 5.18 (s, 
1H), 4.19 (t, J =7.2 Hz, 2H), 3.37 (br, 1H), 1.59 (tt, J =7.2 Hz, 7.2 Hz, 2H), 1.35-1.16 
(m, 4H), 0.85 (t, J =7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 173.80, 138.50, 128.53, 128.38, 126.53, 72.88, 
66.26, 28.01, 27.91, 22.14, 13.89 
[α] 20D  -99.2º (1.1 c, CHCl3) 
 
S - Pentyl mandelate (209h) 
O
OH
O
 
Pale yellow liquid 
The title compound was prepared 
from S – mandelic acid (7.60 g, 50.0 
mmol) and pentanol (13.2 g, 150 
mmol) according to the general 
procedure in 97 % yield (10.8 g, 
48.6 mmol) 
Molecular formula C13H18O3 
Molecular weight 222 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.46-7.43 (m, 2H), 7.39-7.33 (m, 3H), 5.19 (s, 
1H), 4.18 (t, J = 7.0 Hz, 2H), 3.05 (br, 1H), 1.59 (tt, J = 7.0 Hz, 7.2 Hz, 2H), 1.23-
1.15 (m, 4H), 0.85 (t, J =7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 173.82, 138.47, 128.54, 128.40, 126.51, 72.86, 
66.31, 27.90, 27.73, 22.14, 13.89 
[α] 20D  +95.3 (1.0 c, CHCl3) 
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RS - Ethoxyethyl mandelate (209l) 
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Pale yellow liquid 
The title compound was prepared 
from RS – mandelic acid (8.36 g, 
55.0 mmol) and ethoxyethanol 
(13.95 g, 155 mmol) according to 
the general procedure in 99 % yield 
(12.25 g, 54.7 mmol) 
Molecular formula C12H16O4 
Molecular weight 224 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.38-7.30 (m, 2H, H’s1 and 5), 7.29 – 7.22 (m, 
3H, H’s 2-4), 5.12 (s, 1H, H7), 4.5 (br, 1H, H8), 4.29 – 4.19 (m, 2H, H10), 3.57 – 
3.50 (m, 2H, H11), 3.35 (q, J = 6.4 Hz, 2H, H12), 0.12 (t, J = 6.4 Hz, 3H, H13) 
13C NMR (100 MHz, CDCl3) δ ppm 173.66 (CO), 138.19 (ArC), 128.55 (ArC), 
128.45 (ArC), 126.58 (ArC), 72.88 (COH), 67.93 (OCH2), 65.20 (OCH2), 61.80 
(OCH2), 15.10 (CH3) 
 
R - Ethoxyethyl mandelate (209j) 
O
OH
O
O
 
Colourless liquid 
The title compound was prepared 
from R – mandelic acid (8.06 g, 
53.0 mmol) and ethoxyethanol 
(13.95 g, 155 mmol) according to 
the general procedure in 84 % yield 
(10.23 g, 45.7 mmol) 
Molecular formula C12H16O4 
Molecular weight 224 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.47-7.28 (m, 5H), 5.24 (s, 1H), 4.37-4.27 (m, 
2H), 3.62 (br, 1H), 3.55 (m, 2H), 3.44 (q, J = 6.9 Hz, 2H), 1.16 (t, J = 6.9 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 174.00, 139.48, 128.99, 128.67, 127.87, 73.02, 
68.71, 67.89, 64.99, 15.00 
[α] 20D  -94.3º (0.7 c, CHCl3) 
 
 A-84 
S - Ethoxyethyl mandelate (209k) 
O
OH
O
O
 
Colourless liquid 
The title compound was prepared 
from S – mandelic acid (8.82 g, 58.0 
mmol) and ethoxyethanol (13.95 g, 
155 mmol) according to the general 
procedure in 85 % yield (10.98 g, 
49.0 mmol) 
Molecular formula C12H16O4 
Molecular weight 224 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.46-7.43 (m, 2H), 7.38-7.32 (m, 3H), 5.23 (s, 
1H), 4.50 (br, 1H), 4.32-4.27 (m, 2H), 3.58-3.53 (m, 2H), 3.39 (q, J = 6.9 Hz, 2H), 
1.14 (t, J = 6.9 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 173.57, 138.26, 128.45, 128.42, 126.61, 72.92, 
67.91, 66.63, 65.08, 14.97 
[α] 20D  +96.8º (0.7 c, CHCl3) 
 
R - Methyl lactate (210a) 
O
OH
O
 
Colourless liquid 
The title compound was prepared from R – 
lactic acid (7.65 g, 85.0 mmol) and methanol 
(7.04 g, 220 mmol) according to the general 
procedure in 79 % yield (7.00 g, 67.3 mmol) 
Molecular formula C4H8O3 
Molecular weight 104 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 4.32 (q, J =7.0 Hz, 1H, H2), 3.78 (s, 3H, H5), 
2.89 (br, 1H, H3), 1.43 (d, J = 7.0 Hz, 3H, H1) 
13C NMR (100 MHz, CDCl3) δ ppm 176.53 (CO), 66.82 (COH), 52.63 (OCH3), 20.39 
(CH3) 
[α] 20D  -88.2º (0.7 c, CHCl3) 
 
 A-85 
RS - Ethyl lactate (210d) 
1 2
3
4
5
6O
OH
O
 
Colourless liquid 
The title compound was prepared from RS 
– lactic acid (27.00 g, 300 mmol) and 
ethanol (23.0 g, 500 mmol) according to the 
general procedure in 97 % yield (34.22 g, 
290 mmol) 
Molecular formula C5H10O3 
Molecular weight 118 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 4.27 (q, J = 7.0 Hz, 3H, H1), 3.69 (br, 1H, H3), 
3.40 (q, J = 6.8 Hz, 2H, H5), 1.43 (d, J = 7.0 Hz, 1H, H1), 1.29 (t, J = 6.8 Hz, 3H, H6) 
13C NMR (100 MHz, CDCl3) δ ppm 175.53 (CO), 66.64 (COH)), 61.28 (OCH2), 
20.12 (CH3), 13.96 (CH3) 
 
Chiral α-bromoestes 
Representative procedure for the preparation of chiral mandelyl α-bromoesters 
(RS - methyl mandelyl bromoacetate) (211o) 
To a stirred solution of DCM, RS - methyl mandelate 
(1.48 g, 8.92 mmol), and triethylamine (2.02 g, 20.0 
mmol), under a nitrogen atmosphere at -78 ºC was 
added dropwise bromoacetyl bromide (3.03 g, 15.0 
mmol). After stirring at -78 ºC for 5 h, the reaction 
mixture was allowed warm up to -20 ºC and quenched 
by addition of water (20 mL). The organic phase was washed with distilled water (3 x 
20 mL), saturated ammonium chloride (3 x 20 mL), saturated sodium bicarbonate (3 x 
20 mL) and brine (2 x 20 mL). The organic phase was then dried over magnesium 
sulfate, filtered and solvents removed via rotary evaporation to yield a crude product 
in 84 % yield (2.13 g, 7.42 mmol). Column chromatography was performed on the 
crude product (mobile phase: DCM:Hexane, 50:50) to give a pale yellow liquid at RT 
in 73 % yield (1.85 g, 6.45 mmol). 
Molecular formula C1H11BrO4 
Molecular weight 287 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.41-7.34 (m, 5H, H’s 1-5), 5.91 (s, 1H, H7), 3.91 
(d, J= 1.6 Hz, 2H, H9), 3.66 (s, 3H, H11) 
1
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 A-86 
13C NMR (100 MHz, CDCl3) δ ppm 168.60 (CO), 166.61 (CO), 133.00 (ArC), 129.60 
(ArC), 128.94 (ArC), 127.68 (ArC), 75.68 (COO), 52.86 (OCH3), 25.32 (CH2) 
 
RS - Ethyl mandelyl bromoacetate (211c) 
1
2
3
4
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Yellow liquid 
The title compound was prepared from 
RS – ethyl mandelate (8.64 g, 48.0 
mmol) and bromoacetyl bromide (20.20 
g, 100 mmol) according to the general 
procedure in 90 % yield (13.00 g, 43.2 
mmol) 
Molecular formula C12H13BrO4 
Molecular weight 301 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.51-7.38 (m, 5H, H’s 1-5), 5.98 (s, 1H, H7), 
4.30-4.15 (m, 2H, H11), 4.00 (d, J = 2.0 Hz, 2H, H9), 1.27 (t, J = 7.0 Hz, 3H, H12) 
13C NMR (100 MHz, CDCl3) δ ppm 168.10 (CO), 166.62 (CO), 133.12 (ArC), 129.49 
(ArC), 128.88 (ArC), 127.64 (ArC), 75.83 (COO), 62.02 (OCH2), 25.31 (CH2), 13.99 
(CH3) 
 
R - Ethyl mandelyl bromoacetate (211a) 
O
O
O
Br
O
 
Pale yellow liquid 
The title compound was prepared from 
R – ethyl mandelate (5.40 g, 30.0 
mmol) and bromoacetyl bromide (10.10 
g, 50.0 mmol) according to the general 
procedure in 69 % yield (6.22 g, 20.7 
mmol) 
Molecular formula C12H13BrO4 
Molecular weight 301 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.50-7.48 (m, 2H), 7.44-7.39 (m, 3H), 5.98 (s, 
1H), 4.22-4.09 (m, 2H), 4.00 (d, J = 2.4 Hz, 2H), 1.25 (t, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.11, 166.63, 133.09, 129.51, 128.89, 127.64, 
75.83, 62.04, 25.34, 14.00 
 A-87 
[α] 20D  -103.1º (0.7 c, CHCl3) 
 
S - Ethyl mandelyl bromoacetate (211b) 
O
O
O
Br
O
 
Colourless liquid 
The title compound was prepared from 
S – ethyl mandelate (7.92 g, 44.0 mmol) 
and bromoacetyl bromide (16.16 g, 80.0 
mmol) according to the general 
procedure in 66 % yield (8.73 g, 29.0 
mmol) 
Molecular formula C12H13BrO4 
Molecular weight 301 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.51-7.39 (m, 5H), 5.98 (s, 1H), 4.30-4.15 (m, 
2H), 4.00 (d, J = 2.0 Hz, 2H), 1.27 (t, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.10, 166.62, 133.12, 129.49, 128.88, 127.64, 
75.83, 62.02, 25.32, 13.99 
[α] 20D  +100 (0.7 c, CHCl3) 
 
RS - Butyl mandelyl bromoacetate (211f) 
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Colourless liquid 
The title compound was prepared 
from RS – butyl mandelate (10.41 g, 
50.0 mmol) and bromoacetyl 
bromide (16.16 g, 80.0 mmol) 
according to the general procedure 
in  75 % yield (12.31 g, 37.4 mmol) 
Molecular formula C14H17BrO4 
Molecular weight 329 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.49-7.46 (m, 2H, H’s 1 and 5), 7.45-7.40 (m, 3H, 
H’s 2-4), 5.98 (s, 1H, H7), 4.22-4.11 (m, 2H, H11), 4.00 (d, J =2.0 Hz, 2H, H9), 1.62-
1.55 (m, 2H, H12), 1.30 (tq, J = 7.4 Hz, 7.4 Hz, 2H, H13), 0.88 (t, J =7.4 Hz, 3H, 
H14) 
 A-88 
13C NMR (100 MHz, CDCl3) δ ppm 168.18 (CO), 166.61 (CO), 133.16 (ArC), 129.48 
(ArC), 128.86 (ArC), 127.60 (ArC), 75.82 (COO), 65.79 (OCH2), 30.37 (CH2), 25.34 
(CH2), 18.87 (CH2), 13.58 (CH3) 
 
R - Butyl mandelyl bromoacetate (211d) 
O
O
O
Br
O
 
Pale yellow liquid 
The title compound was prepared 
from R – butyl mandelate (12.48 g, 
60.0 mmol) and bromoacetyl 
bromide (13.33, 66.0 mmol) 
according to the general procedure 
in  80 % yield (15.87 g, 48.24 
mmol) 
Molecular formula C14H17BrO4 
Molecular weight 329 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.49-7.45 (m, 2H), 7.42-7.38 (m, 3H), 5.98 (s, 
1H), 4.17-4.08 (m, 2H), 4.00 (d, J =1.6 Hz, 2H), 1.60-1.55 (m, 2H), 1.30 (tq, J =7.6 
Hz, 7.3 Hz, 2H), 0.88 (t, J =7.3 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.19, 166.62, 133.17, 129.30, 128.86, 128.63, 
75.83, 65.79, 30.38, 25.35, 18.88, 13.59 
[α] 20D  -91.2º (0.6 c, CHCl3) 
 
 A-89 
S - Butyl mandelyl bromoacetate (211e) 
O
O
O
Br
O
 
Yellow liquid 
The title compound was prepared 
from S – butyl mandelate (8.32 g, 
40.0 mmol) and bromoacetyl 
bromide (12.12 g, 60.0 mmol) 
according to the general procedure 
in  69 % yield (9.08 g, 27.60 mmol) 
Molecular formula C14H17BrO4 
Molecular weight 329 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.49-7.46 (m, 2H), 7.42-7.39 (m, 3H), 5.98 (s, 
1H), 4.17-4.07 (m, 2H), 4.00 (d, J = 2.0 Hz, 2H), 1.60-1.57 (m, 2H), 1.28 (tq, J = 7.4 
Hz, 7.6 Hz, 2H), 0.88 (t, J = 7.6 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 169.00, 168.85, 135.40, 129.48, 128.86, 127.60, 
75.82, 65.79, 30.37, 25.32, 18.87, 13.57 
[α] 20D  +89.8º (0.6 c, CHCl3) 
 
RS - Pentyl mandelyl bromoacetate (211i) 
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Pale yellow liquid 
The title compound was prepared 
from RS – pentyl mandelate (5.33 g, 
24.0 mmol) and bromoacetyl 
bromide (8.08 g, 40.0 mmol) 
according to the general procedure 
in  63 % yield (5.21 g, 15.2 mmol) 
Molecular formula C15H19BrO4 
Molecular weight 343 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.41-7.37 (m, 5H, H’s 1-5), 5.89 (s, 1H, H7), 4.08 
(t, J = 6.7 Hz, 2H, H11), 3.91 (d, J = 2.0 Hz, 2H, H9), 1.56 (tt, J = 6.7 Hz, 7.2 Hz, 2H, 
H12), 1.23-1.20 (m, 4H, H’s 13 and 14), 0.78 (t, J  = 7.0 Hz, 3H, H15) 
13C NMR (100 MHz, CDCl3) δ ppm 167.13 (CO), 165.55 (CO), 132.16 (ArC), 128.43 
(ArC), 127.81 (ArC), 126.56 (ArC), 74.78 (COO), 64.99 (OCH2), 27.01 (CH2), 26.70 
(CH2), 24.28 (CH2), 21.11 (CH2), 12.86 (CH3) 
 A-90 
R - Pentyl mandelyl bromoacetate (211g) 
O
O
O
Br
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Pale yellow liquid 
The title compound was prepared 
from R – pentyl mandelate (10.43 g, 
47.0 mmol) and bromoacetyl 
bromide (14.14 g, 70.0 mmol) 
according to the general procedure 
in  57 % yield (9.21 g, 26.9 mmol) 
Molecular formula C15H19BrO4 
Molecular weight 343 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.40-7.34 (m, 2H), 7.33-7.28 (m, 3H), 5.89 (s, 
1H), 4.06 (t, J = 7.0 Hz, 2H), 3.91 (d, J =1.6 Hz, 2H), 1.51 (tt, J = 7.0 Hz, 7.2 Hz, 
2H), 1.50-1.37 (m, 4H), 0.77 (t, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.18, 166.60, 133.18, 129.48, 128.85, 127.61, 
75.82, 66.04, 28.05, 27.74, 25.33, 22.15, 13.91 
[α] 20D  -80.3º (0.6 c, CHCl3) 
 
S - Pentyl mandelyl bromoacetate (211h) 
O
O
O
Br
O
 
Colourless liquid 
The title compound was prepared 
from S – pentyl mandelate (11.10 g, 
50.0 mmol) and bromoacetyl 
bromide (14.14 g, 70.00 mmol) 
according to the general procedure 
in  37 % yield (6.33 g, 18.5 mmol) 
Molecular formula C15H19BrO4 
Molecular weight 343 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.50-7.43 (m, 2H), 7.42-7.35 (m, 3H), 5.98 (s, 
1H), 4.16-4.10 (t, J = 6.8 Hz, 2H), 4.01 (d, J = 2.0 Hz, 2H), 1.62 (tt, J = 6.8 Hz, 7.0 
Hz, 2H), 1.25-1.18 (m, 4H), 0.86 (t, J =7.0 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.18, 166.60, 133.19, 129.48, 128.86, 127.61, 
75.82, 66.04, 28.05, 27.74, 25.33, 22.15, 13.91 
[α] 20D : +89.3º (0.5 c, CHCl3) 
 A-91 
RS - Ethoxyethyl mandelyl bromoacetate (211l) 
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Pale yellow liquid 
The title compound was prepared 
from RS – ethoxyethyl mandelate 
(12.10 g, 54.0 mmol) and 
bromoacetyl bromide (12.12 g, 
60.00 mmol) according to the 
general procedure in 65 % yield 
(12.11 g, 35.1 mmol) 
Molecular formula C14H17BrO5 
Molecular weight 345 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.50-7.47 (m, 2H, H’s 1 and 5), 7.42-7.34 (m, 3H, 
H’s 2-4), 6.02 (s, 1H, H7), 4.31 (t, J = 4.8 Hz, 2H, H12), 4.00 (d, J = 2.0 Hz, 2H, H9), 
3.59 (t, J = 4.8 Hz, 2H, H13), 3.43 (q, J = 7.2 Hz, 2H, H14), 1.16 (t, J = 7.2 Hz, 3H, 
H15) 
13C NMR (100 MHz, CDCl3) δ ppm 168.10 (CO), 166.59 (CO), 132.94 (ArC), 129.33 
(ArC), 128.85 (ArC), 127.70 (ArC), 75.73 (COO), 67.92 (OCH2), 66.61 (OCH2), 
64.98 (CH3), 25.34 (CH2), 15.06 (CH3) 
 
R - Ethoxyethyl mandelyl bromoacetate (211j) 
O
O
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Pale yellow liquid 
The title compound was prepared 
from R – ethoxyethyl mandelate 
(8.51 g, 38.0 mmol) and 
bromoacetyl bromide (10.10 g, 50.0 
mmol) according to the general 
procedure in 76 % yield (9.94 g, 
28.8 mmol) 
Molecular formula C14H17BrO5 
Molecular weight 345 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.43-7.36 (m, 5H), 5.93 (s, 1H), 4.24 (t, J = 4.8 
Hz, 2H), 3.91 (d, J = 1.6 Hz, 2H), 3.54 (t, J = 4.8 Hz, 2H), 3.36 (q, J = 6.9 Hz, 2H), 
1.07 (t, J = 6.9 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.09, 166.58, 132.95, 129.52, 128.85, 127.70, 
75.73, 67.92, 66.60, 64.99, 25.34, 15.07 
 A-92 
[α] 20D  -79.2º (0.7 c, CHCl3) 
 
S - Ethoxyethyl mandelyl bromoacetate (211k) 
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Yellow liquid 
The title compound was prepared 
from S – ethoxyethyl mandelate 
(12.10 g, 54.0 mmol) and 
bromoacetyl bromide (12.12 g, 60.0 
mmol) according to the general 
procedure in  65 % yield (12.11 g, 
35.1 mmol) 
Molecular formula C14H17BrO5 
Molecular weight 345 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 7.51-7.47 (m, 2H), 7.42-7.35 (m, 3H), 6.02 (s, 
1H), 4.31 (t, J = 4.8 Hz, 2H), 4.00 (d, J = 1.6 Hz, 2H), 3.59 (t, J = 4.8 Hz, 2H), 3.43 
(q, J = 7.1 Hz, 2H), 1.14 (t, J = 7.1 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.10, 166.58, 132.95, 129.52, 128.85, 127.70, 
75.73, 67.92, 66.60, 64.99, 25.34, 15.07 
[α] 20D  +83.5º (0.5 c, CHCl3) 
 
Representative procedure for the preparation of chiral lactate α-bromoesters (RS 
– methyl lactyl bromoacetate) (212b) 
To a stirred solution of DCM, RS - methyl lactate 
(3.95 g, 38.0 mmol), and triethylamine (20.20 g, 200 
mmol), under a nitrogen atmosphere at -78 ºC was 
added dropwise bromoacetyl bromide (16.16 g, 80.0 
mmol). After stirring at -78 ºC for 4 h and – 20 ºC for 
2 h, the reaction mixture was quenched by addition of 
water (60 mL). The organic phase was washed with distilled water (3 x 30 mL), 
saturated ammonium chloride (3 x 30 mL), saturated sodium bicarbonate (3 x 30 mL) 
and brine (2 x 30 mL). The organic phase was then dried over magnesium sulfate, 
filtered and solvents removed via rotary evaporation to yield a crude product in 99 % 
yield (8.44 g, 37.5 mmol). The crude product was distilled under high vacuum and 3 
fractions were obtained. The first two fractions contained residual starting material, 
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 A-93 
but the third fraction was obtained pure as a clear liquid at RT in 37 % yield (3.17 g, 
14.1 mmol). 
 
Molecular formula C6H9BrO4 
Molecular weight 225 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 5.16 (q, J = 7.3 Hz, 1H, H4), 3.90 (s, 2H, H1), 
3.72 (s, 3H, H6), 1.53 (d, J = 7.3 Hz, 3H, H3) 
13C NMR (100 MHz, CDCl3) δ ppm 170.47 (CO), 166.64 (CO), 70.05 (OCH), 52.55 
(OCH3), 25.31 (CH2), 16.78 (CH3) 
 
R – Methyl lactyl bromoacetate (212a) 
O
O
O
Br
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Colourless liquid 
The title compound was prepared from 
R – methyl lactate (3.95 g, 38.0 mmol) 
and bromoacetyl bromide (20.2 g, 100 
mmol) according to the general 
procedure in 59  % yield (5.01 g, 22.2 
mmol) 
Molecular formula C6H9BrO4 
Molecular weight 225 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 5.12 (q, J = 7.2 Hz, 1H), 3.85 (s, 2H), 3.70 (s, 
3H), 1.48 (d, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 170.40, 166.58, 69.95, 52.50, 25.29, 16.78 
[α] 20D  -102º (0.6 c, CHCl3) 
 
 A-94 
RS – Ethyl lactyl bromoacetate (212d) 
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Pale yellow liquid 
The title compound was prepared from 
RS – ethyl lactate (16.64 g, 141.0 
mmol) and bromoacetyl bromide (40.4 
g, 200.0 mmol) according to the general 
procedure in 57  % yield (19.10 g, 
79.91 mmol) 
Molecular formula C7H11BrO4 
Molecular weight 239 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 5.17(q, J = 7.2 Hz, 1H, H4), 4.25(q, J = 7.2 Hz, 
2H, H6), 3.92(s, 2H, H1), 1.55(d, J= 7.2 Hz, 3H, H3), 1.31(t, J= 7.2 Hz, 3H, H7) 
13C NMR (100 MHz, CDCl3) δ ppm 170.05 (CO), 166.69 (CO), 70.16 (OCH), 61.67 
(OCH2), 25.33 (CH2), 16.74 (CH3), 14.06 (CH3) 
 
RS – Butyl lactyl bromoacetate (212h) 
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Pale yellow liquid 
The title compound was prepared 
from RS – butyl lactate (6.86 g, 47.0 
mmol) and bromoacetyl bromide 
(10.10 g, 50.0 mmol) according to 
the general procedure in 40  % yield 
(4.99 g, 18.69 mmol) 
Molecular formula C9H15BrO4 
Molecular weight 267 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 5.16 (q, J = 7.2 Hz, 1H, H4), 4.18 (t, J = 6.8 Hz, 
2H, H6), 3.93 (s, 2H, H1), 1.68-1.61 (m, 2H, H7), 1.55 (d, J = 7.2 Hz, 3H, H4), 1.44-
1.34 (m, 2H, H8), 0.95 (t, J = 7.4 Hz, 3H, H9) 
13C NMR (100 MHz, CDCl3) δ ppm 170.17 (CO), 166.71 (CO), 70.19 (OCH), 65.53 
(OCH2), 30.47 (CH2), 25.36 (CH2), 19.01 (CH3), 16.81 (CH2), 13.67 (CH3) 
 
 A-95 
Chiral Bromide salts 
Representative procedure for the preparation of chiral bromide salts (RS - 3-
methyl-1-(methylmandelylcarbonylmethyl)imidazolium bromide) (213o) 
 
To a stirred solution of 1-methylimidazole 
(18.0 mmol, 1.48 g) in diethyl ether (100 
mL) at -15 ºC under a nitrogen atmosphere 
was added drop wise RS - methyl mandelyl 
bromoacetate (20.0 mmol, 5.74 g). The 
reaction mixture was stirred vigorously at -
15 ºC for 4 h, then at RT overnight. The ether top phase was decanted and the product 
washed with ether (3 x 10 mL), the solvent removed on the rotary evaporator and 
dried under high vacuum for 8 h to give  an off-white powder at RT in 94 % yield 
(6.90 g, 18.7 mmol). 
 
Molecular formula C15H17BrN2O4 
Molecular weight 369 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 10.25 (s, 1H, H2), 7.61 (s, 1H, H4), 7.47 (s, 1H, 
H3 ), 7.45-7.50 (m, 5H, H’s 9-13), 6.02 (s, 1H, H7), 5.81 (d, J = 17.6 Hz, 1H, H5), 
5.56 (d, J = 17.6 Hz, 1H, H5), 4.05 (s, 3H, H1), 3.72 (s, 3H, H15) 
13C NMR (100 MHz, CDCl3) δ ppm 168.46 (CO), 165.76 (CO), 138.56 (NCH2N), 
132.29 (ArC), 129.88 (ArC), 129.06 (ArC), 127.86 (ArC), 123.72 (NCH2), 123.05 
(NCH2), 76.23 (OCH), 53.09 (NCH2), 50.22 (OCH3), 36.95 (NCH3) 
MP (°C)140 – 142 
IR (KBr disc) (cm-1) 3482, 3393, 3088, 1762, 1744, 1576, 1565, 1453, 1436, 1380, 
1285, 1231, 1213, 1174, 1019 
MS m/z, Found 289.1185 [M-Br-]+, Calcd. C18H23N2O4 289.1188 
MS m/z, 289.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
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 A-96 
R - 3-Methyl-1-(methylmandelylcarbonylmethyl)imidazolium bromide (213m) 
N
N
O
O
O
Br-
O
 
Beige solid 
The title compound was prepared 
from R – mandelate bromoacetate 
(11.48 g, 40.0 mmol) and 1-
methylimidazole (3.12 g, 38.0 
mmol) according to the general 
procedure in 93 % yield (12.97 g, 
35.2 mmol) 
Molecular formula C15H17BrN2O4 
Molecular weight 369 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 10.03 (s, 1H), 7.59 (s, 1H), 7.48 (s, 1H), 7.37-
7.31 (m, 5H), 5.93 (s, 1H), 5.70 (d, J = 17.6 Hz, 1H), 5.50 (d, J = 17.6 Hz, 1H), 3.96 
(s, 3H), 3.63 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.50, 165.88, 138.22, 132.35, 129.84, 129.05, 
127.85, 123.76, 123.28, 76.17, 53.09, 50.18, 36.94 
MP (°C) 99 – 101 
IR (KBr disc) (cm-1) 3477, 3393, 3090, 1761, 1746, 1577, 1564, 1452, 1432, 1380, 
1285 1233, 1218, 1176, 1022 
MS m/z, Found 289.1180 [M-Br-]+, Calcd. C18H23N2O4 289.1188 
MS m/z, 289.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 [α] 20D -62.7º (0.57 c, CHCl3) 
 
S - 3-Methyl-1-(methylmandelylcarbonylmethyl)imidazolium bromide (213n) 
N
N
O
O
O
Br-
O
 
Off-white solid 
The title compound was prepared 
from S – mandelate bromoacetate 
(10.05 g, 35.0 mmol) and 1-
methylimidazole (2.62 g, 32.0 
mmol) according to the general 
procedure in 78 % yield (10.10 g, 
27.4 mmol) 
Molecular formula C15H17BrN2O4 
Molecular weight 369 g/mol 
 A-97 
1H NMR (400 MHz, CDCl3) δ ppm 10.16 (s, 1H), 7.53 (t, J = 1.8 Hz, 1H), 7.39 (t, J = 
1.8 Hz, 1H), 7.387.32 (m ,5H), 5.94 (s, 1H), 5.73 (d, J = 18.0 Hz, 1H), 5.49 (d, J= 
18.0 Hz, 1H), 3.98 (s, 3H), 3.66 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.48, 165.85, 138.34, 132.23, 129.85, 129.05, 
127.85, 123.76, 123.21, 76.19, 53.08, 50.20, 15.29 
MP (°C) 97 – 99 
IR (KBr disc) (cm-1) 3481, 3393, 3086, 2949, 1763, 1744, 1577, 1566, 1452, 1434, 
1380, 1285, 1231, 1213, 1174 1018 
MS m/z, Found 289.1181 [M-Br-]+, Calcd. C18H23N2O4 289.1188 
MS m/z, 289.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 [α] 20D +63.8º (0.59 c, CHCl3) 
 
RS - 3-Methyl-1-(ethylmandelylcarbonylmethyl)imidazolium bromide (213c) 
1
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Beige powder 
The title compound was prepared 
from RS – ethyl mandelyl 
bromoacetate (24.0 mmol, 7.22 g) 
and 1-methylimidazole (21.0 mmol, 
1.72 g) according to the general 
procedure in 68 % yield (5.48 g, 
14.3 mmol) 
Molecular formula C15H17BrN2O4 
Molecular weight 383 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.99 (s, 1H, H2), 7.56 (t, J = 1.7 Hz, 1H, H4), 
7.47 (t, J = 1.7 Hz, 1H, H3), 7.34-7.30 (m, 5H, H’s 9-13), 5.91 (s, 1H, H1), 5.69 (d, J 
= 17.8 Hz, 1H, H5), 5.48 (d, J = 17.8 Hz, 1H, H5), 4.10-4.01 (m, 2H, H15), 3.96 (s, 
3H, H7), 1.14 (t, J = 7.2 Hz, 3H, H16) 
13C NMR (100 MHz, CDCl3) δ ppm 167.96 (CO), 165.77 (CO), 138.34 (NCH2N), 
132.44 (ArC), 129.76 (ArC), 129.00 (ArC), 127.80 (ArC), 123.72 (NCH2), 123.21 
(NCH2), 76.31 (OCH), 62.26 (NCH2), 50.19 (OCH2), 36.93 (NCH3), 13.99 (CH3) 
MP (°C)132 – 134  
IR (KBr disc) (cm-1) 2963, 2928, 1751, 1559, 1539, 1495, 1452, 1403, 1370, 1215, 
1177 
MS m/z, Found 303.1349 [M-Br-]+, Calcd. C16H19N2O4 303.1345 
 A-98 
MS m/z, 303.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
R - 3-Methyl-1-(ethylmandelylcarbonylmethyl)imidazolium bromide (213a) 
N
N
O
O
O
Br-
O
 
Off-white powder 
The title compound was prepared 
from R – ethyl mandelyl 
bromoacetate (20.0 mmol, 6.02 g) 
and 1-methylimidazole (18.0 mmol, 
1.48 g) according to the general 
procedure in 81 % yield (5.55 g, 
14.5 mmol) 
Molecular formula C15H17BrN2O4 
Molecular weight 383 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 10.34 (s, 1H), 7.42 (t, J = 1.2 Hz, 1H), 7.38-7.31 
(m, 5H), 7.23 (t, J = 1.2 Hz, 1H), 5.91 (s, 1H), 5.74 (d, J = 18 Hz, 1H), 5.43 (d, J = 18 
Hz, 1H), 4.21-4.07 (m, 2H), 3.99 (s, 3H), 1.70 (t, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.01, 165.74, 138.71, 132.38, 129.79, 129.01, 
127.83, 123.66, 122.93, 76.36, 62.30, 50.27, 36.97, 13.99 
MP (°C) 130 – 132  
IR (KBr disc) (cm-1) 2962, 2927, 2860, 1750, 1559, 1539, 1495, 1452, 1453, 1398, 
1208, 1178 
MS m/z, Found 303.1331 [M-Br-]+, Calcd. C16H19N2O4 303.1345 
MS m/z, 303.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
[α] 20D -83.8º (1.0 c, CHCl3) 
 
 A-99 
S - 3-Methyl-1-(ethylmandelylcarbonylmethyl)imidazolium bromide (213b) 
N
N
O
O
O
Br-
O
 
Beige powder 
The title compound was prepared 
from S – ethyl mandelyl 
bromoacetate (24.0 mmol,  7.22 g) 
and 1-methylimidazole (21.0 mmol, 
1.72 g) according to the general 
procedure in  82 % yield (6.59 g, 
17.2 mmol) 
Molecular formula C15H17BrN2O4 
Molecular weight 383 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 10.07 (s, 1H), 7.51 (t, J = 1.8 Hz, 1H), 7.39-7.31 
(m, 6H), 5.90 (s, 1H), 5.70 (s, 1H), 5.46 (s, 1H), 4.19-4.11 (m, 2H), 3.97 (s, 3H), 1.15 
(t, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 167.99, 165.75, 138.53, 132.40, 129.78, 129.01, 
127.82, 123.68, 123.05, 76.34, 62.28, 50.22, 36.95, 13.99 
MP (°C) 129 – 131 
IR (KBr disc) (cm-1) 2962, 2926, 2862, 1751, 1559, 159, 1495, 1452, 1398, 1209, 
1175 
MS m/z, Found 303.1323 [M-Br-]+, Calcd. C16H19N2O4 303.1345  
MS m/z, 303.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
[α] 20D : +83.4º (0.9 c, CHCl3) 
 
RS - 3-Methyl-1-(butylmandelylcarbonylmethyl)imidazolium bromide (213f) 
1
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Beige powder 
The title compound was prepared 
from RS – butyl mandelyl 
bromoacetate (22.0 mmol, 7.24 g) 
and 1-methylimidazole (20.0 mmol, 
1.64 g) according to the general 
procedure in  58 % yield (4.81 g, 
11.7 mmol) 
Molecular formula C18H23BrN2O4 
Molecular weight 411 g/mol 
 A-100 
1H NMR (400 MHz, CDCl3) δ ppm 10.03 (s, 1H, H2), 7.51 (s, 1H, H4), 7.40 (s, 1H, 
H3), 7.33-7.26 (m, 5H, H’s 9-13), 5.91 (s, 1H, H7), 5.71 (d, J =18 Hz, 1H, H5), 5.45 
(d, J =18 Hz, 1H, H5), 4.06-3.99 (m, 2H, H15), 3.97 (s, 3H, H1), 1.47-1.40 (m, 2H, 
H16), 1.61 (tq, J =7.4 Hz, 7.4 Hz, 2H, H17), 0.76 (t, J =7.4 Hz, 3H, H18) 
13C NMR (100 MHz, CDCl3) δ ppm 168.08 (CO), 165.74 (CO), 138.48 (NCH2N), 
135.00 (ArC), 132.47 (ArC), 129.75 (ArC), 125.00 (ArC), 123.67 (NCH2), 123.08 
(NCH2), 76.29 (OCH), 66.01 (NCH2), 50.22 (OCH2), 36.94 (NCH3), 30.29 (CH2), 
18.79 (CH2), 13.54 (CH3) 
MP (°C) 118 – 120 
IR (KBr disc) (cm-1) 2927, 2857, 1752, 1733, 1568, 1492, 1452, 1402, 1261, 1167, 
1084, 1051, 1029 
MS m/z, Found 331.1646 [M-Br-]+, Calcd. C18H23N2O4 331.1658 
MS m/z, 331.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
R - 3-Methyl-1-(butylmandelylcarbonylmethyl)imidazolium bromide (213d) 
N
N
O
O
O
Br-
O
 
Off-white powder 
The title compound was prepared 
from R – butyl mandelyl 
bromoacetate (25.0 mmol, 8.23 g) 
and 1-methylimidazole (23.0 mmol, 
1.89 g) according to the general 
procedure in  82 % yield (7.73 g, 
18.8 mmol) 
Molecular formula C18H23BrN2O4 
Molecular weight 411 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 10.18 (s, 1H), 7.49 (t, J =1.6 Hz, 1H), 7.34-7.26 
(m, 6H), 5.91 (s, 1H), 5.75 (d, J =17.8 Hz, 1H), 5.43 (d, J =17.8 Hz, 1H), 4.06-4.02 
(m, 2H), 3.98 (s, 3H), 1.46-1.43 (m, 2H), 1.67 (tq, J =7.4 Hz, 7.5 Hz, 2H), 0.77 (t, J = 
7.5 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.04, 165.66, 138.65, 132.42, 129.77, 128.99, 
127.77, 123.66, 122.98, 76.34, 66.02, 50.24, 36.95, 30.31, 18.81, 13.56 
MP (°C) 88 – 90 
IR (KBr disc) (cm-1) 2930, 2859, 1751, 1730, 1561, 1497, 1445, 1400, 1261, 1166, 
1079, 1050, 1028 
MS m/z, Found 331.1667 [M-Br-]+, Calcd. C18H23N2O4 331.1658 
 A-101 
MS m/z, 331.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
[α] 20D  -74.7º (0.9 c, CHCl3) 
 
S - 3-Methyl-1-(butylmandelylcarbonylmethyl)imidazolium bromide (213h) 
N
N
O
O
O
Br-
O
 
White powder 
 
The title compound was prepared 
from S – butyl mandelyl 
bromoacetate (15.0 mmol, 4.94 g) 
and 1-methylimidazole (13.0 mmol, 
1.07 g) according to the general 
procedure in  64 % yield (3.43 g, 
8.35 mmol) 
Molecular formula C18H23BrN2O4 
Molecular weight 411 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 10.11 (s, 1H), 7.52 (t, J = 1.8 Hz, 1H), 7.45 (t, J = 
1.8 Hz, 1H), 7.34-7.28 (m, 5H), 5.91 (s, 1H), 5.73 (d, J = 18 Hz, 1H), 7.45 (d, J = 18 
Hz, 1H), 4.06-3.97 (m, 2H), 3.97 (s, 3H), 1.46-1.40 (m, 2H), 1.62 (tq, J = 7.4 Hz, 7.4 
Hz, 2H), 0.77 (t, J = 7.4 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.02, 165.69, 138.46, 132.46, 129.75, 128.98, 
127.76, 123.68, 123.13, 76.31, 66.00, 50.19, 36.93, 30.29, 18.80, 13.55 
MP (°C) 89 – 91 
IR (KBr disc) (cm-1) 2932, 2863, 1751, 1730, 1572, 1496, 1451, 1401, 1255, 1162, 
1089, 1051, 1029 
MS m/z, Found 331.1647 [M-Br-]+, Calcd. C18H23N2O4 331.1658 
MS m/z, 331.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
[α] 20D  +77.7º (0.9 c, CHCl3) 
 A-102 
RS - 3-Methyl-1-(pentylmandelylcarbonylmethyl)imidazolium bromide (213i) 
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Off-white powder 
 
The title compound was prepared 
from RS – pentyl mandelyl 
bromoacetate (20.0 mmol, 6.86 g) 
and 1-methylimidazole (18.0 mmol, 
1.48 g) according to the general 
procedure in  60 % yield (4.59 g, 
10.8 mmol) 
Molecular formula C19H25BrN2O4 
Molecular weight 425 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 10.17 (s, 1H, H2), 7.50 (t, J = 1.8 Hz, 1H, H4), 
7.34-7.25 (m, 6H, H’s 4 and 9-13), 5.91 (s, 1H, H7), 5.72 (d, J = 18 Hz, 1H, H5), 5.44 
(d, J = 18 Hz, 1H, H5), 5.04-4.97 (m, 2H, H15), 3.97 (s, 3H, H1), 1.48 (tt, J = 6.8, 7.4 
Hz, 2H, H16), 1.10-0.99 (m, 4H, H’s 17 and 18), 0.75 (t, J = 7.4 Hz, 3H, H19) 
13C NMR (100 MHz, CDCl3) δ ppm 168.08 (CO), 165.71 (CO), 138.60 (NCH2N), 
132.47 (ArC), 129.75 (ArC), 127.00 (ArC), 123.65 (ArC), 122.99 (NCH2), 122.04 
(NCH2), 76.29 (OCH), 66.26 (NCH2), 50.24 (CO), 36.94 (NCH3), 27.98 (CH2), 27.65 
(CH2), 22.10 (CH2), 13.88 (CH3) 
MP (°C) 127 – 129 
IR (KBr disc) (cm-1) 2959, 2926, 2859, 1751, 1608, 1559, 1539, 1495, 1452, 1403, 
1210, 1176 
MS m/z, Found 345.1812 [M-Br-]+, Calcd. C19H25N2O4 345.1814 
MS m/z, 345.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
R - 3-Methyl-1-(pentylmandelylcarbonylmethyl)imidazolium bromide (213g) 
N
N
O
O
O
Br-
O
 
Brown powder 
 
The title compound was prepared 
from R – pentyl mandelyl 
bromoacetate (26.0 mmol, 8.92 g) 
and 1-methylimidazole (22.0 mmol, 
1.80 g) according to the general 
procedure in  68 % yield (6.38 g, 
15.0 mmol) 
Molecular formula C19H25BrN2O4 
Molecular weight 425 g/mol 
 A-103 
1H NMR (400 MHz, CDCl3) δ ppm 10.07 (s, 1H), 7.59 (t, J = 1.8 Hz, 1H), 7.48 (t, J = 
1.8 Hz, 1H), 7.45-7.39 (m, 5H), 5.99 (s, 1H), 5.78 (d, J = 18 Hz, 1H), 5.53 (d, J = 18 
Hz, 1H), 4.11 (t, J = 6.8 Hz, 2H), 4.05 (s, 1H), 1.59 (tt, J = 6.8, 7.0 Hz, 2H), 1.26-1.11 
(m, 4H), 0.82 (t, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.09, 165.75, 138.49, 132.50, 129.74, 128.97, 
127.77, 123.68, 123.08, 76.28, 66.26, 50.24, 36.95, 27.98, 27.64, 22.09, 13.88 
MP (°C) 44 – 45 
IR (KBr disc) (cm-1) 2959, 2928, 2859, 1733, 1608, 1559, 1539, 1495, 1452, 1398, 
1207, 1179 
MS m/z, Found 345.1818 [M-Br-]+, Calcd. C19H25N2O4 345.1814 
MS m/z, 345.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
[α] 20D  -71.3º (0.8 c, CHCl3) 
 
S - 3-Methyl-1-(pentylmandelylcarbonylmethyl)imidazolium bromide (213h) 
N
N
O
O
O
Br-
O
 
Pale brown powder 
 
The title compound was prepared 
from S – pentyl mandelyl 
bromoacetate (24.0 mmol, 8.23 g) 
and 1-methylimidazole (20.0 mmol, 
1.64 g) according to the general 
procedure in  73 % yield (6.21 g, 
14.6 mmol) 
Molecular formula C19H25BrN2O4 
Molecular weight 425 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 10.13 (s, 1H), 7.47 (s, 1H), 7.37-7.29 (m, 6H), 
5.91 (s, 1H), 5.73 (d, J = 18 Hz, 1H), 5.43 (d, J = 18 Hz, 1H), 4.06 (t, J = 7.4 Hz, 2H), 
3.98 (s, 3H), 1.50 (tt, J = 7.4, 7.4 Hz, 2H), 1.12-1.01 (m, 4H), 0.75 (t, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.11, 165.83, 138.21, 132.54, 129.71, 128.95, 
127.76, 123.69, 123.28, 76.21, 66.22, 50.20, 36.94, 27.95, 27.62, 22.07, 13.87 
MP (°C) 73 – 75 
IR (KBr disc) (cm-1) 2958, 2928, 2859, 1750, 1559, 1539, 1495, 1456, 1206, 1174 
MS m/z, Found 345.1808 [M-Br-]+, Calcd. C19H25N2O4 345.1814 
MS m/z, 345.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
[α] 20D  +72.0º (0.8 c, CHCl3) 
 A-104 
RS - 3-Methyl-1-(ethoxyethylmandelylcarbonylmethyl)imidazolium bromide 
(213l) 
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Off-white powder 
 
The title compound was prepared 
from RS – ethoxy ethyl mandelyl 
bromoacetate (34.0 mmol, 11.73 g) 
and 1-methylimidazole (31.0 mmol, 
2.54 g) according to the general 
procedure in  76 % yield (9.99 g, 
23.4 mmol) 
Molecular formula C18H23BrN2O5 
Molecular weight 427 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.96 (s, 1H, H2), 7.60 (t, J = 1.8 Hz, 1H, H4), 
7.52 (t, J = 1.8 Hz, 1H, H3), 7.34-7.27 (m, 5H, H’s 9-13), 5.95 (s, 1H, H7), 5.70 (d, J 
= 17.8 Hz, 1H, H5), 5.48 (d, J = 17.8 Hz, 1H, H5), 4.21 (t, J = 4.6 Hz, 2H, H15), 3.97 
(s, 3H, H1), 3.48 (t, J = 4.6 Hz, 2H, H16), 3.31 (q, J = 7.0 Hz, 2H, H17), 1.02 (t, J = 
7.0 Hz, 3H, H18) 
13C NMR (100 MHz, CDCl3) δ ppm 167.91 (CO), 166.27 (CO), 138.20 (NCH2N), 
132.29 (ArC), 129.75 (ArC), 128.94 (ArC), 127.83 (ArC), 123.77 (NCH2), 123.32 
(NCH2), 76.18 (OCH), 67.80 (NCH2), 66.65 (NCH2), 65.75 (OCH2), 50.15 (OCH2), 
36.86 (OCH2), 15.04 (CH3) 
MP (°C) 124 – 126 
IR (KBr disc) (cm-1) 2969, 2925, 2861, 1733, 1560, 1535, 1493, 1452, 1401, 1370, 
1211, 1174 
MS m/z, Found 347.1611 [M-Br-]+, Calcd. C18H23N2O5 347.1607 
MS m/z, 347.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
 A-105 
R - 3-Methyl-1-(ethoxyethylmandelylcarbonylmethyl)imidazolium bromide 
(213j) 
N
N
O
O
O
Br-
O
O
 
Brown solid 
 
The title compound was prepared 
from R – ethoxy ethyl mandelyl 
bromoacetate (28.0 mmol, 9.66 g) 
and 1-methylimidazole (22.0 mmol, 
1.80 g) according to the general 
procedure in  71 % yield (6.70 g, 
15.7 mmol) 
 
Molecular formula C18H23BrN2O5 
Molecular weight 427 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 10.10 (s, 1H), 7.64 (t, J = 1.6 Hz, 1H), 7.57 (t, J = 
1.6 Hz, 1H), 7.39-7.30 (m, 5H), 5.99 (s, 1H), 5.74 (d, J = 17.8 Hz, 1H), 7.52 (d, J = 
17.8 Hz, 1H), 4.26 (t, J = 5.0 Hz, 2H), 4.00 (s, 3H), 3.52 (t, J = 5.0 Hz, 2H), 3.39 (q, J 
= 7.2 Hz, 2H), 1.07 (t, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 167.97, 165.80, 138.35, 132.30, 129.77, 128.95, 
127.86, 123.75, 123.19, 76.20, 67.82, 66.54, 65.09, 50.17, 36.92, 15.04 
MP (°C) 31 – 33 
IR (KBr disc) (cm-1) 2968, 2927, 2862, 1733, 1559, 1539, 1495, 1452, 1402, 1375, 
1215, 1176 
MS m/z, Found 347.1593 [M-Br-]+, Calcd. C18H23N2O5 347.1607 
MS m/z, 347.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
[α] 20D  -66.2º (1.1 c, CHCl3) 
 
 A-106 
S - 3-Methyl-1-(ethoxyethylmandelylcarbonylmethyl)imidazolium bromide 
(213k) 
N
N
O
O
O
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Brown viscous liquid 
 
The title compound was prepared 
from S – ethoxy ethyl mandelyl 
bromoacetate (8.00 mmol, 2.76 g) 
and 1-methylimidazole (6.00 mmol, 
0.49 g) according to the general 
procedure in  85 % yield (2.17 g, 
5.08 mmol) 
Molecular formula C18H23BrN2O5 
Molecular weight 427 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 10.10 (s, 1H), 7.63 (t, J = 1.8 Hz, 1H), 7.58 (t, J = 
1.8 Hz, 1H), 7.38-7.29 (m, 5H), 5.95 (s, 1H), 5.73 (d, J = 18 Hz, 1H), 5.54 (d, J = 18 
Hz, 1H), 4.15-4.08 (m, 2H), 4.01 (s, 3H), 3.53-3.50 (m, 2H), 3.22-3.15 (m, 2H), 1.19 
(t, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 167.94, 165.78, 138.22, 132.44, 129.75, 128.99, 
127.78, 123.73, 123.30, 76.29, 67.80, 66.66, 62.24, 50.15, 36.91, 13.98 
IR (thin film on salt plate) (cm-1) 2969, 2926, 1751, 1608, 1559, 1539, 1495, 1452, 
1378, 1211, 1176 
MS m/z, Found 347.1599 [M-Br-]+, Calcd. C18H23N2O5 347.1607 
MS m/z, 347.2 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
[α] 20D  +65.6º (1.1 c, CHCl3) 
 
R - 3-Methyl-1-(methyllactylcarbonylmethyl)imidazolium bromide (214a) 
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Off-white powder 
 
The title compound was prepared 
from R – methyl lactyl 
bromoacetate (14.0 mmol, 3.15 g) 
and 1-methylimidazole (13.0 mmol, 
1.07 g) according to the general 
procedure in  66 % yield (2.61 g, 
8.52 mmol) 
Molecular formula C10H15BrN2O4 
Molecular weight 307 g/mol 
 A-107 
1H NMR (400 MHz, CDCl3) δ ppm 10.07 (s, 1H, H2), 7.70 (t, J = 1.8 Hz, 1H, H4), 
7.64 (t, J = 1.8 Hz, 1H, H3), 5.72 (d, J = 18 Hz, 1H, H5), 5.47 (d, J = 18 Hz, 1H, H5), 
5.16 (q, J = 7.2 Hz, 1H, H7), 4.07 (s, 3H, H1), 3.72 (s, 3H, H10), 1.52 (d, J = 7.2 Hz, 
3H, H8) 
13C NMR (100 MHz, CDCl3) δ ppm 170.25 (CO), 165.73 (CO), 138.17 (NCH2N), 
123.84 (NCH2), 123.32 (NCH2), 70.64 (CH), 52.78 (NCH2), 50.09 (OCH3), 36.95 
(NCH3), 16.84 (CH3) 
MP (°C) 115 – 117  
IR (KBr disc) (cm-1) 2928, 2863, 1751, 1632, 1569, 1559, 1495, 1451, 1377, 1217, 
1178 
MS m/z, Found 227.1032 [M-Br-]+, Calcd. C10H15N2O4 227.1032 
MS m/z, 227.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
[α] 20D  -37.3º (0.4 c, CHCl3) 
 
 A-108 
RS - 3-Methyl-1-(ethyllactylcarbonylmethyl)imidazolium bromide (214d) 
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Yellow viscous liquid 
 
The title compound was prepared 
from RS – ethyl lactyl bromoacetate 
(98.0 mmol, 23.42 g) and 1-
methylimidazole (89.0 mmol, 7.30 
g) according to the general 
procedure in  88 % yield (25.30 g, 
78.8 mmol) 
Molecular formula C11H17BrN2O4 
Molecular weight 321 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 10.02 (s, 1H, H2), 7.62 (t, J = 1.8 Hz, 1H, H4), 
7.56 (t, J = 1.8 Hz, 1H, H3), 5.70 (d, J = 18.0 Hz, 1H, H5), 5.40 (d, J = 18.0 Hz, 1H, 
H5), 5.13 (q, J = 7.2, 1H, H7), 4.16 (q, J = 7.2, 2H, H10), 4.06 (s, 3H, H1), 1.49 (d, J 
= 7.2 Hz, 3H, H8), 1.23 (t, J = 7.2 Hz, 3H, H11) 
13C NMR (100 MHz, CDCl3) δ ppm 169.92 (CO), 165.83 (CO), 138.23 (NCH2N), 
123.78 (NCH2), 123.30 (NCH2), 70.72 (CH), 61.92 (NCH2), 50.17 (OCH2), 37.01 
(NCH3), 16.84 (CH3), 14.12 (CH3) 
IR (thin film on salt plate) (cm-1) 3163, 3099, 2929, 2858, 1748, 1636, 1559, 1495, 
1451, 1397, 1374, 1209, 1177 
MS m/z, Found 241.1178 [M-Br-]+, Calcd. C11H17N2O4 241.1188 
MS m/z, 241.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
R - 3-Methyl-1-(ethyllactylcarbonylmethyl)imidazolium bromide (214c) 
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Pale brown viscous liquid 
 
The title compound was prepared 
from R – ethyl lactyl bromoacetate 
(19.0 mmol, 4.54 g) and 1-
methylimidazole (17.0 mmol, 1.39 
g) according to the general 
procedure in  77 % yield (4.21 g, 
13.1 mmol) 
Molecular formula C11H17BrN2O4 
Molecular weight 321 g/mol 
 A-109 
1H NMR (400 MHz, CDCl3) δ ppm 10.25 (s, 1H), 7.49 (t, J = 1.8 Hz, 1H), 7.35 (t, J = 
1.8 Hz, 1H), 5.77 (d, J = 17.6 Hz, 1H), 5.33 (d, J = 17.6 Hz, 1H), 5.13 (q, J = 7.2 Hz, 
1H), 4.17 (q, J = 7.0 Hz, 2H), 4.02 (s, 3H), 1.50 (d, J = 7.2 Hz, 3H), 1.24 (t, J = 7.0 
Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 169.94, 165.80, 138.25, 123.81, 123.32, 70.71, 
61.92, 50.16, 37.06, 16.90, 14.17 
IR (thin film on salt plate) (cm-1) 3159, 3099, 2926, 2858, 1748, 1566, 1559, 1495, 
1451, 1209, 1177 
MS m/z, Found 241.1180 [M-Br-]+, Calcd. C11H17N2O4 241.1188 
MS m/z, 241.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
[α] 20D  -39.1º (0.4 c, CHCl3) 
 
RS - 3-Methyl-1-(propyllactylcarbonylmethyl)imidazolium bromide (214f) 
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Brown viscous liquid 
 
The title compound was prepared 
from RS – propyl lactyl 
bromoacetate (30.0 mmol, 7.59 g) 
and 1-methylimidazole (28.0 mmol, 
2.30 g) according to the general 
procedure in  88 % yield (8.25 g, 
24.6 mmol) 
Molecular formula C12H19BrN2O4 
Molecular weight 335 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 10.13 (s, 1H, H2), 7.55 (t, J = 1.8 Hz, 1H, H4), 
7.47 (t, J  = 1.8 Hz, 1H, H3), 5.74 (d, J = 17.6 Hz, 1H, H5), 5.35 (d, J = 17.6 Hz, 1H, 
H5), 5.14 (q, J = 7.2 Hz, 1H, H7), 4.06-4.01 (m, 3H, H1), 3.89 (t, J = 7.2 Hz, 2H, 
10H) 1.64 (tq, J = 7.2, 7.2 Hz, 2H, H11), 1.50 (d, J = 7.2 Hz, 3H, H8), 0.89 (t, J = 7.2 
Hz, 3H, H12) 
13C NMR (100 MHz, CDCl3) δ ppm 169.90 (CO), 165.66 (CO), 138.50 (NCH2N), 
123.71 (NCH2), 123.10 (NCH2), 70.78 (CH), 67.37 (NCH2), 30.17 (OCH2), 36.99 
(NCH3), 21.85 (CH3), 16.87 (CH2), 10.27 (CH3) 
IR (thin film on salt plate) (cm-1) 3099, 2968, 2927, 2859, 1751, 1559, 1495, 1452, 
1397, 1372, 1205, 1177 
MS m/z, Found 255.1337 [M-Br-]+, Calcd. C12H19N2O4 255.1345 
 A-110 
MS m/z, 255.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
RS - 3-Methyl-1-(butyllactylcarbonylmethyl)imidazolium bromide (214h) 
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Pale brown viscous liquid 
 
The title compound was prepared 
from RS – butyl lactyl bromoacetate 
(32.2 mmol, 8.60 g) and 1-
methylimidazole (30.0 mmol, 2.46 
g) according to the general 
procedure in  82 % yield (8.61 g, 
24.7 mmol) 
Molecular formula C13H21BrN2O4 
Molecular weight 349 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 10.13 (s, 1H, H2), 7.58 (t, J = 1.8 Hz, 1H, H4), 
7.49 (t, J = 1.8 Hz, 1H, H3), 5.66 (d, J = 17.6 Hz, 1H, H5), 5.31 (d, J = 17.6 Hz, 1H, 
H5), 5.14 (q, J = 7.2 Hz, 1H, H7), 4.14 (m, 2H, H10), 4.02 (s, 3H, H1), 1.60 (tt, J = 
7.2, 7.4 Hz, 2H, H11), 1.50 (d, J = 7.2 Hz, 3H, H8), 1.36 (tq, J= 7.4 , 7.4 Hz, 2H, 
H12), 0.88 (t, J = 7.4 Hz, 3H, H13) 
13C NMR (100 MHz, CDCl3) δ ppm 169.97 (CO), 165.77 (CO), 138.30 (NCH2N), 
123.74 (NCH2), 123.26 (NCH2), 70.70 (CH), 65.69 (NCH2), 50.18 (OCH2), 37.42 
(NCH3), 30.42 (CH3), 18.96 (CH2), 16.88 (CH2), 13.65 (CH3) 
IR (thin film on salt plate) (cm-1) 3158, 3095, 2962, 2928, 2862, 1751, 1569, 1559, 
1495, 1457, 1202, 1178 
MS m/z, Found 269.1499 [M-Br-]+, Calcd. C13H21N2O4 269.1501 
MS m/z, 269.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
 
 A-111 
R - 3-Methyl-1-(butyllactylcarbonylmethyl)imidazolium bromide (214g) 
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Pale brown viscous liquid 
 
The title compound was prepared 
from R – butyl lactyl bromoacetate 
(37.0 mmol, 9.88 g) and 1-
methylimidazole (33.0 mmol, 2.71 
g) according to the general 
procedure in  86 % yield (9.88 g, 
28.3 mmol) 
Molecular formula C13H21BrN2O4 
Molecular weight 349 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 10.08 (s, 1H), 7.55 (t, J = 1.8 Hz, 1H), 7.46 (t, J = 
1.8 Hz, 1H), 5.74 (d, J = 17.6 Hz, 1H), 5.35 (d, J = 17.6 Hz, 1H), 5.14 (q, J = 7.2 Hz, 
1H), 4.10 (m, 2H), 4.03 (s, 3H), 1.60 (tt, J = 7.2, 7.3 Hz, 2H), 1.50 (d, J = 7.2 Hz, 
3H), 1.33 (tq, J = 7.3, 7.4 Hz, 2H), 0.88 (t, J = 7.4 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 170.01, 165.79, 138.29, 123.75, 123.27, 70.68, 
65.66, 50.18, 37.41, 30.42, 18.98, 16.89, 13.64 
IR (thin film on salt plate) (cm-1) 3154, 3099, 2962, 2928, 2863, 1751, 1634, 1580, 
1559, 1495, 1457, 1399, 1204, 1175 
MS m/z, Found 269.1492 [M-Br-]+, Calcd. C13H21N2O4 269.1501 
MS m/z, 269.1 [M-Br-]+; MS: m/z, 79 and 81 [Br-] 
[α] 20D  -34.0º (0.5 c, CHCl3) 
 A-112 
Chiral NTf2 salts 
Representative procedure for the preparation of chiral NTf2 salts (RS - 3-methyl-
1-(methylmandelylcarbonylmethyl)imidazolium NTf2) (215o) 
 
A flask was charged with RS-
3-methyl-1-(methyl mandelyl 
carbonylmethyl) imidazolium 
bromide 213o (0.67 g, 1.81 
mmol) and distilled water (10 
mL). LiNTf2 (0.86 g, 3.00 mmol) was added in one portion and the suspension was 
stirred vigorously for overnight at RT. The top aqueous layer was removed and the IL 
was washed with distilled water (3 x 5 mL). The solvent was then removed on the 
rotary evaporator and under high vacuum for 5 h to give an orange crystalline material 
at RT in 92 % yield (0.95 g, 1.67 mmol) 
 
Molecular formula C17H18F6N3O8S2 
Molecular weight 569 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.73 (s, 1H, H1), 7.32 (s, 5H, H’s 9-13), 7.31 (s, 
1H, H4), 7.22 (s, 1H, H3), 5.93 (s, 1H, H7), 5.08 (s, 2H, H5), 3.84 (s, 3H, H1), 3.62 
(s, 3H, H15) 
13C NMR (100 MHz, CDCl3) δ ppm 168.42 (COO), 165.33 (COO), 137.68 (ArC), 
132.25 (NCHN), 129.91 (ArC x 2), 129.05 (ArC x 2), 127.79 (ArC), 123.77 (NCH), 
123.21 (NCH), 121.00 (q, J = 319 Hz, 2CF3), 76.36 (OCH), 63.34 (NCH2), 49.80 
(OCH3), 36.56 (NCH3) 
MP (°C) 73 – 75 
IR (KBr disc) (cm-1) 3470, 3379, 2099, 1750, 1571, 1566, 1459, 1453, 1451, 1390, 
1197, 1127 
MS m/z, 289.1 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
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RS - 3-Methyl-1-(ethylmandelylcarbonylmethyl)imidazolium NTf2 (215c) 
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Pale brown viscous liquid 
 
The title compound was prepared 
from RS - 3-methyl-1-(ethyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213c (0.96 g, 
2.60 mmol) and LiNTf2 (1.00 g, 
3.50 mmol) according to the general 
procedure in  95 % yield (1.43 g, 
2.45 mmol) 
Molecular formula C18H20F6N3O8S2 
Molecular weight 583 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.79 (s, 1H), 7.37 – 7.35 (m, 5H), 7.31 (t, J = 1.8 
Hz, 1H), 7.22 (t, J = 1.8 Hz, 1H), 5.91 (s, 1H), 5.10 (d, J = 2.8 Hz, 2H), 4.20 – 4.03 
(m, 2H), 3.87 (s, 3H), 1.13 (t, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 167.89, 165.27, 137.84, 132.29, 129.86, 129.02, 
127.78, 123.71, 123.25, 121.27 (q, J = 320 Hz, 2CF3), 76.52, 62.33, 49.88, 36.64, 
13.91 
IR (thin film on salt plate) (cm-1) 3167, 3120, 2960, 2927, 2860, 1751, 1566, 1559, 
1540, 1495, 1457, 1354, 1198, 1136 
MS m/z, 303.1 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
R - 3-Methyl-1-(ethylmandelylcarbonylmethyl)imidazolium NTf2 (215a) 
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Orange solid 
 
The title compound was prepared 
from R - 3-methyl-1-(ethyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213a (1.03 g, 
2.70 mmol) and LiNTf2 (0.86 g, 
3.00 mmol) according to the general 
procedure in  95 % yield (1.41 g, 
2.41 mmol) 
Molecular formula C18H20F6N3O8S2 
Molecular weight 583 g/mol 
 A-114 
1H NMR (400 MHz, CDCl3) δ ppm 8.67 (s, 1H), 7.36 – 7.29 (m, 6H), 7.24 (t, J = 1.6 
Hz, 1H), 5.88 (s, 1H), 5.05 (s, 2H), 4.16-4.11 (m, 2H), 3.81 (s, 3H), 1.10 (t, J = 7.2 
Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 167.92, 165.38, 137.49, 132.40, 129.81, 128.99, 
127.74, 123.74, 123.46, 121.58 (q, J = 320 Hz, 2CF3), 76.46, 62.29, 49.72, 36.47, 
13.84 
MP (°C) 44 – 46 
IR (KBr disc) (cm-1) 3156, 3099, 3007, 1761, 1735, 1579, 1568, 1500, 1456, 1430, 
1371, 1356, 1279, 1187, 1132, 1051 
MS m/z, 303.1 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
[α] 20D  -53.7º (0.5 c, CHCl3) 
 
S - 3-Methyl-1-(ethylmandelylcarbonylmethyl)imidazolium NTf2 (215b) 
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Amber solid 
 
The title compound was prepared 
from S - 3-methyl-1-(ethyl mandelyl 
carbonyl methyl) imidazolium 
bromide 213b (0.96 g, 2.50 mmol) 
and LiNTf2 (0.86 g, 3.00 mmol) 
according to the general procedure 
in  85 % yield (1.42 g, 2.44 mmol) 
Molecular formula C18H20F6N3O8S2 
Molecular weight 583 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.72 (s, 1H), 7.36 – 7.32 (m, 5H), 7.30 (t, J = 1.8 
Hz, 1H), 7.23 (t, J = 1.8 Hz, 1H), 5.89 (s, 1H), 5.07 (s, 2H), 4.18 – 4.02 (m, 2H), 3.85 
(s, 3H), 1.12 (t, J = 7.0 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 167.92, 165.34, 137.64, 132.36, 129.83, 129.01, 
127.76, 123.74, 123.38, 121.44 (q, J = 320 Hz, 2CF3), 76.49, 62.31, 49.80, 36.55, 
13.88 
MP (°C) 44 – 46 
IR (KBr disc) (cm-1) 3165, 3099, 2998, 2963, 1759, 1735, 1579, 1564, 1496, 1452, 
1434, 1356, 1279, 1198, 1134, 1044 
MS m/z, 303.1 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 A-115 
[α] 20D  +54.7º (0.7 c, CHCl3) 
 
RS - 3-Methyl-1-(butylmandelylcarbonylmethyl)imidazolium NTf2 (215f) 
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Brown viscous liquid 
 
The title compound was prepared 
from RS - 3-methyl-1-(butyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213f (1.03 g, 
2.50 mmol) and LiNTf2 (0.86 g, 
3.00 mmol) according to the general 
procedure in  94 % yield (1.45 g, 
2.36 mmol) 
Molecular formula C20H24F6N3O8S2 
Molecular weight 612 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.86 (s, 1H), 7.49 – 7.40 (m, 5H), 7.40 (t, J = 1.4 
Hz, 1H), 7.31 (t, J = 1.4 Hz, 1H), 6.00 (s, 1H), 5.18 (d, J = 4.8 Hz, 2H), 4.20 – 4.09 
(m, 2H), 3.95 (s, 3H), 1.59 – 1.52 (m, 2H), 1.25 (tq, J = 7.4, 7.5 Hz, 2H), 0.85 (t, J = 
7.5 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 167.99, 165.26, 137.79, 132.35, 129.83, 129.0, 
127.73, 123.72, 123.29, 121.20 (q, J = 319 Hz, 2CF3), 76.49, 66.07, 49.87, 36.63, 
30.28, 18.78, 13.51 
IR (thin film on salt plate) (cm-1) 3163, 3120, 2963, 2931, 2860, 1751, 1569, 1559, 
1540, 1495, 1457, 1354, 1198, 1136 
MS m/z, 331.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
R - 3-Methyl-1-(butylmandelylcarbonylmethyl)imidazolium NTf2 (215d) 
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Orange viscous liquid 
 
The title compound was prepared 
from R - 3-methyl-1-(butyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213d (1.23 g, 
3.00 mmol) and LiNTf2 (1.00 g, 
3.50 mmol) according to the general 
procedure in  98 % yield (1.80 g, 
2.93 mmol) 
 A-116 
Molecular formula C20H24F6N3O8S2 
Molecular weight 612 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.81 (s, 1H), 7.45 – 7.41 (m, 5H), 7.39 (t, J = 1.6 
Hz, 1H), 7.32 (t, J = 1.6 Hz, 1H), 5.99 (s, 1H), 5.16 (d, J = 3.2 Hz, 2H), 4.18 – 4.08 
(m, 2H), 3.93 (s, 3H), 1.59 – 1.51 (m, 2H), 1.24 (tq, J = 7.4, 7.5 Hz, 2H), 0.85 (t, J 
=7.5 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 167.98, 165.30, 137.65, 132.39, 129.81, 128.98, 
127.72, 123.72, 123.37, 121.26 (q, J = 319 Hz, 2CF3), 76.47, 66.04, 49.81, 36.56, 
30.26, 18.77, 13.49 
IR (thin film on salt plate) (cm-1) 3162, 3124, 2963, 2928, 2860, 1751, 1569, 1559, 
1540, 1495, 1457, 1353, 1198, 1136 
MS m/z, 331.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
[α] 20D  -49.0º (1.1 c, CHCl3) 
 
S - 3-Methyl-1-(butylmandelylcarbonylmethyl)imidazolium NTf2 (215e) 
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Yellow viscous liquid 
 
The title compound was prepared 
from S - 3-methyl-1-(butyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213e (1.03 g, 
2.50 mmol) and LiNTf2 (0.86 g, 
3.00 mmol) according to the general 
procedure in  93 % yield (1.42 g, 
2.32 mmol) 
Molecular formula C20H24F6N3O8S2 
Molecular weight 612 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.74 (s, 1H), 7.36 – 7.33 (m, 5H), 7.30 (t, J = 1.8 
Hz, 1H), 7.23 (t, J = 1.8 Hz, 1H), 5.90 (s, 1H), 5.08 (d, J = 4.4 Hz, 2H), 4.10 – 4.00 
(m, 2H), 3.85 (s, 3H), 1.50 – 1.43 (m, 2H), 1.18 (tq, J = 7.4 Hz, 7.4 Hz, 2H), 0.77 (t, J 
= 7.4 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 167.98, 165.28, 137.72, 129.82, 128.99, 127.73, 
123.71, 123.33, 121.25 (q, J = 320 Hz, 2CF3), 76.48, 66.05, 49.83, 36.59, 30.27, 
18.78, 13.50 
 A-117 
IR (thin film on salt plate) (cm-1) 3165, 3123, 2963, 2928, 1751, 1566, 1559, 1539, 
1495, 1457, 1354, 1198, 1136 
MS m/z, 331.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
[α] 20D  +50.4º (0.5 c, CHCl3) 
 
RS - 3-Methyl-1-(pentylmandelylcarbonylmethyl)imidazolium NTf2 (215i) 
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Brown viscous liquid 
 
The title compound was prepared 
from RS - 3-methyl-1-(pentyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213i (1.06 g, 
2.50 mmol) and LiNTf2 (0.86 g, 
3.00 mmol) according to the general 
procedure in  93 % yield (1.45 g, 
2.32 mmol) 
Molecular formula C21H26F6N3O8S2 
Molecular weight 625 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.86 (s, 1H), 7.35 (m, 5H), 7.31 (t, J = 1.6 Hz, 
1H), 7.20 – 7.19 (m, 1H), 5.92 (s, 1H), 5.13 (d, J = 12.0 Hz, 2H), 4.08 – 4.04 (m, 2H), 
3.90 (s, 3H), 1.53 – 1.45 (m, 2H), 1.19 – 1.07 (m, 4H), 0.75 (t, J = 7.0 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 167.99, 165.32, 137.50, 132.48, 129.77, 128.96, 
127.70, 124.45, 123.74, 123.47, 121.26 (q, J = 320 Hz, 2CF3), 76.42, 66.26, 49.75, 
36.48, 27.94, 27.62, 13.83 
IR (thin film on salt plate) (cm-1) 3165, 3123, 2959, 2928, 2858, 1751, 1559, 1540, 
1495, 1457, 1354, 1198, 1136 
MS m/z, 345.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
 
 
 
 
 
 
 
 A-118 
R - 3-Methyl-1-(pentylmandelylcarbonylmethyl)imidazolium NTf2 (215g) 
 
N
N
O
O
O
O
NTf2-
 
Brown viscous liquid 
 
The title compound was prepared 
from R - 3-methyl-1-(pentyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213g (1.28 g, 
3.00 mmol) and LiNTf2 (1.00 g, 
3.50 mmol) according to the general 
procedure in  87 % yield (1.64 g, 
2.61 mmol) 
 
Molecular formula C21H26F6N3O8S2 
Molecular weight 625 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.86 (s, 1H), 7.37 – 7.30 (m, 5H), 7.28 (t, J = 1.8 
Hz, 1H), 7.20 – 7.19 (m, 1H), 5.92 (s, 1H), 5.13 (d, J = 12.8 Hz, 2H), 4.10 – 4.03 (m, 
2H), 3.91 (s, 3H), 4.49 (tt, J = 7.0, 7.2 Hz, 2H), 1.19 – 1.05 (m, 4H), 0.75 (t, J = 7.0 
Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.02, 165.35, 137.47, 132.48, 129.77, 128.58, 
127.69, 123.74, 123.48, 121.27 (q, J = 320 Hz, 2CF3), 76.42, 66.26, 49.73, 36.46, 
27.71, 27.61, 22.13, 13.82 
IR (thin film on salt plate) (cm-1) 3162, 3121, 2961, 2928, 2859, 1751, 1566, 1559, 
1540, 1495, 1457, 1354, 1198, 1136 
MS m/z, 345.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
[α] 20D  -45.6º (0.6 c, CHCl3) 
 
S - 3-Methyl-1-(pentylmandelylcarbonylmethyl)imidazolium NTf2 (215h) 
 
N
N
O
O
O
O
NTf2-
 
Brown viscous liquid 
 
The title compound was prepared 
from S - 3-methyl-1-(pentyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213h (1.06 g, 
2.50 mmol) and LiNTf2 (0.86 g, 
3.00 mmol) according to the general 
procedure in  96 % yield (1.49 g, 
2.38 mmol) 
 A-119 
Molecular formula C21H26F6N3O8S2 
Molecular weight 625 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.77 (s, 1H), 7.37 – 7.32 (m, 5H), 7.31 (t, J = 1.7 
Hz, 1H), 7.22 (t, J = 1.7 Hz, 1H), 5.91 (s, 1H), 5.10 (d, J = 5.6 Hz, 2H), 4.07 – 4.02 
(m, 2H), 3.89 (s, 3H), 1.52 (tt, J = 7.0, 7.2 Hz,  2H), 1.19 – 1.04 (m, 4H), 0.74 (t, J = 
7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.00, 165.28, 137.78, 132.37, 129.83, 128.99, 
127.74, 123.71, 123.29, 121.19 (q, J = 320 Hz, 2CF3), 76.48, 66.32, 49.87, 36.62, 
27.96, 27.64, 22.09, 13.86 
IR (thin film on salt plate) (cm-1) 3163, 3126, 2958, 2928, 2862, 1751, 1566, 1559, 
1539, 1495, 1457, 1354, 1198, 1136 
MS m/z, 345.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
[α] 20D  +45.8º (0.9 c, CHCl3) 
 
RS - 3-Methyl-1-(ethoxyethylmandelylcarbonylmethyl)imidazolium NTf2 (215l) 
 
N
N
O
O
O
NTf2-
O
O
 
Orange viscous liquid 
 
The title compound was prepared 
from RS - 3-methyl-1-(ethoxy ethyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213l (1.02 g, 
2.40 mmol) and LiNTf2 (0.86 g, 
3.00 mmol) according to the general 
procedure in  79 % yield (1.18 g, 
1.88 mmol) 
Molecular formula C20H24F6N3O9S2 
Molecular weight 627 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.79 (s, 1H), 7.39 – 7.33 (m, 6H), 7.22 (t, J = 1.6 
Hz, 1H), 5.96 (s, 1H), 5.10 (d, J = 7.6 Hz, 2H), 4.25 (t, J = 4.8 Hz, 2H), 3.87 (s, 3H), 
3.51 (t, J = 4.8 Hz, 2H), 3.35 (q, J = 6.9 Hz, 2H), 1.03 (t, J = 6.9 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 167.84, 165.28, 137.82, 132.12, 129.88, 128.99, 
127.83, 123.76, 123.26, 121.27 (d, J = 319 Hz, 2CF3), 76.43, 67.81, 66.54, 65.10, 
49.87, 36.64, 15.01 
IR (thin film on salt plate) (cm-1) 3169, 3122, 2965, 2927, 2859, 1751, 1569, 1559, 
1540, 1495, 1457, 1354, 1198, 1136 
 A-120 
MS m/z, 347.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
R - 3-Methyl-1-(ethoxyethylmandelylcarbonylmethyl)imidazolium NTf2 (215j) 
 
N
N
O
O
O
O
NTf2-
O
 
Orange viscous liquid 
The title compound was prepared 
from R - 3-methyl-1-(ethoxy ethyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213l (1.20 g, 
2.80 mmol) and LiNTf2 (1.00 g, 
3.50 mmol) according to the general 
procedure in  92 % yield (1.62 g, 
2.57 mmol) 
Molecular formula C20H24F6N3O9S2 
Molecular weight 627 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.79 (s, 1H), 7.39 – 7.32 (m, 6H), 7.22 (t, J = 1.8 
Hz, 1H), 5.96 (s, 1H), 5.12 (d, J = 7.2 Hz, 2H), 4.25 (t, J = 5.0 Hz, 2H), 3.89 (s, 3H), 
3.49 (t, J = 5.0 Hz, 2H), 3.35 (q, J = 7.1 Hz, 2H), 1.03 (t, J = 7.1 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 167.85, 165.29, 137.85, 132.12, 129.88, 128.99, 
127.83, 123.76, 123.26, 121.25 (d, J = 319 Hz, 2CF3), 76.44, 67.81, 66.55, 65.11, 
49.88, 36.65, 15.00 
IR (thin film on salt plate) (cm-1) 3167, 3120, 2963, 2927, 2860, 1752, 1565, 1559, 
1539, 1495, 1457, 1354, 1198, 1136 
MS m/z, 347.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
[α] 20D  -46.2º (0.5 c, CHCl3) 
 
S - 3-Methyl-1-(ethoxyethylmandelylcarbonylmethyl)imidazolium NTf2 (215k) 
 
N
N
O
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O
O
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O
 
Brown viscous liquid 
 
The title compound was prepared 
from S - 3-methyl-1-(ethoxy ethyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213k (1.07 g, 
2.50 mmol) and LiNTf2 (0.86 g, 
3.00 mmol) according to the general 
procedure in  86 % yield (1.30 g, 
2.07 mmol) 
 A-121 
Molecular formula C20H24F6N3O9S2 
Molecular weight 627 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.84 (s, 1H), 7.47 – 7.40 (m, 6H), 7.32 – 7.31 (m, 
1H), 6.04 (s, 1H), 5.18 (d, J = 5.2 Hz, 2H), 4.34 (t, J = 4.6 Hz, 2H), 3.94 (s, 3H), 3.56 
(t, J = 4.6 Hz, 2H), 3.44 (q, J = 7.0 Hz, 2H), 1.11 (t, J = 7.0 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 167.86, 165.32, 137.73, 132.14, 129.87, 128.98, 
128.58, 123.77, 123.32, 121.29 (q, J = 319 Hz, 2CF3), 76.41, 67.80, 66.53, 65.10, 
49.83, 36.60, 15.00 
IR (thin film on salt plate) (cm-1) 3166, 3122, 2970, 2927, 2858, 1751, 1569, 1559, 
1540, 1495, 1456, 1354, 1200, 1136 
MS m/z, 347.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
[α] 20D  +46.7º (0.5 c, CHCl3) 
 
RS - 3-Methyl-1-(methyllactylcarbonylmethyl)imidazolium NTf2 (216b) 
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Colourless liquid 
 
The title compound was prepared 
from RS - 3-methyl-1-(methyl 
lactylcarbonylmethyl) imidazolium 
bromide 214b (0.53 g, 1.70 mmol) 
and LiNTf2 (1.15 g, 4.00 mmol) 
according to the general procedure 
in  65 % yield (0.56 g, 1.11 mmol) 
Molecular formula C12H16F6N3O8S2 
Molecular weight 507 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.76 (s, 1H, H2), 7.34 (t, J = 1.8 Hz, 1H, H3), 
7.26 (t, J = 1.8 Hz, 1H, H4), 5.15 (q, J = 7.0 Hz, 1H, H7), 5.13 (d, J = 18 Hz, 1H, H5), 
5.02 (d, J = 18 Hz, 1H, H5), 5.89 (s, 3H, H1), 3.69 (s, 3H, H10), 1.49 (d, J = 7.0 Hz, 
3H, H8) 
13C NMR (100 MHz, CDCl3) δ ppm 170.28 (COO), 165.32 (COO), 137.67 (NCHN), 
123.81 (NCH2), 123.31 (NCH2), 121.00 (q, J = 320 Hz, 2CF3), 70.83 (OCH2), 52.74 
(NCH2), 49.77 (OCH3), 36.58 (NCH3), 16.58 (CCH3) 
IR (thin film on salt plate) (cm-1) 3166, 3121, 2958, 2926, 2858, 1751, 1569, 1559, 
1539, 1495, 1452, 1354, 1192, 1136 
MS m/z, 227.1 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 A-122 
R - 3-Methyl-1-(methyllactylcarbonylmethyl)imidazolium NTf2 (216a) 
 
N
N
O
O
O
O
NTf2-
 
Brown viscous liquid 
 
The title compound was prepared 
from R - 3-methyl-1-(methyl lactyl 
carbonyl methyl) imidazolium 
bromide 214a (0.95 g, 3.10 mmol) 
and LiNTf2 (1.00 g, 3.50 mmol) 
according to the general procedure 
in  57 % yield (0.90 g, 1.78 mmol) 
Molecular formula C12H16F6N3O8S2 
Molecular weight 507 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.85 (s, 1H), 7.42 (t, J = 1.8 Hz, 1H), 7.37 (t, J = 
1.8 Hz, 1H), 5.24 -5.17 (m, 2H), 5.10 (d, J = 18 Hz, 1H), 3.98 (s, 3H), 3.77 (s, 3H), 
1.57 (d, J = 6.8 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 170.24, 165.28, 137.69, 123.79, 123.30, 121.29 
(q, J = 320 Hz, 2CF3), 70.84, 52.73, 49.78, 36.59, 16.58 
IR (thin film on salt plate) (cm-1) 3165, 3124, 2962, 2924, 2860, 1751, 1581, 1569, 
1559, 1495, 1453, 1354, 1198, 1136 
MS m/z, 227.1 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
[α] 20D  -29.1º (0.7 c, CHCl3) 
 
RS - 3-Methyl-1-(ethyllactylcarbonylmethyl)imidazolium NTf2 (216d) 
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O
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Brown viscous liquid 
 
The title compound was prepared 
from RS - 3-methyl-1-(ethyl lactyl 
carbonyl methyl) imidazolium 
bromide 214d (1.00 g, 3.1 mmol) 
and LiNTf2 (1.15 g, 4.00 mmol) 
according to the general procedure 
in  63 % yield (1.01 g, 1.94 mmol) 
Molecular formula C13H18F6N3O8S2 
Molecular weight 521 g/mol 
 A-123 
1H NMR (400 MHz, CDCl3) δ ppm 8.79 (s, 1H), 7.33 (t, J = 1.6 Hz, 1H), 7.25 (t, J = 
1.6 Hz, 1H), 5.12 (m, 2H), 5.01 (d, J = 18 Hz, 1H), 4.17 (q, J = 7.0 Hz, 2H), 3.90 (s, 
3H), 1.49 (d, J = 7.0 Hz, 3H), 1.20 (t, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 169.82, 165.28, 137.75, 123.78, 123.27, 121.22 
(q, J = 320 Hz, 2CF3), 70.96, 61.98, 49.83, 36.63, 16.58, 14.03 
IR (thin film on salt plate) (cm-1) 3165, 3127, 2966, 2927, 2860, 1751, 1569, 1559, 
1495, 1452, 1354, 1197, 1136 
MS m/z, 241.1 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
R - 3-Methyl-1-(ethyllactylcarbonylmethyl)imidazolium NTf2 (216c) 
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Brown viscous liquid 
 
The title compound was prepared 
from R - 3-methyl-1-(ethyl lactyl 
carbonyl methyl) imidazolium 
bromide 214c (0.96 g, 3.00 mmol) 
and LiNTf2 (1.00 g, 3.50 mmol) 
according to the general procedure 
in  72 % yield (1.13 g, 2.17 mmol) 
Molecular formula C13H18F6N3O8S2 
Molecular weight 521 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.79 (s, 1H), 7.33 (t, J = 1.8 Hz, 1H), 7.25 (t, J = 
1.8 Hz, 1H), 5.14 (d, J = 18 Hz, 1H), 5.12 (q, J = 7.2 Hz, 1H), 5.01 (d, J = 18 Hz, 
1H), 4.17 (q, J = 7.2 Hz, 2H), 3.90 (s, 3H), 1.49 (d, J = 7.2 Hz, 3H), 1.21 (t, J = 7.2 
Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 169.82, 165.27, 137.74, 123.78, 123.27, 121.29 
(d, J = 319 Hz, 2CF3), 70.96, 61.97, 49.83, 36.62, 16.57, 14.02 
IR (thin film on salt plate) (cm-1) 3164, 3121, 2961, 2927, 2860, 1751, 1582, 1569, 
1559, 1495, 1452, 1353, 1197, 1136 
MS m/z, 241.1 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
[α] 20D  -28.5º (0.6 c, CHCl3) 
 
 A-124 
RS - 3-Methyl-1-(propyllactylcarbonylmethyl)imidazolium NTf2 (216f) 
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Yellow viscous liquid 
 
The title compound was prepared 
from RS - 3-methyl-1-(propyl lactyl 
carbonyl methyl) imidazolium 
bromide 214f (1.12 g, 3.30 mmol) 
and LiNTf2 (1.06 g, 3.70 mmol) 
according to the general procedure 
in  86 % yield (1.51 g, 2.82 mmol) 
Molecular formula C14H20F6N3O8S2 
Molecular weight 535 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.75 (s, 1H), 7.33 (t, J = 1.8 Hz, 1H), 7.27 (t, J = 
1.8 Hz, 1H), 5.14 – 5.08 (m, 2H), 5.00 (d, J = 18 Hz, 1H), 4.06 – 4.01 (m, 2H), 3.89 
(s, 3H), 1.64 (tq, J = 7.2, 7.4 Hz, 2H), 1.49 (d, J = 7.2 Hz, 3H), 0.86 (t, J = 7.4 Hz, 
3H) 
13C NMR (100 MHz, CDCl3) δ ppm 169.89, 165.28, 137.61, 123.78, 123.36, 121.32 
(q, J = 319 Hz, 2CF3), 70.93, 67.40, 49.79, 36.56, 21.80, 16.61, 10.17 
IR (thin film on salt plate) (cm-1) 3163, 3122, 2970, 2927, 2858, 1751, 1569, 1559, 
1495, 1452, 1353, 1198, 1136 
MS m/z, 255.1 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
R - 3-Methyl-1-(propyllactylcarbonylmethyl)imidazolium NTf2 (216e) 
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Brown viscous liquid 
 
The title compound was prepared 
from R - 3-methyl-1-(propyl lactyl 
carbonyl methyl) imidazolium 
bromide 214e (1.01 g, 3.00 mmol) 
and LiNTf2 (1.00 g, 3.50 mmol) 
according to the general procedure 
in  92 % yield (1.47 g, 2.75 mmol) 
Molecular formula C14H20F6N3O8S2 
Molecular weight 535 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.83 (s, 1H), 7.31 (t, J = 1.8 Hz, 1H), 7.23 (t, J = 
1.8 Hz, 1H), 5.17-5.14 (m, 2H), 5.00 (d, J = 18 Hz, 1H), 4.05 (t, J = 6.6 Hz, 2H), 3.91 
(s, 3H), 1.65 – 1.56 (m, 2H), 1.50 (d, J = 7.2 Hz, 3H), 0.87 (t, J = 7.4 Hz, 3H) 
 A-125 
13C NMR (100 MHz, CDCl3) δ ppm 169.87, 165.23, 137.89, 123.74, 123.19, 121.19 
(q, J = 319 Hz, 2CF3), 70.97, 67.44, 49.89, 36.68, 21.83, 16.63, 10.20 
IR (thin film on salt plate) (cm-1) 3165, 3122, 2964, 2927, 2857, 1751, 1568, 1559, 
1495, 1472, 1452, 1354, 1198, 1136 
MS m/z, 255.1 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
[α] 20D  -26.3º (0.7 c, CHCl3) 
 
RS - 3-Methyl-1-(butyllactylcarbonylmethyl)imidazolium NTf2 (216h) 
 
N
N
O
O
O
NTf2-
O
 
Brown viscous liquid 
 
The title compound was prepared 
from RS - 3-methyl-1-(butyl lactyl 
carbonyl methyl) imidazolium 
bromide 214h (1.11 g, 3.18 mmol) 
and LiNTf2 (1.21 g, 4.20 mmol) 
according to the general procedure 
in  83 % yield (1.46 g, 2.65 mmol) 
Molecular formula C15H22F6N3O8S2 
Molecular weight 549 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.81 (s, 1H), 7.32 (s, 1H), 7.24 (s, 1H), 5.13 (d, J 
= 18 Hz, 1H), 5.11 (q, J = 7.0 Hz, 1H), 5.00 (d, J = 18 Hz, 1H), 4.09 (t, J = 7.0 Hz, 
2H), 3.90 (s, 3H), 1.54 (m, 2H), 1.49 (d, J = 7.0 Hz, 3H), 1.30 (tq, J = 7.2, 7.4 Hz, 
2H), 0.86 (t, J = 7.4 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 169.88, 165.25, 137.79, 123.76, 123.25, 121.29 
(q, J = 319 Hz, 2CF3), 70.94, 65.77, 49.86, 36.66, 30.42, 18.96, 16.63, 13.63 
IR (thin film on salt plate) (cm-1) 3167, 3121, 2966, 2935, 2860, 1751, 1581, 1569, 
1559, 1495, 1452, 1354, 1198, 1136 
MS m/z, 269.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
 A-126 
R - 3-Methyl-1-(butyllactylcarbonylmethyl)imidazolium NTf2 (216g) 
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Brown viscous liquid 
The title compound was prepared 
from R - 3-methyl-1-(butyl lactyl 
carbonyl methyl) imidazolium 
bromide 214g (0.77 g, 2.20 mmol) 
and LiNTf2 (1.00 g, 3.50 mmol) 
according to the general procedure 
in  64 % yield (0.78 g, 1.41 mmol) 
Molecular formula C15H22F6N3O8S2 
Molecular weight 549 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.84 (s, 1H), 7.32 (t, J = 1.6 Hz, 1H), 7.23 (t, J = 
1.6 Hz, 1H), 5.17 (d, J = 17.6 Hz, 1H), 5.13 (q, J = 7.0 Hz, 1H), 5.01 (d, J = 17.6 Hz, 
1H), 4.09 (t, J = 6.4 Hz, 2H), 3.91 (s, 3H), 1.62-1.57 (m, 2H), 1.50 (d, J = 7.0 Hz, 
3H), 1.31 (tq, J = 7.4 Hz, 7.6 Hz, 2H), 0.86 (t, J = 7.6 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 169.88, 165.23, 137.88, 123.74, 123.19, 121.25 
(q, J = 319 Hz, 2CF3), 70.96, 65.78, 49.88, 36.68, 30.43, 18.97, 16.63, 13.63 
IR (thin film on salt plate) (cm-1) 3166, 3122, 2966, 2934, 2863, 1751, 1569, 1559, 
1495, 1452, 1354, 1201, 1135 
MS m/z, 269.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
[α] 20D  -25.5º (0.6 c, CHCl3) 
 
RS - 3-Methyl-1-(pentyllactylcarbonylmethyl)imidazolium NTf2 (216j) 
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Pale brown viscous liquid 
 
The title compound was prepared 
from RS - 3-methyl-1-(pentyl lactyl 
carbonyl methyl) imidazolium 
bromide 214j (1.02 g, 2.80 mmol) 
and LiNTf2 (1.21 g, 4.20 mmol) 
according to the general procedure 
in  87 % yield (1.36 g, 2.42 mmol) 
Molecular formula C16H24F6N3O8S2 
Molecular weight 563 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.75 (s, 1H), 7.33 (t, J = 1.8 Hz, 1H), 7.27 (t, J = 
1.8 Hz, 1H), 5.10 (m, 2H), 5.04 (d, J = 18 Hz, 1H), 4.07 (t, J = 7.0 Hz, 2H), 3.89 (s, 
 A-127 
3H), 1.57 (tt, J = 7.0, 7.2 Hz, 2H), 1.49 (d, J = 7.2 Hz, 3H), 1.25-1.20 (m, 4H), 0.83 (t, 
J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 169.91, 165.29, 137.61, 123.79, 123.36, 121.32 
(q, J = 319 Hz, 2CF3), 70.90, 66.03, 49.79, 36.57, 28.08, 27.82, 22.21, 16.61, 13.92 
IR (thin film on salt plate) (cm-1) 3164, 3124, 2962, 2934, 2860, 1750, 1582, 1569, 
1559, 1495, 1456, 1354, 1198, 1136 
MS m/z, 283.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
R - 3-Methyl-1-(pentyllactylcarbonylmethyl)imidazolium NTf2 (216i) 
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Yellow viscous liquid 
 
The title compound was prepared 
from R - 3-methyl-1-(pentyl lactyl 
carbonyl methyl) imidazolium 
bromide 214i (1.09 g, 3.00 mmol) 
and LiNTf2 (1.00 g, 3.50 mmol) 
according to the general procedure 
in  87 % yield (1.47 g, 2.61 mmol) 
Molecular formula C16H24F6N3O8S2 
Molecular weight 563 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.76 (s, 1H), 7.33 (t, J = 1.8 Hz, 1H), 7.26 (t, J = 
1.8 Hz, 1H), 5.14 (q, J = 7.2 Hz, 1H), 5.13 (d, J = 18 Hz, 1H), 5.00 (d, J = 18 Hz, 
1H), 4.10 – 4.04 (t, J = 7.0 Hz, 2H), 3.89 (s, 3H), 1.61 (tt, J =7.0, 7.2 Hz, 2H), 1.49 (d, 
J = 7.2 Hz, 3H), 1.29 – 1.22 (m, 4H), 0.83 (t, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 169.89, 165.26, 137.66, 123.77, 123.32, 121.30 
(q, J = 319 Hz, 2CF3), 70.91, 66.03, 49.81, 36.58, 28.08, 27.82, 22.20, 16.61, 13.91 
IR (thin film on salt plate) (cm-1) 3167, 3123, 2962, 2934, 2863, 1750, 1569, 1559, 
1495, 1452, 1436, 1354, 1197, 1136 
MS m/z, 283.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
[α] 20D  -28.2º (0.7 c, CHCl3) 
 A-128 
RS - 3-Methyl-1-(ethoxyethyllactylcarbonylmethyl)imidazolium NTf2 (216l) 
 
N
N
O
O
O
NTf2-
O
O
 
Yellow viscous liquid 
 
The title compound was prepared 
from RS - 3-methyl-1-(ethoxy ethyl 
lactyl carbonyl methyl) imidazolium 
bromide 214l (1.13 g, 3.10 mmol) 
and LiNTf2 (1.00 g, 3.50 mmol) 
according to the general procedure 
in  76 % yield (1.33 g, 2.35 mmol) 
Molecular formula C15H22F6N3O9S2 
Molecular weight 565 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.78 (s, 1H), 7.35 (t, J = 1.8 Hz, 1H), 7.25 (t, J = 
1.8 Hz, 1H), 5.18 – 5.10 (m, 2H), 5.01 (d, J = 17.6 Hz, 1H), 4.29 – 4.17 (m, 2H), 3.90 
(s, 3H), 3.57 (t, J = 4.8 Hz, 2H), 3.48 (q, J = 6.8 Hz, 2H), 1.50 (d, J = 6.8 Hz, 3H), 
1.12 (t, J = 6.8 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 169.78, 165.29, 137.71, 123.83, 123.29, 121.29 
(q, J = 319 Hz, 2CF3), 70.90, 67.91, 66.59, 64.74, 49.82, 36.60, 16.56, 15.06 
IR (thin film on salt plate) (cm-1) 3166, 3123, 2959, 2927, 2859, 1751, 1569, 1559, 
1495, 1451, 1354, 1198, 1134 
MS m/z, 285.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
 
R - 3-Methyl-1-(ethoxyethyllactylcarbonylmethyl)imidazolium NTf2 (216k) 
 
N
N
O
O
O
O
NTf2-
O
 
Yellow viscous liquid 
 
The title compound was prepared 
from R - 3-methyl-1-(ethoxy ethyl 
lactyl carbonyl methyl) imidazolium 
bromide 214k (1.10 g, 3.00 mmol) 
and LiNTf2 (1.00 g, 3.50 mmol) 
according to the general procedure 
in  67 % yield (1.14 g, 2.02 mmol) 
Molecular formula C15H22F6N3O9S2 
Molecular weight 565 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 8.77 (s, 1H), 7.35 (t, J = 1.8 Hz, 1H), 7.26 (t, J = 
1.8 Hz, 1H), 5.17 – 5.09 (m, 2H), 5.01 (d, J = 18 Hz, 1H), 4.28 – 4.17 (m, 2H), 3.89 
(s, 3H), 3.57 (t, J = 4.6 Hz, 2H), 3.48 (q, J = 6.9 Hz, 2H), 1.50 (d, J = 7.2 Hz, 3H), 
1.12 (t, J = 6.9 Hz, 3H) 
 A-129 
13C NMR (100 MHz, CDCl3) δ ppm 169.80, 165.30, 137.66, 123.84, 123.32, 121.30 
(q, J = 319 Hz, 2CF3), 70.89, 67.91, 66.58, 64.74, 49.81, 36.58, 16.55, 15.07 
IR (thin film on salt plate) (cm-1) 3170, 3122, 2962, 2927, 2863, 1751, 1582, 1569, 
1559, 195, 1453, 1354, 1198, 1136 
MS m/z, 285.2 [M-NTf2-]+; MS: m/z, 280.0 [NTf2-] 
[α] 20D  -22.5º (0.7 c, CHCl3) 
 
Chiral OctOSO3- salts 
Representative procedure for the preparation of chiral OctOSO3 salts (RS - 3-
methyl-1-(methylmandelylcarbonylmethyl)imidazolium OctOSO3) (217o) 
To a stirred solution of RS – 3 – 
methyl -1- (methyl mandelyl 
carbonyl methyl) imidazolium 
bromide 213o (2.50 mmol, 0.92 g) 
in distilled water (20 mL) was 
added in one portion sodium octyl 
sulfate (2.60 mmol, 0.60 g). The 
mixture was left stirring overnight, then the water was evaporated on the rotary 
evaporator. The remaining product was dissolved in DCM (10 mL) and washed with 
water (2 x 2 mL). The product was then dried on the rotary evaporator and under high 
vacuum for 8 h to give a pale brown solid at RT in 97 % yield (0.89 g, 1.78 mmol) 
 
Molecular formula C23H34N2O8S2 
Molecular weight 498 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.24 (s, 1H, H2), 7.48 (t, J = 1.6 Hz, 1H, H4), 
7.42 (t, J = 1.6 Hz, 1H, H3), 7.36-7.30 (m, 5H, H’s 9-13), 5.91 (s, 1H, H7), 5.32 (d, J 
= 17.8 Hz, 1H, H5), 5.24 (d, J = 17.8 Hz, 1H, H5), 3.88-3.83 (m, 5H, H’s 15 and 16), 
3.61 (s 3H, H1), 1.52 (tt, J = 7.2 Hz, 7.2 Hz, 2H, H17), 1.22-1.12 (m, 10H, H’s 18-
22), 0.81 (t, J = 7.2 Hz, 3H, H23) 
13C NMR (100 MHz, CDCl3) δ ppm 167.50 (COO), 165.11 (COO), 137.55 (NCHN), 
131.54 (ArC), 128.68 (ArC), 127.93 (ArC), 126.75 (ArC), 122.81 (NCH2), 122.45 
(NCH2), 75.08 (CH), 66.75 (OCH3), 51.89 (OCH2), 48.65 (NCH2), 35.40 (CH2), 
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 A-130 
30.78 (NCH3), 28.44 (CH2), 28.31 (CH2), 28.22 (CH2), 24.81 (CH2), 21.62 (CH2), 
13.10 (CH3) 
MP (°C) 61 – 62 
IR (KBr disc) (cm-1) 3159, 3125, 2963, 2932, 2850, 1740, 1552, 1531, 1495, 1454, 
1399, 1210, 1177 
MS m/z, 289.1188 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
 
RS - 3-Methyl-1-(ethylmandelylcarbonylmethyl)imidazolium OctOSO3 (217c) 
N
N
O
O
O
O
OctOSO3-
 
Yellow grease 
 
The title compound was prepared 
from RS - 3-methyl-1-(ethyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213c (2.50 
mmol, 0.94 g) and sodium octyl 
sulfate (2.60 mmol, 0.60 g) 
according to the general procedure 
in  92 % yield (1.18 g, 2.30 mmol) 
Molecular formula C24H36N2O8S2 
Molecular weight 512 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.46 (s, 1H), 7.48 (t, J = 1.6 Hz, 1H), 7.44-7.33 
(m, 5H), 7.36 (t, J = 1.6 Hz, 1H), 5.99 (s, 1H), 5.48 (d, J =18 Hz, 1H), 5.33 (d, J = 18 
Hz, 1H), 4.19-4.09 (m, 2H), 3.98 (s, 3H), 1.63 (m, 2H), 1.31-1.19 (m, 12H), 1.22 (t, J 
= 7.0 Hz, 3H), 0.88 (t, J = 7.0 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.02, 165.93, 138.85, 132.50, 129.72, 128.58, 
127.79, 123.62, 123.11, 76.29, 68.24, 62.22, 49.90, 36.67, 31.82, 29.39, 29.32, 29.25, 
25.80, 22.66, 14.13, 13.97 
IR (thin film on salt plate) (cm-1) 2958, 2927, 2857, 1748, 1559, 1539, 1495, 1452, 
1401, 1202, 1176 
MS m/z, 303.1 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
 
 A-131 
R - 3-Methyl-1-(ethylmandelylcarbonylmethyl)imidazolium OctOSO3 (217a) 
N
N
O
O
O
O
OctOSO3-
 
Pale brown solid 
 
The title compound was prepared 
from R - 3-methyl-1-(ethyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213a (2.50 
mmol, 0.95 g) and sodium octyl 
sulfate (2.60 mmol, 0.60 g) 
according to the general procedure 
in  95 % yield (1.22 g, 2.39 mmol) 
Molecular formula C24H36N2O8S2 
Molecular weight 512 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.46 (s, 1H), 7.39 (t, J = 1.6 Hz, 1H), 7.34-7.24 
(m, 5H), 7.28 (t, J = 1.6 Hz, 1H), 5.90 (s, 1H), 5.41 (d, J = 18 Hz, 1H), 5.25 (d, J = 18 
Hz, 1H), 4.13-3.98 (m, 2H), 3.90 (s, 3H), 1.54 (tt, J = 7.2, 7.4 Hz, 2H), 1.21-1.13 (m, 
12H), 1.13 (t, J = 7.4 Hz, 3H), 0.80 (t, J = 7.4 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.03, 165.94, 138.95, 132.48, 129.73, 128.58, 
126.55, 123.60, 123.07, 76.29, 68.08, 62.23, 49.88, 36.65, 31.83, 29.42, 29.33, 29.25, 
25.81, 22.67, 14.14, 13.98 
MP (°C) 40 – 42 
IR (KBr disc) (cm-1) 3160, 3120, 2956, 2927, 2856, 1751, 1565, 1559, 1539, 1495, 
1456, 1403, 1205, 1177 
MS m/z, 303.1 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
[α] 20D  -44.5º (0.8 c, Acetone) 
 
S - 3-Methyl-1-(ethylmandelylcarbonylmethyl)imidazolium OctOSO3 (217b) 
N
N
O
O
O
O
OctOSO3-
 
Pale brown solid 
 
The title compound was prepared 
from S - 3-methyl-1-(ethyl mandelyl 
carbonyl methyl) imidazolium 
bromide 213b (2.60 mmol, 1.00 g) 
and sodium octyl sulfate (2.70 
mmol, 0.63 g) according to the 
general procedure in  91 % yield 
(1.21 g, 2.36 mmol) 
 A-132 
Molecular formula C24H36N2O8S2 
Molecular weight 512 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.40 (s, 1H), 7.35-7.28 (m, 6H), 7.26 (s, 1H), 5.90 
(s, 1H), 5.38 (d, J = 18 Hz, 1H), 5.22 (d, J = 18 Hz, 1H), 4.10-4.02 (m, 2H), 3.90 (s, 
3H), 1.54-1.49 (m, 2H), 1.17-1.12 (m, 15H), 0.80 (t, J = 7.0 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 167.99, 165.90, 139.09, 132.48, 129.72, 128.97, 
127.80, 123.56, 123.03, 76.31, 68.15, 62.21, 49.87, 36.63, 31.82, 29.41, 29.33, 29.25, 
25.81, 22.66, 14.13, 13.97 
MP (°C) 38 – 40 
IR (KBr disc) (cm-1) 3163, 3116, 2956, 2927, 2856, 1748, 1566, 1559, 1494, 1457, 
1399, 1213, 1177 
MS m/z, 303.1 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
[α] 20D  +43.8º (0.7 c, Acetone) 
 
RS - 3-Methyl-1-(butylmandelylcarbonylmethyl)imidazolium OctOSO3 (217f) 
 
N
N
O
O
O
O
OctOSO3-
 
Brown viscous liquid 
 
The title compound was prepared 
from RS - 3-methyl-1-(butyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213f (2.40 
mmol, 1.00 g) and sodium octyl 
sulfate (2.50 mmol, 0.59 g) 
according to the general procedure 
in  99 % yield (1.29 g, 2.38 mmol) 
Molecular formula C26H40N2O8S2 
Molecular weight 540 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.37 (s, 1H), 7.33-7.22 (m, 6H), 7.27 (t, J = 1.6 
Hz, 1H), 5.91 (s, 1H), 5.39 (d, J = 18.2 Hz, 1H), 5.23 (d, J = 18.2 Hz, 1H), 4.06-3.93 
(m, 2H), 3.90 (s, 3H), 1.49-1.40 (m, 4H), 2.00-1.91 (m, 13H), 0.80 (t, J = 5.8 Hz, 2H), 
0.77 (t, J = 6.4 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.10, 165.91, 138.98, 132.53, 129.70, 128.94, 
127.75, 123.56, 123.06, 76.24, 68.17, 65.96, 49.88, 36.64, 31.83, 30.31, 29.40, 29.33, 
29.25, 25.80, 22.67, 18.81, 14.13, 13.54 
 A-133 
IR (thin film on salt plate) (cm-1) 3163, 3117, 2955, 2928, 2860, 1751, 1565, 1559, 
1539, 1495, 1456, 1399, 1210, 1177 
MS m/z, 331.2 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
 
R - 3-Methyl-1-(butylmandelylcarbonylmethyl)imidazolium OctOSO3 (217d) 
 
N
N
O
O
O
O
OctOSO3-
 
Yellow grease 
 
The title compound was prepared 
from R - 3-methyl-1-(butyl  
mandelyl carbonyl methyl) 
imidazolium bromide 213d (2.40 
mmol, 0.99 g) and sodium octyl 
sulfate (2.50 mmol, 0.58 g) 
according to the general procedure 
in  98 % yield (1.26 g, 2.34 mmol) 
Molecular formula C26H40N2O8S2 
Molecular weight 540 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.51 (s, 1H), 7.40 (t, J = 1.7 Hz, 1H), 7.34-7.27 
(m, 5H), 7.30 (t, J = 1.7 Hz, 1H), 5.90 (s, 1H), 5.45 (d, J = 18 Hz, 1H), 5.26 (d, J = 
17.6 Hz, 1H), 4.05-3.92 (m, 2H), 3.91 (s, 3H), 1.47 -1.39 (m, 4H), 1.18-1.06 (m, 
12H), 0.80 (t, J = 5.8 Hz, 3H), 0.77 (t, J = 6.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.11, 165.90, 138.93, 132.52, 128.96, 127.76, 
126.52, 123.61, 123.07, 76.26, 67.96, 65.97, 49.92, 36.68, 31.83, 30.31, 29.45, 29.35, 
29.27, 25.83, 22.68, 18.81, 14.14, 13.56 
MP 32 - 35 
IR (thin film on salt plate) (cm-1) 3158, 3121, 2957, 2937, 2859, 1751, 1565, 1559, 
1539, 1495, 1456, 1259, 1217, 1176 
MS m/z, 331.2 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
[α] 20D  -42.9º (0.5 c, Acetone) 
 
 A-134 
S - 3-Methyl-1-(butylmandelylcarbonylmethyl)imidazolium OctOSO3 (217e) 
 
N
N
O
O
O
O
OctOSO3-
 
Pale brown grease 
 
The title compound was prepared 
from S - 3-methyl-1-(butyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213e (2.40 
mmol, 0.99 g) and sodium octyl 
sulfate (2.50 mmol, 0.59 g) 
according to the general procedure 
in  77 % yield (1.00 g, 1.85 mmol) 
Molecular formula C26H40N2O8S2 
Molecular weight 540 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.40 (s, 1H), 7.34-7.26 (m, 7H), 5.90 (s, 1H), 5.40 
(d, J = 18 Hz, 1H), 5.23 (d, J = 18 Hz, 1H), 4.06-3.94 (m, 2H), 3.90 (s, 3H), 1.49-1.40 
(m, 4H), 1.17-1.04 (m, 12H), 0.78-0.75 (m, 6H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.09, 165.89, 138.99, 132.53, 128.54, 127.75, 
126.50, 123.55, 123.04, 76.26, 68.24, 65.96, 49.89, 36.64, 31.83, 30.31, 29.39, 29.32, 
29.25, 25.80, 22.67, 18.81, 14.13, 13.54 
MP (°C) 30 - 32 
IR (thin film on salt plate) (cm-1) 3160, 3119, 2957, 2928, 2859, 1751, 1565, 1559, 
1539, 1495, 1457, 1260, 1217, 1176 
MS m/z, 331.2 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
[α] 20D  +42.5º (0.6 c, Acetone) 
 
RS - 3-Methyl-1-(pentylmandelylcarbonylmethyl)imidazolium OctOSO3 (217i) 
 
N
N
O
O
O
O
OctOSO3-
 
Brown solid 
 
The title compound was prepared 
from RS - 3-methyl-1-(pentyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213i (2.40 
mmol, 1.01 g) and sodium octyl 
sulfate (2.50 mmol, 0.59 g) 
according to the general procedure 
in  95 % yield (1.27 g, 2.29 mmol) 
Molecular formula C27H42N2O8S2 
 A-135 
Molecular weight 554 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.41 (s, 1H), 7.34-7.22 (m, 6H), 7.26 (t, J = 1.6 
Hz, 1H), 5.91 (s, 1H), 5.41 (d, J = 18 Hz, 1H), 5.23 (d, J = 18 Hz, 1H), 4.04 (t, J = 6.6 
Hz, 2H), 3.91 (s, 3H), 1.52-1.44 (m, 4H), 1.12-1.01 (m, 14H), 0.80 (t, J = 6.8 Hz, 3H), 
0.76 (t, J = 7.0 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.08, 165.86, 139.03, 132.53, 129.71, 128.94, 
127.75, 123.54, 123.00, 76.26, 68.27, 66.21, 49.90, 36.66, 31.83, 29.39, 29.32, 29.25, 
27.99, 27.66, 25.79, 22.67, 22.11, 14.13, 13.89 
MP (°C) 30 – 32 
IR (KBr disc) (cm-1) 3158, 3118, 2957, 2928, 2859, 1751, 1559, 1539, 1495, 1457, 
1404, 11203, 1176 
MS m/z, 345.3 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
 
R - 3-Methyl-1-(pentylmandelylcarbonylmethyl)imidazolium OctOSO3 (217g) 
 
N
N
O
O
O
O
OctOSO3-
 
Brown solid 
 
The title compound was prepared 
from R - 3-methyl-1-(pentyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213g (2.60 
mmol, 1.10 g) and sodium octyl 
sulfate (2.70 mmol, 0.64 g) 
according to the general procedure 
in  99 % yield (1.43 g, 2.58 mmol) 
Molecular formula C27H42N2O8S2 
Molecular weight 554 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.47 (s, 1H), 7.35-7.23 (m, 6H), 7.24 (s, 1H), 5.91 
(s, 1H), 5.42 (d, J =18 Hz, 1H), 5.22 (d, J = 18 Hz, 1H), 4.05 (s, 2H), 3.91 (s, 3H), 
1.52-1.41 (m, 4H), 1.13-1.02 (m, 14H), 0.81 (t, J = 6.8 Hz, 3H), 0.75 (t, J = 7.2 Hz, 
3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.06, 165.81, 139.19, 132.50, 129.72, 128.94, 
127.76, 123.50, 122.94, 76.29, 68.25, 66.21, 49.92, 36.68, 31.83, 29.40, 29.32, 29.25, 
28.00, 27.66, 25.80, 22.67, 22.11, 14.13, 13.89 
MP (°C) 29 – 31 
IR (KBr disc) (cm-1) 3161, 3118, 2954, 2928, 2859, 1751, 1559, 1439, 1456, 1402, 
1375, 1217, 1176 
 A-136 
MS m/z, 345.3 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
[α] 20D  -36.1º (0.7 c, Acetone) 
 
S - 3-Methyl-1-(pentylmandelylcarbonylmethyl)imidazolium OctOSO3 (217h) 
 
N
N
O
O
O
O
OctOSO3-
 
Brown viscous liquid 
 
The title compound was prepared 
from S - 3-methyl-1-(pentyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213h (2.40 
mmol, 1.04 g) and sodium octyl 
sulfate (2.50 mmol, 0.59 g) 
according to the general procedure 
in  99 % yield (1.32 g, 2.38 mmol) 
Molecular formula C27H42N2O8S2 
Molecular weight 554 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.44 (s, 1H), 7.34 (m, 6H), 7.26 (s, 1H), 5.91 (s, 
1H), 5.42 (d, J = 18 Hz, 1H), 5.23 (d, J = 18 Hz, 1H), 4.04 (t, J = 6.6 Hz, 2H), 3.91 (t, 
J = 6.8 Hz, 3H), 1.51-1.43 (m, 4H), 1.17-1.13 (m, 14H), 0.80 (t, J = 6.6 Hz, 3H), 0.75 
(t, J = 7.0 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 168.07, 165.81, 139.04, 135.00, 129.72, 128.95, 
127.76, 123.55, 123.00, 76.29, 68.20, 66.22, 49.95, 36.71, 31.83, 29.40, 29.33, 29.25, 
28.00, 27.66, 25.80, 22.67, 22.11, 14.13, 13.89 
IR (thin film on salt plate) (cm-1) 3166, 3118, 2954, 2928, 2859, 1746, 1566, 1559, 
1496, 1456, 1398, 1364, 1205, 1178 
MS m/z, 345.3 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
[α] 20D  +35.0º (0.7 c, Acetone) 
 
 A-137 
R - 3-Methyl-1-(ethoxyethylmandelylcarbonylmethyl)imidazolium OctOSO3 
(217j) 
 
N
N
O
O
O
O
OctOSO3-
O
 
Brown viscous liquid 
 
The title compound was prepared 
from R - 3-methyl-1-(ethoxy ethyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213j (2.40 
mmol, 1.04 g) and sodium octyl 
sulfate (2.60 mmol, 0.60 g) 
according to the general procedure 
in  82 % yield (1.09 g, 1.96 mmol) 
Molecular formula C26H40N2O1S2 
Molecular weight 556 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.43 (s, 1H), 7.37-7.35 (m, 3H), 7.33-7.26 (m, 
3H), 7.25 (s, 1H), 5.95 (s, 1H), 5.40 (d, J = 18 Hz, 1H), 5.22 (d, J = 18 Hz, 1H), 4.21-
4.17 (m, 2H), 3.91 (s, 3H), 3.49-3.41 (m, 2H), 3.32-3.17 (m, 2H), 1.55-1.51 (m, 2H), 
1.21-1.06 (m, 10H), 1.03 (t, J =  7.0 Hz, 3H), 0.80 (t, J = 6.8 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 167.97, 165.88, 139.11, 132.30, 129.74, 128.93, 
127.84, 123.58, 122.98, 76.21, 68.22, 67.85, 66.56, 65.05, 49.87, 36.65, 31.82, 29.40, 
29.32, 29.25, 25.80, 22.66, 15.04, 14.13 
IR (thin film on salt plate) (cm-1) 3160, 3116, 2953, 2927, 2857, 1749, 1566, 1559, 
1539, 1495, 1457, 1402, 1203, 1177 
MS m/z, 347.2 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
[α] 20D  -35.7º (0.4 c, Acetone) 
 
 A-138 
S - 3-Methyl-1-(ethoxyethylmandelylcarbonylmethyl)imidazolium OctOSO3 
(217k) 
 
N
N
O
O
O
O
OctOSO3-
O
 
Brown viscous liquid 
 
The title compound was prepared 
from S - 3-methyl-1-(ethoxy ethyl 
mandelyl carbonyl methyl) 
imidazolium bromide 213k (2.30 
mmol, 1.00 g) and sodium octyl 
sulfate (2.40 mmol, 0.56 g) 
according to the general procedure 
in  71 % yield (0.92 g, 1.65 mmol) 
Molecular formula C26H40N2O1S2 
Molecular weight 556 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.36 (s, 1H), 7.39-7.20 (m, 7H),  5.95 (s, 1H), 
5.40 (d, J = 18 Hz, 1H), 5.23 (d, J = 18 Hz, 1H), 4.26-4.16 (m, 2H), 3.91 (s, 3H), 
3.59-3.45 (m, 2H), 3.36-3.29 (m, 2H), 1.58-1.51 (m, 2H), 1.08-1.01 (m, 10H), 1.03 (t, 
J = 7.0 Hz, 3H), 0.80 (t, J = 6.8 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 173.68, 167.98, 165.94, 138.94, 132.35, 129.72, 
128.92, 128.55, 128.43, 127.84, 126.58, 123.63, 76.18, 72.82, 68.18, 66.63, 65.23, 
49.85, 36.62, 31.82, 29.32, 25.80, 22.66, 15.04 
IR (thin film on salt plate) (cm-1) 2955, 2927, 2858, 1751, 1559, 1539, 1495, 1452, 
1204, 1171 
MS m/z, 347.2 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
[α] 20D  +36.1º (0.4 c, Acetone) 
 
R - 3-Methyl-1-(methyllactylcarbonylmethyl)imidazolium OctOSO3 (218a) 
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Brown viscous liquid 
The title compound was prepared 
from R - 3-methyl-1-(methyl lactyl 
carbonyl methyl) imidazolium 
bromide 214a (2.50 mmol, 0.77 g) 
and sodium octyl sulfate (2.60 
mmol, 0.60 g) according to the 
general procedure in  94 % yield 
(1.02 g, 2.33 mmol) 
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Molecular formula C18H32N2O8S 
Molecular weight 436 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.28 (s, 1H, H2), 7.53 (t, J = 1.6 Hz, 1H, H4), 
7.51 (t, J = 1.6 Hz, 1H, H3), 5.33 (d, J = 18.0 Hz, 1H, H5), 5.20 (d, J = 18.0 Hz, 1H, 
H5), 5.14 (q, J = 7.2 Hz, 1H, H7), 3.92 (m 5H, H’s 11 and 10), 3.67 (s, 3H, H1), 1.60 
(tt, J = 7.2, 7.1 Hz, 2H, H12), 1.47 (d, J = 7.1 Hz, 3H, H8), 1.27 (m, 10H, H’s 13-17), 
0.81 (t, J = 6.9 Hz, 3H, H18) 
13C NMR (100 MHz, CDCl3) δ ppm 170.32 (COO), 166.02 (COO), 138.48 (NCHN), 
123.87 (NCH2), 123.46 (NCH2), 70.49 (OCH3), 67.72 (CH), 52.59 (OCH2), 49.61 
(NCH2), 36.43 (NCH3), 31.74 (CH2), 29.44 (CH2), 29.28 (CH2), 29.18 (CH2), 25.81 
(CH2), 22.57 (CH2), 16.73 (CCH3), 14.04 (CH3) 
IR (thin film on salt plate) (cm-1) 3160, 3118, 2958, 2927, 2859, 1751, 1567, 1559, 
1539, 1495, 1452, 1376, 1217, 1133 
MS m/z, 227.1 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
[α] 20D  -30.7º (0.4 c, Chloroform) 
 
RS - 3-Methyl-1-(butyllactylcarbonylmethyl)imidazolium OctOSO3 (218g) 
 
N
N
O
O
O
O
OctOSO3-
 
Pale brown grease 
 
The title compound was prepared 
from RS - 3-methyl-1-(butyl lactyl 
carbonyl methyl) imidazolium 
bromide 214g (2.55 mmol, 0.89 g) 
and sodium octyl sulfate (2.65 
mmol, 0.61 g) according to the 
general procedure in  90 % yield 
(1.10 g, 2.30 mmol) 
Molecular formula C21H38N2O8S 
Molecular weight 478 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.37 (s, 1H), 7.43 (t, J = 1.6 Hz, 1H), 7.40 (t, J = 
1.6 Hz, 1H), 5.39 (d, J = 18.0 Hz, 1H), 5.14-5.11 (m, 2H), 4.10-4.07 (m, 2H), 3.95-
3.92 (m 5H), 1.62-1.57 (m, 4H), 1.48 (d, J = 7.0 Hz, 3H), 1.32 (m, 12H), 0.88 (t, J= 
7.4 Hz, 3H), 0.82 (t, J = 7.0 Hz, 3H) 
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13C NMR (100 MHz, CDCl3) δ ppm 169.93, 165.91, 138.83, 123.67, 123.25, 70.66, 
67.90, 65.60, 49.78, 36.58 31.82, 30.44, 29.49, 29.35, 29.25, 25.86, 22.65, 18.97, 
16.81, 14.11, 13.65  
IR (thin film on salt plate) (cm-1) 3160, 3115, 2958, 2928, 2859, 1751, 1581, 1569, 
1559, 1495, 1457, 1377, 1209, 1131 
MS m/z, 269.2 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
 
R - 3-Methyl-1-(ethoxyethyllactylcarbonylmethyl)imidazolium OctOSO3 (218k) 
 
N
N
O
O
O
O
OctOSO3-
O
 
Pale brown grease 
 
The title compound was prepared 
from R - 3-methyl-1-(ethoxy ethyl 
lactyl carbonyl methyl) imidazolium 
bromide 214k (2.00 mmol, 0.73 g) 
and sodium octyl sulfate (2.10 
mmol, 0.49 g) according to the 
general procedure in  90 % yield 
(0.89 g, 1.80 mmol) 
Molecular formula C21H38N2O9S 
Molecular weight 494 g/mol 
1H NMR (400 MHz, CDCl3) δ ppm 9.46 (s, 1H), 7.42 (t, J = 1.6 Hz, 1H), 7.33 (t, J = 
1.6 Hz, 1H), 5.41 (d, J = 17.6 Hz, 1H), 5.15 (m, 2H), 4.27 (m, 2H), 3.96 (m 5H), 3.58 
(t, J = 4.7 Hz, 2H), 3.48 (t, J = 7.0 Hz, 2H), 1.63 (tt, J = 7.4, 7.0 Hz, 2H), 1.51 (d, J = 
7.1 Hz, 3H), 1.23-1.14 (m, 10H), 1.14 (t, J = 7.0 Hz, 3H), 0.82 (t, J = 6.9 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 169.89, 165.90, 138.92, 123.68, 123.12, 70.66, 
68.11, 67.96, 66.61, 64.69, 49.83, 36.64, 31.82, 29.45, 29.34, 29.26, 25.84, 22.66, 
16.76, 15.11, 14.12 
IR (thin film on salt plate) (cm-1) 3161, 3118, 2957, 2927, 2859, 1749, 1568, 1559, 
1539, 1495, 1456, 1377, 1217 
MS m/z, 285.1 [M-OctOSO3-]+; MS: m/z, 209.1 [OctOSO3-] 
[α] 20D  -27.8º (0.5 c, Chloroform)  
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Synthesis of sodium octyl sulphate (196) 
To a stirred solution of 1-octanol 
(50.0 mmol, 6.50 g) in DCM was 
added in one portion chlorosulfonic 
acid (50.1 mmol, 5.89 g). The 
mixture was stirred at RT for 30 
minutes then slowly neutralised with sodium bicarbonate. The DCM was then 
evaporated via rotary evaporation and methanol was added to the residue. The residue 
was filtered thru a short silica plug. The filtrate was evaporated to dryness to give 
sodium octyl sulfate (white powder) in 99 % yield (11.47 g, 49.44 mmol). 
Molecular formula C8H17NaO4S 
Molecular weight 232 g/mol 
1H NMR (400 MHz, D2O) δ ppm 3.99 (t, J = 6.6 Hz, 2H), 1.63-1.59 (m, 2H), 1.31-
1.22 (m, 10H), 0.81-0.80 (m, 3H) 
13C NMR (100 MHz, D2O) δ ppm 69.64, 30.97, 30.13, 28.22, 28.10, 24.73, 21.92, 
13.31 
Chapter 4 experimental 
Trans-stilbene (220) 
Hydrogenation reaction in [NTf2] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by trans-stilbene 
(0.72 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction mixture 
was stirred for 10 minutes or until reaching 80 °C. Hydrogen was then introduced to 
the reaction via a balloon, and the progress of the reaction was monitored by 1H NMR 
at 5, 24 and 48 hour intervals. Upon termination of the reaction, the products were 
extracted using hexane (10 x 3 mL). The mass recovery after extraction from the IL 
was 100 % (0.72 g). Quantitative analysis of the reaction products was carried out by 
measuring the integration ratio of the peaks from the crude NMR spectrum. 1,2-
diphenylethane was obtained in 99 % yield (0.72 g, 3.96 mmol).  
 
Na+
S OO
O
O-
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Recycle procedure 
Following extraction of the products from the IL, the IL (containing the catalyst) was 
dried via rotary evaporation and analysed by 1H NMR. Following confirmation that 
the IL was substrate/product-free and had not degraded, fresh substrate was then 
added to the system and the reactions repeated as described.  
 
Hydrogenation reaction in [OctOSO3] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by trans-stilbene 
(0.72 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction mixture 
was stirred for 10 minutes or until reaching 80 °C. Hydrogen was then introduced to 
the reaction via a balloon, and due to the viscous nature of the octyl sulfate IL, the 
progress of the reaction could not be monitored by 1H NMR. Upon termination of the 
reaction, the product was distilled from the IL using vacuum distillation at 200 °C. It 
was observed that during this intensive heating procedure, that degraded IL was also 
distilled. Column chromatography was performed (80:20, Hexane:DCM) to separate 
the degraded IL from the product. The mass recovery following distillation and 
column chromatography was 43 % (0.31 g). 1,2-diphenylethane was obtained in 42 % 
yield (0.31 g, 1.70 mmol). 
1,2-diphenylethane
 
229 
1H NMR (400 MHz, CDCl3) δ ppm 7.33-7.28 (m, 4H), 7.24-7.20 (m, 6H), 2.95 (s, 
4H) 
13C NMR (100 MHz, CDCl3) δ ppm 141.87, 128.55, 128.44, 126.06, 38.06 
Data consistent with literature1  
Trans-cinnamaldehyde (94) 
Hydrogenation reaction in [NTf2] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by trans-
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cinnamaldehyde (0.53 g, 4.02 mmol) and 3 N2/vacuum cycles were performed. The 
reaction mixture was stirred for 10 minutes or until reaching 55 °C. Hydrogen was 
then introduced to the reaction via a balloon, and the progress of the reaction was 
monitored by 1H NMR at 5, 24 and 48 hour intervals. Upon termination of the 
reaction, the products were extracted using hexane (10 x 3 mL). The mass recovery 
after extraction from the IL was 100 % (0.53 g). Quantitative analysis of the reaction 
products was carried out by measuring the integration ratio of the peaks from the 
crude NMR spectrum (hydrocinnamadehyde:3-phenyl propanol, 1:0.15). These values 
were then verified by purification of the product by column chromatography 
(hexane:ethyl acetate, 70:30) to give hydrocinnamaldehyde in 82 % yield (0.44 g, 
3.28 mmol) and 3-phenyl propanol in 12 % yield (0.065 g, 0.48 mmol). 
 
Hydrogenation reaction in [OctOSO3] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by trans-
cinnamaldehyde (0.53 g, 4.02 mmol) and 3 N2/vacuum cycles were performed. The 
reaction mixture was stirred for 10 minutes or until reaching 80 °C. Hydrogen was 
then introduced to the reaction via a balloon. Upon termination of the reaction, 
vacuum distillation was used to separate the products from the IL and the catalyst. 
The mass recovery after extraction from the IL was 42 % (0.22 g). Quantitative 
analysis of the reaction products was carried out by measuring the integration ratio of 
the peaks from the crude NMR spectrum (trans-
cinnamaldehyde:hydrocinnamadehyde, 1:0.33). These values were then verified by 
purification of the product by column chromatography (hexane:ethyl acetate, 70:30) 
to give back trans-cinnamaldehyde in 32 % yield (0.17 g, 1,29 mmol) and  
hydrocinnamaldehyde in  9 % yield (0.05 g, 0.37 mmol). 
O
hydrocinnamaldehyde
 
95 
1H NMR (400 MHz, CDCl3) δ ppm 9.85 (t, J = 1.4 Hz, 1H), 7.35-7.31 (m, 2H), 7.26-
7.22 (m, 3H), 2.99 (t, J = 7.4 Hz, 2H), 2.83-2.79 (m, 2H) 
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13C NMR (100 MHz, CDCl3) δ ppm 203.49, 141.32, 128.01, 127.99, 127.89, 40.33, 
29.63 
Data consistent with literature2  
HO
3-phenylpropan-1-ol
 
97 
1H NMR (400 MHz, CDCl3) δ ppm 7.23-7.18 (m, 2H), 7.14-7.10 (m, 3H), 3.62 (t, J = 
6.6 Hz, 2H), 2.62 (t, J = 7.4 Hz, 2H), 1.82 (tt, J = 6.6, 7.4 Hz, 2H), 1.55 (br s, 1H) 
13C NMR (100 MHz, CDCl3) δ ppm 141.20, 129.01, 128.93, 126.50, 62.33, 34.30, 
33.67 
Data consistent with literature3  
O
HO
3-phenylpropanoic acid
 
231 
1H NMR (400 MHz, CDCl3) δ ppm 11.00 (br s, 1H), 7.24-7.20 (m, 2H), 7.14-7.12 (, 
3H), 2.90 (t, J = 7.8 Hz, 2H), 2.63 (t, J = 7.8 Hz, 2H) 
13C NMR (100 MHz, CDCl3) δ ppm 178.39, 147.87, 128.58, 128.29, 126.40, 35.50, 
28.23 
Data consistent with literature4  
Trans-cinnamic acid (221) 
Hydrogenation reaction in [NTf2] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by trans-cinnamic 
acid (0.59 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction 
mixture was stirred for 10 minutes or until reaching 55 °C. Hydrogen was then 
introduced to the reaction via a balloon, and the progress of the reaction was 
monitored by 1H NMR at 5, 24 and 48 hour intervals. Upon termination of the 
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reaction, the products were extracted using hexane (10 x 3 mL). The mass recovery 
after extraction from the IL was 98 % (0.58 g). 3-phenylpropanoic acid was obtained 
in 97 % yield (0.58 g, 3.87 mmol). 
 
Hydrogenation in [OctOSO3] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by trans-cinnamic 
acid (0.59 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction 
mixture was stirred for 10 minutes or until reaching 80 °C. Hydrogen was then 
introduced to the reaction via a balloon. Vacuum distillation was attempted to recover 
the product from the IL, however the only material distilled was the starting alcohol to 
synthesise the IL (The IL had degraded at a temperature of 200 °C). The IL/catalyst 
and product were therefore filtered through a short plug of silica to separate the 
product from the mixture. The mass recovery after extraction from the IL was 15 % 
(0.09 g). 3-phenylpropanoic acid was obtained in 15 % yield (0.09 g, 0.60 mmol). 
O
HO
3-phenylpropanoic acid
 
231 
1H NMR (400 MHz, CDCl3) δ ppm 11.00 (br s, 1H), 7.23-7.19 (m, 2H), 7.14-7.11 (m, 
3H), 2.89 (t, J = 7.8 Hz, 2H), 2.69 (t, J = 7.8 Hz, 2H) 
13C NMR (100 MHz, CDCl3) δ ppm 178.97, 140.16, 128.59, 128.29, 126.40, 35.59, 
30.58 
Data consistent with literature5  
Methyl cinnamate (222) 
Hydrogenation reaction in [NTf2] IL  
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by methyl cinnamate 
(0.65 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction mixture 
was stirred for 10 minutes or until reaching 55 °C. Hydrogen was then introduced to 
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the reaction via a balloon, and the progress of the reaction was monitored by 1H NMR 
at 5, 24 and 48 hour intervals. Upon termination of the reaction, the products were 
extracted using hexane (10 x 3 mL). The mass recovery after extraction from the IL 
was 100 % (0.65 g). Methyl 3-phenylpropanoate was obtained in 98 % yield (0.65 g, 
3.96 mmol). 
 
Hydrogenation reaction in [OctOSO3] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by methyl cinnamate 
(0.65 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction mixture 
was stirred for 10 minutes or until reaching 80 °C. Hydrogen was then introduced to 
the reaction via a balloon. Upon termination of the reaction, the products were 
extracted using vacuum distillation (~150 °C). Degraded IL (the starting alcohol) was 
also obtained in the distillate, therefore column chromatography (Hexane:Ethyl 
Acetate, 90:10) was used to separate this impurity from the desired product. The mass 
recovery was 69 % (0.45 g). Methyl 3-phenylpropanoate was obtained in 68 % yield 
(0.45 g, 2.74 mmol). 
O
O
methyl 3-phenylpropanoate
 
232 
1H NMR (400 MHz, CDCl3) δ ppm 7.23-7.19 (m, 2H), 7.14-7.10 (m, 3H), 3.59 (s, 
3H), 2.89 (t, J = 7.9 Hz, 2H), 2.57 (t, J = 7.9 Hz, 2H) 
13C NMR (100 MHz, CDCl3) δ ppm 173.40, 140.52, 128.53, 128.30, 126.29, 51.67, 
37.44, 30.95 
Data consistent with literature6 
Ethyl trans-cinnamate (223) 
Hydrogenation reaction in [NTf2] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by ethyl trans-
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cinnamate (0.70 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction 
mixture was stirred for 10 minutes or until reaching 55 °C. Hydrogen was then 
introduced to the reaction via a balloon, and the progress of the reaction was 
monitored by 1H NMR at 5, 24 and 48 hour intervals. Upon termination of the 
reaction, the products were extracted using hexane (10 x 3 mL). The mass recovery 
after extraction from the IL was 99 % (0.69 g). Ethyl 3-phenylpropanoate was 
obtained in 97 % yield (0.69 g, 3.88 mmol).  
 
Hydrogenation in [OctOSO3] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by ethyl trans-
cinnamate (0.70 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction 
mixture was stirred for 10 minutes or until reaching 80 °C. Hydrogen was then 
introduced to the reaction via a balloon. Upon termination of the reaction, the 
products were extracted using vacuum distillation (~125 °C). Degraded IL (starting 
alcohol) was obtained in the distillate, and therefore column chromatography 
(Hexane:Ethyl Acetate, 20:80) was used to separate it from the product. The mass 
recovery was 76 % (0.53 g). Ethyl 3-phenylpropanoate was obtained in 74% yield 
(0.53 g, 2.98 mmol). 
O
O
ethyl 3-phenylpropanoate
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1H NMR (400 MHz, CDCl3) δ ppm 7.22-7.20 (m, 2H), 7.15-7.12 (m, 3H), 4.09 (q, J = 
7.2 Hz, 2H), 2.90 (t, J = 7.9 Hz, 2H), 2.57 (t, J = 7.9 Hz, 2H), 1.18 (t, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 172.97, 140.34, 128.52, 126.52, 60.46, 38.03, 
36.01, 14.27 
Data consistent with literature7 
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Benzyl cinnamate (224) 
Hydrogenation reaction in [NTf2] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by benzyl cinnamate 
(0.95 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction mixture 
was stirred for 10 minutes or until reaching 55 °C. Hydrogen was then introduced to 
the reaction via a balloon, and the progress of the reaction was monitored by 1H NMR 
at 5, 24 and 48 hour intervals. Upon termination of the reaction, the products were 
extracted using hexane (10 x 3 mL). Column chromatography (Hexane:Ethyl acetate, 
1:4) was used to separate the resulting product, namely cinnamic acid and benzyl 3-
phenylpropanoate. The mass recovery after extraction from the IL was 45 % (0.43 g). 
3-phenylpropanoic acid was obtained in 72 % yield (0.43 g, 2.87 mmol).  
 
Hydrogenation in [OctOSO3] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by benzyl cinnamate 
(0.95 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction mixture 
was stirred for 10 minutes or until reaching 80 °C. Hydrogen was then introduced to 
the reaction via a balloon. Upon termination of the reaction, vacuum distillation was 
attempted as the method for separation of the product from the IL mixture. It was 
however not viable to separate the product from the IL in this way therefore the 
mixture was filtered through a short plug of silica. The mass recovery was 56 % (0.53 
g). Benzyl 3-phenylpropanoate was obtained in 55 % yield (0.53 g, 2.21 mmol). 
O
O
benzyl 3-phenylpropanoate
 
234 
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1H NMR (400 MHz, CDCl3) δ ppm 7.29-7.09 (m, 10H), 5.03 (s, 2H), 2.91 (t, J = 7.8 
Hz, 2H), 2.62 (t, J = 7.8 Hz, 2H) 
13C NMR (100 MHz, CDCl3) δ ppm 172.80, 140.44, 135.94, 128.60, 128.56, 128.46, 
128.36, 128.27, 126.33, 66.34, 35.21, 30.74 
Data consistent with literature8 
Cinnamamide (226) 
Hydrogenation reaction in [NTf2] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by cinnamamide 
(0.59 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction mixture 
was stirred for 10 minutes or until reaching 55 °C. Hydrogen was then introduced to 
the reaction via a balloon, and the progress of the reaction was monitored by 1H NMR 
at 5, 24 and 48 hour intervals. Upon termination of the reaction, the products were 
extracted using hexane (10 x 3 mL). The mass recovery after extraction from the IL 
was 100 % (0.59 g). 3-phenylpropanamide was obtained in 98 % yield (0.59 g, 4.00 
mmol).  
 
Hydrogenation in [OctOSO3] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by cinnamamide 
(0.59 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction mixture 
was stirred for 10 minutes or until reaching 80 °C. Hydrogen was then introduced to 
the reaction via a balloon. Upon termination of the reaction, the products were 
extracted using vacuum distillation (~190 °C). The mass recovery after extraction 
from the IL was 69 % (0.41 g). 3-phenylpropanamide was obtained in 68 % yield 
(0.41 g, 2.75 mmol). 
O
H2N
3-phenylpropanamide
 
237 
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1H NMR (400 MHz, CDCl3) δ ppm 7.25-7.21 (m, 2H), 7.15-7.12 (m, 3H), 5.52 (br s, 
1H), 5.34 (br s, 1H), 2.92 (t, J = 7.7 Hz, 2H), 2.48 (t, J = 7.7 Hz, 2H) 
13C NMR (100 MHz, CDCl3) δ ppm 174.60, 140.64, 128.60, 128.34, 126.35, 37.54, 
31.39 
Data consistent with literature6 
Cinnamamonitrile (225) 
Hydrogenation reaction in [NTf2] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by cinnamonitrile 
(0.52 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction mixture 
was stirred for 10 minutes or until reaching 55 °C. Hydrogen was then introduced to 
the reaction via a balloon, and the progress of the reaction was monitored by 1H NMR 
at 5, 24 and 48 hour intervals. Upon termination of the reaction, the products were 
extracted using hexane (10 x 3 mL). The mass recovery after extraction from the IL 
was 100 % (0.52 g). 3-phenylpropanenitrile was obtained in 100 % yield (0.52 g, 4.00 
mmol).  
 
Hydrogenation in [OctOSO3] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by cinnamonitrile 
(0.52 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction mixture 
was stirred for 10 minutes or until reaching 80 °C. Hydrogen was then introduced to 
the reaction via a balloon. Upon termination of the reaction, the products were 
extracted using vacuum distillation. The mass recovery after extraction from the IL 
was 35 % (0.18 g). 3-phenylpropanenitrile was obtained in 35 % yield (0.18 g, 1.37 
mmol). 
N
3-phenylpropanenitrile
 
238 
1H NMR (400 MHz, CDCl3) δ ppm 7.40-7.26 (m, 5H), 2.99 (t, J = 7.5 Hz, 2H), 2.65 
(t, J = 7.5 Hz, 2H) 
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13C NMR (100 MHz, CDCl3) δ ppm 138.11, 128.72, 128.47, 127.48, 119.24, 30.99, 
19.38 
Data consistent with literature6 
Allyl cinnamate (227) 
Hydrogenation reaction in [NTf2] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by allyl cinnamate 
(0.75 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction mixture 
was stirred for 10 minutes or until reaching 55 °C. Hydrogen was then introduced to 
the reaction via a balloon, and the progress of the reaction was monitored by 1H NMR 
at 5, 24 and 48 hour intervals. Upon termination of the reaction, the products were 
extracted using hexane (10 x 3 mL). The mass recovery after extraction from the IL 
was 100 % (0.75 g). The products were identified quantitatively by examination of the 
1H NMR spectrum (propyl cinnamate:propyl 3-phenylpropanoate, 1:0.19). The mass 
recovery after extraction from the IL was 100 % (0.75 g). Column chromatography 
was used for the purification of the obtained products (10:90, Hexane:DCM). Propyl 
cinnamate was obtained in 80 % yield (0.61 g, 3.20 mmol) and propyl 3-
phenylpropanoate was obtained in 12 % yield (0.09 g, 0.47 mmol).  
 
Hydrogenation in [OctOSO3] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by allyl cinnamate 
(0.75 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction mixture 
was stirred for 10 minutes or until reaching 80 °C. Hydrogen was then introduced to 
the reaction via a balloon. Upon termination of the reaction, the products were 
extracted using vacuum distillation (~ 180 °C). The mass recovery after extraction 
from the IL was 67 % (0.50 g). Propyl 3-phenylpropanoate was obtained in 65 % 
yield (0.50 g, 2.60 mmol). 
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O
O
propyl cinnamate
 
236 
1H NMR (400 MHz, CDCl3) δ ppm 7.74 (d, J = 16 Hz, 1H), 7.56-7.54 (m, 2H), 7.42-
7.38 (m, 3H), 6.50 (d, J = 16 Hz, 1H), 4.21 (t, J = 6.7 Hz, 2H), 1.79 (tq, J = 6.7, 7.8 
Hz, 2H), 1.04 (t, J = 7.8 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 166.25, 143.20, 131.70, 129.29, 129.26, 129.00, 
118.03, 61.52, 22.83, 17.01 
Data consistent with literature9 
O
O
propyl 3-phenylpropanoate
 
235 
1H NMR (400 MHz, CDCl3) δ ppm 7.34-7.30 (m, 2H), 7.25-7.22 (m, 3H), 4.09 (t, J = 
7.0 Hz, 2H), 3.02 (t, J = 7.8 Hz, 2H), 2.69 (t, J = 7.8 Hz, 2H), 1.71 (tq, J = 7.0, 7.3 
Hz, 2H), 0.97 (t, J = 7.3 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 173.06, 140.60, 128.50, 128.32, 126.25, 66.29, 
37.43, 31.03, 21.98, 10.40 
Data consistent with literature10 
Vinyl cinnamate (228) 
Hydrogenation reaction in [NTf2] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by vinyl cinnamate 
(0.70 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction mixture 
was stirred for 10 minutes or until reaching 55 °C. Hydrogen was then introduced to 
the reaction via a balloon, and the progress of the reaction was monitored by 1H NMR 
at 5, 24 and 48 hour intervals. Upon termination of the reaction, the products were 
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extracted using hexane (10 x 3 mL). The mass recovery after extraction from the IL 
was 100 % (0.70 g) Ethyl 3-phenylpropanoate was obtained in 99 % yield (0.70 g, 
3.93 mmol).  
 
Hydrogenation in [OctOSO3] IL 
10 % Pd/C (5.0 mg, 0.12 mol %) was weighed into a dry 2-neck round bottom flask. 
The pre-dried IL (2.0 mL) was then added to the flask, followed by vinyl cinnamate 
(0.70 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction mixture 
was stirred for 10 minutes or until reaching 80 °C. Hydrogen was then introduced to 
the reaction via a balloon. Upon termination of the reaction, the products were 
extracted using vacuum distillation. The mass recovery after extraction from the IL 
was 67 % (0.47 g). Ethyl 3-phenylpropanoate was obtained in 66 % yield (0.47 g, 
2.64 mmol). 
O
O
ethyl cinnamate
 
223 
1H NMR (400 MHz, CDCl3) δ ppm 7.73 (d, J = 16 Hz, 1H), 7.55-7.52 (m, 2H), 7.42-
7.38 (m, 3H), 6.48 (d, J = 16 Hz, 1H), 4.31 (q, J = 7.1 Hz, 2H), 1.38 (t, J = 7.1 Hz, 
3H) 
13C NMR (100 MHz, CDCl3) δ ppm 166.99, 144.93, 134.74, 130.55, 128.58, 128.06, 
118.64, 60.50, 14.53 
Data consistent with literature9 
O
O
ethyl 3-phenylpropanoate
 
233 
1H NMR (400 MHz, CDCl3) δ ppm 7.34-7.30 (m, 2H), 7.25-7.23 (m, 3H), 4.19 (q, J = 
7.2 Hz, 2H), 3.01 (t, J = 7.8 Hz, 2H), 2.67 (t, J = 7.8 Hz, 2H), 1.29 (t, J = 7.2 Hz, 3H) 
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13C NMR (100 MHz, CDCl3) δ ppm 172.92, 140.62, 128.51, 128.34, 126.26, 60.43, 
35.98, 31.01, 14.24 
Data consistent with literature7 
Experimental Chapter 5 
Dimethyl itaconate (144) 
Hydrogenation reaction in [NTf2] IL 
The catalyst [(10 % Pd/C, 5.0 mg, 0.12 mol %), (Tris(triphenylphosphine)rhodium(I) 
chloride, 0.05 g, 1.35 mol %) (bis(norbornadiene)rhodium(I) BF4, Taniaphos, 0.003 
mmol, 0.75 mol %) ] was weighed into a dry 2-neck round bottom flask. The pre-
dried IL (2.0 mL) was then added to the flask, followed by dimethyl itaconate (0.63 g, 
4.00 mmol) and 3 N2/vacuum cycles were performed. The reaction mixture was 
stirred for 10 minutes or until reaching 55 °C. Hydrogen was then introduced to the 
reaction via a balloon, and the progress of the reaction was monitored by 1H NMR. 
Upon termination of the reaction, the products were extracted using hexane (10 x 3 
mL). The mass recovery after extraction from the IL was 100 % (0.63 g). Dimethyl 2-
methylsuccinate was obtained in 98 % yield (0.63 g, 3.94 mmol). 
 
Recycle procedure 
Following extraction of the products from the IL, the IL (containing the catalyst) was 
dried via rotary evaporation and analysed by 1H NMR. Following confirmation that 
the IL was substrate/product-free and had not degraded, fresh substrate was then 
added to the system and the reactions repeated as described.  
O
O
O
O
dimethyl 2-methylsuccinate
 
157 
1H NMR (400 MHz, CDCl3) δ ppm 3.63 (s, 3H), 3.61 (s, 3H), 2.88-2.83 (m, 1H), 2.70 
(dd, J = 8.2, 8.2 Hz, 1H), 2.37 (dd, J = 6.0, 6.0 Hz, 1H), 1.16 (d, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 175.98, 172.27, 51.89, 51.68, 37.15, 35.64, 16.96 
Data consistent with literature11  
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Tiglic acid (239) 
Hydrogenation reaction in [NTf2] IL 
The catalyst [(10 % Pd/C, 5.0 mg, 0.12 mol %), (Tris(triphenylphosphine)rhodium(I) 
chloride, 0.05 g, 1.35 mol %), (PtO2, 5.0 mg, 0.55 mol %)] was weighed into a dry 2-
neck round bottom flask. The pre-dried IL (2.0 mL) was then added to the flask, 
followed by tiglic acid (0.40 g, 4.00 mmol) and 3 N2/vacuum cycles were performed. 
The reaction mixture was stirred for 10 minutes or until reaching 55 °C. Hydrogen 
was then introduced to the reaction via a balloon, and the progress of the reaction was 
monitored by 1H NMR. Upon termination of the reaction, the products were extracted 
using hexane (10 x 3 mL). The mass recovery after extraction from the IL was 100 % 
(0.40 g). 2-Methylbutanoic acid was obtained in 98 % yield (0.40 g, 3.92 mmol). 
O
OH
2-methylbutanoic acid
 
244 
1H NMR (400 MHz, CDCl3) δ ppm 11.58 (br s, 1H), 2.35 (q, J = 7.2 Hz, 1H), 1.68-
1.61 (m, 1H), 1.46-1.40 (m, 1H), 1.11 (d, J = 7.2 Hz, 3H), 0.89 (t, J = 7.4 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 183.71, 40.74, 26.51, 16.32, 11.51 
Data consistent with literature12 
 
Formation of methyl 2-methylbutanoate 
O
OMe
methyl 2-methylbutanoate
 
247 
To a stirred solution of methanol (1 mL) and toluene (2 mL) was added TMS 
diazomethane in diethylether (0.98 mL, 1.96 mmol). The mixture was allowed to stir 
for 1 hour, after which 2-methylbutanoic acid (0.199 g, 1.96 mmol) in methanol (1 
mL) was added. Upon complete dissipation of the yellow colour, the mixture was 
washed with 10 % acetic acid (2 x 3 mL) and extracted with diethyl ether (2 x 3 mL). 
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The extract was then washed with sodium bicarbonate (2 x 3 mL) and dried on the 
high vacuum to give a pale yellow oil at RT in 82 % yield (0.190 g, 1.64 mmol). 
1H NMR (400 MHz, CDCl3) δ ppm 3.60 (s, 3H), 2.33 (q, J = 7.2 Hz, 1H), 1.66-1.59 
(m, 1H), 1.45-1.40 (m, 1H), 1.09 (d, J = 7.2 Hz, 3H), 0.90 (t, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 180.22, 51.34, 38.78, 24.22, 15.98, 11.01 
Data consistent with literature13 
α-Methyl-trans-cinnamaldehyde (240) 
Hydrogenation reaction in [NTf2] IL 
The catalyst [(10 % Pd/C, 5.0 mg, 0.12 mol %), (Tris(triphenylphosphine)rhodium(I) 
chloride, 0.05 g, 1.35 mol %), (PtO2, 5.0 mg, 0.55 mol %)] was weighed into a dry 2-
neck round bottom flask. The pre-dried IL (2.0 mL) was then added to the flask, 
followed by α-methyl-trans-cinnamaldehyde (0.58 g, 4.00 mmol) and 3 N2/vacuum 
cycles were performed. The reaction mixture was stirred for 10 minutes or until 
reaching 55 °C. Hydrogen was then introduced to the reaction via a balloon, and the 
progress of the reaction was monitored by 1H NMR. Upon termination of the reaction, 
the products were extracted using hexane (10 x 3 mL). The mass recovery after 
extraction from the IL was 98 % (0.57 g). Quantitative analysis of the reaction 
products was carried out by measuring the integration ratio of the peaks from the 
crude 1H NMR spectrum (α-methyl-trans-cinnamaldehyde: 2-methyl-3-
phenylpropanal: 2-methyl-3-phenylpropan-1-ol, 1:0.85:0.42). These values were then 
verified by purification of the product by column chromatography (DCM:hexane, 
50:50) to give α-methyl-trans-cinnamaldehyde in 44 % yield (0.25 g, 1.71 mmol), 2-
methyl-3-phenylpropanal in 35 % yield (0.20 g, 1.35 mmol) and 2-methyl-3-
phenylpropan-1-ol in 18 % yield (0.10 g, 6.67 mmol). 
O
2-methyl-3-phenylpropanal
 
245 
1H NMR (400 MHz, CDCl3) δ ppm 9.75 (d, J = 1.6 Hz, 1H), 7.35-7.20 (m, 5H), 3.15 
(dd, J = 5.6, 5.6 Hz, 1H), 2.73-2.61 (m, 2H), 1.13 (d, J = 6.8 Hz, 3H) 
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13C NMR (100 MHz, CDCl3) δ ppm 182.39, 139.03, 128.84, 128.45, 126.45, 41.24, 
39.30, 16.51 
Data consistent with literature14 
 
HO
2-methyl-3-phenylpropan-1-ol
 
246 
1H NMR (400 MHz, CDCl3) δ ppm 7.26-7.18 (m, 2H), 7.14-7.09 (m, 3H), 3.48-3.37 
(m, 2H), 2.71 (dd, J = 6.4, 6.4 Hz, 1H), 2.38 (dd, J = 8.0, 8.0 Hz, 1H), 1.90-1.83 (m, 
1H), 1.46 (br s, 1H), 0.85 (d, J = 6.8 Hz, 3H) 
13C NMR (100 MHz, CDCl3) δ ppm 141.21, 128.24, 128.03, 126.86, 68.25, 40.00, 
38.29, 16.78 
Data consistent with literature14 
 
Note: A discussion of enantiomeric excess determination is given in section 5.5. 
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X-Ray Crystallographic Data 
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186a 
 
Crystal data and structure refinement for 186a 
 
Identification code  186a 
Empirical formula  C14 H25 N2 O4 Br 
Molecular formula [C14 H25 N2 O4]+[Br]– 
Formula weight  365.27 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c (#14) 
Unit cell dimensions a = 10.584(2) Å  α = 90°. 
 b = 11.258(2) Å  β = 90.776(4)°. 
 c = 28.849(6) Å  γ = 90°. 
Volume 3437.2(12) Å3 
Z 8 
Density (calculated) 1.412 Mg/m3 
Absorption coefficient 2.408 mm–1 
F(000) 1520 
Crystal size 1.00 x 0.60 x 0.20 mm3 
Theta range for data collection 1.92 to 23.00°. 
Index ranges –11<=h<=11, –12<=k<=12, –31<=l<=31 
Reflections collected 21607 
Independent reflections 4766 [R(int) = 0.0493] 
Completeness to theta = 23.00° 99.8 %  
Absorption correction None 
Max. and min. transmission 0.6445 and 0.4335 
Refinement method Full–matrix least–squares on F2 
Data / restraints / parameters 4766 / 86 / 383 
Goodness–of–fit on F2 1.132 
Final R indices [I>2sigma(I)] R1 = 0.0670, wR2 = 0.1597 
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R indices (all data) R1 = 0.0791, wR2 = 0.1647 
Largest diff. peak and hole 1.489 and –2.352 e.Å–3 
 
Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 
103) for 186a. U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
 
Atom x y z U(eq) 
   
Br(1) 2387(1) 7881(1) 1735(1) 18(1) 
Br(2) 7365(1) 3662(1) 6733(1) 18(1) 
C(1) –1605(7) 586(8) 6479(3) 25(2) 
N(1) –680(5) 473(5) 6859(2) 15(1) 
C(2) –611(6) 1141(7) 7236(3) 14(2) 
N(2) 315(5) 705(6) 7512(2) 16(1) 
C(3) 231(7) –408(7) 6890(3) 17(2) 
C(4) 843(7) –263(7) 7297(3) 18(2) 
C(5) 748(7) 1232(7) 7946(3) 17(2) 
C(6) 2105(7) 1672(7) 7909(3) 17(2) 
O(1) 2737(5) 1587(5) 7570(2) 20(1) 
O(2) 2478(4) 2106(4) 8317(2) 16(1) 
C(7) 3808(7) 2450(8) 8342(3) 24(2) 
C(8) 4172(7) 2661(7) 8836(3) 24(2) 
O(3) 3746(5) 3790(5) 8979(2) 21(1) 
C(9) 3973(8) 3994(7) 9455(3) 25(2) 
C(10) 3656(8) 5264(8) 9571(3) 28(2) 
O(4) 4629(5) 6029(5) 9414(2) 26(1) 
C(11) 4290(8) 7256(8) 9447(3) 28(2) 
C(12) 5440(8) 8017(8) 9367(3) 27(2) 
C(13) 5125(8) 9337(8) 9369(3) 30(2) 
C(14) 6308(8) 10109(8) 9351(3) 33(2) 
C(15) 6565(7) –158(7) 3556(3) 18(2) 
N(3) 5688(5) –310(5) 3165(2) 15(1) 
 C-4 
C(16) 5609(6) 349(7) 2789(3) 15(2) 
N(4) 4712(5) –85(5) 2506(2) 14(1) 
C(17) 4829(6) –1231(7) 3122(3) 18(2) 
C(18) 4226(7) –1087(7) 2715(3) 18(2) 
C(19) 4265(7) 416(7) 2074(3) 17(2) 
C(20) 2919(6) 882(6) 2123(3) 13(2) 
O(5) 2317(4) 811(4) 2474(2) 17(1) 
O(6) 2524(4) 1357(5) 1724(2) 19(1) 
C(21) 1196(7) 1694(7) 1715(3) 20(2) 
C(22) 766(7) 1878(7) 1227(3) 21(2) 
O(7) 1214(5) 2996(5) 1067(2) 20(1) 
C(23) 878(7) 3212(7) 597(3) 22(2) 
C(24) 1264(7) 4424(7) 458(3) 23(2) 
O(8) 437(5) 5274(5) 662(2) 26(1) 
C(25) 797(7) 6470(7) 570(3) 24(2) 
C(26) –274(8) 7295(7) 683(3) 26(2) 
C(27) 18(9) 8587(8) 572(3) 34(2) 
C(28) –1134(9) 9399(8) 610(3) 39(2) 
 C-5 
 191a 
 
Crystal data and structure refinement for 191a 
 
Identification code  191a 
Empirical formula  C12 H21 N2 O4 Br 
Molecular formula [C12 H21 N2 O4]+[Br]–  
Formula weight  337.22 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c (#14) 
Unit cell dimensions a = 8.1391(8) Å  α = 90°. 
 b = 26.986(3) Å  β = 114.683(2)°. 
 c = 7.5735(7) Å  γ = 90°. 
Volume 1511.4(3) Å3 
Z 4 
Density (calculated) 1.482 Mg/m3 
Absorption coefficient 2.731 mm–1 
F(000) 696 
Crystal size 0.50 x 0.40 x 0.30 mm3 
Theta range for data 
collection 
2.75 to 27.00°. 
Index ranges –10<=h<=10, –34<=k<=34, –9<=l<=9 
Reflections collected 14017 
Independent reflections 3306 [R(int) = 0.0269] 
Completeness to theta = 
27.00° 
99.9 %  
Absorption correction Semi–empirical from equivalents 
Max. and min. transmission 0.4946 and 0.3733 
Refinement method Full–matrix least–squares on F2 
 C-6 
Data / restraints / parameters 3306 / 0 / 256 
Goodness–of–fit on F2 1.045 
Final R indices [I>2sigma(I)] R1 = 0.0244, wR2 = 0.0593 
R indices (all data) R1 = 0.0290, wR2 = 0.0614 
Largest diff. peak and hole 0.439 and –0.223 e.Å–3 
 
Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 
103) for 191a.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
 
Atom x y z U(eq) 
 
Br 2705(1) 632(1) 3773(1) 17(1) 
C(1) 8535(3) 5129(1) 6566(3) 23(1) 
N(1) 7223(2) 4723(1) 5798(2) 17(1) 
C(2) 6827(2) 4395(1) 6879(3) 16(1) 
C(3) 7643(3) 4375(1) 9022(3) 23(1) 
N(2) 5558(2) 4092(1) 5645(2) 14(1) 
C(4) 5181(2) 4230(1) 3760(3) 17(1) 
C(5) 6215(2) 4624(1) 3856(3) 19(1) 
C(6) 4701(2) 3676(1) 6149(3) 16(1) 
C(7) 5785(2) 3208(1) 6432(2) 14(1) 
O(1) 7248(2) 3176(1) 6418(2) 22(1) 
O(2) 4841(2) 2830(1) 6675(2) 19(1) 
C(8) 5533(2) 2333(1) 6684(3) 19(1) 
C(9) 3952(3) 2006(1) 5598(3) 20(1) 
O(3) 2887(2) 1963(1) 6680(2) 20(1) 
C(10) 1096(2) 1806(1) 5486(3) 20(1) 
C(11) 2(3) 1814(1) 6663(3) 20(1) 
O(4) 561(2) 1425(1) 8038(2) 22(1) 
C(12) –364(3) 1444(1) 9272(4) 32(1) 
 C-7 
 213m 
 
Crystal data and structure refinement for 213m. 
 
Identification code  213m 
Empirical formula  C15 H18.64 N2 O4.82 Br 
Molecular formula [C15 H17 N2 O4]+[Br]– x 0.82 (H2 O) 
Formula weight  386.73 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P1 (#1) 
Unit cell dimensions a = 8.9583(10) Å α = 76.132(2)°. 
 b = 9.7659(11) Å β = 71.333(2)°. 
 c = 11.1941(12) Å γ = 63.809(2)°. 
Volume 826.95(16) Å3 
Z 2 
Density (calculated) 1.553 Mg/m3 
Absorption coefficient 2.512 mm–1 
F(000) 395 
Crystal size 0.60 x 0.50 x 0.10 mm3 
Theta range for data 
collection 
1.93 to 28.30°. 
Index ranges –11<=h<=11, –12<=k<=13, –14<=l<=14 
Reflections collected 16930 
Independent reflections 8130 [R(int) = 0.0223] 
Completeness to theta = 
28.30° 
99.7 %  
Absorption correction Semi–empirical from equivalents 
Max. and min. transmission 0.7873 and 0.4272 
Refinement method Full–matrix least–squares on F2 
 C-8 
Data / restraints / parameters 8130 / 7 / 432 a) 
Goodness–of–fit on F2 1.038 
Final R indices [I>2sigma(I)] R1 = 0.0394, wR2 = 0.0956 
R indices (all data) R1 = 0.0421, wR2 = 0.0972 
Absolute structure parameter 0.010(6) 
Largest diff. peak and hole 1.430 and –0.835 e.Å–3 
a)
 The O–H bond lengths were restrained to be 0.84 Å DFIX.  
 
Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 
103) for 213m.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
 
Atom x y z U(eq) 
  
C(1) 5458(4) 9054(4) 4686(3) 24(1) 
N(1) 3854(3) 9022(3) 5563(2) 16(1) 
C(2) 3165(4) 9541(4) 6692(3) 18(1) 
N(2) 1703(3) 9339(3) 7205(2) 16(1) 
C(3) 2814(4) 8454(4) 5347(3) 23(1) 
C(4) 1470(4) 8646(4) 6379(3) 20(1) 
C(5) 574(4) 9757(3) 8443(3) 18(1) 
C(6) 904(4) 8349(3) 9424(3) 16(1) 
O(1) 1817(3) 7073(3) 9183(2) 21(1) 
O(2) –7(3) 8777(2) 10571(2) 19(1) 
C(7) 294(4) 7569(3) 11604(3) 20(1) 
C(8) 314(4) 8208(4) 12702(3) 23(1) 
O(3) 1317(4) 7520(3) 13348(3) 35(1) 
O(4) –941(3) 9588(3) 12876(2) 24(1) 
C(9) –1038(5) 10281(4) 13927(3) 30(1) 
C(10) –1062(4) 6902(3) 12007(3) 18(1) 
C(11) –2632(4) 7700(4) 11699(3) 20(1) 
C(12) –3858(5) 7060(4) 12134(3) 26(1) 
 C-9 
C(13) –3507(6) 5657(5) 12874(3) 33(1) 
C(14) –1954(6) 4862(4) 13172(4) 35(1) 
C(15) –703(5) 5469(4) 12728(3) 29(1) 
C(16) –4984(6) 4861(5) 10173(4) 29(1) 
N(3) –3178(3) 4142(3) 10225(2) 20(1) 
C(17) –2082(4) 4820(3) 9784(3) 20(1) 
N(4) –601(3) 3845(3) 10053(2) 19(1) 
C(18) –2370(4) 2688(4) 10796(3) 22(1) 
C(19) –758(4) 2507(3) 10694(3) 23(1) 
C(20) 960(4) 4122(4) 9683(3) 23(1) 
C(21) 2180(4) 3323(3) 8532(3) 17(1) 
O(5) 1986(3) 2471(3) 8047(2) 21(1) 
O(6) 3528(3) 3713(3) 8147(2) 20(1) 
C(22) 4748(4) 3084(3) 7007(3) 17(1) 
C(23) 3825(4) 3744(3) 5938(3) 16(1) 
O(7) 2618(3) 4932(3) 5905(2) 24(1) 
O(8) 4594(3) 2809(3) 5028(2) 24(1) 
C(24) 3762(5) 3281(5) 3980(3) 33(1) 
C(25) 6204(4) 3584(3) 6738(3) 17(1) 
C(26) 5878(4) 5085(4) 6842(3) 21(1) 
C(27) 7226(5) 5525(4) 6594(3) 26(1) 
C(28) 8908(5) 4483(4) 6223(4) 29(1) 
C(29) 9233(4) 2984(4) 6100(4) 28(1) 
C(30) 7885(4) 2527(4) 6369(3) 22(1) 
Br(1) 7108(1) 8734(1) 7862(1) 24(1) 
Br(2) 2904(1) 1278(1) 2123(1) 41(1) 
O(9) 3373(4) 9050(4) –4(3) 37(1) 
O(10) a) 6069(6) 1288(5) 9722(4) 31(1) 
a)
 s.o.f. = 0.637(9) (s.o.f.: site occupation factor)  
 C-10 
 213n 
 
Crystal data and structure refinement for 213n. 
 
Identification code  213n 
Empirical formula  C15 H18.68 N2 O4.84 Br 
Molecular formula [C15 H17 N2 O4]+[Br]– x 0.84 (H2 O) 
Formula weight  386.73 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P1 (#1) 
Unit cell dimensions a = 8.9698(4) Å  α = 76.203(1)°. 
 b = 9.7824(5) Å  β = 71.446(1)°. 
 c = 11.1834(5) Å             γ = 63.689(1)°. 
Volume 828.42(7) Å3 
Z 2 
Density (calculated) 1.550 Mg/m3 
Absorption coefficient 2.507 mm–1 
F(000) 395 
Crystal size 0.70 x 0.50 x 0.40 mm3 
Theta range for data 
collection 
1.93 to 31.65°. 
Index ranges –12<=h<=13, –14<=k<=13, –16<=l<=16 
Reflections collected 19676 
Independent reflections 10094 [R(int) = 0.0143] 
Completeness to theta = 
30.00° 
99.8 %  
Absorption correction Semi–empirical from equivalents 
Max. and min. transmission 0.4337 and 0.2612 
Refinement method Full–matrix least–squares on F2 
 C-11 
Data / restraints / parameters 10094 / 7 / 432 a) 
Goodness–of–fit on F2 1.062 
Final R indices [I>2sigma(I)] R1 = 0.0358, wR2 = 0.0884 
R indices (all data) R1 = 0.0384, wR2 = 0.0897 
Absolute structure parameter 0.002(4) 
Largest diff. peak and hole 1.829 and –1.250 e.Å–3 
a)
 The O–H bond lengths were restrained to be 0.84 Å DFIX.  
 
Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 
103) for 213n.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
 
Atom x y z U(eq) 
  
C(1) 4549(3) 933(3) 5305(2) 22(1) 
N(1) 6154(2) 967(2) 4431(2) 15(1) 
C(2) 6836(3) 455(2) 3297(2) 14(1) 
N(2) 8305(2) 654(2) 2791(2) 15(1) 
C(3) 7196(3) 1530(3) 4654(2) 20(1) 
C(4) 8536(3) 1346(3) 3619(2) 19(1) 
C(5) 9428(3) 239(2) 1549(2) 15(1) 
C(6) 9098(3) 1640(2) 579(2) 14(1) 
O(1) 8193(2) 2922(2) 813(2) 19(1) 
O(2) 10010(2) 1212(2) –580(2) 17(1) 
C(7) 9698(3) 2430(2) –1611(2) 16(1) 
C(8) 9689(3) 1769(3) –2708(2) 19(1) 
O(3) 8671(3) 2461(2) –3349(2) 31(1) 
O(4) 10958(2) 393(2) –2885(2) 21(1) 
C(9) 11056(4) –295(3) –3937(2) 26(1) 
C(10) 11046(3) 3093(2) –2008(2) 16(1) 
C(11) 12623(3) 2300(3) –1716(2) 18(1) 
C(12) 13842(3) 2937(3) –2147(2) 23(1) 
 C-12 
C(13) 13481(4) 4353(3) –2878(2) 29(1) 
C(14) 11917(4) 5145(3) –3165(3) 31(1) 
C(15) 10677(4) 4529(3) –2729(2) 25(1) 
C(16) 14979(4) 5154(4) –174(3) 27(1) 
N(3) 13184(3) 5857(2) –235(2) 18(1) 
C(17) 12091(3) 5177(3) 208(2) 18(1) 
N(4) 10609(2) 6143(2) –60(2) 17(1) 
C(18) 12362(3) 7311(3) –802(2) 20(1) 
C(19) 10747(3) 7491(3) –698(2) 21(1) 
C(20) 9049(3) 5864(3) 314(2) 21(1) 
C(21) 7830(3) 6670(2) 1459(2) 16(1) 
O(5) 8023(2) 7527(2) 1946(2) 20(1) 
O(6) 6489(2) 6276(2) 1846(2) 18(1) 
C(22) 5271(3) 6902(2) 2989(2) 14(1) 
C(23) 6195(3) 6242(3) 4058(2) 15(1) 
O(7) 7421(2) 5051(2) 4081(2) 22(1) 
O(8) 5427(2) 7173(2) 4969(2) 21(1) 
C(24) 6241(4) 6699(4) 6022(2) 27(1) 
C(25) 3820(3) 6403(2) 3256(2) 14(1) 
C(26) 4151(3) 4902(3) 3151(2) 19(1) 
C(27) 2797(3) 4462(3) 3393(2) 23(1) 
C(28) 1118(3) 5502(3) 3760(3) 26(1) 
C(29) 795(3) 6997(3) 3879(3) 26(1) 
C(30) 2135(3) 7459(3) 3616(2) 18(1) 
Br(1) 2886(1) 1261(1) 2141(1) 22(1) 
Br(2) 7103(1) 8737(1) 7875(1) 38(1) 
O(9) 6609(3) 972(3) 10006(2) 33(1) 
O(10) a) 3947(4) 8705(3) 267(3) 30(1) 
  
a)
 s.o.f. = 0.682(7) (s.o.f.: site occupation factor) 
 
 
